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The COVID-19 outbreak marked the beginning of an uncertain economic period, which 
impacted all share prices drastically. This uncertainty was reflected not only in stock markets 
but also in the reactions of governments. As little was known about the virus, government 
strategies on how to handle the new situation differed across countries. This paper investigates 
whether the different government actions taken can explain the different share price 
developments across industries and sectors in eight European countries during the COVID-19 
pandemic. It contributes to the existing literature by using company-level data over a time 
period that includes both the first and second waves of COVID-19 infections in Europe. While 
companies in the Consumer Goods and Consumer Services industries recovered more slowly, 
companies in the Health Care and Technology industries recovered faster from the initial stock 
market shock in February and March 2020. As different industries were impacted in different 
ways, we ran both country and industry panel regressions to capture the effect of government 
actions both across industries within a country, and within an industry across countries. 
Overall, we observe a negative effect of increasing COVID-19 infections on share prices 
across countries and industries. While more restrictive measures affect share prices negatively 
in several countries and industries, economic support shows a positive effect in only a few 
countries and industries. Although government actions seem to play a small role in share price 
developments in the short- to medium-term, the magnitude of actions may have a lasting 
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1. Introduction  
Looking back at 2020, it is difficult to associate the year with anything other than the COVID-
19 pandemic. Spreading from the Hubei region in China from the end of December 2019, the 
new coronavirus was soon detected in other countries. Due to the rapid increase in infections 
around the globe, the World Health Organisation (WHO) declared it a pandemic on March 11, 
2020. Even now, more than one year after the declaration of the WHO, it is still not clear when 
vaccinations will be accessible all over the world and the pandemic comes to an end. Because 
of this high level of uncertainty and its global impact, the pandemic is unlike any previous 
health crisis and will continue to affect lives for years to come. 
Europe was the first continent after Asia to detect the novel virus on January 24, 2020 (ZDF, 
2020a). Italy was the second country after China that experienced a large-scale outbreak, 
which led to thousands of deaths and forced the government to take drastic actions in the fight 
against COVID-19 (ZDF, 2020b). Other European countries soon followed and political 
actions across European countries in 2020 were shaped by the progress of the pandemic.  
However, the approach to contain infections differed across European countries with regard 
to regulations and timing. In the beginning of the “first wave” (February to May 2020) 
Germany reacted quickly in increasing its testing capacities and introduced restrictive 
measures even before experiencing larger outbreaks of COVID-19. The UK chose to introduce 
less restrictive measures in the beginning of the wave and expanded the actions only after steep 
increases in COVID-19 infections. Sweden, on the contrary, took a completely different 
approach and relied on voluntary compliance with social distancing recommendations instead 
of introducing mandatory curfews or lockdowns (Boin et al., 2020).  
The outbreak of COVID-19 and the introduction of curfews and lockdowns in multiple 
countries impacted not only the mobility of the population but also its economic well-being, 
showing its effect in stock markets. On February 20, 2020, the main European stock indices 
started to sharply decrease and reached their lowest points in the middle of March. Even 
though the stock markets started to recover, the period between March and April 2020 was 
still characterized by a high level of volatility across all European countries and industries. 
Share prices were impacted to different degrees in different industries. Although all industries 
experienced large share price drops in the beginning of the pandemic, they recovered at 
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different speeds. Industries, such as Consumer Goods and Consumer Services, recovered only 
slowly, whilst other industries, such as Technology and Health Care, regenerated faster. But 
not only were different industries influenced in different ways, also the sectors within each 
industry were impacted differently. A good example is the Consumer Goods industry. After 
the initial share price drop, the Personal Goods sector stagnated for a long time and many 
companies in that sector have still not reached their pre-COVID level again; but most 
companies in the Leisure Goods sector rebounded quickly.  
Share prices react very sensitively to new information, which can impact the whole market as 
well as individual stocks. The COVID-19 outbreak clearly was new information that impacted 
all share prices drastically as it represented the beginning of an uncertain period. Of course, 
this uncertainty was observable not only on stock markets, but also on governments, which 
were forced to quickly decide on which infection containment policies to take. As little was 
known about the virus, European governments followed different strategies when faced with 
similar adverse shocks. In this paper we investigate whether the different government actions 
taken can explain the different development of share prices across industries and sectors during 
the COVID-19 pandemic. 
The existing literature has not covered share price movements on an industry-level in Europe 
and primarily focuses on the first months of the pandemic. Furthermore, past research mainly 
compares the different effects of government actions on indices containing the largest and 
most successful companies of a country. With our analysis we therefore contribute to the 
existing literature by comparing the share price development across four selected focus 
industries (Consumer Goods, Consumer Services, Health Care and Technology) in eight 
European countries (Denmark, France, Germany, Italy, Norway, Spain, Sweden and the 
United Kingdom) that applied different containment policies during the COVID-19 pandemic. 
We do not focus only on the first months but analyse daily share prices until March 1, 2021, 
to provide a longer perspective on the process and to cover the first two COVID-19 waves in 
Europe. Furthermore, we include all listed companies of the countries in our panel dataset, 
excluding only penny stocks and companies without daily available share price information. 
In this way, we are able to derive general statements about the effect on all publicly listed 
firms and not only on the most established companies. We investigate whether there are clearly 
outperforming or underperforming industries in, as well as across, the countries during this 
period and identify what part government actions have had in this development. We can 
thereby provide a better understanding of the European stock market reactions during the 
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crisis. It can also be seen as a basis to compare the development of listed companies with the 
overall economic development in the future. After the current pandemic, the results could be 
useful in evaluating and predicting how future containment policies in pandemics or other 
health crises might affect European stock markets.  
The rest of the paper proceeds as follows: In section 2 we give a brief overview of the impact 
of past pandemics and epidemics on economies and discuss the existing literature on the 
COVID-19 pandemic. The focus will be on the impact of government actions as well as share 
price developments. In section 3 we introduce our data and its sources. We provide an 
overview of the main events related to the COVID-19 pandemic for our chosen time period. 
In addition, we give insights on how share prices and the metrics of government actions varied 
over time in the chosen countries and focus industries. In section 4 we present our 
methodology including our hypotheses. Section 5 proceeds with testing our hypotheses 
through the empirical analysis of our country and industry regressions as well as possible 
implications of the regression results. In section 6 we conclude. 
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2. Literature Review 
There is a lot of finance literature concerning stock markets and stock prices. Different models 
have been developed to understand the functioning of markets and the pricing of stocks. One 
of the most prominent finance theories, Fama’s efficient market hypothesis (EMH), states that 
a market is informationally efficient if prices always correctly reflect all available information. 
Thus, today’s share price reflects expectations about a market’s future development – based 
on all current information – and future share price movements cannot be predicted (Fama, 
1970). Only the appearance of new information will generate price innovations.  
In the simple world of the Capital Asset Pricing Model (CAPM) only the risk-free rate of 
return and the riskiness of a stock (beta) affect its price. However, it is well known that the 
simple CAPM model performs poorly empirically. In order to explain pricing anomalies, 
multi-factor models have been developed – notably the Fama-French-three-factor model from 
1993, which contains the factors company size and book to market value, in addition to market 
risk (beta). Of course, new information can impact the whole market – as well as individual 
stocks – and signal periods of higher or lower returns for all firms. COVID-19 clearly 
represents such a shock. Moreover, when it comes to an unforeseen event or crisis, people tend 
to overreact, which can then also be observed in share prices (De Bondt & Thaler, 1985, Howe, 
1986). Kaminsky and Schmukler (1999) find evidence that during volatile periods large 
changes in share prices can be partly explained by substantial news but seem to be mostly 
driven by herd instincts. The COVID-19 pandemic is a very recent example of such a volatile 
period and leads to a variety of possible financial research topics. It allows to analyse data of 
the share price development during a global crisis as well as to identify new factors that could 
help explain it.  
2.1 Past pandemics and epidemics 
Although there have been pandemics and epidemics in recent history, none have had such a 
drastic impact on the world economy and financial markets as the current COVID-19 
pandemic. As of May 1, 2021, it has caused the death of 3.2 million people worldwide (WHO, 
2021).  
Researchers have examined past pandemics and compare them to the current situation. Correia 
et al. (2020) analyse the economic impact of the Spanish Flu on U.S. cities during 1918. In 
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the short run, the pandemic was associated with similar economic downturns across all cities 
regardless of the strictness of the non-pharmaceutical interventions (NPIs). The NPIs included 
social distancing, the banning of mass gatherings, the closure of schools, theatres, and 
churches as well as the obligation to wear face masks and the isolation of infected people – 
measures similar to the ones installed during the COVID-19 pandemic. In the medium run, 
stricter NPIs seem to have a positive effect on economic outcomes, but there is no strong 
evidence supporting this trend. Lilley et al. (2020) build on the paper of Correia et al. (2020) 
and find no positive or a negative effect of NPIs on economic outcomes. Baker et al. (2020) 
show that the US stock market’s reaction to the COVID-19 pandemic has been much stronger 
than the reaction to the past pandemics of 1918-1919 (Spanish Flu), 1957-1958 (Asian Flu) 
and 1968 (Hong Kong Flu). They identify government restrictions on commercial activities 
and voluntary social distancing combined with the shift to a more service-oriented economy 
as the main reasons for this difference. 
Schell et al. (2020) show that recent health crises declared as a Public Health Risk Emergency 
of International Concern (PHEIC) by the WHO (H1N1, Poliovirus, Ebola and the Zika virus) 
were not followed by significant stock market reactions in a 30-day period. The results indicate 
that there has been a relatively low impact on the world economy. However, after declaring 
COVID-19 a PHEIC, there has been a strong negative effect on stock markets lasting for at 
least 30 days, suggesting that the current pandemic is not comparable to past health crises in 
its impact on the global economy. David et al. (2021) compare the reactions of eleven stock 
exchange indices in 79-day periods after the MERS, SARS, Ebola and COVID-19 outbreaks. 
After all outbreaks, most indices experienced a significant negative shock, but only after the 
COVID-19 outbreak did the volatility remain at a significantly high level. This finding 
suggests a longer recovery period for the financial indices in the current pandemic compared 
to previous health crises.  
Ma et al. (2020) analyse the real Gross Domestic Product (GDP) and unemployment rate of 
countries affected by past pandemics (1968 Flu, SARS, H1N1, MERS, Ebola and the Zika 
virus) relative to unaffected countries. GDP growth initially rebounded quickly but has needed 
five years until it was back to its pre-crisis level. The services and industry sectors were 
relatively strongly affected, while agriculture remained widely unaffected. Affected high 
income countries experienced a larger drop in GDP growth, in relation to their unaffected 
peers, than the lower income countries. There is evidence that higher government 
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expenditures, especially those on health care, are associated with a larger bounce-back effect 
on output growth and thus a faster recovery. 
As the world economy has experienced a very different magnitude of impact during the 
COVID-19 pandemic compared to previous heath crises, research and academia have quickly 
started to analyse the newly available data. 
2.2 COVID-19 
As little was known about the characteristics of the new virus, its best treatment, and the most 
effective measures to contain the spread, the COVID-19 outbreak found governments and the 
world economy unprepared. Since then, authorities have been challenged with finding a 
balance of actions that protect people and prevent a collapse of national health systems without 
placing an excessive burden on the economy. Although effective vaccines have been 
developed and approved in less than a year, the pandemic is not over yet. Thus, it is uncertain 
which countries will have been most affected by the pandemic. Nevertheless, many 
researchers have already started to study the differences in national policy reactions. 
Kuhlmann et al. (2021) compare responses to the COVID-19 pandemic in France, Germany 
and Sweden and find that these are mostly in line with their state traditions and administrative 
cultures. While France used a more hierarchical top-down governance approach, Germany and 
Sweden applied a bottom-up logic. France and Germany introduced strict regulations and 
lockdowns, whilst Sweden used a trust-based approach based on recommendations and thus 
relied on the voluntary compliance of citizens. Although the European countries imposed their 
measures individually and unilaterally, there was a policy convergence to a set of basic 
containment measures. Sweden has been the only country that did not follow this trend. As its 
neighbouring Nordic countries have similar administrative cultures, this difference cannot be 
solely explained by a different mindset.  
Other studies focus on the effects and implications of government policies. Greenstone and 
Nigam (2020) analyse the effect of social distancing on deaths. They predict that a moderate 
social distancing scenario from April until September 2020 could save 1.76 million lives in 
the United States, of which 0.63 million would have died from shortages of hospital intensive 
care unit beds. Sauvagnat et al. (2020) also take the economic impact into account and analyse 
the costs of restricted labour across U.S. states in April 2020. A 10% increase in the share of 
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restricted labour is associated with a 3% drop in employment and a 1.87% drop in firms' 
market value, while the COVID-19 infection and death rates drop by 0.15% and 0.011%, 
respectively. A projection of these preliminary findings suggests that state-mandated business 
closures might have cost $700 billion and saved 36,000 lives up to April 2020. These findings 
show how governments are confronted with a trade-off between economic downturns due to 
lockdown measures on the one hand and the containment of cases and deaths on the other. 
Altig et al. (2020) analyse economic uncertainty measures, such as the implied stock market 
volatility, newspaper-based economic policy uncertainty and twitter chatter about economic 
uncertainty before and during the first months of the COVID-19 pandemic in the USA and the 
UK using textual analysis. All measures indicate a high increase in economic uncertainty. 
Economic uncertainty is also an important driver of share prices in which the global crisis was 
also clearly visible. 
2.3 Stock market reactions in the COVID-19 crisis 
As share price information is available right away, many researchers have used the stock 
market as a proxy to measure the economic impact of the COVID-19 crisis and analysed share 
price as well as volatility changes in the first months of the pandemic to get a first picture of 
the magnitude and possible drivers of the movements.  
While Al-Awadhi et al. (2020) find that both the daily growth in total confirmed cases and in 
total deaths caused by COVID-19 have a significant negative effect on Chinese stock returns 
across all companies, Ashraf (2020a) finds that stock markets reacted more prominently to the 
increase in the number of confirmed cases than to the increase in the number of deaths across 
64 countries. The reaction of stock markets was strongest in the days right after the first 
confirmed cases. Heyden and Heyden (2021) use an event study to analyse the initial reactions 
of U.S. and European stock markets to the first case and the first death reported in a country. 
The announcement of the first case did not lead to a significant change in stock market returns, 
while the announcement of the first death due to COVID-19 was followed by significant 
negative reactions. Furthermore, the announcement of first fiscal policies might lead to higher 
uncertainty among investors, whereas central bank responses can have a calming effect on the 
markets, which can be subject to the central bankers’ communication style. Zhang et al. (2020) 
analyse stock market reactions in the early stage of the pandemic until the end of March 2020 
and show markets’ volatility and unpredictability to have increased substantially as a response 
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to the crisis. They further argue that non-conventional policy interventions such as the U.S.’s 
unlimited quantitative easing to increase uncertainty even more and may result in long-term 
problems, thus contradicting Heyden and Heyden’s (2020) hypothesis of monetary policies 
having a calming effect. 
Ramelli and Wagner (2020) identify the COVID-19 pandemic as a tail risk event and analyse 
investors’ perception at the firm-level using share prices. They show that a company’s 
exposure to countries affected by the pandemic, e.g., to China in the first quartal of 2020, 
impacted share prices. Once the situation improved in the country, those stocks were valued 
more favourably again.  
Capelle-Blancard and Desroziers (2020) analyse how markets have incorporated public 
information about COVID-19 and government policies. Assessing daily economic and health 
data from 74 countries from January to April 2020 the authors find that stock markets initially 
ignored the outbreak until they reacted strongly on February 21, 2020, with a sharp increase 
in volatility. With central banks intervening in March and April, shareholders appeared less 
sensitive to new information about the health crises so that share prices recovered. This 
evidence supports the hypothesis of central banks’ calming effect. Country-specific 
characteristics do not seem to have influenced stock markets’ reaction. Credit facilities and 
government guarantees, as well as lower interest rates and lockdown measures decreased the 
drop in domestic stock prices. 
National and local approaches handling the COVID-19 pandemic differed across countries. 
While there has been a drop in stock prices throughout the world, there have been differences 
in the size of the slump and the speed of the recovery across countries. Ashraf (2020b) studies 
the impact of government responses on daily stock returns in 77 countries from January to 
April 2020. The Oxford COVID-19 Government Response Tracker (OxCGRT, also see 
section 3.3) is used to quantify restrictive as well as economic support measures. He finds the 
announcement of social distancing measures to have a direct negative impact on country 
indices’ performance due to its expected impact on economic activity. At the same time, it has 
a positive impact through the containment of new COVID-19 cases. Therefore, it is difficult 
to quantify the net economic impact of social distancing measures. Announcements of public 
awareness programmes, testing and quarantine policies, as well as economic government 
support packages are largely followed by positive returns.  
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As the pandemic increased (economic) uncertainty, Ashraf (2020c) analyses the relation of a 
country’s uncertainty aversion to its stock market reaction during the first months of the 
pandemic. Using daily data from 43 countries he finds that the decline in stock market returns 
is stronger in countries with a higher uncertainty avoidance suggesting that the cross-country 
difference in the stock markets’ reaction to news is caused by cultural biases. This approach 
provides additional evidence for the impact of governance cultures as also identified by 
Kuhlmann et al. (2021). Capelle-Blancard and Desroziers (2020) show that shareholders were 
sensitive to the number of cases in neighbouring but primarily wealthy countries, indicating 
that not only the national infection behaviour has impacted markets. Haroon and Rizvi (2020) 
show that panic spread through the media is associated with an increase in volatility across the 
world, this link being strongest in industries most hit by the pandemic.  
Lockdowns, temporary business closures and travel restrictions impacted industries 
differently. While some sectors such as hospitality or travel faced major restrictions in their 
daily business, others such as information technology or e-commerce experienced a surge in 
demand. He et al. (2020) use an event study to analyse the impact of the COVID-19 outbreak 
on different industries in China. The closure of the city of Wuhan on January 23, 2020, serves 
as the event day of the outbreak. Studying the returns of 2,895 listed companies in 18 different 
industries they find Mining, Agriculture, Education, Health, Real Estate, Electric and Heating, 
Environment, Construction, and Transportation to have a severe negative impact, while Public 
Management, Information Technology as well as Sports and Entertainment to have 
experienced a strong positive impact. Other industries seem less affected by the COVID-19 
outbreak. Al-Awadhi et al. (2020) use panel data methodology to analyse sector exposure on 
the Chinese market. In accordance with He et al. (2020) they find returns in Information 
Technology to outperform the market, while returns in the Air, Water, and Highway 
Transportation sectors to underperform significantly. Additionally, they find Medicine 
Manufacturing to overperform and Beverages to underperform.  
Mazur et al. (2021) analyse the U.S. stock market collapse in March 2020. While stocks in the 
Health Care, Food, Natural Gas, and Software sectors performed above average and generated 
high returns, firms operating in Crude Petroleum, Real Estate, Entertainment and Hospitality 
lost more than 70% of their market capitalisations. These findings show similarities to the 
Chinese market reactions (compare He et al., 2020) in the Software/Information Technology 
sector as well as Real Estate but differ in the Health Care and Entertainment sectors. Thus, 
this could be evidence that industries have reacted differently across countries.  
10 
The issue of differential impact is a key element in our study. So far, research has not covered 
share price movements on an industry-level in Europe. We contribute to the area and analyse 
how share prices developed and reacted to different government policies in Europe’s five 
biggest economies as well as the Nordics. We analyse daily share prices on a country-level, 
industry-level and sectoral- level. We analyse not only the first months of the crisis but take 
data until March 1, 2021, to provide a wider picture of the development. 
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3. Data  
For our data analysis we focus on the daily share prices of the five largest economies in the 
European Union (EU), including the UK, as well as the three largest economies in Scandinavia 
(Denmark, Norway, and Sweden). In the following we refer to the largest economies in the 
EU as the “GUFIS” and to the three Scandinavian countries as the “Nordics”. The rapid 
evolution of the COVID-
19 pandemic and novelty 
of the research area make 
it necessary to rely on data 
that are updated 
frequently and become 
accessible immediately. 
Share prices meet these 
requirements due to their 
daily availability. 
Furthermore, during the COVID-19 period it is possible to observe a lot of volatility in the 
share price development (see Figure 1 for the development in the GUFIS and Appendix 1 for 
the development in the Nordics), which makes the share prices a suitable dependent variable 
for our analysis. We collected our data using the Bloomberg Terminal. To collect the relevant 
data from the terminal, we filtered the whole security universe of Bloomberg for actively 
traded common stocks. We further selected only companies that are traded on one of the 
countries’ exchanges. For the companies that met these requirements, we extracted the daily 
share price information for all trading days of the country. In addition to the daily share prices, 
we extracted a company’s industry and associated sector affiliation as well as its market 
capitalisation and the percentage revenue generated within its country of listing. Other 
independent variables were more challenging to acquire. The different government actions in 
response to the COVID-19 pandemic were measured with the help of the Oxford COVID-19 
Government Response Tracker, which we downloaded from the website of the University of 
Oxford (Blavatnik School of Government, 2021a). Additionally, daily COVID-19 infections 
per country were retrieved from the website of the WHO (WHO, 2021). We further collected 
data about the effectiveness of the governments from the World Bank website 
(Worldbank.org, 2021) as well as quarterly GDP information (OECD, 2021a and monthly 
changes in the value of goods imported (OECD, 2021b) from the Organisation for Economic 
Figure 1: Average daily share price changes in the GUFIS 
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Cooperation and Development (OECD) website for each country. See section 4 for a detailed 
description and definition of all dependent and independent variables. 
3.1 Time period 
On January 1, 2020, Wuhan’s Huanan Seafood Wholesale Market was closed down after 
samples from the market tested positive for a novel coronavirus. The novel virus was reported 
by the Chinese Center for Disease Control and Prevention on January 9, 2020. On January 24, 
2020, the first European case was detected in France. As the virus quickly reached other 
countries the WHO declared the outbreak of the novel virus a ‘public health emergency of 
international concern’ on January 30, 2020 (ECDC, 2021). The Director General of the WHO 
declared COVID-19 a ‘global pandemic’ on March 11, 2020 (TGH, 2021), and stock markets 
experienced historical losses in the days that followed.  
In order to receive a complete picture of the effect of changing government actions in the 
respective countries and the exposure of different industries from the first reported cases until 
now, we consider the period between January 1, 2020, and March 1, 2021. We use January 1, 
2020, as the starting day as we are thereby including the trading day when the first international 
news about the COVID-19 virus was publicly available as well as preventing the Christmas 
and New Year’s disruption in December 2019 to influence our result. We end March 1, 2021, 
because it enables us to capture both the first and second waves of COVID-19 infections and 
thus add to the existing early literature on the COVID-19 pandemic, which has so far covered 
only the first months of the crisis. Although the countries under consideration were affected 
to different degrees by the individual COVID-19 waves, there are some similarities in the 
temporal progression. For instance, Italy was the first country in Europe to suffer a large-scale 
COVID-19 outbreak, but all countries in our sample experienced the peak of the first wave of 
COVID-19 cases around the end of March and beginning of April 2020, which was 
accompanied by a series of government restrictions (see section 3.3 for details). During the 
summer months, infections in the analysed countries decreased and the governments started 
to reopen borders and businesses. However, the rate of infection picked up again in the course 
of August and September, which prompted many countries to reinstate stricter measures and 
lockdowns in the second half of October 2020 (TGH, 2021). Another, but smaller, drop in 
share prices hit the stock markets in the end of October 2020. European countries reached the 
peak of their second COVID-19 wave in November and December 2020. During the second 
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wave the number of reported cases was much higher than during the first wave. This might be 
partly due to higher testing capacities, more testing and thus a lower number of unregistered 
cases. The beginning of 2021 was then predominantly characterized by declining COVID-19 
cases. See Appendix 2 for a timeline of the most important developments during the crises. 
3.2 Countries 
The countries covered in the analysis are Denmark, France, Germany, Italy, Norway, Spain, 
Sweden and the UK. Germany, the UK, France, Italy and Spain are the five countries with the 
highest GDPs in Europe and were therefore chosen for the analysis. Furthermore, we include 
Sweden in our analysis due to the distinctive way the country has chosen to handle the 
pandemic. As Sweden has a substantial lower GDP and population, we also included Denmark 
and Norway as Nordic peers. Together, the countries in our sample cover around 67 % of the 
overall GDP of all European countries excluding Russia (IMF, 2021). The six member states 
of the EU – Denmark, France, Germany, Italy, Spain and Sweden – cover approximately 69% 
of the total GDP of EU countries (OECD, 2021c). How the countries in our sample are affected 
by the COVID-19 pandemic is therefore decisive for the economic development of the EU as 
well as the whole European continent.  
Table 1 provides an overview of the countries’ population, GDP, Government Effectiveness 
index as well as COVID-19 infection and death numbers per population. 
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of March 1, 
2021 
Denmark 5.8 345,992 59,347 99.04 36,395.9  407.3  
France 66.9 3,077,475 45,495 89.42 54,841.6  1,282.8  
Germany 82.9 4,474,719 53,810 93.27 29,456.3  844.8  
Italy 60.4 2,468,700 41,108 69.23 48,125.3  1,613.8  
Norway 5.3 366,402 68,117 97.6 13,184.1  117.1  
Spain 46.7 1,793,442 37,851 79.81 66,842.1  1,496.8  
Sweden 10.2 556,182 53,720 97.12 65,052.3  1,272.6  
UK 66.4 2,950,091 43,903 90.38 62,775.0  1,847.0  
Total 344.7 16,033,003 46,510  50,064.1  1,340.2  














While Germany is the biggest country in terms of population and total GDP, Norway has the 
highest GDP per capita. Average GDP per capita in the GUFIS is USD 45,647 and USD 
59,622 in the Nordics. The Government Effectiveness index captures the perceived quality of 
public and civil services, as well as the degree of its independence from political pressure. It 
also considers the perceived quality of policy formulation and implementation 
(Worldbank.org, 2021). Italy and Spain have a significantly lower index than the other 
countries in our sample. We will use this metric in our empirical analysis. As of March 1, 
2021, Spain, Sweden and the UK had the highest number of cases, with more than 60,000 
reported COVID-19 infections per 1 million population. The UK and Italy had the most deaths 
per 1 million population. Norway experienced the lowest numbers in both infections and 
deaths related to COVID-19 during the time period. 
As our analysis focuses on the impact across industries, we consider only companies for which 
an industry classification is available. Furthermore, we filtered the data retrieved from 
Bloomberg so that we include only companies for which daily share price information is 
available on all trading days. Additionally, we exclude penny stocks for which share prices 
fell below the value of 1 Euro to eliminate extreme outliers in the price changes, which are 
merely due to low values. We used the average exchange rates during our time period as 
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reported by the European Central Bank (ECB, 2021) to convert the local currencies of 
Denmark, Norway, Sweden and the UK to Euro. 
Table 2: Overview of companies per country 
Country Bloomberg all listed companies 
Companies with full 







Denmark 188 78 68 32 
France 783 417 353 224 
Germany 824 368 316 218 
Italy 364 333 227 155 
Norway 346 150 87 38 
Spain 188 174 127 82 
Sweden 932 633 365 175 
UK 1,423 913 819 486 
Total 5,047 3,066 2,362 1,410 
 
Table 2 shows the number of all listed companies in a country and the number of companies 
for which full share price and industry information is available. Furthermore, it shows the 
number of companies included in our analysis once penny stocks are excluded. Additionally, 
we will analyse whether the percentage of revenue generated within the country of listing is 
relevant for the impact of government actions on share prices. As this information is not 
reported by all companies, this further reduces the number of companies in focus in these 
regressions. 
The following sections refer to the bigger sample including also companies for which no 
revenue information is available. See Appendix 7 for data descriptions of our sample including 
only companies for which domestic revenue information is available. 
In order to observe the development of the share price levels per country, we scaled the share 
prices of every company to 100 on the first trading day in January 2020 and computed a market 
capitalisation weighted average of share prices for each country using all companies in our 
sample.  
 
1 In the following we refer to this dataset as the “big sample”. 
2 In the following we refer to this dataset as the “small sample”. 
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Figure 2: Share price development across countries 
 
The share prices of companies listed in the Nordics and Germany are on a higher average level 
than those listed in the rest of the GUFIS. Denmark and Sweden perform particularly well. 
Spain is the only country in the sample where the average share price level in the beginning 
of March 2021 is below the one observed before the start of the pandemic in Europe. Share 
price levels in Italy and the UK approximately regained their pre-crisis level in February 2021. 
Table 3: Summary of the development of scaled average share prices and market 
capitalisation per country 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 115 (14.6) 93.2 (9.65) 98.0 (11.1) 
   Median [Min, Max] 114 [80.0, 140] 92.1 [66.5, 110] 99.5 [64.9, 118] 
Market Cap. (in €m)    
   Mean (SD)  8,620 (19,600) 6,870 (22,500) 5,800 (15,900) 
   Median [Min, Max] 1,820 [24.5, 141,000,] 441 [3.64, 272,000] 515 [2.06, 127,000] 
# Companies 68 353 316 




 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 90.2 (9.25) 94.5 (11.5) 87.5 (9.12) 
   Median [Min, Max] 89.1 [65.3, 109] 92.6 [67.7, 119] 84.1 [67.3, 106] 
Market Cap. (in €m)    
   Mean (SD)  2,310 (7,120) 2,780 (6,480) 4,470 (11,900) 
   Median [Min, Max] 215 [2.15, 79,300] 746 [44.4, 50,300] 542 [0.306, 87,600] 
# Companies 227 87 127 
# Trading Days 294 291 296 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 109 (15.0) 88.8 (8.84) 96.9 (14.6) 
   Median [Min, Max] 109 [72.3, 138] 86.9 [65.6, 104] 96.2 [64.9, 140] 
Market Cap. (in €m)    
   Mean (SD)  3,570 (8,170) 3,050 (12,700) 4,220 (14,300) 
   Median [Min, Max] 610 [10.4, 56,300] 180 [1.76, 147,000] 380 [0.306, 272,000] 
# Companies 365 819 2,362 
# Trading Days 290 293 289 - 296 
 
Denmark and Sweden were the only countries where share prices levels were on average above 
the starting level of 100. In the GUFIS, Germany had the highest average share price level 
close to 100, while Spain and the UK had the lowest with a mean of 87.5 and 88.8 and a 
median of 84.1 and 86.9, respectively. Italy has on average the smallest companies in terms of 
market capitalisation, while Denmark has the largest. In all countries, the median market 
capitalisation is significantly smaller than the mean, suggesting that fewer large corporations 
drive the mean upwards. This also implies that the market capitalisation weighted share price 
levels per country are under a bias of the larger companies.  
3.3 Government actions 
For our analysis we measured the magnitude of government actions in response to the COVID-
19 pandemic in our selected countries using the Oxford COVID-19 Government Response 
Tracker. The OxCGRT was developed by the Blavatnik School of Government, the 
government and public policy department of the University of Oxford (Blavatnik School of 
Government, 2021b). It quantifies the government responses of 180 countries by collecting 
daily publicly available data starting from January 1, 2020. It consists of 19 indicators that are 
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mapped to three categories. The first category covers containment and closure policies, such 
as school and workplace closures as well as restrictions on movement. The second category 
describes economic policies, such as income support, debt relief for households and fiscal 
measures. The last category records health system policies and includes, among others, the 
testing policy and the investments in vaccines (Blavatnik School of Government, 2021a).  
Most indicators are ordinally scaled taking values between 0 and up to 5. A higher level of 
involvement, e.g., the required closure of schools, will result in the indicator being rated higher 
than a recommended closure. The different indicators are used in the calculation of four 
different policy indices. For each indicator, an individual sub-score is calculated. This is 
computed as the ratio between the value observed and the highest value possible for an 
indicator multiplied by 100. Many indicators additionally report a binary “flag” taking a value 
of 0 or 1, which catches whether the measure described by the indicator is enforced on just a 
selected or a general level, e.g., whether school closings are required in selected local areas 
only or on a countrywide level. Most often the flag refers to the geographic scope of the 
measure. If the measure is implemented on a selected level only, the observed value will be 
reduced by 0.5 such that the highest sub-score of 100 can just be reached if the flag takes the 
value of 1.  
The sub-score 𝐼 of indicator 𝑗 at point in time 𝑡 is denoted by 
𝐼𝑗,𝑡 = 100
𝑣𝑗,𝑡 − 0.5(𝐹𝑗 − 𝑓𝑗,𝑡)
𝑁𝑗
 
where 𝑣𝑗,𝑡 is the realised value of indicator 𝑗 at point in time 𝑡, 𝐹𝑗 takes the value of 1 if 
indicator 𝑗 has a flag, 𝑓𝑗,𝑡 is the realised value of the binary flag and 𝑁𝑗 denotes the highest 
value possible for indicator 𝑗. For 𝑣𝑗,𝑡 = 0 the sub-score will take a value of 0. For example, 
the indicator C1, school closing, can take values between 0 and 3 and has a flag for the 
geographic scope of the measure. Therefore 𝑁𝐶1 takes the value of 3 and 𝐹𝐶1 takes the value 
of 1. If high school closings are required only in certain regions, the value of the flag 𝑓𝐶1,𝑡 will 
be 0 and the value of the indicator 𝑣𝐶1,𝑡 will be 2 (as defined for certain levels of school 







The indices’ scores are calculated based on a simple average of the indicators’ sub-scores and 
reach a level from 0 to 100. See Appendix 4 for further information on the different indicators 
and the composition of indices.  
Looking at the containment and closure policies, expressed by the Stringency index (see 
Figure 3), there is a clear trend observable across all countries, with some differences.  
Figure 3: Development of the Stringency index across countries 
 
On January 20, 2020, the UK was the first country in our sample that introduced COVID-19 
related measures, shortly followed by the other countries, which also took their first actions 
before the end of January. Denmark and Sweden were the only countries that waited 
significantly longer to install first measurements. The Stringency indices sharply increased 
across all countries during the first months of the pandemic and then stayed at relatively high 
levels during the first months. However, most countries loosened the restrictions again after 
the first wave. Sweden remained almost at the same level until November. The UK’s index 
remained at a relatively high level during the summer months. The Stringency index increased 
across all countries after the start of the second wave of COVID-19 infections. Naturally, these 
increases have been more moderate as no country has abolished all restrictions during the 
summer months.  
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In comparison to the Stringency index, there is less variation observable within the countries 
for the Economic Support index (see Figure 4).  
Figure 4: Development of the Economic Support index across countries 
 
As there are only two indicators included in the calculation of the Economic Support index 
(see Appendix 4), it is by definition natural that there are relatively large changes, as a small 
change in one indicator has a high impact on the index score. The little variations in the index 
within the countries show that there have been few adjustments once the first measures have 
been introduced. However, the level of the index varies across countries. While Norway has 
not exceeded the value of 50 throughout the whole time period, the UK has reached the highest 
level of 100 in April 2020 and has stayed on that level since. See Appendix 5 for the 
development of all OxCGRT indices per country. 
As the Containment and Health index includes in part the same indicators as the Stringency 
index, we do not include that index, but individual health indicators instead: H2, testing policy, 
H4, emergency investment in healthcare, H5, investment in vaccines, and H7, vaccination 
policy. This effectively takes additional government health actions into account. In addition 
to the Economic Support index, we also include the fiscal measures indicator E3, which we 
also consider to possibly affect share prices. H2 and H7 are reported as numeric indicators. 
H4 and H5 as well as E3, are reported as US Dollar amounts. See Appendix 4 for a definition 
of the indicators and indices of the OxCGRT.  
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Although the ordinal assessment of indicators allows to distinguish between the severity of 
actions it cannot catch specific details and thus provides only a rough ranking. For instance, 
the income support indicator E1 distinguishes only whether the government is replacing less 
than or above 50% of lost salaries. Hence, there can be big differences between countries, 
which were rated with the same value. Furthermore, an ordinal scale allows us only to identify 
whether restrictions become stricter or looser; it does not allow us to compare the magnitude 
changes. Therefore, it is unclear whether a change from 0 to 1 is comparable to a change from 
1 to 2. Additionally, the individual indicators can only take few different values and therefore 
offer little variation. Another issue that could distort our results is the fact that investments in 
healthcare and vaccination as well as the implementation of fiscal measures are only occurring 
irregularly. This leads to big changes between the trading days that report investments and 
those that do not. In addition, it is not completely clear when the market might absorb the 
information about the investments and fiscal measures. It is likely that discussions and news 
about possible investments, which are available prior to the official decision, are already 
reflected in share prices before the OxCGRT captures a change in one of the indicators. This 
might impair the reliability of the effects on the share prices. Furthermore, the OxCGRT does 
not provide information about details or smaller differences between countries. It also captures 
only actions in scope of the predefined indicators. Thus, any actions taken but not covered by 
one of the indicators will not be captured and might distort the country results. These issues 
can potentially lead to measurement error as the indices might not correctly capture the degree 
of restrictions. However, we believe the OxCGRT to be a useful source to capture government 
actions. It makes it possible to have a consistent evaluation and classification of government 
actions during the and related to the COVID-19 pandemic across countries. Furthermore, the 
OxCGRT has been used in previous research and thus makes it easier to compare our results 
with existing studies. 
3.4 Industries 
We used the Industry Classification Benchmark (ICB), available at the Bloomberg Terminal, 
to obtain industry and associated sector information on each company. After excluding 
companies with incomplete information and penny stocks as described in section 3.2, our 
dataset contains 2,362 companies in ten different industries. Overall, our sample has a similar 
industry distribution as the portfolio of all Bloomberg stocks retrieved. Our sample has a 
slightly lower percentage of companies in Financials and slightly larger percentage in 
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Industrials. On a country-level, there are few cases where the industry share deviates 
significantly from the overall country share. We consider these differences to be negligible 
and hence do not expect any resulting sample selection bias. For a detailed overview of the 
share of each industry within a country as well as an overview of the number of companies in 
the different sectors see Appendix 6.1.  
We scaled the share prices of every company to 100 on the first trading day in January 2020 
and computed a market capitalisation weighted average of share prices for each industry using 
all companies in our sample.  
Table 4: Summary of the development of scaled average share prices and market 
capitalisation across industries 
 Basic Materials Consumer Goods Consumer Services 
Scaled Share Price    
   Mean (SD) 98.7 (16.6) 95.8 (10.8) 94.2 (13.7) 
   Median [Min, Max] 99.9 [36.4, 132] 95.7 [22.5, 113] 93.6 [28.9, 121] 
Market Cap. (in €m.)    
   Mean (SD)  5,290 (17,900) 7,530 (25,700) 2,920 (8,550) 
   Median [Min, Max] 271 [2.49, 147,000] 546 [2.44, 272,000] 359 [0.306, 87,600] 
# Companies 146 247 276 
% Share  6.2 10.5 11.7 
 Financials Health Care Industrials 
Scaled Share Price    
   Mean (SD) 85.5 (12.1) 107 (10.8) 93.6 (14.2) 
   Median [Min, Max] 83.9 [17.4, 106] 110 [50.1, 122] 95.1 [16.7, 116] 
Market Cap. (in €m)    
   Mean (SD)  4,160 (10,400) 4,590 (15,900) 3,150 (9,410) 
   Median [Min, Max] 565 [0.624, 97,100] 302 [13.2, 141,000] 406 [2.31, 110,000] 
# Companies 417 226 578 




 Oil & Gas Technology Telecommunications 
Scaled Share Price    
   Mean (SD) 75.7 (12.9) 109 (18.1) 91.6 (8.25) 
   Median [Min, Max] 70.9 [29.7, 99.5] 111 [7.95, 147] 92.5 [15.3, 107] 
Market Cap. (in €m)    
   Mean (SD)  5,340 (20,200) 2,040 (9,500) 9,370 (15,300) 
   Median [Min, Max] 182 [2.040, 127,000] 154 [1.76, 127,000] 2,800 [16.8, 71,500] 
# Companies 112 278 29 
% Share  4.7 11.8 1.2 
 Utilities Overall  
Scaled Share Price    
   Mean (SD) 104 (12.0) 95.5 (16.3)  
   Median [Min, Max] 106 [23.6, 126] 95.7 [7.95, 147]  
Market Cap. (in €m)    
   Mean (SD)  9,730 (16,700) 4,220 (14,300)  
   Median [Min, Max] 2,700 [32.7, 79,300] 380 [0.306, 272,000]  
# Companies 53 2,362  
% Share across countries 2.2   
 
Over the time period, the Health Care, Technology and Utilities industries showed the highest 
level of mean and median scaled share prices, where both values exceeded the starting level 
of 100. The highest maximum level of 147 was observed in the Technology industry, which 
also had the highest mean and median level of scaled share prices as well as the highest 
standard deviation. With mean and median scaled share price levels below 90, companies in 
the Financials and Oil & Gas industry performed worst during the period. With 417 and 578 
companies respectively, Financials and Industrials hold the most companies in our sample. 
The Telecommunications and Utilities industries are least represented, with shares of 1.2% 
and 2.2%, respectively, which might be because companies in these industries are on average 
the biggest in terms of market capitalisation, indicating a high industry consolidation. The 
mean and median market capitalisation in the Technology industry is the smallest. The 
Consumer Goods industry is home to the largest company in the sample, LVMH Moët 
Hennessy – Louis Vuitton SE (LVMH), which has a market capitalisation of € 272,000 million 
and is listed in France.  
Based on the existing research from China and the U.S. (He et al., 2020 and Mazur et al., 2021, 
see section 2.3), we expect the most interesting insights from the Consumer Goods, Consumer 
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Services, Health Care and Technology industry. After the share price drop in the beginning of 
the first COVID-19 wave, we expect share prices in Consumer Services and Consumer Goods 
to recover more slowly and share prices in Health Care and Technology to recover faster. 
Potential issues that could impact our results are, firstly, that the individual sectors of an 
industry could follow opposing trends and secondly, that outliers in one sector could distort 
the overall sector trend. To verify our expectations while taking these issues into account, we 
examine not only the share price development in the four industries but also within each 
industry’s sectors in more detail. Furthermore, if present, we point out large outliers. See 
Appendix 6.1 for descriptive information on the industries not in focus. 
3.4.1 Consumer Goods 
Figure 5: Share price development in the Consumer Goods industry across countries 
 
The Consumer Goods industry holds 10.5% of companies within the sample. It is most 
prominent in France and Italy where 14.4% and 17.2% of all companies in the sample belong 
to the industry, respectively (see Appendix 6.1). In Denmark and Sweden, scaled share price 
levels were on average above the starting level of 100. The Consumer Goods industry has 
performed best in Sweden, where the highest share price level can be observed. The average 
share price level has been above the other countries’ levels since the drop in share prices in 
March 2020 and was back at its pre-crisis level within a few weeks. In Germany, the mean 
and median level was the lowest with values below 90. The UK is the only country in which 
share prices have not recovered to the pre-crisis level. Italy and Spain have on average much 
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smaller companies in terms of market capitalisation than the other countries. See Appendix 
6.1.2 for a table summarising the development of scaled average share prices as well as market 
capitalisations per country in the Consumer Goods industry. 
Because of its direct exposure to restrictive government actions such as business closures, we 
analysed the sectors of the Consumer Goods industry in more detail. The Consumer Goods 
industry consists of the sectors Automobiles and Parts, Beverages, Food Producers, Household 
Goods and Home Construction, Leisure Goods, Personal Goods and Tobacco.  
Companies in the Automobiles and Parts sector faced large share price drops in the beginning 
of the pandemic. Most companies managed to regain their pre-crisis share price level but only 
few reached significantly higher levels.  
Most companies in the Beverages sector could not regain their pre-crisis level and only one 
company in Italy has had a level above 150 at the end of the period. Lockdowns could be 
partly responsible for this development as beverage producers faced major drops in demand, 
e.g., from restaurants and bars. This is also in line with the research by Al-Awadhi et al. 
(2020).  
Many companies in the Food Producers sector have not again reached their pre-crisis share 
price level. However, there are a few companies in every country that significantly increased 
their share price levels during the crisis.  
There is no clear trend for companies in the Household Goods and Home Construction sector. 
While about half of the companies have not again reached their pre-crisis share price levels, 
others could increase their level. There are no companies listed in Norway and Spain, while 
most companies in the sector are listed in the UK. Here, the majority of companies did not 
again reach their pre-crisis share price.  
The majority of companies within the Leisure Goods sector increased their share price level 
significantly with many companies doubling their share prices. The positive development in 
this sector is not surprising, as the well performing companies offer mainly digital leisure 
goods. Among these are developers of computer games, smart home solutions or virtual reality 
equipment. This also applies to the best performing company, the German Cliq Digital AG, 
which provides streaming entertainment services. 
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Most companies in the Personal Goods sector could not regain their pre-crisis share price level 
and stayed at a similar level after the share price drop in the beginning of the pandemic. There 
are only a few companies that significantly increased their share prices. In France, more than 
half of the companies reached a higher level by the end of the period.  
Only four companies in our sample belong to the Tobacco sector. While the companies listed 
in Denmark and Sweden could increase their share price levels, the two companies listed in 
the UK ended on significantly lower share price levels.  
Overall, when only looking at the individual sector graphs, there is no clear positive nor 
negative trend observable in most cases. See Appendix 6.2.1 for graphs showing the share 
price development of individual companies in the Consumer Goods industry. 
3.4.2 Consumer Services 
Figure 6: Share price development in the Consumer Services industry across 
countries 
 
The Consumer Services industry holds 11.7% of companies within the sample. It is most 
prominent in France and the UK, where 14.2% and 14.9% of all companies in the sample 
belong to the industry, respectively (see Appendix 6.1). In the Nordics and Germany, share 
price levels were on average above the starting level of 100. The Consumer Services industry 
has performed best in Germany and Sweden, where the highest minimum and maximum share 
price levels could be observed. The average share price levels of the two countries have been 
above the other countries’ levels since the drop in share prices in March 2020 and reached a 
27 
 
significantly higher level until the end of the period. In Italy the industry has performed worst 
with a mean share price level of 73.4 and a median level of 67.9. In Italy and Spain, share 
prices have not recovered to the pre-crisis level, while it was just reached in France and the 
UK at the end of the time period. See Appendix 6.1.3 for a table summarising the development 
of scaled average share prices as well as market capitalisations per country in the Consumer 
Services industry. 
Due to its dependence on customer interactions, the Consumer Services industry is directly 
exposed to restrictive government actions. Therefore, we analyse the sectors of the Consumer 
Service industry in more detail. The Consumer Service industry consists of the sectors “Food 
and Drug Retailers”, “General Retailers”, “Media” and “Travel and Leisure”.  
In most countries companies that belong to the Food and Drug Retailers sector have not again 
reached their pre-crisis share price level. However, the two companies listed in Germany could 
more than triple their share prices during the time period. There is only one company listed in 
Spain and two companies listed in Italy and Sweden that belong to the Food and Drug Retailers 
sector. The sector is not represented on Danish and Norwegian stock exchanges.  
There is no clear trend for companies that belong to the General Retailers sector. While some 
companies could not recover after the share price drop in March 2020 or just reached the pre-
crisis level until the end of the time period, other companies could significantly increase their 
share price level. In France and Sweden about half of the companies have doubled their share 
prices during the time period. The most companies are listed in the UK, while there is only 
one company listed in Denmark that belongs to the General Retailers sector. 
Most companies that belong to the Media sector have not again reached their pre-crisis share 
price level and stayed on a similar level after the share price drop. However, half of the 
companies listed in Germany have increased their share price levels. In Denmark and Sweden 
only one and two companies belong to the Media sector, respectively. Most companies in the 
sector are listed in France and the UK.  
Companies that belong to the Travel and Leisure sector have experienced a significantly larger 
drop in share prices. However, some companies could quickly recover and increase their share 
price levels. When looking at some of the best performing companies, it shows that these 
companies are not “traditional” tourism providers. In France, the best performing company is 
Pierre&Vacances, which does not only offer hotel stays but also holds a large portfolio of 
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vacation homes. In many countries renting vacation homes was less restricted than hotel stays 
and therefore demand decreased less dramatically. In Germany, the best performing 
companies are Zeal Network SE, a provider of online gambling, and ÜSTRA AG, a provider 
of regional public transport. In the UK, the outliers with the best share price development are 
Best of the Best PLC, a provider of online gambling, and Gaming Realms PLC, a developer 
of real money games. Therefore, it is more difficult to see a clear trend for the Travel and 
Leisure industry as it consists of very heterogeneous companies that are not equally affected 
by the COVID-19 crisis and the related government actions. See Appendix 6.2.2 for graphs 
showing the share price development of individual companies in the Consumer Services 
industry. 
3.4.3 Health Care 
Figure 7: Share price development in the Health Care industry across countries 
 
The Health Care industry holds 9.6% of companies within the sample. It is most prominent in 
Denmark and Sweden, where 22.1% and 16.4% of all companies in the sample belong to the 
industry, respectively. However, when looking at all listed companies, only 10.1% of 
companies listed in Denmark belong to the Health Care industry, while it is 21.4% of 
companies listed in Sweden (also see Appendix 6.1 for details on all countries). Except for 
Germany and Spain, share price levels were on average above the starting level of 100. All 
countries have again reached their pre-crisis level at the end of the time period. The Nordics, 
Italy and France could increase their levels, with Sweden ending on a significantly higher level 
than the other countries. In Sweden, the highest mean and median share price as well as 
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maximum level of 164 was observed. With € 141,000 million the company with the biggest 
market capitalisation in the Health Care industry is listed in Denmark, where the median, mean 
and standard deviation of the market capitalisation is also highest. Norway and Sweden have 
on average much smaller companies in terms of market capitalisation than the other countries. 
See Appendix 6.1.5 for a table summarising the development of scaled average share prices 
as well as market capitalisations per country in the Health Care industry. 
Because of its direct exposure to the COVID-19 pandemic, e.g., through the increased demand 
for respirators or vaccines, we analysed the sectors of the Health Care industry in more detail. 
The Health Care industry consists of the sectors “Health Care Equipment and Services” and 
“Pharmaceuticals and Biotechnology”. 
Most companies in the Health Care Equipment and Services as well as the Pharmaceuticals 
and Biotechnology sector could increase their share price levels during the time period, with 
several companies reaching a multiple of their pre-crisis share prices. In the Health Care 
Equipment and Services sector, the two best performing companies have been Biosynex, a 
French company producing Rapid Diagnostic Tests and Genedrive PCL, a British company 
developing, among others, COVID-19 PCR tests. Both companies benefitted from an 
increasing demand for their products directly caused by the pandemic. 
In the Pharmaceuticals and Biotechnology sector, one of the best performing companies was 
synairgen PLC, a British drug discovery company with focus on respiratory diseases. COVID-
19 often leads to respiratory infections and therefore the company experienced a sharp share 
price increase in July 2020 when the company published positive news about the effectiveness 
of their drug in COVID-19 patients (synairgen, 2021). In Norway and Spain, the best 
performing companies BerGenBio AS and PharmaMar SA, are as well developers of drugs 
that show effectiveness in COVID-19 patients. Both companies experienced above average 
share price increases.  
There is a clear indication that the best performing companies in the Health Care industry 
provide products and services, which experienced an increasing demand due to the COVID-
19 pandemic. See Appendix 6.2.3 for graphs showing the share price development of 
individual companies in the Health Care industry. 
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3.4.4 Technology 
Figure 8: Share price development in the Technology industry across countries 
 
The Technology industry holds 11.8% of companies within the sample. It is most prominent 
in France and Germany where 14.4% and 16.1% of all companies in the sample belong to the 
industry, respectively (see Appendix 6.1). Except for Spain, share price levels were on average 
above the starting level of 100 and the countries could increase their pre-crisis level during the 
time period. Companies listed in Norway could significantly increase their share price levels, 
ending at an average level more than three times higher than at the beginning. Here the highest 
mean and median share price of 182 and 156, respectively, as well as the highest maximum 
level of 397 was observed. In Spain, mean and median share price levels were below 80. With 
€ 127,000 million the company with the biggest market capitalisation in the Technology 
industry is listed in Germany where also the highest mean and standard deviation of the market 
capitalisation was observed. The highest median of the market capitalisation was observed in 
Norway. In Italy and the UK fewer companies of the Technology industry have high market 
capitalisations compared to the other countries in the sample, leading to the lowest mean 
market capitalisations in these two countries. See Appendix 6.1.8 for a table summarising the 
development of scaled average share prices as well as market capitalisations per country in the 
Technology industry. 
Because of its exposure to the COVID-19 pandemic and the restrictive government actions, 
e.g., through the increased demand for home office equipment, we analysed the sectors of the 
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Technology industry in more detail. The Technology industry consists of the sectors “Software 
and Computer Services” and “Technology Hardware and Equipment”. 
There has been a positive trend in the Software and Computer Services sector with several 
companies reaching a multiple of their pre-crisis share prices. In Denmark and Norway all 
companies have at least reached their pre-crises level. The best performing company in 
Norway was KAHOOT! AS, a provider of a game-based learning platform. However, there 
have also been a number of companies in the sector for which share prices did not rebound 
after the drop.  
With only 57 companies, compared to 221, there are many fewer companies in the Technology 
Hardware and Equipment sector. Overall, share price levels have rebounded and increased 
further at the end of 2020. The best performing company in Italy, esprinet, is a provider of 
office supply, such as desktops and workstations. In the UK, the best performing company is 
BATM Advanced Communications, that, among others, develops real-time communication 
solutions, but also COVID-19 tests.  
There is a clear indication that the best performing companies in the Technology industry 
provide products and services, which experienced an increasing demand due to the COVID-
19 pandemic. See Appendix 6.2.4 for graphs showing the share price development of 
individual companies in the Technology industry. 
3.4.5 Industry comparison 
Overall, the data supports our expectations. While the Consumer Goods industry in Norway 
and the UK as well as the Consumer Service industry in France, Spain, Italy and the UK have 
not recovered until the end of our analysed period, the Health Care industry in all countries as 
well as the Technology industries in all countries, except in Spain, have recovered to pre-
COVID-19 share price levels. When looking at share price developments of the individual 
sectors within an industry we see, however, some diverging trends. For example, in the 
Consumer Goods industry many companies that belong to the Personal Goods sector could 
not regain their pre-crisis share price level, while the majority of companies in the Leisure 
Goods sectors could significantly increase their share prices. To account for different trends 
across sectors of the same industry, we are including them in our regression analysis. While 
the sector classification helps to group companies according to more precise business areas, 
there can still be very different companies within a sector. In the Travel and Leisure sector, 
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there are both travel companies such as airlines, which were negatively impacted by restrictive 
government measures, as well as online gaming and gambling platforms, which experienced 
a higher demand during the pandemic. However, the size of our sample does not allow to apply 
a more granular classification as it would reduce the observations in each group to a level, 
which makes general conclusions difficult. Furthermore, some companies performed 
extremely well. When looking at these companies’ business models in more detail it shows 
that these companies often directly benefit from the pandemic. Nevertheless, we believe that 
these outliers are not distorting our results but contributing to capture the whole variety of 
responses to the crisis. 
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4. Methodology  
Our analysis aims to identify the share price impact of government actions related to COVID-
19 across different industries in eight European countries. In order to investigate how different 
measures affect share prices, it is necessary to understand share price development in general. 
The share price 𝑃 on day 𝑡 can be expressed as follows:  
𝑃𝑡 = 𝑃𝑡−1 + 𝜀𝑡  
The share price 𝑃𝑡 is a function of yesterday’s share price 𝑃𝑡−1 and an error term 𝜀𝑡, which is 
independent and identically distributed (i.i.d.) and has a mean of 0: 𝔼(𝜀𝑡) = 0. The error term 
can be interpreted as new information arriving on day 𝑡 that is relevant to the value of the 
business. Hence, share prices follow a random walk and cannot be predicted. However, 
shareholders demand a holding return, which is subject to the stock’s risk and a market’s risk 
premium as well as the risk-free rate. Then the model might be written: 
 ln (𝑃𝑡) = 𝛼 + ln (𝑃𝑡−1) + 𝜀𝑡  
where 𝛼 is the daily holding return.  
The Capital Asset Pricing Model defines the expected return 𝜇 of stock 𝑖 as follows: 
𝜇𝑖 = 𝑟𝑓 + 𝛽𝑖 ⋅ (𝜇𝑚 − 𝑟𝑓) 
where 𝑟𝑓 is the risk-free rate, 𝛽𝑖 =
𝐶𝑜𝑣(𝑟𝑖,𝑟𝑚)
𝑉𝑎𝑟(𝑟𝑚)
 is the amount of systematic risk of stock 𝑖 and 
measures the co-movement of stock 𝑖 with the market 𝑚, and (𝜇𝑚 − 𝑟𝑓) is the premium per 
unit of risk (Bodie et al., 2014). This is the underlying mechanism that should determine a in 
a simple world. 
Pricing anomalies, and with them other factors influencing a stock’s return, have been 
identified (also see section 2). In their three-factor model, Fama and French have included a 
small-minus-big (SMB) as well as a high-minus-low (HML) factor next to the market risk 
premium factor (𝜇𝑚 − 𝑟𝑓). The SMB factor captures the excess return small sized firms 
realise, while the HML factor captures the excess return that companies with a higher book-
to-market value, “value companies”, realise.  
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Including these factors, our expected return 𝜇 of stock 𝑖 becomes: 
𝜇𝑖 = 𝑟𝑓 + 𝛽1 ⋅ (𝜇𝑚 − 𝑟𝑓) + 𝛽2 ⋅ 𝑆𝑀𝐵 + 𝛽3 ⋅ 𝐻𝑀𝐿 
where (𝜇𝑚 − 𝑟𝑓), SMB and HML are the FF3 factors, and the betas are the respective 
sensitivities. 
If we believe the FF3 model holds, then an appropriate regression model would be: 
ln(𝑃𝑖,𝑡) = 𝛼𝑖 + 𝛽𝑖 ⋅ ln (𝑃𝑖,𝑡−1) + 𝜀𝑖,𝑡 
where 𝛼𝑖 = 𝑑𝑎𝑖𝑙𝑦 𝜇𝑖 and 𝛽𝑖 = 1 on average. 
Following this model, the effect government actions have on share prices is captured in the 
error term 𝜀𝑖,𝑡. In theory, we could include the FF3 factors in our regressions to account for 
their effect on share prices. However, it is not possible to obtain FF3 data on a country basis 
but only for Europe as a whole, so there will be no variation across our sample and its impact 
will be absorbed by any time fixed effects. Furthermore, there is no FF3 data available on an 
industry-level for Europe. Therefore, we cannot include the FF3 factors in our regressions but 
regress share prices on government actions and selected control variables. As share prices 
follow a random walk, and thus should not be explainable, we can expect small R2s for our 
regressions. It is nevertheless worth analysing the magnitude of the effect as we know from 
previous stock market shocks (see section 2), that share prices often behave abnormally in 
these times.  
To get a better understanding of the development in the different industries and their sectors, 
we plotted graphs showing the share price developments of all individual companies within a 
respective sector in each country between January 2020 and March 2021 (see Appendix 6.2 
for the graphs of the industries in focus). As discussed in section 3.4, we identified not only 
differences across countries and industries but also within industries, as the sectors of an 
industry in the same country do not always follow the same trend. We then decided to conduct 
both within-country and cross-country industry analyses. The country analyses enable us to 
compare the development across industries within the same country, while the industry 
regressions enable us to see cross-country differences. For the industry analysis we also 





As we already described in our descriptive data analysis (see section 3), companies in the 
Consumer Goods and Consumer Services industry struggled during the COVID-19 pandemic, 
while companies in the Health Care and Technology industry performed above average. Our 
analysis aims to identify what part government actions have had in this development.  
We expect economic support as well as fiscal measures to have a positive impact on share 
prices. We expect this effect to hold in particular for those industries that experienced a 
negative impact, as economic support is typically provided only to companies in need of it. 
Furthermore, we expect government investments in health to mostly affect the Health Care 
industry. 
It is not entirely clear what effect more restrictive measures have in the different industries. 
On the one hand it might have a positive effect as it can decrease COVID-19 infections in the 
medium-term, whereas on the other hand it might also have a negative effect if it forces 
businesses to close down. We expect the latter effect to dominate for the Consumer Services 
industry as many services cannot be sold online. For the Technology industry we expect a 
positive effect of stricter measurements as many companies and institutions had to invest in 
new digital solutions to enable their employees to work from home and provide them with the 
appropriate technology and hardware.  
Additionally, we expect the effect of government actions of a company’s home country to be 
stronger for companies generating a higher share of revenue within their country of listing. 
Based on existing literature (Ashraf, 2020a and Al-Awadhi et al., 2020), we expect the number 
of confirmed COVID-19 infections to have a negative effect on share prices. Comprehensive 
testing strategies as well as a fast vaccination progress can help to reduce the number of cases 
and hence the negative effect of COVID-19 cases on share prices. Furthermore, an increase in 
these policies will lead to a higher demand for tests and vaccines and are therefore likely to 
increase share prices of companies in the Health Care industry, which are producing them. 
However, as more people are vaccinated, the increased demand in health care products and 
services that arose during the pandemic could decrease again. Therefore, it is unclear what the 
overall effect of the vaccination progress on share prices in the Health Care industry is.  
There are differences between governments’ restriction and support measures across 
countries. For instance, although experiencing high infection rates, Sweden based its 
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containment policy on voluntary measures and kept its policy relatively constant over time 
even when infection numbers increased rapidly. This can also be seen when looking at the 
Stringency index. The Stringency index of its Nordic peers was on a similarly low level. 
However, in contrast to Sweden, they experienced lower infection numbers over the time 
period (see Appendix 3). Therefore, comparing the effect of government actions on share 
prices in Sweden with the effect in its Nordic peers can offer insights on whether this strategy 
impacted the share price development.  
4.2 Panel data approach 
During the chosen time period, there have been other events on a country-, industry-, sector-, 
and company-level that coincided with the COVID-19 pandemic, such as non-covid related 
political changes, or M&A activities of individual companies. These unobserved variables 
could influence and compromise the relevance of our results. We chose a panel data approach 
due to its ability to control for such unobserved heterogeneity as a result of omitted variables 
by including fixed effects as well as the ability to apply the approach to both within-country 
and cross-country regressions. 
Panel datasets require observations for multiple entities (cross-sectional data, e.g., different 
countries or companies) that are observed on at least two points in time (time-series data, e.g., 
different days, months, or years). In our case the entities are the listed companies and the points 
in time are the countries’ trading days. Hence, each observation can be connected to a specific 
company name on a specific trading day. Our dataset is unbalanced, which means that some 
variables are not available for certain entities or periods. For example, the information about 
the share of domestic revenue is not available for all companies in the dataset. Therefore, when 
running regressions that include the independent variable “RevHomeCountry”, our database 
is reduced to the remaining companies with domestic revenue information.  
There are four different assumptions that need to be fulfilled before running ordinary least 
squares (OLS) panel data regressions. Firstly, the expected value of the error term, given the 
independent variables, is zero. This means there is supposed to be no omitted variable bias. 
Secondly, the independent variables as well as the error term need to be identically and 
independently distributed (i.i.d.). This means there is supposed to be no sample selection bias. 
This holds for example if the entities are selected randomly from the population. In our case 
the population consists of all listed companies in the analysed countries. Our sample consists 
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only of the listed companies for which daily share price information is available and that are 
not penny stocks. By limiting the population in this way, there could be a certain degree of 
selection bias because companies that are penny stocks and companies that have no daily share 
price information could share certain characteristics, which differentiate them from our 
remaining sample companies. However, the third panel data assumption is that large outliers 
are unlikely. When excluding penny stocks, we can reduce the probability of large outliers in 
our dependent variable. We consider the benefit arising from the reduction of outliers through 
the exclusion of penny stocks to outweigh the potential threat of a selection bias resulting from 
it. To reduce the threat of outliers even further, we scale all share prices to a value of 100 on 
the first trading day in 2020 to account for differences in their levels (see section 4.3.1). The 
last necessary assumption is that there is no perfect multicollinearity. This issue and how it 
might affect our analysis, is discussed in section 4.3.4 (Stock and Watson, 2015). 
One of the biggest advantages of panel data regressions is the ability to control for certain 
types of omitted variables by including fixed effects. There are two kinds of fixed effects, 
entity- and time-fixed effects. Entity-fixed effects control for omitted variables that differ 
between entities but stay constant over time. In contrary, time-fixed effects adjust for omitted 
variables that differ over time but stay constant between entities (Stock and Watson, 2015).  
To decide which kind of fixed effects best describes our underlying data, we ran a simulation. 
The dataset for the simulation consists of two countries with three industries each, a neutral 
industry that is not affected by COVID-19 government actions, a “high” industry that responds 
positively to newly introduced government actions and a “low” industry that responds 
negatively to newly introduced government actions. We constructed two fictional companies 
for each industry in the two different countries, for which share prices respond to the COVID-
19 government actions neutrally, positively or negatively depending on the industry they are 
part of. Furthermore, we included the variable “Response”, which should mimic the 
Stringency index and shows when government actions are getting more or less strict in the 
respective country. With the constructed dataset, we ran several regressions that included 
either none (1), only time-fixed effects (2), only entity-fixed effects (3) or both time- and 
entity-fixed (“twoway”) effects (4). We applied this simulation approach to both within-
country and cross-country regressions and thereby discovered that the model including time-
fixed effects only (2) best captures the variance in our underlying dataset as it showed the 
highest adjusted R2s. In conclusion, we followed that we are going to use time-fixed effects 
for our within- and cross-country data analyses. 
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To analyse whether most of the variation in our panel data stems from variation within or 
between panel entities, we set up our country and industry regressions using the between, 
within as well as the random model in R. The between model captures the time-invariant 
variation between entities and the within model captures the time-variant variation within 
entities. Random models capture both the time-invariant as well as time-variant variation. The 
between (within) model reports the R2 for the between (within) entity variation, while the R2 
for the random model reports the overall variation explained through our model. As the within 
and overall R2 were similar in size, we could conclude that most variation in our data stems 
from the time variation. The random effects model can explain both types of variation. It 
should be preferred over the fixed effects model as it is more efficient when its central 
assumption – the independent variables being uncorrelated with the time-invariant attributes 
of entities – holds. If this is not the case, it produces inconsistent estimators. Then, the fixed-
effects – the within model – is preferred as it does not require this assumption to hold. In order 
to see which model is best for our regressions, we conducted a Hausman test for the within 
and random model (Wooldridge, 2010). For the country regressions we got the result that we 
can use the random model, while for the industry regressions the null hypothesis that the 
estimators are consistent was rejected. We therefore proceeded using the random effects model 
for the country regressions and the within model for the industry regressions. For both types 
of regressions, we controlled for time-fixed effects. 
Furthermore, we use robust standard errors to control for a potential violation of the 
assumption that error terms are independent and identically distributed. There are two 
scenarios in which standard errors should additionally be clustered, one where clustering 
occurred when choosing the sample, so in the sampling design and one where the treatment 
effect is clustered, so in the experimental design (The World Bank, 2017). As we do not expect 
a significant sample selection bias in our data, we also do not expect clustering within our 
sample, and we are able to make general statements about the listed companies within our 
chosen countries. In our country regressions all companies get the same treatment through 
government policies as these are the same within a country. Therefore, the treatment is not 
subject to an underlying cluster. In our industry regressions the government actions are 
dependent on the country the company is listed in and thus vary across companies. Hence, the 
treatment is subject to clustering in the experimental design so that we use clustered errors in 
our industry regressions to account for this issue. 
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4.3 Dependent & Independent variables 
4.3.1 Dependent variable 
Our analysis aims to measure the impact of government actions on share prices. As we are 
interested in how the severity of restrictions and the extent of economic support impact share 
prices of the companies listed in the country, we use the logarithmic transformation of the 
scaled daily share price of company 𝑖 on trading day 𝑡 as the dependent variable. The 
logarithmic transformation naturally permits the regression coefficients to be interpreted as 
elasticities (Stock and Watson, 2015). To abstract from arbitrary differences in company share 
price levels, we scale all share prices to 100 on the first trading day of our time period.  
Using share price levels rather than daily share price changes, leads to the case that the 
dependent time series variables (the daily traded share prices) are correlated with their lagged 
values and are therefore serially correlated. This could raise the problem of a potential 
stochastic, nonstationary trend – also known as unit roots. Unit roots can cause biased 
estimators and t-statistics with a nonnormal distribution (Stock and Watson, 2015). To 
investigate whether our data follow a stochastic trend, we applied two different unit root tests 
– the Augmented Dickey-Fuller Test, which is the most well-known test for unit roots; and the 
Im-Pesaran-Shin Unit-Root Test, which is recommended for unbalanced panel datasets such 
as ours (Barbieri, 2015). Both tests reject the hypothesis that the underlying data are 
nonstationary. This is surprising but may be due to the shortness of the time series and/or the 
unusual shocks hitting the stock markets during the pandemic. 
4.3.2 Independent variables 
The key independent variables are the countries’ government actions. However, we also 
control for company-specific characteristics – such as the industry, sector and the percentage 
of revenue generated in its country of listing. Government actions are measured as the level 
of the countries’ Economic Support and Stringency indices as defined by the OxCGRT. 
Additionally, we include the individual health indicators H2, testing policy, H4, emergency 
investment in healthcare, H5, investment in vaccines, and H7, vaccination policy as well as 
the fiscal measures indicator E3, which we also consider to possibly affect share prices. H2 
and H7 are reported as numeric indicators. H4 and H5 as well as E3 are reported as US Dollar 
amounts. To make the three indicators more comparable across countries, we computed the 
indicators in relation to the population, obtaining per capita values. 
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We also include the daily COVID-19 cases per 1 million inhabitants for each country using 
the cases reported to the WHO. As the information of new cases is available only on the next 
day, we use the number of cases reported for the previous day to account for the delay in 
information availability. We scale all variables that are on a predefined scale such that they 
can take values between 0 and 1, where the highest observation within our sample normalised 
to unity. This offers the convenience that we can interpret the coefficient as what would 
happen if a country moved from no intervention in that domain to the highest intervention that 
was actually observed in the Western Europe. We use log transformations for variables that 
can take any value – such as investment amounts or new infections. This way we can interpret 
the coefficients of our variables as percentage changes (elasticities).  
The Industry Classification Benchmark (ICB), the market capitalisation and the revenue share 
in the country of listing are provided by the Bloomberg database. As we see in our data analysis 
the size of companies varies across countries and industries. Therefore, we scale the market 
capitalisation of each company to make a comparison of the impacts on companies across 
countries and industries easier. We scale by identifying the highest value of market 
capitalisation in a country/industry and then calculating all companies’ market capitalisation 
within this country/industry in relation to the highest identified value. The variable can 
therefore take values between 0 and 1. As we want to see whether the industries within a 
country and sectors within an industry reacted differently to government policies, we also 
include them as interaction variables with the government action variables.  
It is unclear whether similar government actions have the same effect on share prices across 
countries. A possible reason for differing effects can be the perceived effectiveness of 
governments. New government actions in countries with a lower perceived effectiveness 
might have a lower impact on share prices, as investors discount government policy 
announcement. Therefore, we additionally include the variable “Effectiveness” as an 
interaction variable with the government action variables in our industry regressions. The 
variable takes the value of a country’s Government Effectiveness index in 2019 as reported 
by Worldbank.org (see section 3.2). The index captures the perceived quality of public and 
civil services, as well as the degree of its independence from political pressure. It also 
considers the perceived quality of policy formulation and implementation. In our regressions 




We also include the variable “Import_change_previous” to account for possible effects on 
share prices resulting from a change in international trade. International trade was clearly 
disrupted during the lockdowns, and we would expect this to impact different countries 
differently (net importers versus net exporters, for example). For each country, the 
“Import_change_previous” variable describes the percentage change in the value of imported 
goods from the month before last to the previous month. We use a variable called “Time” to 
control for a potential time trend effect.  
We noted above that the impact of government policy on the stock prices will plausibly depend 
on the share of revenue that is generated domestically. For example, there are several mining 
companies listed on the London Stock Exchange, which have most of their operations abroad; 
their stock price is unlikely to be strongly impacted by the domestic UK government response 
to COVID-19, but rather by the government policies of the countries in which their mining 
operations take place.  
Table 5: Overview of the independent variables 
Variable Definition 
𝑇𝑖𝑚𝑒𝑡 Time trend taking ascending values from 0 to 420 for every 
day 𝑡 in the period of January 6, 2020 to March 1 2021  
𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 Country of listing of company 𝑖 
𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖 Industry classification of company 𝑖 as defined by the ICB 
𝑆𝑒𝑐𝑡𝑜𝑟𝑖 Sector classification of company 𝑖 as defined by the ICB 
𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝𝑖 Market capitalisation of company 𝑖 in relation to the highest 
market capitalisation within its country/industry 
𝑅𝑒𝑣𝐻𝑜𝑚𝑒𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 Company 𝑖‘s percentage of revenue generated in the country 
of listing 
𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 Government Effectiveness index of country 𝑐 in 2019 
𝐸𝑐𝑜𝑛𝑜𝑚𝑖𝑐𝑆𝑐𝑎𝑙𝑒𝑑𝑐,𝑡 Value of the Economic Support index in country 𝑐 on day 𝑡 
in relation to the highest sample value observed 
𝑆𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑐𝑦𝑆𝑐𝑎𝑙𝑒𝑑𝑐,𝑡 Value of the Stringency index in country 𝑐 on day 𝑡 in 
relation to the highest sample value observed 
𝑇𝑒𝑠𝑡𝑖𝑛𝑔𝑆𝑐𝑎𝑙𝑒𝑑𝑐,𝑡 Value of the H2 indicator in country 𝑐 on day 𝑡 in relation 
to the highest sample value observed 
𝑉𝑎𝑐𝑐𝑖𝑛𝑎𝑡𝑖𝑜𝑛𝑆𝑐𝑎𝑙𝑒𝑑𝑐,𝑡 Value of the H7 indicator in country 𝑐 on day 𝑡 in relation 
to the highest sample value observed 
𝑉𝑎𝑐𝑐𝑖𝑛𝑒𝐼𝑛𝑣𝑒𝑠𝑡𝑐,𝑡 H5 indicator – amount of US Dollar invested per capita in 
country 𝑐 on day 𝑡 
𝐻𝑒𝑎𝑙𝑡ℎ𝐼𝑛𝑣𝑒𝑠𝑡𝑐,𝑡 H4 indicator – amount of US Dollar invested per capita in 
country 𝑐 on day 𝑡  
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Variable Definition 
𝐹𝑖𝑠𝑐𝑎𝑙_𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑠𝑐,𝑡 E3 indicator – amount of US Dollar invested per capita in 
country 𝑐 on day 𝑡 
𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒𝑐,𝑡−1 Daily reported cases of new COVID-19 infections per one 
million people of population in country 𝑐 on day 𝑡 − 1 
𝐼𝑚𝑝𝑜𝑟𝑡_𝑐ℎ𝑎𝑛𝑔𝑒_𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑐,𝑡 Percentage change in the value of goods imported from the 
month before the last to the previous month in country 𝑐 
(stays constant over a month) 
 
4.3.3 Instrumental variables 
A possible limitation of the explanatory power of our independent variables is the appearance 
of endogeneity. Variables are endogenous if they are correlated with the error term of the 
regression and therefore violate the first of the necessary assumptions for panel data 
regressions (Stock and Watson, 2015).  
In our regression model there could be a threat of endogeneity especially for the variables 
“EconomicScaled” and “StringencyScaled”. Recessions or shocks to the economy will 
negatively impact share prices and can lead to a government response, for example an 
economic support package. Then causation will be running from share prices to 
“EconomicScaled”, as well as from “EconomicScaled” to share prices. One could argue that 
the timing would enable us to unpick the line of causation – for example, business health 
responds to economic policy with a lag. But any change in policy (or even the hint of a change 
in policy) will be immediately incorporated into share prices, so this is not a reliable approach. 
The Stringency index could also be correlated with omitted variables, such as the hospital 
capacity in the respective country. To account for this potential violation of the first 
assumption for panel data regressions, we performed instrumental variables (IV) regressions.  
IV regressions can eliminate the problem of endogeneity by introducing further – exogeneous 
– variables (z) in a two-stage approach. In a first stage, the endogenous variable is regressed 
on the instrument 𝑧. Instrumental variables need to fulfil certain conditions to be valid. Firstly, 
they need to be relevant. That means the instrumental variables need to be correlated with the 
endogenous variable – the instrument relevance condition 𝑐𝑜𝑣(𝑥, 𝑧)  ≠  0 has to hold. 
Secondly, instrumental variables need to be uncorrelated with the error term. Therefore, the 
instrument exogeneity condition 𝑐𝑜𝑣(𝑧, 𝑢)  =  0 has to hold. In addition to the conditions of 
validity, it is also necessary that the IV regression consists of at least as many instrumental 
43 
 
variables as potential endogenous variables. If these conditions are met, it is possible to capture 
the exogeneous movements of 𝑥 and thereby estimate unbiased coefficients (Stock and 
Watson, 2015). 
In the first stage the endogenous variable (𝑥) is divided into two parts – a part that might be 
correlated with the error term (𝑢) and a part that is exogeneous. The exogeneous part is 
obtained by regressing 𝑥 on 𝑧. Because 𝑥 and 𝑧 are correlated, but 𝑧 is uncorrelated with the 
error term, the fitted values for 𝑥 (?̂?) are uncorrelated with the error term as well. In this first 
regression also the other exogeneous independent variables (𝑤) of the initial regression are 
included. 
1. stage: ?̂? = 𝜋0 + 𝜋1 ⋅ 𝑧 + 𝜋2 ⋅ 𝑤 + 𝑣 
In the second stage the predicted value ?̂? from the first stage regression, is used to estimate the 
two-staged least squares (2SLS) estimator (𝛽12𝑆𝐿𝑆). As 𝐶𝑜𝑣(𝛽12𝑆𝐿𝑆, 𝑢) = 0 holds by 
construction, the 2SLS estimator is unbiased (Stock and Watson, 2015). 
2. stage: 𝑦 = 𝛽0 + 𝛽12𝑆𝐿𝑆 ⋅ ?̂? + 𝛽2 ⋅ 𝑤 + 𝑢 
To adjust for the potential endogeneity problem of the variable “EconomicScaled”, we include 
the instrumental variable “GDPprevious”. The variable captures the quarterly percentage 
change in GDP of the previous quarter in the respective country.  
To adjust for the potential endogeneity problem of the variable “StringencyScaled”, we 
include the instrumental variable “CaseChange_2weeks”. The variable takes the percentage 
change of accumulated new COVID-19 cases of a two-week time period to the accumulated 
cases of the preceding two weeks in time. The variable therefore captures how much the 
accumulated new cases in the past two weeks changed in comparison to the preceding two 
weeks.  
As described above, it is necessary to have at least as many instruments as potential 
endogenous variables. Our industry regressions consist of two potential endogenous variables 
and two instrumental variables. Therefore, we fulfil the requirement. Furthermore, it is 
important that the instruments are valid. To make sure our instruments fulfil this requirement, 
we tested for weak instruments to check if the instrument relevance condition is met. The test 
for weak instruments helps to find out if enough of the variation in 𝑥 is explained by the 
instrument 𝑧 and therefore the 2SLS estimator is reliable. The first-stage F-statistic is a 
common approach to test for weak instruments (Stock and Watson, 2015). There are many 
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different variants of first-stage F-statistic tests available, as the Sanderson-Windmeijer F-test 
and the Stock-Yogo test. For implementation reasons we decided to test for weak instruments 
using the Stock-Yogo test.  
The null hypothesis (H0) of the Stock-Yogo test states that instrumental variables are 
considered weak if the coefficients of the instrumental variables in the first stage of the IV 
regression are zero or nearly zero. But rejecting only the H0 is not enough to assume an 
instrument to be sufficiently strong. Stock and Yogo also take into account to what extent the 
2SLS estimator is biased in relation to the OLS estimator. They claim that there is a problem 
of validity if the bias of the 2SLS estimator is more than 10% of the bias of the OLS estimator. 
The rule of thumb for ruling out that issue is to check if the value of the F-statistic is larger 
than 10. If the F-statistic is larger than 10, then a set of instrumental variables can be 
considered appropriate to instrument for the respective endogenous explanatory variable 
(Stock and Yogo, 2005). We applied the Stock-Yogo test to all of our first stage IV regressions. 
We almost always obtained F-statistics larger than 10 and thereby concluded that our 
introduced instruments are not weak and that the instrument relevance condition is met. 
However, our instrument for the “StringencyScaled” variable did not pass the test in the 
Financials industry. Therefore, we introduced the instrument “CaseChange_1week” for the 
Financials regression. Analogously to our original instrument, it captures how much the 
accumulated number of new COVID-19 cases in the past week changed in comparison to the 
preceding week. See Appendix 9 and 10 for the results of the F-statistic for both variables in 
each industry.  
Testing for exogeneity is important to find out if all the instruments are uncorrelated with the 
error term of the second stage regression and thus can be excluded from it. Otherwise, it is not 
possible to isolate the exogenous component of 𝑥 in the first stage regression. In this case ?̂? 
will be correlated with the error term and the 2SLS is inconsistent. The Overidentifying 
Restrictions Test, also known as J-statistic, can be used to test for exogeneity. Hereby, the 
residuals obtained in the second stage of the 2SLS regression are regressed on all exogeneous 
variables – the instrumental and control variables. Again, the F-statistic is computed for the 
null hypothesis that all instruments are zero (and therefore exogeneous). By multiplying the 
F-statistic with the number of instruments (𝑚) it is possible to receive the J-statistic. The p-
value of the J-statistic is obtained by taking into account the difference between the number 
of instruments and the number of endogenous variables (𝑘). 
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𝐽 − 𝑠𝑡𝑎𝑡𝑖𝑠𝑡𝑖𝑐 =  𝑚 ⋅ 𝐹~ 𝑥𝑞2   𝑤𝑖𝑡ℎ 𝑞 = 𝑚 − 𝑘 
If H0 cannot be rejected, the instruments can be considered exogeneous. If H0 is rejected, at 
least one instrument is not exogeneous and the instrument exogeneity condition does not hold.  
As the name of the test already implies, it is only possible to test for exogeneity if the 
coefficients are overidentified, which means that there are more instruments than endogenous 
variables. As our IV regressions are exactly identified, but not overidentified, we cannot test 
for exogeneity. Therefore, it is unclear whether our instruments can be validly used. As share 
prices instantly reflect all publicly available information, we chose instruments that rely on 
historic data. In this way the information that our instruments provide should already be 
reflected in the share prices and thus be exogeneous. As governments typically need longer to 
react, our instruments can however explain and be the information base for current government 
actions.  
4.3.4 Multicollinearity 
Another issue that could influence the significance of our regression results is multicollinearity 
between our variables. Multicollinearity can be a problem if it is either perfect or imperfect. 
Perfect multicollinearity is the term used when two variables are a perfect linear combination 
of each other. If a regression model has a perfect multicollinearity problem, the OLS estimator 
cannot be determined, and most statistical software will return an error message when running 
the regression. In contrast, imperfect multicollinearity describes the case in which an 
independent variable is highly (but not perfectly) correlated to one or more of the other 
independent variables of a multiple regression. In this case the software will not return an error 
message but coefficients of at least one of the correlated variables will be measured 
imprecisely and the standard errors for the affected variables will be inflated (Stock and 
Watson, 2015). To rule out this potential problem of multicollinearity, we calculate the 
variance inflation factor (VIF) to our dataset. The VIF measures the collinearity between 
variables and ranges from 1 (no collinearity) to infinity. The larger the VIF the higher the 
collinearity between the variables. There is no hard cut-off value, but the general rule of thumb 
states that if the VIF is larger than 10, the collinearity between the variables is too high 
(Marquardt, 1970). The VIFs we obtain from our dataset are ranging from 1.0 to 6.6, therefore 
we can discount any potential multicollinearity problem.  
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4.3.5 Regression design 
We run both country as well as industry regressions to identify the differences of government 
actions on share prices across countries and industries. In our country regressions, the 
companies listed in the same home country are exposed to the same set of government actions. 
Hence, we can eliminate a potential measurement error arising from different countries’ 
government actions being evaluated inconsistently by the OxCGRT, or them being correlated 
with some omitted variable. Therefore, we do not need to run IV regressions within countries. 
One reason for suspecting we may not find strong results with country studies pooling all 
industries is that there are relatively few changes in the policy variables over time, often only 
one or two over the whole period. By contrast, if we focus on an industry – and pool all 
countries – there are many changes in the policy variables (such as the level of economic 
support, which is implemented at different times and with different degrees of generosity by 
different governments). However, to account for the potential endogeneity of the government 
action variables “StringencyScaled” and “EconomicScaled”, we include instrumental 
variables in the industry regressions. 
We conduct four industry regressions to show different regression results when including 
instrumental variables. In the first, we do not use instruments and have a potential endogeneity 
problem for our “EconomicScaled” and “StringencyScaled” variables. In the second, we 
instrument for our “EconomicScaled” variable only. In the third regression, we instrument for 
our “StringencyScaled” variable only, while we instrument for both variables in the fourth 
regression. Conducting the different regressions enables us to see the way the instruments 
work individually as well as together. 
We followed iterative steps for our focus industry regressions to eliminate some of the 
independent non-explanatory variables which had insignificant coefficients in all their 
interactions across all four regressions. We excluded one insignificant variable at a time until 
all variables showed some significance in one of the regressions. After each elimination of an 
independent variable, we reran our first stage regressions and F-statistic to check whether our 
weak instrument test still holds.  
As the geographic revenue information is not available for all companies and decreases the 
number of observations significantly, we run two sets of regressions – one with and one 
without the geographic revenue information for both the country and the industry regressions.  
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5. Empirical Analysis  
5.1 Regression within countries  
In order to see the differences of government actions on share prices across industries, we 
conducted within country regressions.  
Our government action variables are included as independent variables as follows: 



























Furthermore, we include the time trend variable “Time”, as well as yesterday’s daily reported 
COVID-19 cases per one million population “LaggedCaseChange”, the change in monthly 
imports “Import_change_previous” as well as the scaled market capitalisation of the company 
“ScaledMarketCap”. We interact the independent variables with “Industry” dummies in order 
to see the different impact of each variable across industries. See section 4 for a definition of 
each variable. 
𝑙𝑜𝑔(𝑆𝑐𝑎𝑙𝑒𝑑𝑝𝑥𝑖,𝑡)
= 𝛽0 + 𝛽1 ⋅ 𝑇𝑖𝑚𝑒𝑡                                                                                                    
+ 𝛽2 ⋅ 𝐺𝑜𝑣𝑒𝑟𝑛𝑚𝑒𝑛𝑡 𝐴𝑐𝑡𝑖𝑜𝑛𝑠𝑐,𝑡 ⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖                                                     
+ 𝛽3 ⋅ 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒𝑐,𝑡−1) ⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖                                 
+ 𝛽4 ⋅ 𝐼𝑚𝑝𝑜𝑟𝑡_𝑐ℎ𝑎𝑛𝑔𝑒_𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑐,𝑡 ⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖                                               
+ 𝛽5 ⋅ 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝𝑖 ⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖 + 𝑢𝑖  
In the regressions including only companies that report the percentage of revenue generated 
within their country of listing, we interact the variable “RevHomeCountry” with the 
“Government Actions” variables as well as the case changes and percentage change in monthly 
imports. This allows us to see whether companies that generate a higher share of revenue 
within their home country are impacted more by the respective government actions and 
COVID-19 course of infection.  
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𝑙𝑜𝑔(𝑆𝑐𝑎𝑙𝑒𝑑𝑝𝑥𝑖,𝑡)
= 𝛽0 + 𝛽1 ⋅ 𝑇𝑖𝑚𝑒𝑡 + 𝛽2 ⋅ 𝐺𝑜𝑣𝑒𝑟𝑛𝑚𝑒𝑛𝑡 𝐴𝑐𝑡𝑖𝑜𝑛𝑠𝑐,𝑡 ⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖
⋅ 𝑅𝑒𝑣𝐻𝑜𝑚𝑒𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 + 𝛽3 ⋅ 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒𝑐,𝑡−1)
⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖 ⋅ 𝑅𝑒𝑣𝐻𝑜𝑚𝑒𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 + 𝛽4 ⋅ 𝐼𝑚𝑝𝑜𝑟𝑡_𝑐ℎ𝑎𝑛𝑔𝑒_𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑐,𝑡
⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖 ⋅ 𝑅𝑒𝑣𝐻𝑜𝑚𝑒𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 + 𝛽5 ⋅ 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝𝑖 ⋅ 𝐼𝑛𝑑𝑢𝑠𝑡𝑟𝑦𝑖
+ 𝑢𝑖 
See Appendix 8 for the full country regression results. In the following we discuss results on 
the effect of government actions only across our focus industries: Consumer Goods, Consumer 
Services, Health Care and Technology.  
5.1.1 Results for Denmark 
Table 6: Country regression output – Denmark3 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.001*** 0.001*** 
 t = 3.865 t = 2.824 
IndustryConsumer Goods 0.080* 0.062 
 t = 1.758 t = 1.038 
IndustryHealth Care 0.138*** 0.128* 
 t = 2.632 t = 1.901 
IndustryIndustrials 0.002 0.223*** 
 t = 0.050 t = 5.728 
IndustryOil and Gas -0.726** -0.031*** 
 t = -2.158 t = -14.107 
IndustryTechnology 0.367*** 0.325*** 
 t = 2.680 t = 535.580 
IndustryUtilities 4.493 0.359*** 
 t = 1.427 t = 3.154 
EconomicScaled -0.193*** -0.163*** 






3 Regression outputs only display significant values. 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
RevHomeCountry 0.322*** 
  t = 383.062 
StringencyScaled -0.514*** -0.391*** 
 t = -32.711 t = -15.400 
log(1 + LaggedCaseChange) 0.003 -0.027*** 
 t = 0.966 t = -5.045 
TestingScaled 0.304*** 0.146*** 
 t = 9.192 t = 2.599 
VaccinationScaled 0.424*** 0.127*** 
 t = 18.476 t = 3.416 
log(1 + VaccineInvest) 0.128*** 0.127*** 
 t = 9.772 t = 5.850 
log(1 + HealthInvest) 0.037*** 0.031*** 
 t = 78.967 t = 34.610 
log(1 + Fiscal_measures) -0.010*** -0.008*** 
 t = -62.956 t = -27.951 
Import_change_previous -0.084*** 0.056 
 t = -3.268 t = 1.338 
IndustryConsumer Goods:EconomicScaled 0.223*** 0.210*** 
 t = 9.868 t = 3.134 
IndustryConsumer Services:EconomicScaled 0.217*** 0.267*** 
 t = 6.025 t = 5.597 
IndustryFinancials:EconomicScaled 0.234*** 0.041 
 t = 6.991 t = 0.544 
IndustryHealth Care:EconomicScaled 0.212*** 0.184*** 
 t = 10.777 t = 3.974 
IndustryIndustrials:EconomicScaled 0.248*** 0.263*** 
 t = 10.802 t = 6.634 
IndustryHealth Care:RevHomeCountry  -0.241*** 
  t = -2.832 
IndustryIndustrials:RevHomeCountry  -0.344*** 
  t = -6.574 
IndustryConsumer Services:StringencyScaled 0.028 0.321*** 
 t = 0.225 t = 2.621 
IndustryFinancials:StringencyScaled 0.135** 0.689*** 
 t = 2.151 t = 4.772 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryHealth Care:StringencyScaled 0.358*** 0.175 
 t = 4.596 t = 0.979 
IndustryIndustrials:StringencyScaled -0.046 -0.250** 
 t = -0.865 t = -2.401 
IndustryTechnology:StringencyScaled 0.269 -0.019*** 
 t = 1.212 t = -125,901.1 
IndustryConsumer Goods:log(1 + LaggedCaseChange) 0.006 0.063*** 
 t = 0.518 t = 6.213 
IndustryConsumer Services:log(1 + LaggedCaseChange) -0.008 -0.067*** 
 t = -0.533 t = -4.144 
IndustryFinancials:log(1 + LaggedCaseChange) -0.017*** -0.015 
 t = -4.076 t = -1.429 
IndustryHealth Care:log(1 + LaggedCaseChange) -0.024*** 0.014 
 t = -3.362 t = 1.123 
IndustryIndustrials:log(1 + LaggedCaseChange) 0.006 0.055*** 
 t = 0.943 t = 3.778 
RevHomeCountry:log(1 + LaggedCaseChange)  0.077*** 
  t = 1,639,423 
IndustryConsumer Goods:TestingScaled -0.205*** 0.132 
 t = -2.649 t = 0.487 
IndustryConsumer Services:TestingScaled -0.186 -0.479*** 
 t = -1.460 t = -3.087 
IndustryFinancials:TestingScaled -0.336*** -0.246** 
 t = -7.261 t = -2.043 
IndustryHealth Care:TestingScaled -0.192*** -0.038 
 t = -3.407 t = -0.549 
IndustryIndustrials:TestingScaled -0.207*** -0.058 
 t = -3.375 t = -1.055 
IndustryConsumer Goods:VaccinationScaled -0.118 0.214** 
 t = -1.096 t = 2.509 
IndustryConsumer Services:VaccinationScaled -0.241*** -0.761*** 
 t = -3.891 t = -9.606 
IndustryFinancials:VaccinationScaled -0.258*** -0.367*** 
 t = -5.428 t = -4.119 
IndustryHealth Care:VaccinationScaled -0.348*** -0.143 
 t = -6.644 t = -1.318 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryIndustrials:VaccinationScaled -0.142*** 0.272** 
 t = -2.941 t = 2.379 
IndustryOil and Gas:VaccinationScaled 0.169** 0.527 
 t = 2.239  
IndustryTechnology:VaccinationScaled -0.293** -0.129*** 
 t = -2.126 t = -1,942,694 
IndustryFinancials:log(1 + VaccineInvest) 0.025 -0.357*** 
 t = 0.839 t = -7.585 
IndustryHealth Care:log(1 + VaccineInvest) -0.166*** -0.113* 
 t = -6.527 t = -1.819 
IndustryOil and Gas:log(1 + VaccineInvest) 0.001 -0.056*** 
 t = 0.034 t = -514,383.5 
IndustryTechnology:log(1 + VaccineInvest) -0.209*** -0.138 
 t = -8.672  
IndustryConsumer Goods:log(1 + HealthInvest) -0.035*** -0.021*** 
 t = -11.507 t = -8.706 
IndustryConsumer Services:log(1 + HealthInvest) -0.036*** -0.051*** 
 t = -6.347 t = -8.283 
IndustryFinancials:log(1 + HealthInvest) -0.035*** -0.046*** 
 t = -8.663 t = -4.678 
IndustryHealth Care:log(1 + HealthInvest) -0.040*** -0.030*** 
 t = -12.743 t = -10.569 
IndustryIndustrials:log(1 + HealthInvest) -0.036*** -0.035*** 
 t = -11.801 t = -6.628 
IndustryConsumer Goods:log(1 + Fiscal_measures) 0.014*** 0.013*** 
 t = 9.628 t = 17.634 
IndustryConsumer Services:log(1 + Fiscal_measures) 0.011*** 0.014*** 
 t = 5.267 t = 7.466 
IndustryFinancials:log(1 + Fiscal_measures) 0.010*** -0.005** 
 t = 8.310 t = -2.137 
IndustryHealth Care:log(1 + Fiscal_measures) 0.002** 0.004** 
 t = 1.985 t = 2.430 
IndustryIndustrials:log(1 + Fiscal_measures) 0.011*** 0.009*** 
 t = 11.224 t = 6.118 
IndustryTechnology:log(1 + Fiscal_measures) 0.003 -0.001*** 
 t = 1.066 t = -160,337 
   
52 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryUtilities:log(1 + Fiscal_measures) 0.015*** 0.014*** 
 t = 856,301.1 t = 5,872,823 
IndustryConsumer Goods:Import_change_previous 0.588*** 0.749*** 
 t = 4.175 t = 3.378 
IndustryConsumer Services:Import_change_previous 0.314 0.383* 
 t = 1.266 t = 1.903 
IndustryFinancials:Import_change_previous 0.254*** 0.093 
 t = 2.719 t = 0.566 
IndustryIndustrials:Import_change_previous 0.318*** 0.431** 
 t = 3.196 t = 1.962 
RevHomeCountry:Import_change_previous  -0.461*** 
  t = -382,027.6 
IndustryConsumer Goods:ScaledMarketCap 12.989 4.765*** 
 t = 1.329 t = 13.508 
IndustryHealth Care:ScaledMarketCap 13.434 1.941** 
 t = 1.376 t = 2.508 
IndustryOil and Gas:ScaledMarketCap 19.881**  
 t = 2.036  
IndustryFinancials:EconomicScaled:RevHomeCountry  0.208* 
  t = 1.698 
IndustryHealth Care:EconomicScaled:RevHomeCountry  0.109** 




 t = 2.240 
IndustryIndustrials:RevHomeCountry:StringencyScaled  0.591*** 
  t = 2.580 
IndustryConsumer Goods:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.134*** 
 t = -11.430 
IndustryFinancials:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.047*** 
 t = -2.706 
IndustryHealth Care:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.082*** 
 t = -6.109 
IndustryIndustrials:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.104*** 




 t = -2.096 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryHealth Care:RevHomeCountry:TestingScaled -0.331* 
  t = -1.722 
IndustryIndustrials:RevHomeCountry:TestingScaled  -0.512** 




 t = -9.654 
IndustryFinancials:RevHomeCountry:VaccinationScaled  -0.440*** 




 t = -5.401 
IndustryIndustrials:RevHomeCountry:VaccinationScaled  -0.918*** 
  t = -5.241 
IndustryFinancials:RevHomeCountry: 
log(1 + VaccineInvest) 
 0.380*** 
 t = 4.991 
IndustryConsumer Goods:RevHomeCountry: 
log(1 + HealthInvest) 
 -0.040*** 
 t = -14.105 
IndustryHealth Care:RevHomeCountry: 
log(1 + HealthInvest) 
 -0.016*** 
 t = -4.150 
IndustryConsumer Goods:RevHomeCountry:log(1 + 
Fiscal_measures) 
 0.005*** 
 t = 5.305 
IndustryFinancials:RevHomeCountry: 
log(1 + Fiscal_measures) 
 0.018*** 
 t = 5.188 
IndustryIndustrials:RevHomeCountry: 
log(1 + Fiscal_measures) 
 0.005** 
 t = 2.204 
Constant 4.571*** 4.399*** 
 t = 113.074 t = 538.704 
Observations 19,584 9,216 
R2 0.449 0.758 
Adjusted R2 0.446 0.755 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
In Denmark, companies that are part of the Health Care and Technology industry perform 
better (have higher average share prices) than those that are part of the Consumer Goods and 
Consumer Services industry. This is in line with our expectations after the data analysis. The 
Economic Support index has a negative effect in the Technology industry, while it has a small 
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positive effect in the other industries. The effect is largest in the Consumer Services industry, 
which is evidence for our expectation that economic support packages have a positive effect 
and that this effect is bigger for industries more affected by the pandemic. A higher Stringency 
index has a negative effect on share prices in all industries, while this effect is smaller in the 
Health Care industry. Again, this in line with our expectations. However, the effects are very 
small for both indices. For instance, an increase in the Stringency index from 0 to 1, decreases 
share prices by only 0.514%. The effect is even smaller for “EconomicScaled”. Higher 
COVID-19 infections have only a small negative effect in the Health Care industry. There is 
no significant effect of COVID-19 infections on the share prices in the other industries. This 
is partly in line with our hypothesis that increasing COVID-19 cases have a significant 
negative impact on share prices, still, we would have expected more significant results. Fiscal 
measures have a small positive effect in the Consumer Goods and Consumer Services industry, 
while it is negative in the Health Care and Technology industry. It is unclear why fiscal 
measures should reduce share prices. A possible explanation could be that news about the 
fiscal measures have already been reflected in share prices and the expectations were higher 
than the eventual support so that the effect has to be corrected downwards. An increase in the 
testing as well as vaccination policy has a positive impact on share prices across all industries 
in focus. The effect of testing is largest in the Consumer Services as well as Technology 
industry. More testing could lead on the one hand to higher reported infections and thus more 
restrictive measures but on the other hand to lower infections in the long term as infection 
chains can be traced more easily. “VaccinationScaled” has the largest effect in the Consumer 
Goods and Consumer Services industry. With more people vaccinated these industries are 
closer to conducting business as usual again, which has a positive effect on share prices. 
The results are similar when considering only companies for which revenue information is 
available. Companies that generate 100% of their revenues in Denmark have 0.322% higher 
share prices in the Consumer Goods, Health Care and Technology industry compared to 
companies listed in Denmark that do not generate their revenues in the country. A reason for 
this could be that shareholders have more trust in companies that conduct business in 
Denmark, as it is the country with the highest “Efficiency” score in our sample. This indicates 
that the public perceives the ability of the government to enforce policies, and thus also 
COVID-19 policies, to be greater in Denmark than in most other countries. Therefore, 
companies generating most of their revenues in Denmark are expected to reach an earlier 
normalisation of their daily business. The effect is smaller in the Consumer Services industry. 
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In the Consumer Goods industry, share prices of companies that generate a higher percentage 
of revenue in Denmark experience a higher positive effect from fiscal measures. This is in line 
with our expectation that a higher share of revenue generated within the country of listing 
amplifies the effect of government actions on share prices.  
5.1.2 Results for France 
In France, companies that are part of the Consumer Services and Health Care industry have 
slightly higher share prices than those that are part of the Consumer Goods and Technology 
industry, which is partly what we expected. It is surprising, that the Consumer Services 
industry performed better than the Technology industry, which contradicts the insights from 
the descriptive analysis. The reason could be the market capitalisation weighted average in the 
descriptive analysis and the consideration of various interactions in the regression. The 
Economic Support index has a negative effect across all industries in focus. This contradicts 
our expectation of economic support packages to have a positive effect on share prices. The 
Stringency index, as well as fiscal measures, higher COVID-19 infections, and changes in the 
testing policy do not have a significant effect, which again does not provide evidence for our 
hypotheses. There is a positive effect of a higher “VaccinationScaled” on share prices in all 
industries. This is in line with our expectation that, as more people are vaccinated, companies 
are closer to conduct business as usual again and that this positive outlook increases share 
prices.  
The results are similar when considering only companies with available revenue information. 
However, an increase in “EconomicScaled” has a small positive effect on companies in the 
Health Care industry, while it is still negative for companies that belong to one of the other 
industries in focus. Higher COVID-19 infections have a small negative effect across all except 
the Health Care industry. The effect is biggest in the Consumer Services industry. These 
results support our hypothesis that COIVD-19 infections might have a positive effect on the 
Health Care industry, but negatively impact the Consumer Services industry. Companies that 
generate 100% of their revenues in France have 0.26% higher share prices in the Health Care 
industry compared to companies that are just listed on French stock exchanges but do not 
generate their revenues in the country. The effect is significantly smaller in the other 
industries. The percentage of revenue generated within the country of listing impacts the 
magnitude of the effect of government actions on share prices only partially. “TestingScaled” 
has a positive effect on share prices of companies in the Health Care industry. A higher 
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demand for tests that comes along with a more comprehensive testing policy could generate 
higher revenues and thus increase share prices in the industry.  
5.1.3 Results for Germany 
In Germany, companies that are part of the Health Care industry have slightly higher share 
prices than those that are part of one of the other industries in focus. This is in line with our 
expectations. The Economic Support index has a small positive effect across all industries, the 
effect being largest in the Health Care industry. This result provides evidence for our 
expectation that economic support packages have a positive effect. However, it contradicts our 
hypothesis that this effect is bigger for industries more negatively affected by the pandemic. 
A higher Stringency index has a negative effect on share prices in all industries. This is again 
in line with our expectations. However, the effects are very small for both indices. For 
instance, an increase in the Stringency index from 0 to 1 decreases share prices by only 
0.284%. The effect is even smaller for “EconomicScaled”. Higher COVID-19 infections have 
only a small negative effect across all industries in focus. Fiscal measures do not have a 
significant effect on share prices in Germany. An increase in the testing policy has a negative 
impact on share prices across all industries in focus, including Health Care, which contradicts 
our expectations. “VaccinationScaled” has a negative effect on share prices in the Health Care 
industry, while there is no significant effect on share prices in other industries. As we already 
hypothesized, one reason could be that as more people are vaccinated, the increased demand 
in health care products and services, which arose during the pandemic, could decrease again. 
When considering only companies with available revenue information, “EconomicScaled” no 
longer has a significant effect in Germany. A higher Stringency index leads to lower share 
prices. This effect is bigger for companies that generate a higher percentage of revenue in 
Germany, which support our expectations. Higher COVID-19 infections are associated with 
lower share prices only in the Health Care industry, while the effect is otherwise insignificant. 
This is partly in line with our hypothesis that increasing COVID-19 cases have a significant 
negative impact on share prices, still, we would have expected significant results also for the 
other industries. Fiscal measures have a small negative effect on share prices across all 
industries which contradicts or expectations. In the smaller sample, a higher 
“VaccinationScaled” increases share prices in the Consumer Services as well as Technology 
industry, while it is again negative in the Health Care industry. The increased share prices in 
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the Consumer Services industry support our expectations. The testing policy no longer has a 
significant effect on share prices in Germany.  
5.1.4 Results for Italy 
In Italy, companies in the Consumer Goods and Consumer Services industry have by 0.119% 
and 0.122% higher share prices than those in the Health Care and Technology industry, which 
is the opposite of what we expected. The Economic Support index has no significant effect in 
Italy. A higher Stringency index has a positive effect on share prices in all industries. Again, 
this contradicts our expectations. Higher COVID-19 infections have negative effects on share 
prices across all countries, this effect being biggest in the Consumer Services industry. This 
supports our expectation of COVID-19 infections to have a negative impact on share prices. 
Fiscal measures have a small positive effect across all industries. This is in line with our 
expectations. An increase in the testing policy has a negative impact on share prices across all 
industries in focus. The effect of testing is smallest in the Health Care industry where some 
companies might benefit from higher demand in COVID-19 tests. “VaccinationScaled” has a 
small positive effect in the Consumer Goods as well as Technology industry, while the effect 
is negative in the Consumer Services and Health Care industry. The negative effects, 
especially on Consumer Services, contradict our hypothesis. In Italy companies with a higher 
market capitalisation have higher share prices in all except the Consumer Services industry. 
This indicates that smaller companies struggled more during the pandemic. 
When considering only companies with available revenue information, “EconomicScaled”, 
“StringencyScaled” as well as “LaggedCaseChange” no longer have a significant effect on 
share prices. Companies in the Health Care industry, which generate 100% of their revenues 
in Italy, have 0.752% higher share prices compared to companies that are just listed on Italian 
stock exchanges but do not generate their revenues in the country. The effect is smaller in the 
other industries. The 0.752% higher share prices in the Health Care industry are relatively high 
compared to the results in other countries such as Denmark or France. “VaccinationScaled” 
has a positive effect on companies that generate a high (low) percentage of revenue in their 
home country in the Consumer Services and Health Care (Consumer Goods and Technology) 
industry. Thus, no clear effect of the impact of “RevHomeCountry” can be observed. In this 
sample, companies with a higher market capitalisation have lower share prices in all except 
the Technology industry. This contrasting results to the bigger sample could be evidence for 
a sample selection bias.  
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5.1.5 Results for Norway 
In Norway, companies in the Consumer Services industry have 1.011% lower share prices 
than those in other industries, which is also what we expected. The Economic Support index 
has a negative effect on share prices in the Consumer Goods industry, while it is positive in 
the Technology industry. A higher Stringency index has a negative effect on share prices in 
all industries, while this effect is largest in the Technology industry. This in partly in line with 
our expectations. It is surprising that out of all industries in focus, Stringency has the most 
negative effect on Technology, where we expected the effect to be less severe or even positive. 
However, the effects are very small for both indices. Except for the Technology industry, 
higher COVID-19 infections have a small negative effect on share prices, the effect being 
biggest in the Consumer Services industry and thus in line with our expectations. Fiscal 
measures have a small negative effect across all industries, which contradicts our expectations. 
“TestingScaled” has no significant effect. “VaccinationScaled” has a positive effect in the 
Health Care and Technology industry, while it is negative in the Consumer Goods and 
Consumer Services industry.  
When considering only companies with available revenue information, Consumer Services no 
longer has significantly lower share prices than other industries. An increase in 
“EconomicScaled” as well as “VaccinationScaled” has a positive effect on share prices in the 
Health Care and Technology industry. This is partly in line with our expectations. The effect 
of these two variables is also positive for companies belonging to the Consumer Services 
industry which generate a high percentage of their revenue in Norway. This trend supports our 
hypothesis that companies, which business relies more on the country of listing, are impacted 
more by government actions. In general, companies that generate 100% of their revenues in 
Norway, have 0.123% higher share prices in the Consumer Services, Consumer Goods as well 
as Health Care industry compared to companies that do not generate any revenues in the 
country. The effect is smaller in the Technology industry. As in the first regression, fiscal 
measures have a small negative effect on share prices across all industries. Furthermore, 
“TestingScaled” has a negative effect on share prices across all industries. The effect is smaller 
(bigger) for companies that generate a high percentage of their revenues within Norway in the 
Consumer Services and Health Care (Consumer Goods) industry. Thus, it is difficult to 
identify a clear trend for the variable.  
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5.1.6 Results for Spain 
In Spain, the Economic Support index has a small negative effect across all industries except 
for the Health Care industry, where it has a positive effect. Again, we would have expected a 
positive effect in all industries. A higher Stringency index has a negative effect on share prices 
in the Technology industry, while it has no significant effect in the other industries, which is 
contradicting our expectations. Fiscal measures have a small positive effect in the Health Care 
industry, while it is negative for the other industries. This is contradicting our hypothesis of 
fiscal measures to have a positive effect on share prices. Higher COVID-19 infections as well 
as “TestingScaled” have a negative effect across all, except the Technology industry, where it 
is positive. This is in line with our expectations. As more testing could lead to more reported 
cases, it is reasonable that it has a negative effect on all but the Technology industry. 
“VaccinationScaled” has no significant effect on share prices in Spain. Overall, even if 
sometimes contradicting our hypotheses, the Consumer Goods and Services industries are 
affected in the same way, while there are some different effects in the Health Care and 
Technology industry. 
The results are similar when considering only companies with available revenue information. 
Overall, the effects of government actions on share prices have been very similar across all 
industries in focus. “VaccinationScaled” only has a positive significant effect on share prices 
of companies in the Consumer Services as well as Technology industry. However, as a higher 
percentage of revenue is generated within Spain, this effect becomes smaller in the 
Technology industry. There is no clear trend of a higher percentage of revenue generated 
within Spain to amplify the effect of government actions. 
5.1.7 Results Sweden 
In Sweden, an increase in the Economic Support index has a negative effect across all 
industries. A higher Stringency index has a negative effect on share prices in the Consumer 
Goods and Technology industry. These results contradict our expectations that 
“EconomicScaled” has a positive effect across all industries and that “StringencyScaled” has 
a negative effect on the Consumer Services industry. Higher COVID-19 infections have a 
negative effect across all industries which is in line with our expectations. However, higher 
fiscal measures as well as a higher vaccination progress have negative effects on share prices 
across all industries. Both differ from what we expected. “TestingScaled” has a small positive 
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effect on share prices in the Consumer Services industry while it is negative for the other 
industries. The positive effect on Consumer Services is in line with our expectations. 
When considering only companies with available revenue information, “EconomicScaled” has 
a positive effect on share prices of companies which generate a high percentage of their 
revenue in Sweden in all but the Consumer Services industry. There is still a negative effect 
of an increase in the Stringency index in the Consumer Goods and Technologies industry, 
which is bigger for companies generating a higher percentage of revenue in their country of 
listing. In the smaller sample there is also a negative effect on share prices in the Consumer 
Services and Health Care industry though here the effect gets smaller as the percentage of 
revenue increases. Companies that generate 100% of their revenues in Sweden have 0.357% 
higher share prices in the Consumer Goods, Health Care as well as Technology industry 
compared to companies that are listed in Sweden but do not generate their revenues in the 
country. For companies in the Consumer Services industry this effect is -0.109%. These effects 
are similar to the effects in Denmark. Both countries belong to the Nordics and share a lot of 
characteristics, but they also have different approaches to the COVID-19 pandemic. Therefore, 
it is interesting that shareholders value companies that gain most of their revenues in one of 
these countries in the same way. Hence, Sweden’s distinct approach on how to handle the 
pandemic does not seem to have an impact on share prices. As in the first regression, higher 
fiscal measures as well as an increase in “VaccinationScaled” have negative effects on share 
prices across all industries. However, in the smaller sample “TestingScaled” has a negative 
effect across all industries.  
5.1.8 Results for the United Kingdom 
In the UK, companies that are part of Technology industry have slightly higher share prices 
than those that are part of the other focus industries. An increase in the Economic Support 
index has a negative effect in the Consumer Goods and Consumer Services industry, while it 
has a positive effect on share prices in the Health Care and no effect in the Technology 
industry. This contradicts our expectations. A higher Stringency index has a negative effect 
on share prices in all industries, while this effect is smaller in the Consumer Goods and 
Technology industry. Higher COVID-19 infections are associated with lower share prices in 
the Consumer Services industry. These results are in line with our expectations. Fiscal 
measures have small negative effects on share prices across all industries. Again, this 
contradicts our expectation. An increase in “TestingScaled” has a negative effect in the 
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Consumer Goods and Consumer Services industry, while it is positive in the Technology and 
Health Care industry, where the effect is largest. This could be due to the fact that the demand 
for tests, and thus revenues of health care companies, rise as the testing policy becomes 
stricter. “VaccinationScaled” has a positive effect on share prices in all industries, this effect 
being biggest in the Consumer Services and Technology industry. This result is in line with 
our expectations. As more people are being vaccinated, it is more likely that businesses will 
be able to resume their pre-covid operations faster. 
When considering only companies for which revenue information is available, an increase in 
“EconomicScaled” has a small negative effect on share prices across all but the Health Care 
industry. For companies that generate a higher percentage of their revenues in the UK, the 
negative effect is smaller in the Consumer Goods and Health Care industry, while it is bigger 
in the Consumer Services and Technology industry. Hence, no clear trend of the amplifying 
effect of revenue generated in the home country can be observed. There is a small negative 
(positive) effect of higher COVID-19 infections in the Consumer Goods and Health Care 
(Consumer Services and Technology) industry, which increases as the percentage of revenue 
increases. As in the first regression, contradicting our expectations, there is a small negative 
effect of fiscal measures across all industries. There is a positive effect of a higher 
“VaccinationScaled” across all industries, which becomes bigger (smaller) as more revenue is 
generated for companies in the Consumer Services, Health Care and Technology (Consumer 
Goods) industry. “TestingScaled” no longer has a significant effect on share prices in the 
smaller sample. 
5.1.9 Cross-country comparison 
Combining all insights from the country regressions, we cannot observe a clear trend for any 
of our countries or industries in focus. At this point we cannot find enough evidence for most 
of our hypotheses. When looking at the Stringency Index, it shows that there is a negative 
effect in Denmark, Germany, Norway and the UK, but it is not clear that any industry is 
especially negatively affected across all countries. The same applies when looking at the 
individual health measures and when looking at the Economic Support index. The Economic 
Support index should have a positive or at least not a negative impact on share prices in all 
industries, which is not the case. Germany and Italy are the only countries, where the index 
has no negative effect on share prices in any industry. The result is similar for fiscal measures, 
which show only a positive effect across all industries in Italy and have otherwise mixed, 
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negative or no significant effect at all. We find evidence for our hypothesis that higher 
COVID-19 infections have a negative impact on share prices in all countries. However, this 
effect cannot be seen across all industries in every country.  
The percentage revenue generated within the country of listing does not always amplify the 
effect of government actions. Furthermore, companies with a higher percentage of revenue 
generated in the Nordics, but also in Italy, have higher share prices in most industries. 
Therefore, this effect cannot be solely due to the higher perceived government effectiveness 
in the Nordics. As the sample is significantly smaller when including revenue information, 
results could be less meaningful, especially in countries, which generally have only few 
companies listed on their stock exchanges, such as Denmark and Norway. 
As Sweden has similarly low Stringency measures as Denmark and Norway, although 
experiencing higher COVID-19 infections, it is worthwhile to compare the two variables 
across the three countries. In Sweden, “StringencyScaled” has only a negative effect on the 
Consumer Goods and Technology industry, while it has a negative effect on all industries in 
Denmark and Norway. When comparing the effect of higher COVID-19 cases, we see a 
negative effect across all industries in Sweden, while it does not have an effect on the 
Technology industry in Norway and has only a negative effect in the Health Care industry in 
Denmark. These results indicate that government actions were perceived as less restrictive in 
Sweden compared to Denmark and Norway. Additionally, shareholders in Sweden could have 
perceived the restrictive measures implemented as appropriate so that they neither had a 
positive nor negative effect on share prices. The negative effect of COVID-19 cases across all 
industries in Sweden further supports our hypothesis of high infection rates to negatively 
impact share prices. 
The regression tables of the full country regressions can be found in Appendix 8. To see if 
there are more pronounced trends in the individual industries, we also run cross-country 
regressions for each industry. Again, we will focus on the four industries Consumer Goods, 
Consumer Services, Health Care and Technology in our interpretation.  
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5.2 Regressions within industries 
In order to see the differences of government actions on share prices across countries within 
industries, we conducted within industry regressions. As mentioned in section 4.3.2 we 
additionally include the variables “Effectiveness” and “Sectors” in our industry regressions. 
We started with general formulations that included all the variables in the regressions:  
𝑙𝑜𝑔(𝑆𝑐𝑎𝑙𝑒𝑑𝑝𝑥𝑖,𝑡)
= 𝛽0 + 𝛽1 ⋅ 𝑇𝑖𝑚𝑒𝑡 + 𝛽2 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐺𝑜𝑣𝑒𝑟𝑛𝑚𝑒𝑛𝑡 𝐴𝑐𝑡𝑖𝑜𝑛𝑠𝑐,𝑡
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽3 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒𝑐,𝑡−1)
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽4 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐼𝑚𝑝𝑜𝑟𝑡_𝑐ℎ𝑎𝑛𝑔𝑒_𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑐,𝑡 ⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖
+ 𝛽5 ⋅ 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝𝑖 ⋅ 𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 + 𝑢𝑖 
𝑙𝑜𝑔(𝑆𝑐𝑎𝑙𝑒𝑑𝑝𝑥𝑖,𝑡)
= 𝛽0 + 𝛽1 ⋅ 𝑇𝑖𝑚𝑒𝑡 + 𝛽2 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐺𝑜𝑣𝑒𝑟𝑛𝑚𝑒𝑛𝑡 𝐴𝑐𝑡𝑖𝑜𝑛𝑠𝑐,𝑡
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽3 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒𝑐,𝑡−1)
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽4 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐼𝑚𝑝𝑜𝑟𝑡_𝑐ℎ𝑎𝑛𝑔𝑒_𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑐,𝑡 ⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖
+ 𝛽5 ⋅ 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝𝑖 ⋅ 𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 + 𝛽6 ⋅ 𝑅𝑒𝑣𝐻𝑜𝑚𝑒𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖
⋅ 𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖 + 𝑢𝑖 
We then followed iterative steps to exclude insignificant variables (see section 4.3.5). As our 
“EconomicScaled” and “StringencyScaled” variables are the key variables of interest, we 
never exclude them from the regressions. In total we run four different regressions for both 
the dataset with and without revenue information. Our baseline is regression (1), in which we 
do not instrument. To address the potential endogeneity of our independent variables 
“EconomicScaled” and “StringencyScaled” we run three different IV regressions: In 
regression (2) we instrument for “EconomicScaled” only, in regression (3) we instrument for 
“StringencyScaled” only and in regression (4) we instrument for both “EconmicScaled” and 
“StringencyScaled”.  
Before running our final IV regressions, we conducted first stage regressions to obtain the F-
statistics for the weak instrument test. We run one first stage regression for each instrument. 
For both regressions we excluded the respective endogenous variable from the right-hand side 
of our first stage regression. 
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The first stage regression for “StringencyScaled” is: 
𝑆𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑐𝑦𝑆𝑐𝑎𝑙𝑒𝑑
= 𝛽0 + 𝛽1 ⋅ 𝑇𝑖𝑚𝑒𝑡 + 𝛽2 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐺𝑜𝑣𝑒𝑟𝑛𝑚𝑒𝑛𝑡 𝐴𝑐𝑡𝑖𝑜𝑛𝑠𝑐,𝑡
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽3 ∗ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒𝑐,𝑡−1)
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽4 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐼𝑚𝑝𝑜𝑟𝑡_𝑐ℎ𝑎𝑛𝑔𝑒_𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑐,𝑡 ⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖
+ 𝛽5 ⋅ 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝𝑖 ⋅ 𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖
+ 𝛽6 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒_1𝑤𝑒𝑒𝑘𝑡 ⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝑢𝑖 
The first stage regression for “EconomicScaled” is: 
𝐸𝑐𝑜𝑛𝑜𝑚𝑖𝑐𝑆𝑐𝑎𝑙𝑒𝑑
=  𝛽0 + 𝛽1 ⋅ 𝑇𝑖𝑚𝑒𝑡 + 𝛽2 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐺𝑜𝑣𝑒𝑟𝑛𝑚𝑒𝑛𝑡 𝐴𝑐𝑡𝑖𝑜𝑛𝑠𝑐,𝑡
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽3 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒𝑐,𝑡−1)
⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖 + 𝛽4 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅ 𝐼𝑚𝑝𝑜𝑟𝑡_𝑐ℎ𝑎𝑛𝑔𝑒_𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑐,𝑡 ⋅ 𝑆𝑒𝑐𝑡𝑜𝑟𝑖
+ 𝛽5 ⋅ 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝𝑖 ⋅ 𝐶𝑜𝑢𝑛𝑡𝑟𝑦𝑖
+ 𝛽6 ⋅ 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠𝑐 ⋅  𝐺𝐷𝑃𝑝𝑟𝑒𝑣𝑖𝑜𝑢𝑠𝑡 ⋅  𝑆𝑒𝑐𝑡𝑜𝑟𝑖  +  𝑢𝑖 
See Appendix 9 for the first stage regressions, F-statistics as well as the full set of regression 





5.2.1 Results for Consumer Goods 
Regression results including all companies in the sample 
Table 7: First stage regression output including all companies in the sample – 
Consumer Goods4 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.00001 0.0004*** 
 t = -0.284 t = 5.178 
EconomicScaled -1.402***  
 t = -6.409  
CaseChange_2weeks 0.003***  
 t = 9.829  
GDPprevious  -2.985*** 
  t = -7.902 
Import_change_previous -2.591*** 4.848*** 
 t = -11.638 t = 12.960 
log(1 + LaggedCaseChange) 0.087*** 0.369*** 
 t = 8.682 t = 8.981 
VaccinationScaled -0.474*** 0.200* 
 t = -3.645 t = 1.950 
TestingScaled 1.595*** -0.741 
 t = 5.247 t = -1.304 
log(1 + Fiscal_measures) -0.003 -0.026** 
 t = -0.318 t = -2.427 
Effectiveness:EconomicScaled 0.021***  
 t = 8.695  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -9.418  
Effectiveness:StringencyScaled  0.019** 
  t = 2.445 
Effectiveness:GDPprevious  0.027*** 
  t = 6.294 
   
 
4 Regression outputs only display significant values. 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:Import_change_previous 0.026*** -0.054*** 
 t = 10.632 t = -13.195 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.004*** 
 t = -4.867 t = -8.721 
Effectiveness:VaccinationScaled 0.007*** -0.006*** 
 t = 4.822 t = -4.891 
Effectiveness:TestingScaled -0.019*** 0.009 
 t = -5.798 t = 1.527 
Effectiveness:log(1 + Fiscal_measures) -0.00001 0.0004*** 
 t = -0.063 t = 2.845 
Observations 72,116 81,115 
R2 0.731 0.754 
Adjusted R2 0.730 0.754 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 118.93 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 31.964 
Table 8: Final regression output including all companies in the sample – Consumer 
Goods5 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.023** 0.030** -0.174 -0.064 
 t = 2.231 t = 2.062 t = -0.330 t = -1.432 










t = 1.906 t = 1.792 t = -0.374 t = -0.224 
     
 
5 Regression outputs only display significant values. 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
SectorPersonal Goods 0.606* 0.774 -24.239 -4.004 
 t = 1.832 t = 1.471 t = -0.508 t = -1.594 
StringencyScaled 2.370** 0.912 -3.723 -2.781 
 t = 2.056 t = 0.516 t = -0.670 t = -0.427 
EconomicScaled -1.303 -1.529 -1.310 -1.246 
 t = -1.308 t = -0.392 t = -1.562 t = -0.491 
log(1 + LaggedCaseChange) -0.262* -0.099 0.119 0.157 
 t = -1.824 t = -0.732 t = 0.404 t = 0.584 
CountryItaly 0.521** 0.670** -3.571 -0.544 
 t = 2.271 t = 2.210 t = -0.321 t = -0.682 
CountryNorway -0.103 0.003 0.638 -0.442* 
 t = -0.902 t = 0.022 t = 0.154 t = -1.879 
CountrySpain 0.303** 0.379** -3.883 -0.235 
 t = 2.137 t = 2.183 t = -0.698 t = -0.572 
Effectiveness:SectorHousehold Goods and 
Home Construction 
-0.007* -0.013* 0.191 0.002 
t = -1.897 t = -1.751 t = 0.362 t = 0.042 
Effectiveness:SectorPersonal Goods -0.007* -0.009 0.262 0.042 
 t = -1.832 t = -1.422 t = 0.497 t = 1.395 
Effectiveness:StringencyScaled -0.030** -0.008 0.038 0.020 
 t = -2.109 t = -0.354 t = 0.606 t = 0.256 
SectorHousehold Goods and Home 
Construction:StringencyScaled 
-2.520* -1.263 2.830 9.238 
t = -1.846 t = -0.669 t = 0.289 t = 1.278 
SectorPersonal Goods:StringencyScaled 0.436 2.117 13.785 13.747* 
 t = 0.244 t = 0.919 t = 1.566 t = 1.722 
SectorTobacco:StringencyScaled -0.525 39.324* 13.750 -45.318 
 t = -0.151 t = 1.654 t = 0.161 t = -0.683 
SectorBeverages:EconomicScaled 1.152 0.447 1.965* 2.463 
 t = 0.889 t = 0.109 t = 1.657 t = 0.677 
SectorFood Producers:EconomicScaled 2.294 -0.248 2.938*** 8.636* 
 t = 1.644 t = -0.056 t = 2.802 t = 1.921 
SectorLeisure Goods:EconomicScaled 3.581* 2.235 2.184 -22.980 
 t = 1.723 t = 0.329 t = 1.095 t = -1.038 
SectorBeverages:Import_change_previous 0.796 -0.843 6.799* 4.239 
 t = 0.582 t = -0.284 t = 1.673 t = 0.620 
SectorPersonal Goods: 
Import_change_previous 
0.871 -2.954 6.125 9.437* 
t = 0.913 t = -1.104 t = 1.354 t = 1.780 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
SectorTobacco:Import_change_previous -5.858*** 7.729 0.617 -17.730 
 t = -3.099 t = 0.842 t = 0.063 t = -1.098 
Effectiveness:log(1 + LaggedCaseChange) 0.003* 0.001 -0.001 -0.001 
 t = 1.876 t = 0.893 t = -0.318 t = -0.401 
SectorHousehold Goods and Home 
Construction:log(1 + LaggedCaseChange) 
0.299* -0.075 -0.102 -0.423 
t = 1.769 t = -0.480 t = -0.198 t = -1.239 
SectorLeisure Goods: 
log(1 + LaggedCaseChange) 
-0.163 -0.287* -0.681 -0.198 
t = -0.675 t = -1.733 t = -0.481 t = -0.426 
SectorPersonal Goods: 
log(1 + LaggedCaseChange) 
0.071 -0.271 -0.701 -0.562* 
t = 0.401 t = -1.451 t = -1.474 t = -1.796 
SectorPersonal Goods:log(1 + VaccineInvest) 0.816 -0.331 -1.952* -1.766 
 t = 0.586 t = -0.143 t = -1.692 t = -0.417 
SectorTobacco:TestingScaled -5.494*** -28.726 -3.825 -14.971 
 t = -3.211 t = -1.032 t = -0.139 t = -0.587 
SectorFood Producers:log(1 + HealthInvest) 0.152* 0.127 0.135 0.344 
 t = 1.923 t = 0.550 t = 1.579 t = 1.097 
SectorLeisure Goods:log(1 + HealthInvest) 0.210* 0.162 0.059 -1.505 
 t = 1.908 t = 0.450 t = 0.217 t = -0.989 
SectorTobacco:log(1 + HealthInvest) 
0.325** 1.150 -0.513 0.974 
t = 2.553 t = 0.938 t = -0.604 t = 0.678 
SectorFood Producers: 
log(1 + Fiscal_measures) 
-0.086** -0.081 0.012 0.069 
t = -2.234 t = -1.359 t = 0.216 t = 0.510 
Effectiveness:SectorFood Producers: 
StringencyScaled 
0.027* -0.009 0.029 0.097 
t = 1.647 t = -0.359 t = 0.323 t = 0.898 
Effectiveness:SectorHousehold Goods and 
Home Construction:StringencyScaled 
0.031* 0.019 -0.032 -0.086 
t = 1.848 t = 0.771 t = -0.285 t = -0.966 
Effectiveness:SectorBeverages: 
EconomicScaled 
-0.014 0.0004 -0.024* -0.032 
t = -0.868 t = 0.007 t = -1.678 t = -0.712 
Effectiveness:SectorFood Producers: 
EconomicScaled 
-0.027 0.014 -0.037*** -0.109** 
t = -1.501 t = 0.267 t = -2.877 t = -1.969 
Effectiveness:SectorLeisure Goods: 
EconomicScaled 
-0.044* -0.021 -0.025 0.279 
t = -1.656 t = -0.258 t = -1.237 t = 1.049 
Effectiveness:SectorBeverages: 
Import_change_previous 
-0.012 0.005 -0.076* -0.041 
t = -0.738 t = 0.150 t = -1.663 t = -0.523 
Effectiveness:SectorLeisure Goods: 
Import_change_previous 
0.025* 0.036 -0.065 -0.171 
t = 1.800 t = 0.837 t = -0.400 t = -1.184 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:SectorPersonal 
Goods:Import_change_previous 
-0.013 0.029 -0.070 -0.106* 
t = -1.128 t = 0.959 t = -1.393 t = -1.747 
Effectiveness:SectorTobacco: 
Import_change_previous 
0.061*** -0.079 -0.010 0.191 
t = 2.888 t = -0.828 t = -0.102 t = 1.104 
Effectiveness:SectorBeverages: 
log(1 + LaggedCaseChange) 
-0.003* -0.002 0.003 0.0001 
t = -1.861 t = -1.213 t = 0.774 t = 0.033 
Effectiveness:SectorHousehold Goods and 
Home Construction: 
log(1 + LaggedCaseChange) 
-0.004* 0.0003 0.001 0.004 
t = -1.889 t = 0.173 t = 0.173 t = 1.019 
Effectiveness:SectorLeisure Goods: 
log(1 + LaggedCaseChange) 
0.002 0.003* 0.008 0.004 
t = 0.597 t = 1.804 t = 0.465 t = 0.829 
Effectiveness:SectorPersonal Goods: 
log(1 + VaccineInvest) 
-0.009 0.003 0.022* 0.019 
t = -0.584 t = 0.137 t = 1.693 t = 0.407 
Effectiveness:SectorPersonal Goods: 
TestingScaled 
0.020 0.062* 0.067 0.049 
t = 0.915 t = 1.646 t = 1.236 t = 0.771 
Effectiveness:SectorTobacco:TestingScaled 
0.057*** 0.320 0.034 0.147 
t = 3.225 t = 1.036 t = 0.117 t = 0.548 
Effectiveness:SectorFood Producers: 
log(1 + HealthInvest) 
-0.002* -0.001 -0.001 -0.004 
t = -1.666 t = -0.355 t = -1.386 t = -1.046 
Effectiveness:SectorLeisure Goods: 
log(1 + HealthInvest) 
-0.002* -0.002 -0.001 0.017 
t = -1.846 t = -0.415 t = -0.192 t = 0.988 
Effectiveness:SectorTobacco: 
log(1 + HealthInvest) 
-0.003** -0.013 0.006 -0.010 
t = -2.415 t = -0.952 t = 0.647 t = -0.651 
Effectiveness:SectorFood Producers: 
log(1 + Fiscal_measures) 
0.001** 0.001 -0.0001 -0.001 
t = 2.232 t = 1.073 t = -0.096 t = -0.459 
Observations 71,689 71,689 63,479 63,479 
R2 0.251 0.183 0.329 0.051 
Adjusted R2 0.246 0.178 0.324 0.044 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
For the Consumer Goods industry we could not eliminate an independent variable as all of 
them had a significant effect on share prices in one of the regressions when including all 
companies in the sample. As only four companies in the sample are part of the Tobacco sector, 
it is difficult to rely on the results and derive insights for the sector in general. For that reason, 
we exclude it from our analysis here.  
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Countries with a one percentage point higher Government Effectiveness index have 0.023% 
higher share prices. When looking at the variable “Country” individually, Italy and Spain, the 
countries with the lowest Government Effectiveness index, have however 0.5021% and 
0.303% higher share prices. Thus, it is difficult to see big differences between the countries 
overall. Companies in the Household Goods and Home Construction sector have slightly 
higher share prices in Italy and slightly lower prices in the other countries.  
When analysing the effect of the different government actions, a higher “StringencyScaled” 
variable and thus more restrictive measures, have a small positive effect on share prices in 
countries with a lower government effectiveness. The higher the effectiveness, the smaller the 
effect, eventually this effect even turns negative. One reason for the changing effect of the 
variable could be that more effective governments are expected to enforce stricter measures 
more effectively and thus the same measures have a more restricting effect on businesses in 
these countries. However, in the Household Goods and Home Construction sector a one 
percentage point increase in the Stringency index decreases share prices by 0.0005% in 
Denmark, where “Effectiveness” is highest, and by 0.0008% in Italy, where “Effectiveness” 
is lowest. Therefore, in this sector we no longer see a noteworthy difference arising from the 
level of effectiveness. An increase in the Economic Support index does not have a significant 
effect on share prices in the Consumer Goods industry overall. There is however a significant 
increase in share prices for the Leisure Goods sector, which is smaller for countries with a 
higher government effectiveness. Investments in Health are associated with higher share prices 
in the Food Producers and Leisure Goods sector, again this effect is smaller when the 
government effectiveness is higher. It is surprising that in both cases the effect decreases when 
“Effectiveness” is increasing, as we would have expected the opposite due to the perceived 
ability of those governments to implement measures more effectively. With an increase in 
monthly imports there is a positive effect in the Leisure Goods sector which increases with a 
higher government effectiveness. A 1% increase in COVID-19 infections is associated with 
0.262% lower share prices. This supports our expectation as well as past literature, that an 
increase in COVID-19 cases leads to lower share prices. For more effective governments this 
effect is smaller. One reason could be that more effective countries are perceived as more 
capable of dealing with an increase in COVID-19 infections.  
When instrumenting for “EconomicScaled” and “StringencyScaled” individually, regressions 
(2) and (3), respectively, as well as jointly, regression (4), less variables have a significant 
effect on share prices. The insignificant, negative effect of “EconomicScaled” without using 
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any instruments – regression (1) – does not change when instrumenting for the variable in 
regression (2). However, when instrumenting for both variables, we see a positive effect of an 
increase in “StringencyScaled” on share prices in the Personal Goods sector as well as a 
positive effect of a higher Economic Support index on share prices in the Food Producers 
Sector. Instrumenting for the two potentially endogenous variables individually, regressions 
(2) and (3), does not seem to change the effect they have on share prices.  
Regression results including all companies where revenue information is 
available 
When considering only companies where revenue information is available, we were able to 
eliminate the independent variables “HealthInvest”, “Fiscal_measures”, “VaccineInvest”, 
“TestingScaled” and “Import_change_previous” as none of them had a significant effect on 
share prices in one of the regressions. As the companies belonging to the Tobacco sector did 
not report the percentage of revenue generated within the country of listing, the sector is no 
longer represented in the regressions.  
Countries with a one percentage point higher Government Effectiveness index have 0.033% 
higher share prices. Companies listed in Italy have 0.861% higher share prices, while there is 
no longer a significant positive effect for companies listed in Spain in this sample. Companies 
belonging to the Food Producers sector have higher share prices. For companies listed in the 
Nordics, where the Government Effectiveness index is higher, share prices in the Household 
Goods and Home Construction as well as in the Personal Goods sector are lower. While 
companies with a higher market capitalisation have higher share prices in Denmark, Norway, 
Spain and Sweden, this is not the case in the other countries. Companies, which are listed in 
Italy and generate a higher share of revenue in their home country, have lower share prices. 
As Italy has been hit by the COVID-19 pandemic worse than many other European countries, 
companies relying more on revenue generated in Italy might have had more difficulties to 
conduct business as usual. Furthermore, Italy is the country with the lowest perceived 
government effectiveness in the sample. Thus, there might have been higher uncertainty 
whether the government takes appropriate actions and whether the ones implemented work. 
The government actions do not have a significant effect on share prices in the smaller sample. 
This also holds for the daily COVID-19 cases, which have only a significant negative effect 
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on companies in the Household Goods and Home Construction sector. Therefore, we cannot 
find additional support for our hypotheses in the smaller sample.  
When instrumenting for “EconomicScaled” and “StringencyScaled”, we see that the sign of 
the variables’ coefficients changes. The insignificant, negative effect of “EconomicScaled” 
when using no instruments, turns into an insignificant, positive effect when instrumenting for 
the variable in regression (2). Furthermore, the positive coefficient of “StringencyScaled” in 
regression (1) turns negative across all IV regressions. This is closer to what we expected 
compared to the result without instrumenting. However, the effects are not statistically 
different from 0. Again, instrumenting for the two potentially endogenous variables does not 
seem to change the effect they have on share prices. As the adjusted R2 decreases significantly 
when instrumenting for “StringencyScaled”, the usefulness of the instrument is especially 
debatable. 
5.2.2 Results Consumer Services 
Regression results including all companies in the sample 
For the Consumer Services industry we were able to eliminate the independent variables 
HealthInvest, VaccineInvest, Fiscal_measures and Import_change_previous as none of them 
had a significant effect on share prices in any of the regressions when including all companies 
in the sample.  
Companies listed in France, Germany and Spain have slightly higher share prices compared 
to the other countries. The same holds for companies belonging to the Media sector. Here, the 
effect is bigger for companies that are listed in a country with a higher government 
effectiveness. 
When taking all interactions into account, a higher “StringencyScaled” and thus more 
restrictive measures, have a small positive effect on share prices in the Food and Drug 
Retailers, while the effect is negative in the General Retailers, Media as well as Travel and 
Leisure sectors. As food and drug retailers provide essential products, they were typically not 
subject to business closures. Being the only shops open during a lockdown, it is not surprising 
to see share prices increasing in this sector. Overall, the Stringency index has a remarkably 
small effect. We expected share prices in the Consumer Services industry to react especially 
negatively to stricter government actions as the industry relies more than others on a physical 
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customer interaction. The Economic Support index has no significant effect on share prices in 
the Consumer Services industry. Again, this contradicts our hypothesis as we expected the 
industry to benefit from economic support. One possible explanation could be that smaller and 
medium sized enterprises, which are not publicly listed – such as restaurants, hotels and 
hairdressers – were more strongly affected by the restrictions and also benefitted more from 
economic support packages than the listed companies in our sample. 
In interaction with government effectiveness, new COVID-19 cases have a negative impact 
on share prices. Furthermore, companies in the Media as well as Travel and Leisure sector 
experience a larger negative effect on their share prices. This is evidence for our expectation 
that higher COVID-19 case numbers decrease share prices, especially in the Travel and 
Leisure sector. However, it contradicts our expectation of the effect being smaller in countries 
with a higher “Effectiveness”.  
When instrumenting for “EconomicScaled” and “StringencyScaled” individually, regressions 
(2) and (3), respectively, as well as jointly, regression (4), less variables have a significant 
effect on share prices. There are no new significant effects arising when instrumenting for both 
potentially endogenous variables. However, the insignificant, negative effect of 
“EconomicScaled” in regression (1), turns into an insignificant positive effect when 
instrumenting for the variable in regression (2). This is closer to what we expected. When 
instrumenting for “StringencyScaled” in regressions (3) and (4) we no longer see a significant 
effect on share prices. 
Regression results including all companies where revenue information is 
available 
For the Consumer Services industry we could eliminate the independent variables 
HealthInvest, TestingScaled and Import_change_previous as none of them had a significant 
effect on share prices in all regressions when including only companies with revenue 
information.  
In France companies which generate a higher share of revenue within their home country have 
slightly higher share prices. In the smaller sample we see similar effects of the Stringency and 
Economic support index as in the larger sample. Additionally, we see that higher fiscal 
measures are associated with higher share prices in the General Retailers sector for companies 
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listed in the GUFIS. This effect is smaller for companies with a higher effectiveness. This 
result contradicts our expectations that government actions have a higher effect in countries 
where the effectiveness is high. However, the countries in which share prices dropped the most 
are the countries with a lower effectiveness. Hence, fiscal measures might have had a bigger 
effect there than in the Nordics where share prices recovered more quickly. Higher COVID-
19 infection numbers lead to lower share prices. In the Food and Drug Retailers sector, the 
effect is again bigger in countries with a higher government effectiveness. However, for the 
other sectors, “Effectiveness” reduces the negative effect of COVID-19 infections and thus 
supports our hypothesis in the smaller sample. Overall, we do not see big differences for the 
smaller sample.  
When instrumenting for “EconomicScaled” and “StringencyScaled”, less variables have a 
significant effect on share prices. There are no new significant effects arising when 
instrumenting for the two potentially endogenous variables jointly. However, as in the larger 
sample, the insignificant, negative effect of “EconomicScaled” in regression (1), turns into an 
insignificant positive effect when instrumenting for the variable in regression (2). This is again 
closer to what we expected. When instrumenting for “StringencyScaled” in regressions (3) 
and (4) we no longer see a significant effect on share prices. 
5.2.3 Results Health Care 
Regression results including all companies in the sample 
For the Health Care industry, we were able to eliminate the independent variables 
TestingScaled and VaccineInvest as they had no significant effect on share prices in any of 
the regressions when including all companies in our sample.  
Companies that belong to the Health Care industry and are listed in Germany, Italy and 
Norway have lower share prices than companies listed in the other countries. We cannot see a 
single trend of the company size impacting share prices in the Health Care industry. 
The different levels of the Stringency index have no significant effect on share prices in the 
respective country. This is not surprising as the Health Care industry was exposed to stricter 
government actions mostly through production constraints during hard lockdowns but was 
otherwise less affected. The Economic Support index has a small positive effect in countries 
where the Government Effectiveness index exceeds 83. For companies that belong to the 
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Pharmaceuticals and Biotechnology sector a one percentage point higher index increases share 
prices by another 0.0214%. A higher “VaccinationScaled” has a positive effect on share prices 
in all countries, this effect increases with effectiveness. The positive effect is bigger for 
companies that belong to the Pharmaceuticals and Biotechnology sector. This is a coherent 
result because companies that produce COVID-19 vaccines or products associated with it, are 
typically part of the Pharmaceuticals and Biotechnology sector and can therefore directly 
profit from an increasing vaccination policy of a country. Here, the effect decreases with 
higher effectiveness. Fiscal measures have a positive effect on share prices, this effect is larger 
for more effective countries in the Health Care Equipment & Services sector, while the 
effectiveness does not play a large role in the Pharmaceuticals and Biotechnology sector. 
Higher COVID-19 cases have a small negative impact on share prices in the Pharmaceuticals 
and Biotechnology sector. As the expected demand for COVID-19 drugs should increase with 
higher COVID-19 infections, this result is partly contradicting the assumption that the sector 
profits from more COVID-19 drug sales. The impact is less severe for countries with a higher 
effectiveness.  
When instrumenting for “EconomicScaled” and “StringencyScaled” individually, regressions 
(2) and (3), respectively, as well as jointly, regression (4), less variables have a significant 
effect on share prices. There are no new significant effects arising from the two potentially 
endogenous variables. The significant, negative effect of “EconomicScaled” in regression (1), 
turns into an insignificant effect when instrumenting for the variable. In regression (2) this 
effect, even if insignificant, turns positive. This is closer to what we expected than the results 
without instrumenting. However, in regression (2) we can also see a significant negative effect 
in the interaction of “EconomicScaled” with “Effectiveness”, turning the overall effect 
negative and hence contradicting our hypothesis that “EconomicScaled” can either have a 
positive or no effect on an industry. Furthermore, it halves the adjusted R2 and it is therefore 
questionable whether the instrument can be validly used in the industry.  
In general, the Health Care industry benefitted from the COVID-19 crisis due to increased 
demand in health care products and services. However, the increased demand for health care 
supply was not equally distributed, but relevant only for certain products as face masks, 
disinfectants or respirators. Therefore, not all companies of the industry benefitted in the same 
way.  
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Regression results including all companies where revenue information is 
available 
For the Health Care industry, we could again eliminate the independent variables 
TestingScaled and VaccineInvest as they had no significant effect on share prices in any of 
the regressions when including only the companies with available revenue information. 
Hence, the same variables as in the bigger sample were excluded. 
Companies that belong to the Health Care industry and have a higher Government 
Effectiveness index have lower share prices. Companies that are listed in Norway have slightly 
higher share prices. In Germany and the UK, companies with a higher market capitalisation 
have lower share prices, in all other countries the opposite effect can be observed. 
None of the government actions nor the percentage generated in the home country have a 
significant effect on share prices in the smaller sample. It seems that the small sample of 
companies is less exposed to the government actions than the overall dataset. The insignificant, 
negative effect of “EconomicScaled” without instrumenting, does not change when 
instrumenting for both variables in regression (4), but turns into a positive, insignificant effect 
in regression (2). This is closer to what we expected than the results without instrumenting. In 
this sample the adjusted R2 decreases significantly when instrumenting for “StringencyScaled” 
(3). Overall, it is therefore questionable whether the instrument should be used in the industry.  
5.2.4 Results Technology 
Regression results including all companies in the sample 
For the Technology industry, we were able to eliminate the independent variables HealthInvest 
and VaccineInvest because they had no significant effect on share prices in any of the 
regressions when including all companies in our sample. 
In the Technology industry, share prices increase in all countries, ranging from 4.65 % in 
France to 5.15% in Denmark. Companies with a one percentage point higher market 




The Stringency index as well as the Economic Support index does not have a significant effect 
on share prices in the Technology industry. The insignificance of “StringencyScaled” 
contradicts our hypothesis that the technology industry benefits from the closure of institutions 
and businesses, due to an increasing demand for digital solutions to work at home as well as 
home office technology hardware. “VaccinationScaled” has a negative impact on share prices 
of companies listed in a country where the Government Effectiveness index is below 94.6 and 
therefore has only a negative effect on the GUFIS.  
The insignificant, negative effect of “EconomicScaled” without instrumenting, turns into a 
positive effect when instrumenting for the variable. This effect is significant at the 10%-level 
in regression (2). This shows that government support has a positive effect on the share prices 
of companies in the Technology industry. In this regression there are also some new significant 
effects, which however cannot be found when also instrumenting for “StringencyScaled” (4). 
As there are no significant effects in the regression where we instrument only for 
“StringencyScaled” (3) and the adjusted R2 is significantly lower, it is questionable whether 
the instrument should be used in the industry. 
Regression results including all companies where revenue information is 
available 
In the small sample, we could eliminate the independent variables TestingScaled, HealthInvest 
and VaccineInvest as they had no significant effect on share prices in any of the regressions. 
When considering only companies for which revenue information is available, companies that 
are listed in countries with a higher Government Effectiveness index have lower share prices. 
However, as the coefficients of countries with a high effectiveness (Norway and Sweden) are 
positive and the coefficients of the countries with the lowest effectiveness (Italy and Spain) 
are negative there does not seem to be a big difference across countries overall. Companies 
with a by one percentage point higher market capitalisation have by 2.73% and 1.52% higher 
share prices in Denmark and Italy, respectively, while it is by 1.17% lower in Spain. The effect 
is neglectable in the other countries. Hence, the company size seems to play a bigger role in 
the countries with low sample sizes, such as Denmark, Italy and Spain where less than 15 
companies are part of the Technology industry. 
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Companies listed in Norway and Spain that generate a higher percentage of their revenue 
within their home countries, have higher share prices. This effect is significantly bigger in 
Spain, while it does not play a role in other countries. The Stringency index has a positive 
effect on share prices in the Software & Computer Services sector for companies that are listed 
in Italy, where the Government Effectiveness index is below 77. A possible explanation for 
that could be that especially in the beginning of the pandemic, Italy experienced severe 
lockdowns through which the demand for digital solutions in different areas of life increased. 
The effect is negative for the countries with a higher effectiveness score, implicating that 
companies in the Software & Computer Services sector, listed in these countries, experienced 
declining share prices when government actions got more restrictive. Again, this is 
contradicting our original hypothesis.  
An opposite trend can be seen for the Hardware and Equipment sector. Here, 
“StringencyScaled” has a positive effect on share prices of companies in countries where the 
effectiveness score is above 83.8. “VaccinationScaled” has a negative impact on share prices 
of companies in the Software & Computer Services sector listed in a country where the 
Government Effectiveness index is below 95.88, therefore for all countries outside the 
Nordics. Again, the effect works the opposite way in the Hardware and Equipment sector 
where it has a negative effect in the Nordics. It is interesting that the Nordics follow an 
opposing trend compared to the GUFIS, which shows that there seems to be structural 
differences between the two regions across the technology industry. However, there are only 
two technology companies in Denmark and three in Norway, therefore there could be a small 
sample bias.  
When instrumenting for “EconomicScaled” and “StringencyScaled”, many variables still have 
a significant effect on share prices similar to the regression where we do not instrument (1). 
The insignificant, negative effect of “EconomicScaled” without instrumenting, turns into an 
insignificant, positive effect when instrumenting for the variable. Furthermore, we can see an 
increased adjusted R2. However, this sample is significantly smaller with only two companies 
listed in Denmark, three in Norway and five in Spain. This could lead to a small sample 
selection bias in our sample, which would also explain why the adjusted R2 is significantly 
higher in comparison to the full technology dataset and why there are many country 
interactions that are highly significant. 
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5.2.5 Cross-industry comparison 
Combining all insights from the different industry regressions, the results are similarly 
heterogeneous as those of the country regressions. No country out- or underperformed across 
all industries. Furthermore, no industry was exceptionally influenced by the government 
actions. In the cases where the “StringencyScaled” coefficient is significant, we see both 
negative and positive effects on the share prices in the focus industries. This is in line with 
what we see in the country regressions. In the full sample regressions “EconomicScaled” has 
no significant influence on the share prices, except for more effective countries in the Health 
Care industry and the Leisure Goods sector, where the effect is positive. The insignificant or 
even positive impact of the Economic Support index in most industries is more in line with 
what we expected than the results that we see in our country regressions, where it also has 
negative effects in some cases. This could be due to the low variety of the index within a 
country and hence within our country regressions. The stand-alone impact of “Effectiveness” 
depends on the industry, for example it has a negative impact on share prices in the Consumer 
Services industry and a positive impact in the Technology industry. Our hypothesis that the 
effect of government actions is bigger in more efficient countries does not always hold. 
Increasing COVID-19 infections have, as expected, a negative impact on the Consumer 
Goods, Consumer Services and Health Care industries. For the Technology industry the results 
are insignificant, which is also in line with our hypotheses. 
The percentage of revenue generated within the country of listing has no consistent cross-
country effect on share prices in one industry. In Consumer Goods it has a negative effect on 
share prices of companies listed in Italy, in Consumer Services it has a positive effect in France 
and in Technology it has a positive effect in Norway and Spain. While in the country 
regressions, companies with a higher percentage of revenue generated in Denmark, Italy, 
Norway and Sweden show higher share prices, this cannot be seen in a cross-country 
comparison within industries.  
Overall, instrumenting for “EconomicScaled” seems to work partially. In the full samples, 
except for Consumer Goods, the negative coefficients of the variable when using no 
instruments, turn positive when using “GDPprevious” as an instrument. In the small samples 
this applies to all industries. However, these results are in the most cases insignificant. 
Instrumenting for “StringencyScaled” leaves us with mostly insignificant coefficients of the 
variable and significantly lower adjusted R2s. One possible reason is that the instrument 
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“CaseChange_2weeks” is not capturing the effect of “StringencyScaled” well and therefore 
does not provide good estimates for the variables. Another possible explanation is that the 
instrument works and the Stringency index simply does not have explanatory power for share 
prices. Although there might be issues with the measurement of the index (see section 3) and 
we hypothesised different effects for the industries, we consider it unlikely that the variable 
has no effect on share prices in any industry. Hence, we assume that the instrument is not well 




6. Conclusion  
In this paper, we have investigated the impact of government actions on share prices in 
different industries during the COVID-19 pandemic in eight European countries. We 
contribute to the existing literature by analysing the effect of the COVID-19 pandemic on 
European stock markets using company-level data. We study the effect of government actions 
both across industries within a country as well as within an industry across countries. Our time 
period includes both the first and second waves of COVID-19 infections in Europe. This 
allows to draw conclusions over the course of the pandemic that are not limited to the initial 
shock only. 
We included all listed companies in Denmark, France, Germany, Italy, Norway, Spain, 
Sweden and the UK in our panel dataset. In our data analysis we see that share price 
development differed in our four focus industries as well as their sectors. Companies in the 
Consumer Goods and Consumer Services industries recovered more slowly, while companies 
in the Health Care and Technology industries recovered faster from the initial stock market 
shock in February and March 2020.  
We ran both country and industry regressions to capture the effect of government actions on 
share prices in different industries. The country regressions allowed us to compare the impact 
of the same government action on different industries. The industry regressions enabled us to 
compare the impact of different (national) government actions within the same industry. As 
the information of revenue generated within the country of listing is not available for all 
companies, and reduced our sample significantly, we ran – both on industry- as well as 
country-level – two sets of regressions, where only one includes the revenue information.  
In our country regressions, we do not see an effect of government actions on share prices that 
holds for all industries across all countries. In Denmark, Germany, Norway, and the UK, we 
see that more restrictive measures, as expected, affect share prices negatively. We see a 
positive effect of economic support only in Germany and Italy, which is surprising as we 
expected a positive effect across all countries. As also evident in previous research and in line 
with our expectations, increasing COVID-19 infections affect share prices negatively across 
all countries. However, it does not affect all industries across the eight countries to the same 
extent.  
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In our industry regressions, our results are similarly heterogeneous. No country out- or 
underperformed across all industries. Furthermore, no industry was exceptionally influenced 
by the government actions. We can see both positive and negative effects of stricter measures 
on share prices across industries, which is consistent with what we see in the country 
regressions. We see a positive effect of economic support in the Health Care industry and the 
Leisure Good sector, while it is otherwise insignificant. This is partly in line with our 
expectation. We cannot find enough evidence supporting our hypothesis that the perceived 
government effectiveness amplifies the impact of government actions on share prices, which 
is surprising. Again, we see a negative impact of increasing COVID-19 infections in the 
Consumer Goods, Consumer Services and Health Care industries, while the result is 
insignificant in the Technology industry. This is in line with our expectations, since infections 
certainly adversely affect physical consumer purchasing and services but boosted the 
consumption of technology. 
We were concerned by the seeming ineffectiveness of economic support and wondered if this 
was due to an endogeneity issue. Instrumenting for potential endogeneity in our economic 
support variable seems to work partially. In some industry regressions, it turns the coefficients 
from negative to positive; however, the results are insignificant in most cases. Instrumenting 
for government stringency leaves us with mostly insignificant coefficients of the variable and 
significantly lower adjusted R2s. Hence, we assume that our instrument for stringency is not 
powerful enough to predict accurately the potentially endogenous variable. 
There are some other issues that could impair our results. Although the sector classification 
within our industries allows us to group companies according to more precise business areas, 
and thus to test policy impact on a sector-level, there can still be very different companies 
within a sector. This can make it difficult to identify an effect that applies to all companies in 
the same way and might therefore explain insignificant coefficients in our industry regressions. 
Furthermore, our underlying data for government actions are an imperfect measure of the 
magnitude of a country’s stringency measures and economic support. Nonetheless, we do see 
differences between the European countries. But these differences might not be captured by 
the indices in the granularity needed to see a clear differentiable impact on share prices across 
countries.  
A general issue with analysing the effect of government actions on share prices is the time 
governments need to introduce new restrictions. As share prices, according to the EMH, 
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instantly reflect publicly available information, any rumours of new measures will be 
incorporated into share prices before the official and final decision is made. It is therefore 
difficult to capture the effect directly as a change in the index. However, using the levels, 
which typically stay constant over some time, enables us to compare the effect of different 
countries’ levels. 
This paper offers insights on share price development of listed companies across different 
industries and sectors in Europe during the COVID-19 pandemic. Although it is still unclear 
when this pandemic will be over and the world economy will have fully recovered, our results 
already provide indications of the medium-term development of the various industries. While 
government actions seem to play a small role in share price developments in the short- to 
medium-term, the magnitude of actions is likely to have a lasting impact on the economic 
development and thus share prices in the long-term. We leave the investigation of this question 
for future research.  
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Appendix 1 Share price changes in the Nordics  
Figure A1. 1: Timeline of average daily share price changes in the Nordics 
 
The share price changes across the eight different countries have been similar during the first 
year of the pandemic with small outliers. There has been a higher volatility during the first 
wave and less extreme daily changes during the second wave.  
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Appendix 2 Timeline of the most important developments during the 
COVID-19 pandemic 
The following timeline provides an overview of the development of the COVID-19 pandemic 
and reactions in the EU as documented by the European Centre for Disease Prevention and 
Control (ECDC) (2021) and Think Global Health (TGH) (2021). 
Table A2. 1: Timeline of the most important developments during the COVID-19 pandemic 
2019  
On 31 December 2019 The Wuhan Municipal Health Commission in Wuhan City, 
Hubei province, China, reported a cluster of pneumonia cases 
(including seven severe cases) of unknown aetiology, with a 
common reported link to Wuhan's Huanan Seafood Wholesale 
Market, a wholesale fish and live animal market (ECDC, 2021). 
2020  
On 1 January 2020 The market was closed down. According to the Wuhan 
Municipal Health Commission, samples from the market tested 
positive for a novel coronavirus. Cases showed symptoms such 
as fever, dry cough and dyspnoea. Radiological findings showed 
bilateral lung infiltrates (ECDC, 2021). 
On 9 January 2020 The Chinese Center for Disease Control and Prevention reported 
that a novel coronavirus (later named SARS-CoV-2, the virus 
causing COVID-19) had been detected as the causative agent for 
15 of the 59 cases of pneumonia (ECDC, 2021). 
On 10 January 2020 The first novel coronavirus genome sequence was made publicly 
available (ECDC, 2021). 
On 11 January 2020 China reported the first death related to the novel coronavirus 
(ZDF, 2020a). 
By 20 January 2020 There were reports of confirmed cases from three countries 
outside China: Thailand, Japan and South Korea. These cases had 
all been exported from China (ECDC, 2021). 
On 23 January 2020 Wuhan City was locked down – with all travel in and out of 
Wuhan prohibited – and movement inside the city was restricted 
(ECDC, 2021). 
On 24 January 2020 The first European case was reported in France. This case had a 
travel history to China. On 28 January 2020, Germany, also 
reported cases, related to a person visiting from China (ECDC, 
2021). 
On 30 January 2020 The World Health Organization (WHO) declared this first 
outbreak of novel coronavirus a ‘public health emergency of 
international concern’ (ECDC, 2021). 
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On 15 February 2020 France reports the first death related to the coronavirus in Europe. 
(TGH, 2021). 
On 22 February 2020 And over the following days, the Italian authorities reported 
clusters of cases in several regions (Lombardy, Piedmont, Veneto 
etc). During the following week, several European countries 
reported cases of COVID-19 in travellers from the affected areas 
in Italy, as well as cases without epidemiological links to Italy, 
China or other countries with ongoing transmission (ECDC, 
2021). 
On 8 March 2020 Italy issued a decree to install strict public health measures 
including social distancing, starting in the most affected regions 
and on 11 March 2020 extending these measures at national 
level. Following this, Spain, France and many other European 
countries installed similar public health measures (ECDC, 2021). 
On 9 March 2020 Italy announced nation-wide lockdown (TGH, 2021). 
On 10 March 2020 Coronavirus is reported in all 26 EU member states (TGH, 2021). 
On 11 March 2020 The Director General of the WHO declared COVID-19 a ‘global 
pandemic’ and Italy closes all shops and venues across the 
country (TGH, 2021). 
On 12 March 2020 France closes all schools in the country (TGH, 2021). 
On 16 March 2020 France, Germany, Spain follow the example Denmark (13 
March) to close country borders (TGH, 2021). 
On 17 March 2020 The European Commission introduced travel restriction from 
third countries into the European Union for 30 days with 
immediate effect (European Commission, 2020). 
On 22 March 2020 Germany introduces a contact ban, banning groups of more than 
two people (TGH, 2021). 
On 23 March 2020 UK announced national lockdown (TGH, 2021). 
On 3 April 2020 The number of confirmed COVID-19 cases reported worldwide 
surpassed one million (ECDC, 2021). 
During the course of 
April 2020 
Many EU/EEA countries started to adjust their response 
measures (i.e., the gradual opening of schools, small shops and 
other businesses) (ECDC, 2021). 
On 23 April 2020 Germany approves first trials for coronavirus vaccine (TGH, 
2021) and the number of confirmed cases of COVID-19 in the 
EU/EAA and the United Kingdom (UK) surpassed one million 
(ECDC, 2021). 
During the course of 
June and July 2020 
Many EU/EEA countries started to reopen their borders (TGH, 
2021). 
On 14 July 2020 The first potential coronavirus vaccine of Moderna was tested in 
humans, showing a positive immune response (TGH, 2021). 
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On 20 July 2020 EU negotiates a $859bn Covid-19 stimulus package (TGH, 
2021). 
During the course of 
August and September 
2020 
Many European countries were hit by a 2nd wave of Covid-19 
(TGH, 2021). 
On 29 September 2020 The number of COVID-19 deaths worldwide surpassed 1 million 
(ECDC, 2021). 
Starting the second 
half of October 2020 
Many European countries reintroduced stricter regulations as 
well as regional and nationwide lockdowns (TGH, 2021). 
On 9 November 2020 The number of confirmed COVID-19 cases worldwide surpassed 
50 million (ECDC, 2021). 
On 2 December 2020 The UK grants the world’s first emergency use authorization to 
the Pfizer-BioNTech vaccine candidate (TGH, 2021). 
On 8 December 2020 The UK identifies a new variant of SARS-CoV-2 that appears to 
be more transmissible and begins its nationwide Covid-19 
immunization campaign (TGH, 2021). 
On 20 December 2020 Several EU countries impose travel restrictions on the UK due to 
the new Covid-19 variant (TGH, 2021). 
On 27 December 2020 Official start of vaccination in the EU and in Norway (Reuters, 
2020 and Norwegian Institute of Public Health, 2021). 
2021  
On 7 January 2021 Pfizer-BioNTech vaccine is reported as effective against 
mutations in new Covid-19 variants (TGH, 2021). 
On 19 January 2021 EU announces its target to vaccinate at least 70 % of adults by 
summer 2021 (TGH, 2021). 
On 4 February 2021 The number of confirmed COVID-19 cases worldwide surpassed 
100 million (ECDC, 2021). 





Appendix 3 Development of the Stringency index and COVID-19 
infections per country 
 
Figure A3. 1:  Development of the 
Stringency index and daily COVID-19 
infections in Denmark 
  
Figure A3. 2: Development of the 
Stringency index and daily COVID-19 
infections in France 
 
Figure A3. 3: Development of the 
Stringency index and daily COVID-19 
infections in Germany 
 
Figure A3. 4: Development of the 
Stringency index and daily COVID-19 
infections in Italy 
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Figure A3. 5: Development of the 
Stringency index and daily COVID-19 
infections in Norway 
 
Figure A3. 6: Development of the 
Stringency index and daily COVID-19 
infections in Spain 
 
  
Figure A3. 7: Development of the 
Stringency index and daily COVID-19 
infections in Sweden 
  
Figure A3. 8: Development of the 
Stringency index and daily COVID-19 







Appendix 4 Composition of the OxCGRT indices and description of the 
indicators 
Table A4. 1: Composition of the four indices of the OxCGRT (on the basis of Hale et al., 2020) 












Closures and  
Containment 
C1 x x x   
C2 x x x   
C3 x x x   
C4 x x x   
C5 x x x   
C6 x x x   
C7 x x x   
C8 x x x   
Economic Measures 
E1 x     x 
E2 x     x 
E3         
E4         
Health Measures 
H1 x x x   
H2 x x     
H3 x x     
H4         
H5         
H6 x x     
H7 x x     




Table A4. 2: Description of the indicators of the OxCGRT (on the basis of Hale et al., 2020) 
Indicator Description Scale 
C1 Record closings of schools and universities 0 to 3 
C2 Record closings of workplaces 0 to 3 
C3 Record cancelling of public events 0 to 2 
C4 Record the cut-off size for bans on private gatherings 0 to 4 
C5 Record closing of public transport 0 to 2 
C6 Record orders to "shelter-in-place" and otherwise confine to home 0 to 3 
C7 Record restrictions on internal movement 0 to 2 
C8 Record restrictions on international travel 0 to 4 
E1 
Record if the government is covering the salaries or providing 
direct cash payments, universal basic income, or similar, of 
people who lose their jobs or cannot work. (include payments to 
firms if explicitly linked to payroll/salaries) 
0 to 2 
E2 
Record if government is freezing financial obligations (e.g., 
stopping loan repayments, preventing services like water from 
stopping, or banning evictions) 
0 to 2 
E3 What economic stimulus policies are adopted? Monetary value in USD 
E4 Announced offers of COVID-19 related aid spending to other countries 
Monetary  
value in USD 
H1 Record presence of public information campaigns 0 to 2 
H2 Who can get tested? 0 to 3 
H3 Are governments doing contact tracing? 0 to 2 
H4 Short-term spending on, e.g., hospitals, masks, etc. Monetary  value in USD 
H5 Announced public spending on vaccine development Monetary  value in USD 
H6 Record policies on the use of facial coverings outside the home 0 to 4 
H7 Record policies for vaccine delivery for different groups 0 to 5 








Appendix 5 Development of OxCGRT indices per country over time 
 
Figure A5. 1: Development of OxCGRT 
indices in Denmark 
  
Figure A5. 2: Development of OxCGRT 
indices in France 
 
Figure A5. 3: Development of OxCGRT 
indices in Germany 
 
Figure A5. 4: Development of OxCGRT 
indices in Italy 
 
Figure A5. 5: Development of OxCGRT 
indices in Norway 
 
Figure A5. 6: Development of OxCGRT 
indices in Spain 
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Figure A5. 7: Development of OxCGRT 
indices in Sweden 
 
Figure A5. 8: Development of OxCGRT 






Appendix 6 Industry summaries 
Appendix 6.1 Overview of industry and sector share of companies in sample 
Table A6. 1: Overview of company shares per industry within countries 






















  % % % % % % % % % % 
Basic Materials 1.1 1.5 4.2 3.1 4.6 7.0 2.2 1.8 2.9 4.6 
Consumer Goods 10.1 11.8 13.2 14.4 10.7 9.2 15.9 17.2 9.5 11.5 
Consumer Services 12.2 5.9 15.8 14.2 11.9 8.5 14.8 11.9 5.2 5.7 
Financials 28.7 13.2 13.4 11.3 26.8 19.9 17.3 18.1 19.7 24.1 
Health Care 10.1 22.1 11.6 12.5 6.3 7.0 4.1 4.8 5.2 8.0 
Industrials 22.9 32.4 21.6 23.5 17.4 23.7 23.9 25.1 22.8 27.6 
Oil & Gas 2.1 2.9 2.8 3.7 2.8 2.5 3.0 3.5 18.5 8.0 
Technology 11.2 8.8 14.6 14.4 14.2 16.1 11.3 10.6 9.8 6.9 
Telecommunications 0.0 0.0 0.5 0.6 1.6 2.5 1.9 1.3 1.2 2.3 
Utilities 1.1 1.5 2.0 2.3 2.8 3.5 5.5 5.7 3.2 1.1 
N/A 0.5 0.0 0.3 0.0 1.0 0.0 0.0 0.0 2.0 0.0 
  100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 

















Sample   
 % % % % % % % %   
Basic Materials 5.3 5.5 5.4 4.7 11.0 9.8 6.1 6.2   
Consumer Goods 8.5 7.9 8.7 10.7 7.7 7.4 10.0 10.5   
Consumer Services 10.6 11.0 8.9 7.4 13.9 14.9 12.2 11.7   
Financials 26.1 26.0 13.7 20.8 21.4 16.4 19.7 17.6   
Health Care 6.4 7.1 21.4 16.4 7.7 7.1 10.2 9.6   
Industrials 21.8 21.3 20.5 26.0 18.9 23.8 20.2 24.5   
Oil & Gas 5.3 4.7 2.5 1.6 8.1 7.6 5.4 4.7   
Technology 7.4 8.7 14.3 11.2 8.8 10.7 11.9 11.8   
Telecommunications 2.7 2.4 0.9 0.5 0.9 1.1 1.1 1.2   
Utilities 4.3 5.5 0.8 0.5 1.3 1.2 2.1 2.2   
N/A 1.6 0.0 3.0 0.0 0.3 0.0 1.0 0.0   






Table A6. 2: Overview of company shares per sectors overall 
  
All listed companies Sample 
 #  %  #  % 
Basic Materials      308           6.1  146 6.2 
Chemicals        94           1.9  48 2.0 
Forestry & Paper        26           0.5  17 0.7 
Industrial Metals & Mining        47           0.9  24 1.0 
Mining      141           2.8  57 2.4 
Consumer Goods      507         10.0  247 10.5 
Automobiles & Parts        58           1.1  30 1.3 
Beverages        59           1.2  28 1.2 
Food Producers      112           2.2  52 2.2 
Household Goods & Home Construction        97           1.9  48 2.0 
Leisure Goods        81           1.6  39 1.7 
Personal Goods        96           1.9  46 1.9 
Tobacco         4           0.1  4 0.2 
Consumer Services      618         12.2  276 11.7 
Food & Drug Retailers        27           0.5  15 0.6 
General Retailers      187           3.7  89 3.8 
Media      213           4.2  84 3.6 
Travel & Leisure      191           3.8  88 3.7 
Financials      993         19.7  417 17.7 
Banks      139           2.8  71 3.0 
Equity Investment Instruments        26           0.5  10 0.4 
Financial Services      459           9.1  169 7.2 
Life Insurance        11           0.2  8 0.3 
Nonequity Investment Instruments        39           0.8  4 0.2 
Nonlife Insurance        39           0.8  27 1.1 
Real Estate Investment & Services      260           5.2  118 5.0 
Real Estate Investment Trusts        20           0.4  10 0.4 
Health Care      515         10.2  226 9.6 
Health Care Equipment & Services      217           4.3  87 3.7 
Pharmaceuticals & Biotechnology      298           5.9  139 5.9 
Industrials   1,022         20.2  578 24.5 
Aerospace & Defense        44           0.9  31 1.3 
Construction & Materials      155           3.1  99 4.2 
Electronic & Electrical Equipment      184           3.6  97 4.1 
General Industrials        56           1.1  42 1.8 
Industrial Engineering      194           3.8  108 4.6 
Industrial Transportation      114           2.3  60 2.5 
Support Services      275           5.4  141 6.0 
Oil & Gas      272           5.4  112 4.7 
Alternative Energy        70           1.4  29 1.2 
Oil & Gas Producers      136           2.7  61 2.6 
Oil Equipment, Services & Distribution        66           1.3  22 0.9 
Technology      599         11.9  278 11.8 
Software & Computer Services      477           9.5  221 9.4 
Technology Hardware & Equipment      122           2.4  57 2.4 
Telecommunications        54           1.1  19 1.2 
Fixed Line Telecommunications        20           0.4  12 0.5 
Mobile Telecommunications        34           0.7  17 0.7 
Utilities      106           2.1  53 2.2 
Electricity        78           1.5  32 1.4 
Gas, Water & Multiutilities        28           0.6  21 0.9 
N/A        53           1.1  0                                       0.0 




Appendix 6.2 Industry data analysis 
Appendix 6.2.1 Basic Materials industry 
Figure A6. 1: Share price development in the Basic Materials industry across countries 
 
The Basic Materials industry holds 6.2% of companies within the sample. It is most prominent 
in Germany and the UK where 7% and 9.8% of all companies in the sample belong to the 
industry, respectively. However, when looking at all listed companies, only 4.6% of 
companies listed in Germany belong to the Basic Materials industry, while it is 11% of 
companies listed in the UK (also see Table A6.1 for details on all countries). The industry 
plays a small role in Denmark and Italy where less than 2% of listed companies are part of the 
industry. In France, Italy, Sweden, and the UK scaled share price levels were on average above 
the starting level of 100. In Spain, the mean and median levels were significantly lower than 
in the other countries, at 80.9 and 75.9, respectively. In the Nordics, Italy, and Spain the mean 
and median values of the market capitalisation were close to each other while there seem to 
be few large companies in the rest of the GUFIS that drive the mean market capitalisation 
upwards. Italy, Denmark, and Spain have on average much smaller companies in terms of 
market capitalisation, while the average in France is the largest. As there is only one company 
listed in Denmark that is part of the Basic Materials industry, the SP Group A/S, it is difficult 
to compare it to the other countries as the numbers do not show an average of multiple 
companies but provide only information about one company. 
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See the table below for a summary of the development of scaled average share prices as well 
as market capitalisations per country in the Basic Materials industry. 
Table A6. 3: Summary of the development of scaled average share prices and market 
capitalisation per country in the Basic Materials industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 95.0 (19.4) 102 (8.13) 92.2 (13.0) 
   Median [Min, Max] 94.4 [55.4, 147] 106 [75.3, 111] 91.6 [60.5, 116] 
Market Cap (in €m.)    
   Mean (SD)  577 (NA) 6,940 (17,800) 6,150 (13,800) 
   Median [Min, Max] 577 [577, 577] 419 [24.9, 60,100] 1,050 [3.73, 64,500] 
# Companies 1 11 22 
% Within sample 1.5 3.1 7 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 104 (14.6) 98.9 (13.1) 80.9 (11.3) 
   Median [Min, Max] 99.9 [72.5, 138] 96.0 [72.7, 137] 75.9 [62.5, 103] 
Market Cap (in €m)    
   Mean (SD)  495 (613) 5,890 (4,890) 692 (976) 
   Median [Min, Max] 265 [46.5, 1,400] 5,620 [1,620, 10,700] 261 [5.67, 2,770] 
# Companies 4 4 7 
% Within sample 1.8 4.6 5.5 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 106 (13.7) 101 (17.5) 97.5 (16.1) 
   Median [Min, Max] 102 [74.3, 135] 101 [61.3, 142] 97.3 [55.4, 147] 
Market Cap (in €m)    
   Mean (SD)  4,800 (4,580) 5,610 (22,100) 5,290 (17,900) 
   Median [Min, Max] 3,550 [31.9, 12,800] 109 [2.49, 147,000] 271 [2.49, 147,000] 
# Companies 17 80 146 




Appendix 6.2.2 Consumer Goods industry 
Table A6. 4: Summary of the development of scaled average share prices and market 
capitalisation per country in the Consumer Goods industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 102 (11.8) 99.1 (10.8) 89.1 (12.2) 
   Median [Min, Max] 102 [69.8, 126] 97.7 [72.4, 121] 89.5 [57.1, 110] 
Market Cap (in €m)    
   Mean (SD)  6,920 (8,710) 15,800 (47,400) 13,100 (24,900) 
   Median [Min, Max] 2,900 [57, 20,300] 649 [13.6, 272,000] 429 [8.25, 94,900]  
# Companies 8 51 29 
% Within sample 11.8 14.4 9.2 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 95.0 (12.1) 91.4 (5.09) 95.1 (8.66) 
   Median [Min, Max] 95.2 [65.1, 121] 90.5 [77.4, 104] 93.6 [75.3, 114] 
Market Cap (in €m)    
   Mean (SD)  1,320 (2,890) 3,700 (3,420) 1,160 (1,290) 
   Median [Min, Max] 136 [9.780, 13,600] 2,750 [298, 10,500] 455 [11.5, 2,740] 
# Companies 39 10 10 
% Within sample 17.2 11.5 7.9 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 118 (16.9) 93.8 (4.91) 97.8 (13.8) 
   Median [Min, Max] 118 [80.9, 150] 94.2 [76.5, 104] 95.7 [57.1, 150] 
Market Cap (in €m)    
   Mean (SD)  2,650 (4,320) 6,800 (19,700) 7,530 (25,700) 
   Median [Min, Max] 742 [29.3, 17,600] 544 [2.44, 113,000] 546 [2.44, 272,000] 
# Companies 39 61 247 
% Within sample 10.7 7.4 10.5 
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Appendix 6.2.3 Consumer Services industry 
Table A6. 5: Summary of the development of scaled average share prices and market 
capitalisation per country in the Consumer Services industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 114 (15.1) 86.8 (8.92) 134 (31.7) 
   Median [Min, Max] 115 [77.3, 142] 86.7 [64.4, 103] 135 [69.6, 203] 
Market Cap (in €m)    
   Mean (SD)  330 (195) 3,910 (11,100) 3,560 (5,990) 
   Median [Min, Max] 332 [103, 555] 347 [3.64, 69,700] 904 [2.25, 22,200] 
# Companies 4 50 27 
% Within sample 5.9 14.2 8.5 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 73.4 (11.1) 106 (13.7) 80.7 (9.05) 
   Median [Min, Max] 67.9 [55.4, 101] 108 [63.7, 127] 77.8 [63.7, 101] 
Market Cap (in €m)    
   Mean (SD)  323 (650) 389 (244) 6,810 (23,300) 
   Median [Min, Max] 50.1 [2.15, 2,850] 362 [196, 798] 477 [0.306, 87,600] 
# Companies 27 5 14 
% Within sample 11.9 5.7 11 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 129 (26.9) 84.7 (11.5) 101 (28.0) 
   Median [Min, Max] 128 [76.1, 195] 82.9 [54.6, 101] 96.4 [54.6, 203] 
Market Cap (in €m)    
   Mean (SD)  3,170 (7,260) 2,630 (5,910) 2,920 (8,550) 
   Median [Min, Max] 899 [30.6, 31,900] 378 [2.2, 37,100] 359 [0.306, 87,600] 
# Companies 27 122 276 




Appendix 6.2.4 Financials industry 
Figure A6. 2: Share price development in the Financials industry across countries 
 
The Financials industry holds 17.6% of companies within the sample and is the second biggest 
industry looking at the number of companies. It is most prominent in Spain where 26% of all 
companies in the sample belong to the industry. However, when looking at all listed companies 
it is the industry with the most companies in Denmark (28.7%), Germany (26.8%) and the UK 
(21.4%) (also see Table A6.1 for details on all countries). On average, only in Sweden were 
scaled share price levels above the starting level of 100. There, also the highest minimum and 
maximum share price level could be observed. In Spain, the industry has performed worst with 
a mean share price level of 68.8 and a median level of 64. In the Nordics and Germany share 
price levels have recovered to an above pre-crisis level, while in the rest of the GUFIS the 
levels have not reached 100 again at the end of the time period. Overall, the countries’ average 
share price levels have followed a similar pattern. With € 97,100 million the company with 
the biggest market capitalisation in the Financials industry is listed in the UK. The highest 
mean and standard deviation of the market capitalisation could be observed in France. 
See the table below for a summary of the development of scaled average share prices as well 




Table A6. 6: Summary of the development of scaled average share prices and market 
capitalisation per country in the Financials industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 92.8 (9.10) 75.0 (12.5) 97.0 (9.75) 
   Median [Min, Max] 93.7 [68.5, 110] 72.2 [53.6, 104] 98.4 [64.0, 114] 
Market Cap (in €m)    
   Mean (SD)  3,920 (4,140) 5,950 (13,600) 4,730 (12,500) 
   Median [Min, Max] 2,340 [1,070, 13,600] 835 [20.8, 63,100] 602 [2.06, 85,000] 
# Companies 9 40 63 
% Within sample 13.2 11.3 19.9 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 80.4 (11.3) 89.7 (11.7) 68.8 (14.9) 
   Median [Min, Max] 78.5 [59.1, 109] 87.2 [62.1, 109] 64.0 [50.0, 103] 
Market Cap (in €m)    
   Mean (SD)  4,290 (8,270) 2,810 (5,540) 3,620 (10,200) 
   Median [Min, Max] 1,030 [5.16, 41,900] 811 [191, 25,000] 238 [0.624, 50,200] 
# Companies 41 21 33 
% Within sample 18.1 24.1 26 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 102 (11.5) 77.2 (10.7) 85.3 (15.9) 
   Median [Min, Max] 103 [71.2, 122] 72.7 [61.6, 101] 85.3 [50.0, 122] 
Market Cap (in €m)    
   Mean (SD)  5,350 (9,460) 3,000 (10,400) 4,160 (10,400) 
   Median [Min, Max] 1,390 [26.7, 47,500] 157 [2.51, 97,100] 565 [0.624, 97,100] 
# Companies 76 134 417 





Appendix 6.2.5 Health Care industry 
Table A6. 7: Summary of the development of scaled average share prices and market 
capitalisation per country in the Health Care industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 119 (8.19) 109 (9.36) 96.4 (6.80) 
   Median [Min, Max] 120 [93.4, 137] 111 [81.4, 130] 96.6 [72.5, 107] 
Market Cap (in €m)    
   Mean (SD)  17,100 (35,200) 5,550 (17,400) 9,660 (18,500) 
   Median [Min, Max] 8,440 [374, 141,000] 349 [20.3, 96,100] 200 [13.6, 59,000] 
# Companies 15 44 22 
% Within sample 22.1 12.5 7 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 119 (14.4) 106 (15.0) 97.0 (5.59) 
   Median [Min, Max] 123 [76.4, 143] 108 [62.5, 133] 97.4 [75.6, 111 
Market Cap (in €m)    
   Mean (SD)  2,690 (4,130) 229 (142) 2,350 (3,970) 
   Median [Min, Max] 201 [13.2, 9,250] 240 [44.4, 483] 1,100 [177, 12,700] 
# Companies 11 7 9 
% Within sample 4.8 8 7.1 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 123 (20.7) 104 (6.68) 109 (15.2) 
   Median [Min, Max] 127 [76.6, 164] 105 [80.2, 117] 106 [62.5, 164] 
Market Cap (in €m)    
   Mean (SD)  809 (1,160) 3,820 (15,900) 4,590 (15,900) 
   Median [Min, Max] 353 [18.8, 5,740] 153 [13.5, 102,000] 302 [13.2, 141,000] 
# Companies 60 58 226 




Appendix 6.2.6 Industrials industry 
Figure A6. 3: Share price development in the Industrials industry across countries 
 
The Industrials industry holds 24.5% of companies within the sample and is the industry with 
the most companies. It is most prominent in Denmark and Norway where 32.4% and 27.6% 
of all companies in the sample belong to the industry respectively. When looking at all listed 
companies however, only 22.9% of companies listed in Denmark belong to the Industrials 
industry, while it is 22.8% of companies listed in Norway (also see Table A6.1 for details on 
all countries). In our sample it is the industry with the most listed companies in the Nordics, 
France, Germany, Italy, and the UK while when looking at all listed companies it is only the 
biggest industry on stock markets in France, Italy and Norway. Consequently, the sample 
overrepresents industrials. The Nordics were the only countries where share price levels were 
on average above the starting level of 100. Only Spain has not again reached its pre-crisis level 
at the end of the time period while the Nordics and Germany could increase their share price 
levels significantly. In Denmark the highest mean share price of 106 as well as maximum level 
of 146 was observed. Overall, the countries’ average share price levels have followed a similar 
pattern. With € 119,000 million the company with the biggest market capitalisation in the 
Industrials industry is listed in Germany while the highest mean and median of the market 
capitalisation was observed in Denmark. 
See the table below for a summary of the development of scaled average share prices as well 
as market capitalisations per country in the Industrials industry. 
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Table A6. 8: Summary of the development of scaled average share prices and market 
capitalisation per country in the Industrials industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 106 (22.4) 86.8 (11.3) 94.1 (13.5) 
   Median [Min, Max] 102 [59.0, 146] 85.0 [56.9, 105] 95.2 [58.3, 120] 
Market Cap (in €m)    
   Mean (SD)  6,390 (12,000) 6,050 (14,300) 4,420 (14,300) 
   Median [Min, Max] 1,060 [24.5, 35,500] 556 [5.92, 77,700] 459 [4.17, 110,000] 
# Companies 22 83 75 
% Within sample 32.4 23.5 23.7 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 92.4 (9.63) 103 (12.1) 85.9 (9.24) 
   Median [Min, Max] 92.2 [63.6, 112] 102 [69.4, 126] 82.6 [65.5, 105] 
Market Cap (in €m)    
   Mean (SD)  1,140 (2,390) 856 (1,140) 2,900 (4,980) 
   Median [Min, Max] 248 [7.86, 12,800] 500 [100, 5,190] 959 [11.3, 21,100] 
# Companies 57 24 27 
% Within sample 25.1 27.6 21.3 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 104 (15.0) 92.3 (10.7) 95.6 (15.4) 
   Median [Min, Max] 104 [65.7, 133] 91.5 [63.9, 111] 95.2 [56.9, 146] 
Market Cap (in €m)    
   Mean (SD)  4,520 (10,900) 1,280 (2,810) 3,150 (9,410) 
   Median [Min, Max] 590 [20.7, 56,300] 207 [2.31, 20,100] 406 [2.31, 110,000] 
# Companies 95 195 578 
% Within sample 26 23.8 24.5 
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Appendix 6.2.7 Oil & Gas industry 
Figure A6. 4: Share price development in the Oil & Gas industry across countries 
 
The Oil & Gas industry holds 4.7% of companies within the sample. It is most prominent in 
Norway and the UK where 8% and 7.6% of all companies in the sample belong to the industry 
respectively. When looking at all listed companies however, 18.5% of companies listed in 
Norway belong to the Oil & Gas industry, which is by far the greatest share within a country 
(also see Table A6.1 for details on all countries). In Denmark, Germany and Spain share price 
levels were on average above the starting level of 100 and could significantly increase during 
the time period. The other countries have not again reached their pre-crisis levels. In Denmark 
the highest mean and median share price of 137 and 127 respectively as well as the highest 
minimum and maximum level was observed. In Italy and the UK, the industry has performed 
worst with mean and median share price levels below 70. In these two countries the share price 
level at the end of the time period was also lowest. With € 127,000 million the company with 
the biggest market capitalisation in the Oil & Gas industry is listed in the UK while the highest 
mean and median of the market capitalisation was observed in Denmark. However, there are 
only two companies listed in Denmark, which explains the relatively high average levels 
compared to the other countries. As the two companies significantly differ in size, the bigger 
company is also the main driver of the average scaled share price. Hence, Denmark’s displayed 




See the table below for a summary of the development of scaled average share prices as well 
as market capitalisations per country in the Oil & Gas industry. 
Table A6. 9: Summary of the development of scaled average share prices and market 
capitalisation per country in the Oil & Gas industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 137 (42.7) 73.5 (10.4) 112 (35.3) 
   Median [Min, Max] 127 [71.8, 233] 71.9 [44.4, 100] 104 [57.1, 194] 
Market Cap (in €m)    
   Mean (SD)  16,200 (21,100) 8,250 (28,300) 803 (940) 
   Median [Min, Max] 16,200 [1,350, 31,100] 150 [9.83, 102,000] 396 [24.3, 2,570] 
# Companies 2 13 8 
% Within sample 2.9 3.7 2.5 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 69.7 (11.7) 81.0 (10.1) 107 (25.1) 
   Median [Min, Max] 67.5 [51.3, 101] 78.0 [53.9, 101] 100 [64.6, 171] 
Market Cap (in €m)    
   Mean (SD)  7,730 (12,100) 9,580 (18,100) 7,500 (8,920) 
   Median [Min, Max] 1,190 [13.9, 34,200] 2,550 [304, 50,300] 3,430 [47.4, 20,700] 
# Companies 8 7 6 
% Within sample 3.5 8 4.7 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 74.8 (12.5) 65.3 (13.5) 89.9 (33.4) 
   Median [Min, Max] 72.6 [46.0, 103] 61.8 [42.4, 100] 78.7 [42.4, 233] 
Market Cap (in €m)    
   Mean (SD)  1,510 (3,020) 4,330 (22,500) 5,340 (20,200) 
   Median [Min, Max] 329 [31.5, 7,660] 49.9 [2.04, 127,000] 182 [2.04, 127,000] 
# Companies 6 62 112 




Appendix 6.2.8 Technology industry 
Table A6. 10: Summary of the development of scaled average share prices and market 
capitalisation per country in the Technology industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 131 (25.0) 104 (13.7) 105 (11.4) 
   Median [Min, Max] 129 [74.7, 174] 105 [66.2, 135] 106 [69.4, 121] 
Market Cap (in €m)    
   Mean (SD)  1,530 (1,910) 2,520 (8,010) 4,330 (18,700) 
   Median [Min, Max] 455 [72, 4,120] 213 [19.3, 45,900] 320 [2.9, 127,000] 
# Companies 6 51 51 
% Within sample 8.8 14.4 16.1 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 121 (26.4) 182 (88.7) 75.4 (13.2) 
   Median [Min, Max] 116 [66.4, 173] 156 [65.2, 397] 71.1 [51.1, 108] 
Market Cap (in €m)    
   Mean (SD)  342 (810) 1,860 (1,730) 2,730 (8,350) 
   Median [Min, Max] 61.9 [4.5, 3,740] 1,330 [109, 4,770] 80.3 [7.64, 27,900] 
# Companies 24 6 11 
% Within sample 10.6 6.9 8.7 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 128 (24.8) 107 (28.1) 119 (46.9) 
   Median [Min, Max] 132 [78.4, 181] 102 [65.7, 231] 107 [51.1, 397] 
Market Cap (in €m)    
   Mean (SD)  2,870 (8,420) 458 (1,050) 2,040 (9,500) 
   Median [Min, Max] 153 [10.4, 34,600] 97.1 [1.76, 7,060] 154 [1.76, 127,000] 
# Companies 41 88 278 





Appendix 6.2.9 Telecommunications industry 
Figure A6. 5: Share price development in the Telecommunications industry across countries 
 
With only 1.2% of companies belonging to Telecommunications, the industry holds the 
smallest share of companies within the sample. For every country the share of companies listed 
within the industry is below 3% and there is no company listed in Denmark which is part of 
the Telecommunications industry. There is little variation in the mean and median share price 
levels across the countries. Italy and Germany are the only countries that have again reached 
their pre-crisis level at the end of the time period. Companies listed in the UK have performed 
worst with mean and median share price levels close to 80. With € 71,500 million the company 
with the biggest market capitalisation in the Telecommunications industry is listed in Germany 
while the highest mean and median of the market capitalisation was observed in Spain, where 
two relatively large companies dominate the market.  
See the table below for a summary of the development of scaled average share prices as well 




Table A6. 11: Summary of the development of scaled average share prices and market 
capitalisation per country in the Telecommunications industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) - 93.7 (5.00) 97.9 (6.72) 
   Median [Min, Max] - 92.8 [74.9, 106] 101 [72.0, 112] 
Market Cap (in €m)    
   Mean (SD)  - 17,300 (11,900) 10,700 (24,700) 
   Median [Min, Max] - 17,300 [8,880, 25,700] 1,400 [16.8, 71,500] 
# Companies - 2 8 
% Within sample  0.6 2.5 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 108 (6.68) 94.0 (4.19) 96.0 (5.61) 
   Median [Min, Max] 107 [85.1, 125] 93.5 [83.2, 106] 96.1 [72.8, 111] 
Market Cap (in €m)    
   Mean (SD)  2,950 (4,610) 9,540 (13,000) 14,600 (11,400) 
   Median [Min, Max] 370 [212, 8,280] 9,540 [358, 18,700] 20,400 [1,460, 21,800] 
# Companies 3 2 3 
% Within sample 1.3 2.3 2.4 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 88.6 (6.28) 80.1 (9.30) 94.0 (10.1) 
   Median [Min, Max] 86.9 [77, 107] 79.9 [63.2, 103] 94.5 [63.2, 125] 
Market Cap (in €m)    
   Mean (SD)  10,400 (4,510) 6,580 (12,400) 9,370 (15,300) 
   Median [Min, Max] 10,400 [7,250, 13,600] 1,250 [19.2, 37,500] 2,390 [16.8, 71,500] 
# Companies 2 9 29 





Appendix 6.2.10 Utilities industry 
Figure A6. 6: Share price development in the Utilities industry across countries 
 
The Utilities industry holds 2.2% of companies within the sample and is the second smallest 
industry. It is most prominent in Italy and Spain where 5.7% and 5.5% of all companies in the 
sample belong to the industry respectively while the share of listed companies is below 1.5% 
in the Nordics and the UK. Except for France and the UK, scaled share price levels were on 
average above the starting level of 100 and apart from the UK all countries could again reach 
their pre-crisis level at the end of the time period. Denmark and Sweden ended on a 
significantly higher level than the other countries. However, the Utilities industry in the 
Nordics is represented only by one company in Denmark and Norway and two companies in 
Sweden, thus making it difficult to compare them to the GUFIS with its overall 49 utility 
companies. With € 79,300 million the company with the biggest market capitalisation in the 
Utilities industry is listed in Italy. The three companies listed in Norway and Sweden are 
significantly smaller while the one company listed in Denmark is the third biggest company 
of the industry in the sample. Therefore, the highest mean and median of the market 
capitalisation was observed in Denmark. The highest mean and standard deviation of the 
market capitalisation in the GUFIS was observed in Spain, while the median was highest in 
France.  
See the table below for a summary of the development of scaled average share prices as well 
as market capitalisations per country in the Utilities industry. 
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Table A6. 12: Summary of the development of scaled average share prices and market 
capitalisation per country in the Utilities industry 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 132 (27.5) 95.9 (14.4) 111 (9.22) 
   Median [Min, Max] 131 [85.7, 202] 95.3 [69.7, 123] 114 [83.3, 128] 
Market Cap (in €)    
   Mean (SD)  54,600 (NA) 11,500 (12,300) 6,000 (8,340) 
   Median [Min, Max] 54,600 [54,600, 54,600] 7,580 [115, 31,100] 1,820 [286, 22,400] 
# Companies 1 8 11 
% Within sample 1.5 2.3 3.5 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 104 (9.60) 136 (16.1) 104 (8.23) 
   Median [Min, Max] 106 [73.7, 119] 138 [97.0, 176] 105 [80.2, 119] 
Market Cap (in €)    
   Mean (SD)  8,680 (21,400) 710 (NA) 16,900 (23,700) 
   Median [Min, Max] 2,700 [32.7, 79,300] 710 [710, 710] 7,500 [199, 66,500] 
# Companies 13 1 7 
% Within sample 5.7 1.1 5.5 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 117 (16.8) 94.6 (5.68) 112 (20.9) 
   Median [Min, Max] 114 [75.5, 160] 93.7 [79.4, 112] 109 [69.7, 202] 
Market Cap (in €)    
   Mean (SD)  108 (91.5) 7,130 (10,300) 9,730 (16,700) 
   Median [Min, Max] 108 [43, 172] 3,960 [36.7, 33,100] 2,700 [32.7, 79,300] 
# Companies 2 10 53 





Appendix 6.3 Scaled share price development by sectors 
Appendix 6.3.1 Consumer Goods 
Automobiles & Parts 
Figure A6. 7: Share price development in 
the Automobiles and Parts sector in France 
 
Figure A6. 8: Share price development in 
the Automobiles and Parts sector in 
Germany 
 
Figure A6. 9: Share price development in 
the Automobiles and Parts sector in Italy 
 
Figure A6. 10: Share price development in 
the Automobiles and Parts sector in Spain 
 
Figure A6. 11: Share price development in 
the Automobiles and Parts sector in 
Sweden 
 
Figure A6. 12: Share price development in 







Figure A6. 13: Share price development in 
the Beverages sector in Denmark 
 
Figure A6. 14: Share price development in 
the Beverages sector in France 
 
Figure A6. 15: Share price development in 
the Beverages sector in Germany 
 
Figure A6. 16: Share price development in 
the Beverages sector in Italy 
 
Figure A6. 17: Share price development in 
the Beverages sector in Norway 
 
Figure A6. 18: Share price development in 
the Beverages sector in Spain 
 
Figure A6. 19: Share price development in 
the Beverages sector in Sweden 
 
Figure A6. 20: Share price development in 
the Beverages sector in the UK 
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Food Producers 
Figure A6. 21: Share price development in 
the Food Producers sector in France 
 
Figure A6. 22: Share price development in 
the Food Producers sector in Germany 
 
Figure A6. 23: Share price development in 
the Food Producers sector in Italy 
 
Figure A6. 24: Share price development in 
the Food Producers sector in Norway 
 
Figure A6. 25: Share price development in 
the Food Producers sector in Spain 
 
Figure A6. 26: : Share price development 
in the Food Producers sector in Sweden 
 
Figure A6. 27: Share price development in 





Household Goods and Home Construction 
Figure A6. 28: Share price development in 
the Household Goods and Home 
Construction sector in Denmark 
 
Figure A6. 29: Share price development in 
the Household Goods and Home 
Construction sector in France 
 
Figure A6. 30: Share price development in 
the Household Goods and Home 
Construction sector in Germany 
 
Figure A6. 31: Share price development in 
the Household Goods and Home 
Construction sector in Italy 
 
Figure A6. 32: Share price development in 
the Household Goods and Home 
Construction sector in Sweden 
 
Figure A6. 33: Share price development in 
the Household Goods and Home 






Leisure Goods  
Figure A6. 34: Share price development in 
the Leisure Goods sector in Denmark 
 
Figure A6. 35: Share price development in 
the Leisure Goods sector in France 
 
Figure A6. 36: Share price development in 
the Leisure Goods sector in Germany 
 
Figure A6. 37: Share price development in 
the Leisure Goods sector in Italy 
 
Figure A6. 38: Share price development in 
the Leisure Goods sector in Sweden 
 
Figure A6. 39: Share price development in 






Personal Goods  
Figure A6. 40: Share price development in 
the Personal Goods sector in Denmark 
 
Figure A6. 41: Share price development in 
the Personal Goods sector in France 
  
Figure A6. 42: Share price development in 
the Personal Goods sector in Germany 
 
Figure A6. 43: Share price development in 
the Personal Goods sector in Italy 
 
Figure A6. 44: Share price development in 
the Personal Goods sector in Sweden 
 
Figure A6. 45: Share price development in 







Figure A6. 46: Share price development in 
the Tobacco sector in Denmark 
 
Figure A6. 47: Share price development in 
the Tobacco sector in Sweden 
 
Figure A6. 48: Share price development in 





Appendix 6.3.2 Consumer Services 
Food and Drug Retailers 
Figure A6. 49: Share price development in 
the Food and Drug Retailers sector in 
France 
 
Figure A6. 50: Share price development in 
the Food and Drug Retailers sector in 
Germany 
 
Figure A6. 51: Share price development in 
the Food and Drug Retailers sector in Italy 
 
Figure A6. 52: Share price development in 
the Food and Drug Retailers sector in 
Spain 
 
Figure A6. 53: Share price development in 
the Food and Drug Retailers sector in 
Sweden 
 
Figure A6. 54: Share price development in 








Figure A6. 55: Share price development in 
the General Retailers sector in Denmark 
 
Figure A6. 56: Share price development in 
the General Retailers sector in France 
 
Figure A6. 57: Share price development in 
the General Retailers sector in Germany 
 
Figure A6. 58: Share price development in 
the General Retailers sector in Italy 
 
Figure A6. 59: Share price development in 
the General Retailers sector in Norway 
 
Figure A6. 60: Share price development in 
the General Retailers sector in Spain 
 
Figure A6. 61: Share price development in 
the General Retailers sector in Sweden 
 
Figure A6. 62: Share price development in 





Figure A6. 63: Share price development in 
the Media sector in Denmark 
 
Figure A6. 64: Share price development in 
the Media sector in France 
 
Figure A6. 65: Share price development in 
the Media sector in Germany 
 
Figure A6. 66: Share price development in 
the Media sector in Italy 
 
Figure A6. 67: Share price development in 
the Media sector in Spain 
 
Figure A6. 68: Share price development in 
the Media sector in Sweden 
 
Figure A6. 69: Share price development in 





Travel and Leisure 
Figure A6. 70: Share price development in 
the Travel and Leisure sector in Denmark 
 
Figure A6. 71: Share price development in 
the Travel and Leisure sector in France 
 
Figure A6. 72: Share price development in 
the Travel and Leisure sector in Germany 
 
Figure A6. 73: Share price development in 
the Travel and Leisure sector in Italy 
 
Figure A6. 74: Share price development in 
the Travel and Leisure sector in Norway 
 
Figure A6. 75: Share price development in 
the Travel and Leisure sector in Spain 
 
Figure A6. 76: Share price development in 
the Travel and Leisure sector in Sweden 
 
130 
Figure A6. 77: Share price development in 
the Travel and Leisure sector in the UK 
 
(exclusion of “Best of the Best PLC” 









Appendix 6.3.3 Health Care 
Health Care Equipment and Services 
Figure A6. 78: Share price development in 
the Health Care Equipment and Services 
sector in Denmark 
 
Figure A6. 79: Share price development in 
the Health Care Equipment and Services 
sector in France 
 
Figure A6. 80: Share price development in 
the Health Care Equipment and Services 
sector in Germany 
 
Figure A6. 81: Share price development in 
the Health Care Equipment and Services 




Figure A6. 82: Share price development in 
the Health Care Equipment and Services 
sector in Norway 
 
Figure A6. 83: Share price development in 
the Health Care Equipment and Services 
sector in Spain 
 
Figure A6. 84: Share price development in 
the Health Care Equipment and Services 
sector in Sweden 
 
Figure A6. 85: Share price development in 
the Health Care Equipment and Services 
sector in the UK 
 
 
Pharmaceuticals and Biotechnology 
Figure A6. 86: Share price development in 
the Pharmaceuticals and Biotechnology 
sector in Denmark 
 
Figure A6. 87: Share price development in 
the Pharmaceuticals and Biotechnology 
sector in France 
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Figure A6. 88: Share price development in 
the Pharmaceuticals and Biotechnology 
sector in Germany 
 
Figure A6. 89: Share price development in 
the Pharmaceuticals and Biotechnology 
sector in Italy 
 
Figure A6. 90: Share price development in 
the Pharmaceuticals and Biotechnology 
sector in Norway 
 
Figure A6. 91: Share price development in 
the Pharmaceuticals and Biotechnology 
sector in Spain 
 
Figure A6. 92: Share price development in 
the Pharmaceuticals and Biotechnology 
sector in Sweden 
 
Figure A6. 93: Share price development in 
the Pharmaceuticals and Biotechnology 






Appendix 6.3.4 Technology 
Software and Computer Services 
Figure A6. 94: Share price development in 
the Software and Computer Services sector 
in Denmark 
 
Figure A6. 95: Share price development in 
the Software and Computer Services sector 
in France 
 
Figure A6. 96: Share price development in 
the Software and Computer Services sector 
in Germany 
 
Figure A6. 97: Share price development in 
the Software and Computer Services sector 
in Italy 
 
Figure A6. 98: Share price development in 
the Software and Computer Services sector 
in Norway 
 
Figure A6. 99: Share price development in 




Figure A6. 100: Share price development 
in the Software and Computer Services 
sector in Sweden 
 
Figure A6. 101: Share price development 
in the Software and Computer Services 
sector in the UK 
 
(Company “Argo Blockchain plc” 
excluded from the Software and Computer 
Sector in the UK) 
 
Technology Hardware and Equipment 
Figure A6. 102: Share price development 
in the Technology Hardware and 
Equipment sector in Denmark 
 
Figure A6. 103: Share price development 
in the Technology Hardware and 
Equipment sector in France 
 
Figure A6. 104: Share price development 
in the Technology Hardware and 
Equipment sector in Germany 
 
Figure A6. 105: Share price development 
in the Technology Hardware and 




Figure A6. 106: Share price development 
in the Technology Hardware and 
Equipment sector in Norway 
 
Figure A6. 107: Share price development 
in the Technology Hardware and 
Equipment sector in Spain 
 
Figure A6. 108: Share price development 
in the Technology Hardware and 
Equipment sector in Sweden 
 
Figure A6. 109: Share price development 
in the Technology Hardware and 




Appendix 7 Data analysis including only companies with available 
revenue information  
Figure A7. 1: Share price development across countries (only companies with available 
revenue information) 
 
Table A7. 1: Summary of the development of scaled average share prices and market 
capitalisation per country (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 116 (19.5) 93.6 (11.0) 97.7 (12.1) 
   Median [Min, Max] 116 [77.0, 155] 91.8 [63.7, 114] 99.9 [63.1, 119] 
Market Cap (in €m)    
   Mean (SD)  7,550 (13,000) 5,770 (22,700) 5,330 (16,600) 
   Median [Min, Max] 1,420 [42.7, 54,600] 416 [3.64, 272,000] 515 [2.25, 127,000] 
# Companies 32 224 218 
# Trading Days 289 296 294 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 94.0 (8.54) 86.1 (8.44) 94.7 (8.07) 
   Median [Min, Max] 93.2 [67.9, 110] 84.0 [63.8, 105] 93.5 [72.3, 109]  
Market Cap (in €m)    
   Mean (SD)  2,230 (7,480) 3,280 (8,600) 4,640 (12,800) 
   Median [Min, Max] 208 [5.99, 79,300] 687 [109, 50,300] 801 [0.306, 87,600] 
# Companies 155 38 82 
# Trading Days 294 291 296 
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 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 108 (16.8) 95.1 (12.2) 98.2 (15.5) 
   Median [Min, Max] 106 [70.2, 143] 93.6 [64.2, 121] 96.5 [63.1, 155] 
Market Cap (in €m)    
   Mean (SD)  2,120 (4,180) 1,920 (6,940) 3,440 (12,900) 
   Median [Min, Max] 590 [25.4, 31,900] 218 [1.76, 120,000] 386 [0.306, 272,000] 
# Companies 175 486 1,410 
# Trading Days 290 293 289 - 296 
 
Table A7. 2: Summary of the development of scaled average share prices and market 
capitalisation across industries (only companies with available revenue information) 
 Basic Materials Consumer Goods Consumer Services 
Scaled Share Price    
   Mean (SD) 97.5 (17.3) 96.0 (14.8) 90.7 (13.2) 
   Median [Min, Max] 96.8 [38.5, 136 95.1 [6.57, 124] 90.8 [31.5, 113] 
Market Cap (in €m.)    
   Mean (SD)  6,810 (19,000) 5,740 (25,600) 2,470 (7,640) 
   Median [Min, Max] 1,100 [5.67, 120,000] 429 [7.14, 272,000] 381 [0.306, 87,600] 
# Companies 55 161 201 
% Share  3.9 11.4 14.3 
 Financials Health Care Industrials 
Scaled Share Price    
   Mean (SD) 90.5 (11.3) 119 (17.1) 91.2 (13.6) 
   Median [Min, Max] 90.2 [22.8, 107] 125 [45.9, 151] 92.0 [17.4, 112] 
Market Cap (in €m)    
   Mean (SD)  2,080 (5,060) 2,750 (7,040) 2,710 (8,900) 
   Median [Min, Max] 483 [0.624, 52,200] 325 [13.5, 48,900] 394 [2.31, 110,000] 
# Companies 212 99 392 
% Share  15.0 7.0 27.8 
 Oil & Gas Technology Telecommunications 
Scaled Share Price    
   Mean (SD) 83.8 (12.9) 109 (18.7) 91.6 (8.23) 
   Median [Min, Max] 81.7 [3.20, 108] 110 [8.23, 153] 92.5 [14.7, 107] 
Market Cap (in €m)    
   Mean (SD)  6,770 (19,200) 1,590 (9,960) 10,800 (16,400) 
   Median [Min, Max] 384 [6.32, 102,000] 139 [1.76, 127,000] 3,270 [19.2, 71,500] 
# Companies 37 189 24 
% Share  2.6 13.4 1.7 
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 Utilities Overall  
Scaled Share Price    
   Mean (SD) 104 (12.1) 97.3 (17.4)  
   Median [Min, Max] 105 [25.5, 126] 95.9 [3.20, 153]  
Market Cap (in €m)    
   Mean (SD)  11,900 (18,400) 3,440 (12,900)  
   Median [Min, Max] 3,820 [36.7, 79,300] 386 [0.306, 272,000]  
# Companies 40 1,410  




Appendix 7.1 Overview of industry and sector share in sample with revenue 
information 
Table A7. 3: Overview of company shares per industry within countries (only companies with 
available revenue information) 






















  % % % % % % % % % % 
Basic Materials 1.1 3.1 4.2 3.1 4.6 5.0 2.2 1.9 2.9 7.9 
Consumer Goods 10.1 9.4 13.2 17.0 10.7 8.3 15.9 19.4 9.5 15.8 
Consumer Services 12.2 9.4 15.8 14.7 11.9 9.6 14.8 12.9 5.2 10.5 
Financials 28.7 18.8 13.4 11.2 26.8 17.0 17.3 11.0 19.7 13.2 
Health Care 10.1 18.8 11.6 8.5 6.3 4.6 4.1 3.9 5.2 2.6 
Industrials 22.9 28.1 21.6 24.6 17.4 27.1 23.9 29.0 22.8 28.9 
Oil & Gas 2.1 3.1 2.8 1.8 2.8 2.3 3.0 4.5 18.5 7.9 
Technology 11.2 6.3 14.6 16.1 14.2 19.7 11.3 9.0 9.8 7.9 
Telecommunications 0.0 0.0 0.5 0.9 1.6 2.8 1.9 1.3 1.2 5.3 
Utilities 1.1 3.1 2.0 2.2 2.8 3.7 5.5 7.1 3.2 0.0 
N/A 0.5 0.0 0.3 0.0 1.0 0.0 0.0 0.0 2.0 0.0 
  100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 

















Sample   
 % % % % % % % %   
Basic Materials 5.3 8.5 5.4 5.1 11.0 2.9 6.1 3.9   
Consumer Goods 8.5 9.8 8.7 12.0 7.7 7.6 10.0 11.4   
Consumer Services 10.6 12.2 8.9 9.1 13.9 19.3 12.2 14.3   
Financials 26.1 15.9 13.7 19.4 21.4 15.4 19.7 15.0   
Health Care 6.4 9.8 21.4 8.6 7.7 7.0 10.2 7.0   
Industrials 21.8 24.4 20.5 30.9 18.9 28.6 20.2 27.8   
Oil & Gas 5.3 4.9 2.5 1.1 8.1 2.3 5.4 2.6   
Technology 7.4 6.1 14.3 11.4 8.8 13.6 11.9 13.4   
Telecommunications 2.7 3.7 0.9 1.1 0.9 1.4 1.1 1.7   
Utilities 4.3 4.9 0.8 1.1 1.3 1.9 2.1 2.8   
N/A 1.6 0.0 3.0 0.0 0.3 0.0 1.0 0.0   




Table A7. 4: Overview of company shares per sectors overall (only companies with available 
revenue information) 
  
All listed companies Sample 
 #  %  #  % 
Basic Materials      308           6.1             55  3.9 
Chemicals        94           1.9          23  1.6 
Forestry & Paper        26           0.5            10  0.7 
Industrial Metals & Mining        47           0.9             12  0.9 
Mining      141           2.8            10  0.7 
Consumer Goods      507         10.0           161  11.4 
Automobiles & Parts        58           1.1             20  1.4 
Beverages        59           1.2            18  1.3 
Food Producers      112           2.2             35  2.5 
Household Goods & Home Construction        97           1.9           36  2.6 
Leisure Goods        81           1.6            23  1.6 
Personal Goods        96           1.9             29  2.1 
Tobacco         4           0.1  0 0.0 
Consumer Services      618         12.2         201  14.3 
Food & Drug Retailers        27           0.5            13  0.9 
General Retailers      187           3.7            65  4.6 
Media      213           4.2          63  4.5 
Travel & Leisure      191           3.8          60  4.3 
Financials      993         19.7           212  15.0 
Banks      139           2.8             19  1.3 
Equity Investment Instruments        26           0.5               4  0.3 
Financial Services      459           9.1            89  6.3 
Life Insurance        11           0.2               6  0.4 
Nonequity Investment Instruments        39           0.8  0 0.0 
Nonlife Insurance        39           0.8             12  0.9 
Real Estate Investment & Services      260           5.2            80  5.7 
Real Estate Investment Trusts        20           0.4               2  0.1 
Health Care      515         10.2             99  7.0 
Health Care Equipment & Services      217           4.3            48  3.4 
Pharmaceuticals & Biotechnology      298           5.9           51  3.6 
Industrials   1,022         20.2          392  27.8 
Aerospace & Defense        44           0.9            25  1.8 
Construction & Materials      155           3.1            69  4.9 
Electronic & Electrical Equipment      184           3.6           69  4.9 
General Industrials        56           1.1             29  2.1 
Industrial Engineering      194           3.8             66  4.7 
Industrial Transportation      114           2.3            37  2.6 
Support Services      275           5.4            97  6.9 
Oil & Gas      272           5.4            37  2.6 
Alternative Energy        70           1.4            14  1.0 
Oil & Gas Producers      136           2.7            15  1.1 
Oil Equipment, Services & Distribution        66           1.3              8  0.6 
Technology      599         11.9           189  13.4 
Software & Computer Services      477           9.5           154  10.9 
Technology Hardware & Equipment      122           2.4            35  2.5 
Telecommunications        54           1.1             24  1.7 
Fixed Line Telecommunications        20           0.4            11  0.8 
Mobile Telecommunications        34           0.7             13  0.9 
Utilities      106           2.1  40 2.8 
Electricity        78           1.5  20 1.4 
Gas, Water & Multiutilities        28           0.6  20 1.4 
N/A        53           1.1  0                                       0.0 




Appendix 7.2 Industry data analysis in sample with revenue information 
Appendix 7.2.1 Basic Material Industry 
Figure A7. 2: Share price development in the Basic Materials industry across countries (only 
companies with available revenue information) 
 
 
Table A7. 5: Summary of the development of scaled average share prices and market 
capitalisation per country in the Basic Materials industry (only companies with available 
revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 95.0 (19.4) 89.7 (11.4) 86.4 (13.3) 
   Median [Min, Max] 94.4 [55.4, 147] 89.9 [56.0, 113] 83.6 [57.8, 110] 
Market Cap (in €)    
   Mean (SD)  577 (NA) 1,930 (2,760) 7,600 (19,000) 
   Median [Min, Max] 577 [577, 577] 419 [24.9, 7,380] 1,520 [30.2, 64,500] 
# Companies 1 7 11 
% Within sample 3.1 3.1 5.0 
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 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 109 (16.1) 97.2 (19.6) 80.9 (11.3) 
   Median [Min, Max] 105 [77.2, 146] 91.3 [65.6, 152] 75.9 [62.5, 103]  
Market Cap (in €)    
   Mean (SD)  569 (729) 4,280 (4,510) 692 (976) 
   Median [Min, Max] 259 [46.5, 1,400] 1,740 [1,620, 9,500] 261 [5.67, 2,770] 
# Companies 3 3 7 
% Within sample 1.9 7.9 8.5 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 104 (14.3) 104 (18.4) 95.7 (18.2) 
   Median [Min, Max] 99.2 [71.4, 135] 103 [65.4, 150] 94.7 [55.4, 152] 
Market Cap (in €)    
   Mean (SD)  6,870 (5,120) 14,500 (34,000) 6,810 (19,000) 
   Median [Min, Max] 8,930 [53.6, 12,800] 613 [8.36, 120,000] 1,100 [5.67, 120,000] 
# Companies 9 14 55 
% Within sample 5.1 2.9 3.9 
 
Appendix 7.2.2 Consumer Goods Industry 
Figure A7. 3: Share price development in the Customer Goods industry across countries (only 






Table A7. 6: Summary of the development of scaled average share prices and market 
capitalisation per country in the Consumer Goods industry (only companies with available 
revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 132 (41.6) 98.8 (13.3) 87.9 (14.3) 
   Median [Min, Max] 124 [59.8, 205] 96.5 [66.8, 126] 87.4 [52.7, 116] 
Market Cap (in €)    
   Mean (SD)  2,780 (4,600) 13,200 (47,900) 14,000 (28,300) 
   Median [Min, Max] 188 [57, 8,090] 435 [30.1, 272,000] 473 [22.8, 94.900] 
# Companies 3 38 18 
% Within sample 9.4 17.0 8.3 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 94.9 (12.1) 96.2 (7.28) 98.3 (7.35) 
   Median [Min, Max] 92.7 [66.9, 120] 96.2 [75.2, 120] 97.9 [77.9, 114] 
Market Cap (in €)    
   Mean (SD)  1,240 (3,130) 2,410 (2,260) 1,100 (126,0) 
   Median [Min, Max] 97.3 [9.78, 13,600] 1,520 [298, 6,180] 455 [11.5, 2,690] 
# Companies 30 6 8 
% Within sample 19.4 15.8 9.8 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 137 (34.8) 90.9 (10.4) 104 (27.6) 
   Median [Min, Max] 136 [74.5, 213] 90.2 [60.6, 107] 97.9 [52.7, 213] 
Market Cap (in €)    
   Mean (SD)  1,590 (2,470) 1,850 (3,920) 5,740 (25,600) 
   Median [Min, Max] 630 [29.3, 9,560] 467 [7.14, 21,100] 429 [7.14, 272,000] 
# Companies 21 37 161 




Appendix 7.2.3 Consumer Services Industry 
Figure A7. 4: Share price development in the Customer Services industry across countries 
(only companies with available revenue information) 
 
 
Table A7. 7: Summary of the development of scaled average share prices per country in the 
Consumer Goods industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 109 (11.4) 88.3 (8.53) 123 (29.2) 
   Median [Min, Max] 108 [77.0, 136] 87.0 [68.8, 114] 121 [60.9, 185] 
Market Cap (in €)    
   Mean (SD)  305 (230) 2,150 (6,250) 2,630 (4,780) 
   Median [Min, Max] 256 [103, 555] 336 [3.64, 34,800] 904 [2.25, 21,700] 
# Companies 3 33 21 
% Within sample 9.4 14.7 9.6 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 70.3 (12.7) 108 (15.3) 80.0 (9.13) 
   Median [Min, Max] 64.0 [52.9, 101] 110 [62.2, 132] 77.3 [63.4, 101]  
Market Cap (in €)    
   Mean (SD)  367 (711) 437 (253) 9,380 (27,500) 
   Median [Min, Max] 86.3 [7.68, 2,850] 372 [208, 798] 553 [0.306, 87,600] 
# Companies 20 4 10 
% Within sample 12.9 10.5 12.2 
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 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 94.0 (11.5) 89.9 (13.4) 95.2 (22.1) 
   Median [Min, Max] 94.4 [65.8, 114] 89.9 [54.7, 112] 93.2 [52.9, 185] 
Market Cap (in €)    
   Mean (SD)  3,530 (7,800) 2,230 (4,170) 2,470 (7,640) 
   Median [Min, Max] 1,050 [30.6, 31,900] 572 [2.2, 27,800] 381 [0.306, 87,600] 
# Companies 16 94 201 
% Within sample 9.1 19.3 14.3 
 
 
Appendix 7.2.4 Financials Industry 
Figure A7. 5: Share price development in the Financials industry across countries (only 





Table A7. 8: Summary of the development of scaled average share prices per country in the 
Financials industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 95.6 (6.43) 78.3 (10.5) 107 (11.4) 
   Median [Min, Max] 95.7 [73.4, 108] 76.7 [54.9, 103] 107 [73.3, 137] 
Market Cap (in €)    
   Mean (SD)  2,960 (2,410) 3,440 (10,400) 2,550 (5,640) 
   Median [Min, Max] 2,090 [1,070, 7,560] 672 [20.8, 52,200] 404 [3.55, 30,500] 
# Companies 6 25 37 
% Within sample 18.8 11.2 17.0 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 84.2 (11.4) 81.4 (20.4) 78.6 (9.35) 
   Median [Min, Max] 80.2 [59.9, 112] 77.8 [40.7, 126] 74.6 [66.5, 101] 
Market Cap (in €)    
   Mean (SD)  2,630 (4,680) 1,370 (2,070) 969 (1,580) 
   Median [Min, Max] 1,030 [5.99, 16,500] 523 [191, 5,060] 293 [0.624, 4,950] 
# Companies 17 5 13 
% Within sample 11.0 13.2 15.9 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 97.5 (10.2) 89.8 (9.50) 89.0 (15.2) 
   Median [Min, Max] 100 [68.3, 111] 87.7 [61.6, 105] 88.5 [40.7, 137] 
Market Cap (in €)    
   Mean (SD)  2,070 (2,820) 1,450 (3,400) 2,080 (5,060) 
   Median [Min, Max] 1,390 [26.7, 12,300] 169 [3.52, 18,200] 483 [0.624, 52,200] 
# Companies 34 75 212 





Appendix 7.2.5 Health Care Industry 
Figure A7. 6: Share price development in the Health Care industry across countries (only 
companies with available revenue information) 
 
 
Table A7. 9: Summary of the development of scaled average share prices per country in the 
Health Care industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 125 (12.6) 151 (33.7) 98.5 (8.44) 
   Median [Min, Max] 131 [88.6, 145] 158 [85.8, 227] 99.1 [72.5, 118] 
Market Cap (in €)    
   Mean (SD)  12,500 (9,130) 2,530 (7,610) 5,930 (15,200) 
   Median [Min, Max] 9,650 [1,200, 27,300] 302 [22, 33,400] 647 [58.5, 48,900] 
# Companies 6 19 10 
% Within sample 18.8 8.5 4.6 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 124 (14.8) 142 (39.6) 96.9 (5.56) 
   Median [Min, Max] 130 [81.7, 147] 154 [56.4, 220] 97.3 [75.8, 111] 
Market Cap (in €)    
   Mean (SD)  3,760 (4,860) 250 (NA) 2,620 (4,150) 
   Median [Min, Max] 455 [34.7, 9,250] 250 [250, 250] 1,540 [177, 12,700] 
# Companies 6 1 8 
% Within sample 3.9 2.6 9.8 
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 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 137 (34.6) 116 (14.4) 124 (30.1) 
   Median [Min, Max] 144 [69.3, 202] 119 [74.0, 141] 119 [56.4, 227] 
Market Cap (in €)    
   Mean (SD)  755 (833) 1,060 (2,590) 2,750 (7,040) 
   Median [Min, Max] 367 [32.6, 2,450] 186 [13.5, 13,700] 325 [13.5, 48,900] 
# Companies 15 34 99 
% Within sample 8.6 7.0 7.0 
 
 
Appendix 7.2.6 Industrials Industry 
Figure A7. 7: Share price development in the Industrials industry across countries (only 






Table A7. 10: Summary of the development of scaled average share prices per country in the 
Industrials industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 102 (25.4) 88.4 (10.8) 94.0 (14.1) 
   Median [Min, Max] 97.3 [56.5, 157] 86.6 [58.6, 106] 96.8 [56.2, 118] 
Market Cap (in €)    
   Mean (SD)  9,160 (15,000) 5,590 (13,700) 4,570 (15,800) 
   Median [Min, Max] 1,370 [42.7, 35,500] 618 [5.92, 71,500] 644 [8.95, 110,000] 
# Companies 9 55 59 
% Within sample 28.1 24.6 27.1 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 92.1 (9.66) 94.9 (9.81) 85.4 (9.36) 
   Median [Min, Max] 91.8 [63.4, 114] 93.2 [67.8, 114] 82.2 [64.8, 105] 
Market Cap (in €)    
   Mean (SD)  1,320 (2,650) 791 (926) 3,530 (5,650) 
   Median [Min, Max] 230 [13.9, 12,800] 410 [110, 3,020] 1,110 [11.3, 21,100] 
# Companies 45 11 20 
% Within sample 29.0 28.9 24.4 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 102 (14.8) 89.0 (11.0) 93.4 (15.1) 
   Median [Min, Max] 104 [62.7, 129] 86.2 [62.1, 109] 92.6 [56.2, 157] 
Market Cap (in €)    
   Mean (SD)  1,850 (4,230) 1,180 (2,850) 2,710 (8,900) 
   Median [Min, Max] 482 [25.4, 27,900] 218 [2.31, 20,100] 394 [2.31, 110,000] 
# Companies 54 139 392 




Appendix 7.2.7 Oil & Gas Industry 
Figure A7. 8: Share price development in the Oil & Gas industry across countries (only 
companies with available revenue information) 
 
 
Table A7. 11: Summary of the development of scaled average share prices per country in the 
Oil & Gas industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 43.0 (18.5) 72.9 (10.5) 117 (23.6) 
   Median [Min, Max] 34.8 [26.4, 100] 71.4 [43.8, 100] 115 [67.5, 179] 
Market Cap (in €)    
   Mean (SD)  1,350 (NA) 25,800 (51,000) 380 (399) 
   Median [Min, Max] 1,350 [1,350, 1,350] 479 [72.1, 102,000] 384 [24.3, 1,020] 
# Companies 1 4 5 
% Within sample 3.1 1.8 2.3 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 71.3 (10.9) 76.3 (9.16) 135 (40.8) 
   Median [Min, Max] 69.3 [52.5, 100] 75.0 [51.6, 100] 130 [73.0, 236] 
Market Cap (in €)    
   Mean (SD)  7,310 (13,000) 19,500 (27,000) 7,050 (9,240) 
   Median [Min, Max] 140 [13.9, 34,200] 7,760 [304, 50,300] 3,430 [657, 20,700] 
# Companies 7 3 4 
% Within sample 4.5 7.9 4.9 
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 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 125 (27.3) 259 (127) 112 (80.0) 
   Median [Min, Max] 121 [64.5, 206] 239 [96.0, 607] 90.4 [26.4, 607] 
Market Cap (in €)    
   Mean (SD)  370 (163) 473 (964) 6,770 (19,200) 
   Median [Min, Max] 370 [255, 485] 82.2 [6.32, 3,330] 384 [6.32, 102,000] 
# Companies 2 11 37 
% Within sample 1.1 2.3 2.6 
 
 
Appendix 7.2.8 Technology Industry 
Figure A7. 9: Share price development in the Technology industry across countries (only 





Table A7. 12: Summary of the development of scaled average share prices per country in the 
Technology industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 210 (73.4) 98.6 (15.5) 104 (11.4) 
   Median [Min, Max] 188 [95.8, 383] 101 [58.0, 131] 105 [68.4, 120] 
Market Cap (in €)    
   Mean (SD)  383 (237) 1,120 (3,840) 4,900 (20,300) 
   Median [Min, Max] 383 [216, 550] 207 [19.3, 23,100] 502 [2.9, 127,000] 
# Companies 2 36 43 
% Within sample 6.3 16.1 19.7 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 119 (25.9) 103 (15.7) 100 (14.2) 
   Median [Min, Max] 110 [72.1, 173] 101 [61.0, 138] 104 [71.0, 128] 
Market Cap (in €)    
   Mean (SD)  154 (176) 768 (732) 336 (549) 
   Median [Min, Max] 74.9 [9.75, 543] 638 [109, 1,560] 80.3 [41.8, 1,310] 
# Companies 14 3 5 
% Within sample 9.0 7.9 6.1 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 210 (83.3) 115 (41.9) 132 (62.8) 
   Median [Min, Max] 207 [88.6, 435] 104 [64.6, 302] 108 [58.0, 435] 
Market Cap (in €)    
   Mean (SD)  813 (2,250) 397 (860) 1,590 (9,960) 
   Median [Min, Max] 183 [35.2, 10,200] 83.9 [1.76, 5,370] 139 [1.76, 127,000] 
# Companies 20 66 189 





Appendix 7.2.9 Telecommunications Industry 
Figure A7. 10: Share price development in the Telecommunications industry across countries 
(only companies with available revenue information) 
 
 
Table A7. 13: Summary of the development of scaled average share prices per country in the 
Telecommunications industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) - 93.7 (5.00) 98.3 (7.05) 
   Median [Min, Max] - 92.8 [74.9, 106] 101 [72.3, 113] 
Market Cap (in €)    
   Mean (SD)   17,300 (11,900) 13,100 (28,600) 
   Median [Min, Max]  17,300 [8,880, 25,700] 1,400 [46.3, 71,500] 
# Companies - 2 6 
% Within sample - 0.9 2.8 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 107 (6.81) 94.0 (4.19) 96.0 (5.61) 
   Median [Min, Max] 106 [84.7, 124] 93.5 [83.2, 106] 96.1 [72.8, 111] 
Market Cap (in €)    
   Mean (SD)  4,320 (5,590) 9,540 (13,000) 14,600 (11,400) 
   Median [Min, Max] 4,320 [370, 8,280] 9,540 [358, 18,700] 20,400 [1,460, 21,800] 
# Companies 2 2 3 
% Within sample 1.3 5.3 3.7 
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 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 88.6 (6.28) 79.3 (9.55) 93.8 (10.2) 
   Median [Min, Max] 86.9 [77, 107] 78.9 [64.5, 104] 94.4 [64.5, 124] 
Market Cap (in €)    
   Mean (SD)  10,400 (4,510) 7,710 (14,100) 10,800 (16,400) 
   Median [Min, Max] 10,400 [7,250, 13,600] 1,060 [19.2, 37,500] 3,270 [19.2, 71,500] 
# Companies 2 7 24 
% Within sample 1.1 1.4 1.7 
 
 
Appendix 7.2.10 Utilities Industry 
Figure A7. 11: Share price development in the Utilities industry across countries (only 





Table A7. 14: Summary of the development of scaled average share prices per country in the 
Utilities industry (only companies with available revenue information) 
 Denmark France Germany 
Scaled Share Price    
   Mean (SD) 132 (27.5) 92.7 (14.2) 110 (9.31) 
   Median [Min, Max] 131 [85.7, 202] 91.2 [67.6, 123] 112 [80.9, 127] 
Market Cap (in €)    
   Mean (SD)  54,600 (NA) 17,100 (12,600) 7,330 (9,510) 
   Median [Min, Max] 54,600 [54,600, 54,600] 13,100 [1,310, 31,100] 1,680 [286, 22,400] 
# Companies 1 5 8 
% Within sample 3.1 2.2 3.7 
 Italy Norway Spain 
Scaled Share Price    
   Mean (SD) 104 (9.59) - 105 (8.46) 
   Median [Min, Max] 106 [73.7, 119] - 107 [82.5, 123] 
Market Cap (in €)    
   Mean (SD)  10,200 (23,100) - 23,800 (29,600) 
   Median [Min, Max] 3,500 [458, 79,300] - 13,800 [898, 66,500] 
# Companies 11 - 4 
% Within sample 7.1 - 4.9 
 Sweden UK Overall 
Scaled Share Price    
   Mean (SD) 117 (16.8) 94.6 (5.67) 103 (13.5) 
   Median [Min, Max] 114 [75.5, 160] 93.7 [79.4, 112] 105 [67.6, 202] 
Market Cap (in €)    
   Mean (SD)  108 (91.5) 7,910 (10,600) 11,900 (18,400) 
   Median [Min, Max] 108 [43, 172] 4,360 [36.7, 33,100] 3,820 [36.7, 79,300] 
# Companies 2 9 40 
% Within sample 1.1 1.9 2.8 
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Appendix 8 Country regression outputs 
Regression outputs only display significant values. 
 
Appendix 8.1 Results for France 
Table A8. 1: Country regression output – France 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.001*** 0.001*** 
 t = 6.094 t = 5.802 
IndustryConsumer Goods 0.020 0.143* 
 t = 0.643 t = 1.950 
IndustryConsumer Services 0.069** 0.216*** 
 t = 2.239 t = 2.607 
IndustryFinancials 0.144*** 0.434** 
 t = 4.813 t = 2.158 
IndustryHealth Care 0.094** 0.065 
 t = 2.444 t = 0.481 
IndustryIndustrials 0.062* 0.188** 
 t = 1.906 t = 2.517 
   
Notes on how to read the country regression tables: 
The baseline industry for our country regressions is always the Basic Materials industry. 
As we use the natural logarithm of share prices, we can interpret the effect on our 
dependent variable as a percentage change. The coefficients of the independent variables 
where we applied a logarithmic transformation can be interpreted as the percentage 
change of share prices when the independent variable increases by 1%. For the variables 
that did not require a logarithmic transformation the coefficients need to be multiplied with 
0.01 in order to observe the percentage effect of a one percentage point higher independent 
variable. Our “Industry” variables can be seen as dummies that turn “1” if the company 
is part of the respective industry and therefore the coefficients can be read as the 
percentage change as well.  
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryOil and Gas 0.078* 0.971 
 t = 1.952 t = 0.268 
IndustryTechnology 0.010 0.153** 
 t = 0.307 t = 2.052 
IndustryTelecommunications 0.634*** -1.224*** 
 t = 3.105 t = -4.090 
IndustryUtilities 0.249*** 0.505*** 
 t = 3.461 t = 5.186 
EconomicScaled -0.168* -0.282*** 
 t = -1.712 t = -2.861 
RevHomeCountry  0.260*** 
  t = 3.153 
StringencyScaled -0.117 -0.045 
 t = -1.471 t = -0.323 
log(1 + LaggedCaseChange) -0.013 -0.033*** 
 t = -1.304 t = -3.929 
VaccinationScaled 0.254** 0.266* 
 t = 2.111 t = 1.656 
log(1 + VaccineInvest) -0.017* -0.027** 
 t = -1.933 t = -2.018 
ScaledMarketCap 0.339 11.378*** 
 t = 0.540 t = 5.104 
IndustryHealth Care:EconomicScaled 0.114 0.317** 
 t = 1.125 t = 2.337 
IndustryConsumer Goods:RevHomeCountry  -0.224** 
  t = -2.277 
IndustryConsumer Services:RevHomeCountry  -0.286*** 
  t = -2.767 
IndustryFinancials:RevHomeCountry  -0.401* 
  t = -1.925 
IndustryIndustrials:RevHomeCountry  -0.216** 
  t = -2.351 
IndustryTechnology:RevHomeCountry  -0.245*** 
  t = -2.629 
IndustryTelecommunications:RevHomeCountry  0.910*** 
  t = 3.525 
IndustryUtilities:RevHomeCountry  -0.416** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
  t = -2.469 
IndustryConsumer Goods:log(1 + LaggedCaseChange) 0.004 0.029*** 
 t = 0.373 t = 3.048 
IndustryFinancials:log(1 + LaggedCaseChange) -0.024** 0.025 
 t = -2.328 t = 1.224 
IndustryHealth Care:log(1 + LaggedCaseChange) -0.006 0.045*** 
 t = -0.488 t = 3.179 
IndustryTechnology:log(1 + LaggedCaseChange) 0.013 0.026* 
 t = 1.187 t = 1.953 
IndustryTelecommunications:log(1 + LaggedCaseChange) -0.017 -0.024*** 
 t = -1.383 t = -3.157 
IndustryConsumer Services:TestingScaled -0.156 -0.334** 
 t = -1.515 t = -2.406 
IndustryFinancials:TestingScaled -0.192** 0.216 
 t = -1.963 t = 1.152 
IndustryHealth Care:TestingScaled -0.013 0.298** 
 t = -0.113 t = 2.050 
IndustryOil and Gas:TestingScaled -0.065 -0.353** 
 t = -0.369 t = -2.282 
IndustryTelecommunications:TestingScaled -0.115 -0.640*** 
 t = -0.595 t = -7.098 
IndustryFinancials:VaccinationScaled -0.317*** -0.247 
 t = -2.670 t = -1.442 
IndustryIndustrials:VaccinationScaled -0.200* -0.215 
 t = -1.675 t = -1.321 
IndustryOil and Gas:VaccinationScaled -0.139 -0.540** 
 t = -0.965 t = -2.149 
IndustryTelecommunications:VaccinationScaled -0.502*** -0.378** 
 t = -4.112 t = -2.421 
IndustryUtilities:VaccinationScaled -0.224* -0.215 
 t = -1.719 t = -1.317 
IndustryHealth Care:log(1 + VaccineInvest) 0.023** 0.049* 
 t = 2.025 t = 1.845 
IndustryOil and Gas:log(1 + VaccineInvest) 0.0003 -0.077*** 
 t = 0.022 t = -4.417 
IndustryConsumer Services:log(1 + HealthInvest) 0.008 0.014* 
 t = 1.430 t = 1.662 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryFinancials:log(1 + HealthInvest) 0.013** 0.007 
 t = 2.331 t = 0.701 
IndustryOil and Gas:log(1 + HealthInvest) 0.004 0.051*** 
 t = 0.470 t = 4.256 
IndustryTelecommunications:log(1 + HealthInvest) 0.007 0.029*** 
 t = 0.935 t = 5.847 
IndustryUtilities:log(1 + HealthInvest) 0.004 0.018*** 
 t = 0.655 t = 2.841 
RevHomeCountry:log(1 + HealthInvest)  0.019** 
  t = 2.375 
IndustryHealth Care:log(1 + Fiscal_measures) -0.004** -0.004 
 t = -2.529 t = -1.121 
IndustryOil and Gas:log(1 + Fiscal_measures) 0.0002 -0.008*** 
 t = 0.133 t = -2.636 
IndustryConsumer Services:Import_change_previous -0.080 -0.375*** 
 t = -0.832 t = -3.769 
IndustryFinancials:Import_change_previous -0.178* 0.206** 
 t = -1.884 t = 2.074 
IndustryIndustrials:Import_change_previous -0.119 -0.132* 
 t = -1.285 t = -1.658 
IndustryOil and Gas:Import_change_previous 0.005 -0.309* 
 t = 0.027 t = -1.803 
IndustryTelecommunications:Import_change_previous 0.046 -0.515*** 
 t = 0.272 t = -8.285 
IndustryUtilities:Import_change_previous -0.096 -0.309*** 
 t = -0.956 t = -3.271 
RevHomeCountry:Import_change_previous  -0.335* 
  t = -1.937 
IndustryConsumer Goods:ScaledMarketCap -0.065 -11.064*** 
 t = -0.102 t = -4.952 
IndustryConsumer Services:ScaledMarketCap -0.122 -8.775*** 
 t = -0.164 t = -3.664 
IndustryFinancials:ScaledMarketCap -1.502** -13.720*** 
 t = -2.098 t = -5.527 
IndustryHealth Care:ScaledMarketCap -0.693 -9.136*** 
 t = -0.808 t = -2.811 
IndustryIndustrials:ScaledMarketCap -0.280 -11.085*** 
160 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = -0.320 t = -4.831 
IndustryTechnology:ScaledMarketCap 0.041 -10.911*** 
 t = 0.053 t = -4.134 
IndustryTelecommunications:ScaledMarketCap -8.919***  
 t = -14.195  
IndustryUtilities:ScaledMarketCap -3.762*** -13.852*** 




 t = 2.076 
IndustryFinancials:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.053** 
 t = -2.142 
IndustryTelecommunications:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.026** 
 t = 2.224 
IndustryConsumer Services:RevHomeCountry:TestingScaled  0.497** 
  t = 2.503 
IndustryOil and Gas:RevHomeCountry:TestingScaled  0.992* 
  t = 1.851 
IndustryTelecommunications:RevHomeCountry:TestingScaled  1.022*** 
  t = 8.614 
IndustryUtilities:RevHomeCountry:TestingScaled  0.540*** 
  t = 3.512 
IndustryOil and Gas:RevHomeCountry:VaccinationScaled  0.834* 
  t = 1.780 
IndustryOil and Gas:RevHomeCountry:log(1 + VaccineInvest)  0.127*** 
  t = 3.588 
IndustryConsumer Services:RevHomeCountry: 
log(1 + HealthInvest) 
 -0.026** 
 t = -2.250 
IndustryIndustrials:RevHomeCountry:log(1 + HealthInvest)  -0.016* 
  t = -1.774 
IndustryOil and Gas:RevHomeCountry:log(1 + HealthInvest)  -0.096*** 
  t = -4.467 
IndustryTechnology:RevHomeCountry:log(1 + HealthInvest)  -0.025** 
  t = -2.521 
IndustryTelecommunications:RevHomeCountry: 
log(1 + HealthInvest) 
 -0.049*** 
 t = -6.165 
IndustryUtilities:RevHomeCountry:log(1 + HealthInvest)  -0.038*** 
  t = -4.027 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryOil and Gas:RevHomeCountry:log(1 + Fiscal_measures)  0.011** 




 t = 3.535 
IndustryOil and Gas:RevHomeCountry:Import_change_previous  1.207* 




 t = 6.656 
IndustryUtilities:RevHomeCountry:Import_change_previous  0.727*** 
  t = 3.792 
Constant 4.550*** 4.403*** 
 t = 157.872 t = 63.708 
Observations 103,782 65,856 
R2 0.127 0.183 
Adjusted R2 0.126 0.180 
Note: *p<0.1, **p<0.05. ***p<0.01 
 
Appendix 8.2 Results for Germany 
Table A8. 2: Country regression output – Germany 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.001*** 0.001*** 
 t = 7.900 t = 7.548 
IndustryFinancials 0.073*** 0.126* 
 t = 3.206 t = 1.954 
IndustryHealth Care 0.085** 0.132 
 t = 2.532 t = 1.363 
IndustryTelecommunications 0.068** 1.551*** 
 t = 2.001 t = 8.110 
IndustryUtilities 0.130*** 0.581*** 
 t = 3.190 t = 2.910 
EconomicScaled 0.071* 0.160 
 t = 1.756 t = 1.344 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
StringencyScaled -0.284*** -0.656*** 
 t = -4.218 t = -11.572 
log(1 + LaggedCaseChange) -0.036*** -0.007 
 t = -3.252 t = -0.262 
TestingScaled -0.190*** -0.157 
 t = -4.752 t = -1.410 
VaccinationScaled 0.088 0.330*** 
 t = 1.258 t = 2.688 
log(1 + VaccineInvest) 0.029*** 0.035*** 
 t = 5.594 t = 3.208 
log(1 + HealthInvest) -0.010* -0.014 
 t = -1.846 t = -1.209 
log(1 + Fiscal_measures) -0.004 -0.016** 
 t = -1.283 t = -2.483 
IndustryHealth Care:EconomicScaled 0.145*** 0.156 
 t = 2.813 t = 1.239 
IndustryTelecommunications:EconomicScaled 0.118* -0.047 
 t = 1.703 t = -0.379 
IndustryUtilities:EconomicScaled -0.080 -0.283* 
 t = -1.594 t = -1.860 
IndustryTelecommunications:RevHomeCountry  -1.559*** 
  t = -7.892 
IndustryUtilities:RevHomeCountry  -0.556*** 
  t = -2.683 
IndustryFinancials:StringencyScaled 0.108 0.740*** 
 t = 1.565 t = 3.162 
IndustryHealth Care:StringencyScaled 0.164 0.858*** 
 t = 1.542 t = 3.184 
IndustryIndustrials:StringencyScaled -0.114* 0.238** 
 t = -1.708 t = 2.528 
IndustryOil and Gas:StringencyScaled -0.234* 0.151 
 t = -1.760 t = 0.487 
IndustryTechnology:StringencyScaled -0.051 0.455*** 
 t = -0.592 t = 3.541 
IndustryTelecommunications:StringencyScaled 0.207** 0.452*** 
 t = 2.234 t = 4.148 
IndustryUtilities:StringencyScaled 0.100 0.524*** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = 1.318 t = 3.684 
RevHomeCountry:StringencyScaled  0.848*** 
  t = 10.174 
IndustryFinancials:log(1 + LaggedCaseChange) -0.014 -0.173** 
 t = -1.023 t = -2.028 
IndustryHealth Care:log(1 + LaggedCaseChange) -0.038* -0.073** 
 t = -1.811 t = -2.347 
IndustryOil and Gas:log(1 + LaggedCaseChange) 0.042* 0.003 
 t = 1.670 t = 0.080 
IndustryTelecommunications:log(1 + LaggedCaseChange) -0.049** -0.030 
 t = -2.531 t = -0.677 
IndustryConsumer Services:TestingScaled 0.118* 0.108 
 t = 1.707 t = 0.505 
IndustryTechnology:TestingScaled 0.120*** 0.004 
 t = 2.689 t = 0.032 
IndustryUtilities:TestingScaled 0.166*** 0.192 
 t = 3.450 t = 1.390 
IndustryConsumer Goods:VaccinationScaled 0.062 -0.337* 
 t = 0.586 t = -1.718 
IndustryFinancials:VaccinationScaled -0.055 -0.965*** 
 t = -0.595 t = -3.040 
IndustryHealth Care:VaccinationScaled -0.282*** -0.507*** 
 t = -2.879 t = -3.824 
IndustryOil and Gas:VaccinationScaled 0.296** -0.150 
 t = 2.253 t = -0.625 
IndustryTelecommunications:VaccinationScaled -0.168 -0.462** 
 t = -1.437 t = -2.211 
IndustryConsumer Services:log(1 + VaccineInvest) -0.011* 0.005 
 t = -1.910 t = 0.365 
IndustryHealth Care:log(1 + VaccineInvest) -0.013** -0.020 
 t = -2.298 t = -1.531 
IndustryOil and Gas:log(1 + VaccineInvest) -0.014 -0.032** 
 t = -1.479 t = -2.424 
IndustryTelecommunications:log(1 + VaccineInvest) -0.016** -0.008 
 t = -2.483 t = -0.684 
IndustryUtilities:log(1 + VaccineInvest) -0.020*** -0.039*** 
 t = -3.194 t = -2.782 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryHealth Care:log(1 + HealthInvest) 0.022** 0.034** 
 t = 2.161 t = 2.356 
IndustryFinancials:log(1 + Fiscal_measures) 0.001 0.021*** 
 t = 0.166 t = 2.696 
IndustryIndustrials:log(1 + Fiscal_measures) 0.001 0.012* 
 t = 0.390 t = 1.781 
IndustryTelecommunications:log(1 + Fiscal_measures) 0.001 0.017** 
 t = 0.380 t = 2.291 
IndustryUtilities:log(1 + Fiscal_measures) 0.002 0.014* 
 t = 0.631 t = 1.949 
IndustryHealth Care:Import_change_previous 0.032 -0.493* 
 t = 0.223 t = -1.770 
IndustryOil and Gas:Import_change_previous 0.422* 0.580 
 t = 1.937 t = 1.394 
RevHomeCountry:Import_change_previous  -0.627* 
  t = -1.914 
IndustryTelecommunications:ScaledMarketCap -0.119 -2.688*** 
 t = -0.337 t = -6.635 
IndustryUtilities:ScaledMarketCap -1.388** -2.541*** 
 t = -2.148 t = -5.921 
IndustryConsumer Goods:RevHomeCountry:StringencyScaled  -0.678*** 
  t = -3.043 
IndustryConsumer Services:RevHomeCountry:StringencyScaled  -0.901* 
  t = -1.835 
IndustryFinancials:RevHomeCountry:StringencyScaled  -1.049*** 
  t = -4.056 
IndustryHealth Care:RevHomeCountry:StringencyScaled  -1.316*** 
  t = -3.637 
IndustryIndustrials:RevHomeCountry:StringencyScaled  -0.773*** 
  t = -4.284 
IndustryTechnology:RevHomeCountry:StringencyScaled  -1.137*** 
  t = -4.015 
IndustryTelecommunications:RevHomeCountry:StringencyScaled  -0.659*** 
  t = -3.050 
IndustryUtilities:RevHomeCountry:StringencyScaled  -0.960*** 
  t = -3.923 
IndustryFinancials:RevHomeCountry:log(1 + LaggedCaseChange)  0.185* 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
  t = 1.831 
IndustryFinancials:RevHomeCountry:TestingScaled  0.499** 
  t = 1.988 
IndustryFinancials:RevHomeCountry:VaccinationScaled  1.037** 
  t = 2.500 
IndustryOil and Gas:RevHomeCountry:VaccinationScaled  0.605* 




 t = 1.725 
IndustryFinancials:RevHomeCountry:log(1 + Fiscal_measures)  -0.041** 
  t = -2.013 
IndustryTelecommunications:RevHomeCountry: 
log(1 + Fiscal_measures) 
 -0.034* 
 t = -1.649 
IndustryFinancials:RevHomeCountry:Import_change_previous  0.726* 
  t = 1.870 
IndustryHealth Care:RevHomeCountry:Import_change_previous  0.890* 
  t = 1.774 
IndustryUtilities:RevHomeCountry:Import_change_previous  1.502** 
  t = 2.152 
Constant 4.564*** 4.520*** 







R2 0.093 0.172 
Adjusted R2 0.092 0.170 








Appendix 8.3 Results for Italy 
Table A8. 3: Country regression output – Italy 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.001*** 0.001*** 
 t = 6.539 t = 6.513 
IndustryConsumer Goods 0.119* -0.465** 
 t = 1.675 t = -2.257 
IndustryConsumer Services 0.122* -0.456** 
 t = 1.650 t = -2.140 
IndustryFinancials 0.151** -0.460** 
 t = 2.128 t = -2.146 
IndustryHealth Care -0.039 -1.322** 
 t = -0.392 t = -2.122 
IndustryIndustrials 0.114 -0.479** 
 t = 1.580 t = -2.329 
IndustryOil and Gas 0.209** -0.441** 
 t = 2.345 t = -2.046 
IndustryTechnology 0.070 -0.613*** 
 t = 0.981 t = -2.807 
IndustryTelecommunications 0.230** 1.732*** 
 t = 2.373 t = 4.442 
IndustryUtilities 0.180** -0.146 
 t = 2.410 t = -0.693 
EconomicScaled -0.124 0.078 
 t = -0.965 t = 0.253 
RevHomeCountry  -2.109*** 
  t = -3.678 
StringencyScaled 0.132** 0.036 
 t = 2.198 t = 0.171 
log(1 + LaggedCaseChange) -0.033** -0.070 
 t = -2.513 t = -1.558 
TestingScaled -0.477*** -0.285*** 
 t = -5.307 t = -7.598 
VaccinationScaled 0.196*** 0.073** 
 t = 5.635 t = 2.381 
log(1 + HealthInvest) -0.025** -0.031* 
 t = -2.361 t = -1.799 
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log(1 + Fiscal_measures) 0.004*** 0.002* 
 t = 2.610 t = 1.680 
Import_change_previous 0.010 -0.557** 
 t = 0.049 t = -2.452 
ScaledMarketCap 19.359*** 30.391 
 t = 3.605 t = 1.102 
IndustryFinancials:EconomicScaled -0.107 -0.531* 
 t = -0.844 t = -1.653 
IndustryConsumer Goods:RevHomeCountry  2.103*** 
  t = 3.662 
IndustryConsumer Services:RevHomeCountry  2.103*** 
  t = 3.646 
IndustryFinancials:RevHomeCountry  2.112*** 
  t = 3.665 
IndustryHealth Care:RevHomeCountry  2.861*** 
  t = 3.588 
IndustryIndustrials:RevHomeCountry  2.116*** 
  t = 3.689 
IndustryOil and Gas:RevHomeCountry  2.179*** 
  t = 3.774 
IndustryTechnology:RevHomeCountry  2.101*** 
  t = 3.598 
IndustryUtilities:RevHomeCountry  1.851*** 
  t = 3.212 
IndustryConsumer Services:log(1 + LaggedCaseChange) -0.041** -0.021 
 t = -1.973 t = -0.384 
IndustryOil and Gas:log(1 + LaggedCaseChange) -0.030* -0.015 
 t = -1.856 t = -0.303 
IndustryConsumer Services:TestingScaled -0.044 -0.488** 
 t = -0.391 t = -2.155 
IndustryFinancials:TestingScaled 0.105 -0.209** 
 t = 1.166 t = -2.285 
IndustryHealth Care:TestingScaled 0.221* 0.463*** 
 t = 1.949 t = 4.201 
IndustryIndustrials:TestingScaled 0.088 -0.131* 
 t = 0.962 t = -1.949 
IndustryTelecommunications:TestingScaled 0.422*** 0.417*** 
 t = 3.491 t = 5.429 
IndustryUtilities:TestingScaled 0.391*** 0.107 
 t = 4.471 t = 0.999 
RevHomeCountry:TestingScaled  -0.283*** 
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  t = -3.328 
IndustryConsumer Goods:VaccinationScaled -0.175*** 0.018 
 t = -4.879 t = 0.358 
IndustryConsumer Services:VaccinationScaled -0.244*** -0.328** 
 t = -3.527 t = -2.348 
IndustryFinancials:VaccinationScaled -0.204*** 0.189*** 
 t = -4.626 t = 4.228 
IndustryHealth Care:VaccinationScaled -0.333*** -0.320*** 
 t = -5.298 t = -7.383 
IndustryIndustrials:VaccinationScaled -0.117*** 0.051 
 t = -2.847 t = 0.866 
IndustryOil and Gas:VaccinationScaled -0.227*** -0.099 
 t = -3.234 t = -0.703 
IndustryTechnology:VaccinationScaled -0.182*** 0.193 
 t = -2.780 t = 0.904 
IndustryTelecommunications:VaccinationScaled -0.264* -0.597*** 
 t = -1.943 t = -6.037 
IndustryUtilities:VaccinationScaled -0.167* 0.115 
 t = -1.878 t = 0.424 
RevHomeCountry:VaccinationScaled  0.317*** 
  t = 9.552 
IndustryHealth Care:log(1 + HealthInvest) 0.013 0.042** 
 t = 1.137 t = 1.977 
IndustryConsumer Services:log(1 + Fiscal_measures) 0.0004 0.008** 
 t = 0.231 t = 2.071 
IndustryConsumer Goods:Import_change_previous -0.022 0.662*** 
 t = -0.112 t = 2.744 
IndustryFinancials:Import_change_previous 0.122 1.225** 
 t = 0.581 t = 2.365 
IndustryHealth Care:Import_change_previous -0.402* 0.238 
 t = -1.749 t = 0.628 
IndustryIndustrials:Import_change_previous -0.086 0.524** 
 t = -0.429 t = 2.138 
IndustryUtilities:Import_change_previous 0.082 1.330*** 
 t = 0.393 t = 3.745 
RevHomeCountry:Import_change_previous  1.088* 
  t = 1.725 
IndustryConsumer Goods:ScaledMarketCap -18.717*** -29.753*** 
 t = -3.471 t = -59.042 
IndustryConsumer Services:ScaledMarketCap -22.652*** -34.190*** 
 t = -3.485 t = -11.165 
169 
 
IndustryFinancials:ScaledMarketCap -19.706*** -30.235*** 
 t = -3.668 t = -84.688 
IndustryHealth Care:ScaledMarketCap -15.432*** -24.623*** 
 t = -2.839 t = -6.674 
IndustryIndustrials:ScaledMarketCap -18.320*** -29.316*** 
 t = -3.345 t = -26.512 
IndustryOil and Gas:ScaledMarketCap -20.166*** -31.016*** 
 t = -3.746 t = -95.767 
IndustryTechnology:ScaledMarketCap -8.972 42.532** 
 t = -1.360 t = 2.146 
IndustryTelecommunications:ScaledMarketCap -21.602*** -31.735*** 
 t = -3.996 t = -2,893,052 
IndustryUtilities:ScaledMarketCap -19.366*** -30.564*** 
 t = -3.606 t = -761.021 
IndustryConsumer Goods:RevHomeCountry:TestingScaled  0.446** 
  t = 2.484 
IndustryConsumer Services:RevHomeCountry:TestingScaled  0.594* 
  t = 1.913 
IndustryFinancials:RevHomeCountry:TestingScaled  0.450*** 
  t = 3.476 
IndustryHealth Care:RevHomeCountry:TestingScaled  -0.258* 
  t = -1.830 
IndustryIndustrials:RevHomeCountry:TestingScaled  0.356*** 
  t = 2.645 
IndustryOil and Gas:RevHomeCountry:TestingScaled  0.769* 
  t = 1.943 
IndustryUtilities:RevHomeCountry:TestingScaled  0.395*** 
  t = 2.688 
IndustryConsumer Goods:RevHomeCountry:VaccinationScaled  -0.497*** 
  t = -3.834 
IndustryFinancials:RevHomeCountry:VaccinationScaled  -0.581*** 
  t = -5.180 
IndustryIndustrials:RevHomeCountry:VaccinationScaled  -0.433*** 
  t = -4.783 
IndustryOil and Gas:RevHomeCountry:VaccinationScaled  -0.382** 
  t = -2.132 
IndustryTechnology:RevHomeCountry:VaccinationScaled  -0.597** 




 t = -2.244 
 -1.328* 
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IndustryConsumer Services: RevHomeCountry: 
Import_change_previous 
 t = -1.744 
IndustryFinancials:RevHomeCountry:Import_change_previous  -1.726** 
  t = -2.199 
IndustryHealth Care: RevHomeCountry: 
Import_change_previous 
 -1.339* 
 t = -1.789 
IndustryIndustrials:RevHomeCountry:Import_change_previous  -1.180* 
  t = -1.827 
IndustryUtilities:RevHomeCountry:Import_change_previous  -1.827** 
  t = -2.546 
Constant 4.494*** 5.084*** 
 t = 62.676 t = 24.762 
Observations 65,992 44,968 
R2 0.181 0.266 
Adjusted R2 0.180 0.263 
Note: *p<0.1, **p<0.05, ***p<0.01 
  
Appendix 8.4 Results for Norway 
Table A8. 4: Country regression output – Norway 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.001*** 0.001 
 t = 3.960 t = 1.641 
IndustryConsumer Services -1.011* -0.063 
 t = -1.688 t = -0.273 
IndustryHealth Care -0.223 -0.108*** 
 t = -1.318 t = -165.642 
IndustryOil and Gas -0.121 0.764*** 
 t = -0.978 t = 13.056 
IndustryTechnology -0.111 0.230*** 
 t = -0.698 t = 6.245 
IndustryTelecommunications -0.131 0.069* 
 t = -1.320 t = 1.928 
EconomicScaled 0.382 0.881*** 
 t = 1.527 t = 3.397 
RevHomeCountry  0.123*** 
  t = 3.438 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
StringencyScaled -0.318** -0.496*** 
 t = -2.496 t = -3.108 
TestingScaled -0.276 -0.575*** 
 t = -1.579 t = -5.851 
VaccinationScaled 0.509*** 0.904*** 
 t = 2.751 t = 6.319 
log(1 + VaccineInvest) -0.019** -0.035*** 
 t = -2.364 t = -5.240 
log(1 + Fiscal_measures) -0.008*** -0.012*** 
 t = -3.531 t = -4.374 
Import_change_previous 0.307 0.748*** 
 t = 1.347 t = 4.530 
IndustryConsumer Goods:EconomicScaled -0.555** -0.927*** 
 t = -2.152 t = -3.477 
IndustryConsumer Services:EconomicScaled -0.919 -5.018** 
 t = -1.011 t = -2.063 
IndustryFinancials:EconomicScaled -0.220 1.288*** 
 t = -0.867 t = 4.291 
IndustryHealth Care:EconomicScaled -0.086 0.990*** 
 t = -0.256 t = 246.611 
IndustryIndustrials:EconomicScaled 0.093 -0.691*** 
 t = 0.344 t = -2.653 
IndustryTechnology:EconomicScaled 0.877** -0.654*** 
 t = 2.289 t = -2.949 
IndustryTelecommunications:EconomicScaled -0.613** -0.942*** 
 t = -2.479 t = -4.255 
IndustryOil and Gas:RevHomeCountry  -0.862*** 
  t = -12.070 
IndustryTechnology:RevHomeCountry  -0.100* 
  t = -1.958 
IndustryTelecommunications:RevHomeCountry  -0.166*** 
  t = -4.633 
EconomicScaled:RevHomeCountry  -0.581*** 
  t = -2.624 
IndustryConsumer Goods:StringencyScaled 0.255* 0.418** 
 t = 1.888 t = 2.094 
IndustryConsumer Services:StringencyScaled 0.245 1.599* 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = 0.719 t = 1.806 
IndustryFinancials:StringencyScaled -0.092 -1.501*** 
 t = -0.666 t = -7.597 
IndustryHealth Care:StringencyScaled 0.054 0.120*** 
 t = 0.326 t = 43.717 
IndustryOil and Gas:StringencyScaled -0.160 1.071*** 
 t = -1.008 t = 3.495 
IndustryTechnology:StringencyScaled -0.451** 0.016 
 t = -2.324 t = 0.107 
IndustryTelecommunications:StringencyScaled 0.170 0.539*** 
 t = 1.039 t = 3.558 
IndustryConsumer Goods:log(1 + LaggedCaseChange) -0.011*** 0.001 
 t = -3.095 t = 0.372 
IndustryConsumer Services:log(1 + LaggedCaseChange) -0.024* -0.073** 
 t = -1.948 t = -2.081 
IndustryFinancials:log(1 + LaggedCaseChange) -0.004 0.008*** 
 t = -1.597 t = 2.747 
IndustryHealth Care:log(1 + LaggedCaseChange) -0.023*** -0.049*** 
 t = -3.000 t = -5,059.203 
IndustryOil and Gas:log(1 + LaggedCaseChange) -0.016*** 0.009*** 
 t = -3.104 t = 15.478 
IndustryTelecommunications:log(1 + LaggedCaseChange) 0.002 -0.004*** 
 t = 0.473 t = -6.768 
IndustryUtilities:log(1 + LaggedCaseChange) -0.007***  
 t = -2.908  
RevHomeCountry:log(1 + LaggedCaseChange)  0.009*** 
  t = 16.871 
IndustryConsumer Goods:TestingScaled -0.014 0.451*** 
 t = -0.079 t = 4.118 
IndustryConsumer Services:TestingScaled -0.541 -2.700* 
 t = -0.881 t = -1.658 
IndustryFinancials:TestingScaled -0.054 -0.376*** 
 t = -0.317 t = -4.821 
IndustryHealth Care:TestingScaled -0.015 -0.203*** 
 t = -0.078 t = -161.726 
IndustryOil and Gas:TestingScaled -0.450** 0.648 
 t = -2.243 t = 1.574 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryTechnology:TestingScaled 0.208 0.183** 
 t = 1.172 t = 2.506 
IndustryTelecommunications:TestingScaled 0.054 0.285*** 
 t = 0.304 t = 4.110 
IndustryUtilities:TestingScaled 0.464***  
 t = 2.744  
RevHomeCountry:TestingScaled  0.798*** 
  t = 11.524 
IndustryConsumer Goods:VaccinationScaled -0.544*** -0.858*** 
 t = -2.798 t = -7.566 
IndustryConsumer Services:VaccinationScaled -0.743* -2.473* 
 t = -1.654 t = -1.855 
IndustryFinancials:VaccinationScaled -0.121 2.756*** 
 t = -0.629 t = 34.314 
IndustryHealth Care:VaccinationScaled -0.373 -0.269*** 
 t = -1.251 t = -366.983 
IndustryIndustrials:VaccinationScaled -0.005 -0.705** 
 t = -0.025 t = -2.209 
IndustryTechnology:VaccinationScaled 0.551* -0.383*** 
 t = 1.657 t = -7.055 
IndustryTelecommunications:VaccinationScaled -0.602** -1.273*** 
 t = -2.508 t = -31.541 
IndustryUtilities:VaccinationScaled -0.899***  
 t = -5.154  
RevHomeCountry:VaccinationScaled  -0.393*** 
  t = -9.742 
IndustryConsumer Goods:log(1 + VaccineInvest) 0.007 0.020*** 
 t = 0.767 t = 2.645 
IndustryConsumer Services:log(1 + VaccineInvest) 0.012 0.095** 
 t = 0.642 t = 1.989 
IndustryFinancials:log(1 + VaccineInvest) 0.003 -0.039*** 
 t = 0.396 t = -3.989 
IndustryHealth Care:log(1 + VaccineInvest) -0.013 -0.088*** 
 t = -0.987 t = -750.397 
IndustryTechnology:log(1 + VaccineInvest) -0.007 0.025*** 
 t = -0.716 t = 3.808 
IndustryTelecommunications:log(1 + VaccineInvest) 0.022** 0.028*** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = 2.448 t = 4.337 
IndustryUtilities:log(1 + VaccineInvest) 0.014*  
 t = 1.804  
RevHomeCountry:log(1 + VaccineInvest)  0.035*** 
  t = 5.408 
IndustryConsumer Services:log(1 + HealthInvest) 0.089 0.572* 
 t = 0.772 t = 1.710 
IndustryHealth Care:log(1 + HealthInvest) -0.046 -0.266*** 
 t = -1.175 t = -410.550 
IndustryIndustrials:log(1 + HealthInvest) 0.011 0.117** 
 t = 0.365 t = 2.350 
IndustryOil and Gas:log(1 + HealthInvest) -0.005 0.254*** 
 t = -0.148 t = 3.974 
IndustryTechnology:log(1 + HealthInvest) -0.068* 0.110*** 
 t = -1.937 t = 3.064 
IndustryTelecommunications:log(1 + HealthInvest) 0.030 0.080** 
 t = 1.128 t = 2.240 
RevHomeCountry:log(1 + HealthInvest)  0.089** 
  t = 2.483 
IndustryConsumer Goods:log(1 + Fiscal_measures) 0.001 0.008* 
 t = 0.284 t = 1.689 
IndustryFinancials:log(1 + Fiscal_measures) -0.002 -0.036*** 
 t = -0.844 t = -6.743 
IndustryHealth Care:log(1 + Fiscal_measures) -0.014** -0.040*** 
 t = -2.281 t = -801.173 
IndustryOil and Gas:log(1 + Fiscal_measures) -0.013*** 0.042*** 
 t = -3.119 t = 2.889 
IndustryTechnology:log(1 + Fiscal_measures) -0.006* 0.007** 
 t = -1.957 t = 2.398 
IndustryTelecommunications:log(1 + Fiscal_measures) 0.013*** 0.008*** 
 t = 2.866 t = 2.965 
IndustryUtilities:log(1 + Fiscal_measures) 0.005**  
 t = 2.271  
RevHomeCountry:log(1 + Fiscal_measures)  0.010*** 
  t = 3.677 
IndustryConsumer Goods:Import_change_previous -0.179 -0.674*** 
 t = -0.754 t = -2.892 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryFinancials:Import_change_previous -0.020 0.988*** 
 t = -0.087 t = 4.443 
IndustryHealth Care:Import_change_previous 0.038 1.105*** 
 t = 0.134 t = 368.771 
IndustryOil and Gas:Import_change_previous 0.215 -0.948** 
 t = 0.750 t = -2.084 
IndustryTechnology:Import_change_previous -0.339 -0.433*** 
 t = -1.334 t = -2.585 
IndustryTelecommunications:Import_change_previous -0.470** -0.826*** 
 t = -2.033 t = -5.000 
IndustryUtilities:Import_change_previous -0.724***  
 t = -3.182  
RevHomeCountry:Import_change_previous  -0.997*** 
  t = -6.033 
IndustryFinancials:ScaledMarketCap 0.640 -9.506* 
 t = 0.827 t = -1.688 
IndustryIndustrials:ScaledMarketCap 5.121*** 7.783** 
 t = 2.845 t = 2.553 
IndustryTechnology:ScaledMarketCap 4.509** -7.589 
 t = 2.426  
IndustryConsumer Services:EconomicScaled:RevHomeCountry  5.765** 
  t = 2.366 
IndustryFinancials:EconomicScaled:RevHomeCountry  -1.486*** 
  t = -3.737 
IndustryIndustrials:EconomicScaled:RevHomeCountry  1.009** 
  t = 2.423 
IndustryTechnology:EconomicScaled:RevHomeCountry  1.174*** 




 t = 1.940 
IndustryConsumer Services:RevHomeCountry:StringencyScaled  -1.871** 
  t = -2.005 
IndustryFinancials:RevHomeCountry:StringencyScaled  1.472*** 
  t = 5.751 
IndustryOil and Gas:RevHomeCountry:StringencyScaled  -1.141*** 
  t = -2.955 
 -0.454*** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryTelecommunications:RevHomeCountry: 
StringencyScaled 
 t = -2.996 
IndustryConsumer Goods:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.036*** 
 t = -8.413 
IndustryConsumer Services:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.058* 
 t = 1.670 
IndustryFinancials:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.018*** 
 t = -4.134 
IndustryOil and Gas:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.035*** 
 t = -59.463 
IndustryTechnology:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.010*** 
 t = -6.514 
IndustryTelecommunications:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.002*** 
 t = 4.096 
IndustryConsumer Goods:RevHomeCountry:TestingScaled  -1.070*** 
  t = -6.979 
IndustryIndustrials:RevHomeCountry:TestingScaled  -0.602* 
  t = -1.655 
IndustryOil and Gas:RevHomeCountry:TestingScaled  -1.623*** 
  t = -2.972 
IndustryTechnology:RevHomeCountry:TestingScaled  -0.386*** 
  t = -3.289 
IndustryTelecommunications:RevHomeCountry:TestingScaled  -0.620*** 




 t = 1.794 
IndustryFinancials:RevHomeCountry:VaccinationScaled  -2.961*** 
  t = -24.663 
IndustryIndustrials:RevHomeCountry:VaccinationScaled  0.914* 
  t = 1.957 
IndustryTechnology:RevHomeCountry:VaccinationScaled  0.474*** 




 t = 24.264 
IndustryConsumer Goods:RevHomeCountry: 
log(1 + VaccineInvest) 
 -0.041*** 
 t = -2.595 
IndustryConsumer Services:RevHomeCountry: 
log(1 + VaccineInvest) 
 -0.134*** 
 t = -2.794 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryFinancials:RevHomeCountry:log(1 + VaccineInvest)  0.029** 
  t = 2.120 
IndustryIndustrials:RevHomeCountry:log(1 + VaccineInvest)  -0.033** 
  t = -2.219 
IndustryTechnology:RevHomeCountry:log(1 + VaccineInvest)  -0.046*** 
  t = -6.031 
IndustryTelecommunications:RevHomeCountry: 
log(1 + VaccineInvest) 
 -0.021*** 
 t = -3.202 
IndustryConsumer Services:RevHomeCountry: 
log(1 + HealthInvest) 
 -0.703** 
 t = -2.103 
IndustryIndustrials:RevHomeCountry:log(1 + HealthInvest)  -0.167*** 
  t = -3.003 
IndustryOil and Gas:RevHomeCountry:log(1 + HealthInvest)  -0.274*** 
  t = -3.454 
IndustryTechnology:RevHomeCountry:log(1 + HealthInvest)  -0.295*** 
  t = -8.257 
IndustryTelecommunications:RevHomeCountry: 
log(1 + HealthInvest) 
 -0.105*** 
 t = -2.925 
IndustryConsumer Goods:RevHomeCountry: 
log(1 + Fiscal_measures) 
 -0.026*** 
 t = -3.838 
IndustryFinancials:RevHomeCountry:log(1 + Fiscal_measures)  0.030*** 
  t = 3.749 
IndustryIndustrials:RevHomeCountry:log(1 + Fiscal_measures)  -0.007** 
  t = -1.994 
IndustryOil and Gas:RevHomeCountry:log(1 + Fiscal_measures)  -0.070*** 
  t = -3.605 
IndustryTechnology:RevHomeCountry:log(1 + Fiscal_measures)  -0.019*** 




 t = 4.648 
IndustryFinancials:RevHomeCountry:Import_change_previous  -0.510* 
  t = -1.743 
IndustryIndustrials:RevHomeCountry:Import_change_previous  0.869*** 
  t = 2.610 
IndustryOil and Gas:RevHomeCountry:Import_change_previous  1.849*** 
  t = 3.140 
IndustryTechnology:RevHomeCountry:Import_change_previous  0.512** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 




 t = 5.147 
Constant 4.644*** 4.523*** 
 t = 47.700 t = 123.466 
Observations 25,230 11,020 
R2 0.311 0.563 
Adjusted R2 0.308 0.556 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Appendix 8.5 Results for Spain 
Table A8. 5: Country regression output – Spain 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.001*** 0.001*** 
 t = 5.876 t = 4.750 
IndustryTelecommunications -0.016 -8.282*** 
 t = -0.092 t = -24.542 
IndustryUtilities -0.043 -1.434*** 
 t = -0.921 t = -12.169 
EconomicScaled -0.057*** -0.069*** 
 t = -3.940 t = -2.958 
RevHomeCountry  0.090*** 
  t = 2.893 
StringencyScaled -0.076 -0.198** 
 t = -1.242 t = -2.133 
log(1 + LaggedCaseChange) -0.037*** -0.009 
 t = -3.609 t = -1.397 
TestingScaled -0.213*** -0.093 
 t = -3.055 t = -1.569 
log(1 + VaccineInvest) -0.274*** -0.171** 
 t = -3.167 t = -2.074 
log(1 + HealthInvest) -0.037*** -0.015 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = -3.322 t = -1.170 
log(1 + Fiscal_measures) -0.160*** -0.020 
 t = -3.163 t = -0.504 
Import_change_previous -0.145** -0.134 
 t = -2.116 t = -1.634 
IndustryConsumer Services:EconomicScaled -0.042 -0.177** 
 t = -0.812 t = -2.165 
IndustryFinancials:EconomicScaled -0.070** 0.102 
 t = -2.302 t = 0.877 
IndustryHealth Care:EconomicScaled 0.195* 0.302 
 t = 1.760 t = 1.193 
IndustryOil and Gas:EconomicScaled 0.054** 0.061*** 
 t = 2.041 t = 2.730 
IndustryUtilities:EconomicScaled -0.018 -0.189** 
 t = -0.585 t = -2.203 
IndustryFinancials:RevHomeCountry  -0.240** 
  t = -2.042 
IndustryTelecommunications:RevHomeCountry  7.721*** 
  t = 22.842 
IndustryUtilities:RevHomeCountry  1.467*** 
  t = 12.509 
IndustryTechnology:StringencyScaled -0.401* 1.550 
 t = -1.933 t = 0.524 
IndustryTelecommunications:StringencyScaled -0.049 0.384** 
 t = -0.338 t = 2.025 
IndustryUtilities:StringencyScaled -0.255** 0.289 
 t = -2.397 t = 1.495 
RevHomeCountry:StringencyScaled  0.308** 
  t = 2.423 
IndustryConsumer Services:log(1 + LaggedCaseChange) 0.007 -0.065*** 
 t = 0.478 t = -2.922 
IndustryFinancials:log(1 + LaggedCaseChange) 0.009 -0.043* 
 t = 0.827 t = -1.905 
IndustryTechnology:log(1 + LaggedCaseChange) 0.065** -0.065 
 t = 2.426 t = -0.166 
IndustryUtilities:log(1 + LaggedCaseChange) 0.037** 0.014 
 t = 2.548 t = 1.370 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
RevHomeCountry:log(1 + LaggedCaseChange)  -0.069*** 
  t = -6.785 
IndustryIndustrials:TestingScaled 0.149** 0.126 
 t = 2.014 t = 1.261 
IndustryTechnology:TestingScaled 0.435** -1.334 
 t = 2.347 t = -0.473 
IndustryUtilities:TestingScaled 0.234*** 0.368*** 
 t = 2.619 t = 5.424 
RevHomeCountry:TestingScaled  -0.304** 
  t = -2.525 
IndustryConsumer Services:VaccinationScaled 0.080 0.405* 
 t = 0.566 t = 1.682 
IndustryIndustrials:VaccinationScaled -0.011 0.331** 
 t = -0.098 t = 1.960 
IndustryOil and Gas:VaccinationScaled 0.109 0.561*** 
 t = 0.601 t = 2.807 
IndustryTechnology:VaccinationScaled 0.131 5.484*** 
 t = 0.715 t = 6.551 
IndustryConsumer Goods:log(1 + VaccineInvest) 0.247** 0.161 
 t = 2.269 t = 1.084 
IndustryConsumer Services:log(1 + VaccineInvest) 0.063 -0.279** 
 t = 0.607 t = -1.975 
IndustryFinancials:log(1 + VaccineInvest) 0.157* 0.224* 
 t = 1.691 t = 1.761 
IndustryTelecommunications:log(1 + VaccineInvest) 0.249*** 0.123 
 t = 2.777 t = 1.251 
RevHomeCountry:log(1 + VaccineInvest)  -0.261* 
  t = -1.699 
IndustryConsumer Services:log(1 + HealthInvest) -0.001 -0.053*** 
 t = -0.057 t = -3.409 
IndustryFinancials:log(1 + HealthInvest) 0.008 -0.086** 
 t = 0.695 t = -2.575 
IndustryHealth Care:log(1 + HealthInvest) -0.005 -0.028* 
 t = -0.412 t = -1.672 
IndustryIndustrials:log(1 + HealthInvest) 0.003 -0.037** 
 t = 0.235 t = -2.393 
IndustryOil and Gas:log(1 + HealthInvest) -0.011 -0.034** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = -0.739 t = -1.977 
IndustryTelecommunications:log(1 + HealthInvest) -0.007 -0.044** 
 t = -0.488 t = -2.459 
IndustryUtilities:log(1 + HealthInvest) -0.025** -0.023 
 t = -2.059 t = -1.268 
RevHomeCountry:log(1 + HealthInvest)  -0.055*** 
  t = -2.817 
IndustryConsumer Services:log(1 + Fiscal_measures) 0.032 -0.279*** 
 t = 0.534 t = -3.326 
IndustryHealth Care:log(1 + Fiscal_measures) 0.179** 0.135 
 t = 2.372 t = 0.806 
IndustryIndustrials:log(1 + Fiscal_measures) 0.094* -0.066 
 t = 1.750 t = -1.085 
IndustryTechnology:log(1 + Fiscal_measures) 0.150** 0.876 
 t = 2.068 t = 1.254 
IndustryUtilities:log(1 + Fiscal_measures) 0.154*** -0.179* 
 t = 2.681 t = -1.885 
RevHomeCountry:log(1 + Fiscal_measures)  -0.354*** 
  t = -4.444 
IndustryFinancials:Import_change_previous 0.178** 0.286*** 
 t = 2.474 t = 2.600 
IndustryOil and Gas:Import_change_previous 0.090 0.170** 
 t = 1.047 t = 2.001 
IndustryTelecommunications:Import_change_previous 0.162** 0.198** 
 t = 2.310 t = 2.328 
IndustryUtilities:Import_change_previous 0.027 0.771*** 
 t = 0.212 t = 2.869 
IndustryConsumer Services:ScaledMarketCap 2.657 3.257* 
 t = 1.296 t = 1.695 
IndustryOil and Gas:ScaledMarketCap 2.727 5.870*** 
 t = 0.986 t = 2.591 
IndustryTechnology:ScaledMarketCap 1.027 -77.320*** 
 t = 0.490 t = -5.251 
IndustryTelecommunications:ScaledMarketCap 2.726 27.540*** 
 t = 1.176 t = 14.342 
IndustryUtilities:ScaledMarketCap 2.947 4.282** 
 t = 1.435 t = 2.230 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryUtilities:EconomicScaled:RevHomeCountry  0.171* 




 t = -4.217 
IndustryUtilities:RevHomeCountry:StringencyScaled  -0.712** 
  t = -2.151 
IndustryConsumer Services:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.115*** 
 t = 4.259 
IndustryFinancials:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.103*** 
 t = 4.121 
IndustryHealth Care:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.104*** 
 t = 3.006 
IndustryTelecommunications:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.160*** 
 t = 3.306 
IndustryUtilities:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.045** 
 t = 2.240 
IndustryTelecommunications:RevHomeCountry:TestingScaled  0.636** 
  t = 2.023 
IndustryIndustrials:RevHomeCountry:VaccinationScaled  -0.836** 
  t = -2.464 
IndustryOil and Gas:RevHomeCountry:VaccinationScaled  -0.937** 
  t = -2.068 
IndustryTechnology:RevHomeCountry:VaccinationScaled  -10.734*** 
  t = -6.319 
IndustryConsumer Services:RevHomeCountry: 
log(1 + VaccineInvest) 
 0.563*** 
 t = 2.703 
IndustryIndustrials:RevHomeCountry:log(1 + VaccineInvest)  0.573** 
  t = 2.530 
IndustryTelecommunications:RevHomeCountry: 
log(1 + VaccineInvest) 
 0.304* 
 t = 1.862 
IndustryConsumer Goods:RevHomeCountry: 
log(1 + HealthInvest) 
 0.104*** 
 t = 2.920 
IndustryConsumer Services:RevHomeCountry: 
log(1 + HealthInvest) 
 0.088*** 
 t = 3.288 
IndustryFinancials:RevHomeCountry:log(1 + HealthInvest)  0.135*** 
  t = 3.516 
IndustryHealth Care:RevHomeCountry:log(1 + HealthInvest)  0.065*** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
  t = 2.631 
IndustryIndustrials:RevHomeCountry:log(1 + HealthInvest)  0.093*** 
  t = 3.431 
IndustryOil and Gas:RevHomeCountry:log(1 + HealthInvest)  0.041* 
  t = 1.688 
IndustryTelecommunications:RevHomeCountry: 
log(1 + HealthInvest) 
 0.085*** 
 t = 3.620 
IndustryConsumer Services:RevHomeCountry: 
log(1 + Fiscal_measures) 
 0.560*** 
 t = 4.522 
IndustryFinancials:RevHomeCountry:log(1 + Fiscal_measures)  0.308** 
  t = 2.266 
IndustryIndustrials:RevHomeCountry:log(1 + Fiscal_measures)  0.363*** 
  t = 3.332 
IndustryOil and Gas:RevHomeCountry: 
log(1 + Fiscal_measures) 
 0.576*** 
 t = 2.991 
IndustryTelecommunications:RevHomeCountry: 
log(1 + Fiscal_measures) 
 0.371*** 
 t = 2.649 
IndustryUtilities:RevHomeCountry:log(1 + Fiscal_measures)  0.599*** 
  t = 3.800 
IndustryUtilities:RevHomeCountry:Import_change_previous  -1.008* 
  t = -1.893 
Constant 4.617*** 4.584*** 
 t = 190.366 t = 140.649 
Observations 37,465 24,190 
R2 0.173 0.463 
Adjusted R2 0.170 0.458 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Appendix 8.6 Results for Sweden 
Table A8. 6: Country regression output – Sweden 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.002*** 0.002*** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = 9.390 t = 9.320 
IndustryConsumer Services -0.009 0.266** 
 t = -0.129 t = 2.014 
IndustryIndustrials 0.032 0.238** 
 t = 0.535 t = 2.450 
IndustryOil and Gas 0.059 0.192** 
 t = 0.579 t = 2.239 
IndustryTelecommunications 0.154** -0.078 
 t = 2.512 t = -0.919 
IndustryUtilities -0.108 -0.291* 
 t = -1.028 t = -1.831 
EconomicScaled -0.551*** -0.525*** 
 t = -6.662 t = -6.260 
RevHomeCountry  0.357* 
  t = 1.799 
StringencyScaled 0.179 0.148* 
 t = 1.533 t = 1.897 
log(1 + LaggedCaseChange) -0.046*** -0.025** 
 t = -4.064 t = -2.171 
TestingScaled -0.152** -0.151* 
 t = -2.445 t = -1.846 
VaccinationScaled -0.371*** -0.288*** 
 t = -4.084 t = -3.933 
log(1 + VaccineInvest) 0.005 0.030** 
 t = 0.107 t = 1.999 
log(1 + HealthInvest) 0.006 0.010** 
 t = 1.080 t = 2.294 
log(1 + Fiscal_measures) -0.021*** -0.018*** 
 t = -4.568 t = -2.994 
Import_change_previous 0.529*** 0.460*** 
 t = 5.197 t = 4.199 
ScaledMarketCap 0.649 0.932* 
 t = 1.292 t = 1.936 
IndustryConsumer Goods:EconomicScaled 0.370*** 0.397** 
 t = 3.427 t = 2.370 
IndustryConsumer Services:EconomicScaled 0.284** -0.224 
 t = 2.065 t = -0.732 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryHealth Care:EconomicScaled 0.297*** 0.554*** 
 t = 2.914 t = 3.006 
IndustryIndustrials:EconomicScaled 0.197** -0.025 
 t = 2.330 t = -0.175 
IndustryOil and Gas:EconomicScaled -0.445*** -0.289*** 
 t = -3.469 t = -3.994 
IndustryTechnology:EconomicScaled 0.449*** 0.447*** 
 t = 4.446 t = 3.159 
IndustryTelecommunications:EconomicScaled -0.182 0.227*** 
 t = -1.336 t = 3.133 
IndustryUtilities:EconomicScaled -0.371*** -0.824*** 
 t = -4.247 t = -12.261 
IndustryConsumer Services:RevHomeCountry  -0.466** 
  t = -2.005 
IndustryIndustrials:RevHomeCountry  -0.388* 
  t = -1.883 
EconomicScaled:RevHomeCountry  0.421*** 
  t = 3.620 
IndustryConsumer Goods:StringencyScaled -0.463*** -0.448*** 
 t = -3.322 t = -2.642 
IndustryConsumer Services:StringencyScaled -0.233 -0.571** 
 t = -1.447 t = -2.135 
IndustryFinancials:StringencyScaled -0.378*** -0.270 
 t = -3.337 t = -1.458 
IndustryHealth Care:StringencyScaled -0.108 -0.521** 
 t = -0.793 t = -2.322 
IndustryIndustrials:StringencyScaled -0.352*** -0.015 
 t = -3.016 t = -0.104 
IndustryOil and Gas:StringencyScaled -0.009 0.227*** 
 t = -0.042 t = 3.246 
IndustryTechnology:StringencyScaled -0.388*** -0.308** 
 t = -2.796 t = -1.992 
IndustryTelecommunications:StringencyScaled 0.210 -0.481*** 
 t = 0.967 t = -6.892 
IndustryUtilities:StringencyScaled 0.129 0.822*** 
 t = 1.084 t = 10.768 
RevHomeCountry:StringencyScaled  -0.658*** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
  t = -5.495 
IndustryConsumer Goods:log(1 + LaggedCaseChange) 0.029** 0.006 
 t = 2.265 t = 0.383 
IndustryFinancials:log(1 + LaggedCaseChange) 0.021** 0.001 
 t = 1.970 t = 0.088 
IndustryIndustrials:log(1 + LaggedCaseChange) 0.021* -0.016 
 t = 1.862 t = -1.077 
IndustryOil and Gas:log(1 + LaggedCaseChange) -0.007 -0.086*** 
 t = -0.391 t = -8.344 
IndustryTelecommunications:log(1 + LaggedCaseChange) -0.028 0.017* 
 t = -1.379 t = 1.681 
IndustryUtilities:log(1 + LaggedCaseChange) -0.016 -0.013** 
 t = -1.600 t = -2.121 
IndustryConsumer Goods:TestingScaled 0.100* 0.079 
 t = 1.646 t = 0.842 
IndustryConsumer Services:TestingScaled 0.202*** 0.168 
 t = 2.755 t = 1.418 
IndustryTechnology:TestingScaled 0.125** 0.075 
 t = 2.072 t = 0.540 
IndustryTelecommunications:TestingScaled -0.196*** -0.196*** 
 t = -4.406 t = -2.803 
IndustryUtilities:TestingScaled 0.206 0.383** 
 t = 1.290 t = 2.015 
IndustryConsumer Goods:VaccinationScaled 0.239** 0.253 
 t = 2.156 t = 1.563 
IndustryHealth Care:VaccinationScaled 0.018 0.465*** 
 t = 0.172 t = 2.876 
IndustryIndustrials:VaccinationScaled 0.200** -0.042 
 t = 2.190 t = -0.412 
IndustryOil and Gas:VaccinationScaled -0.059 -0.468*** 
 t = -0.367 t = -9.310 
IndustryTechnology:VaccinationScaled 0.333*** 0.257* 







 t = -3.687 t = -4.082 
IndustryUtilities:VaccinationScaled -0.005 -0.244* 
 t = -0.059 t = -1.888 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryConsumer Services:log(1 + VaccineInvest) -0.031 -0.138*** 
 t = -0.690 t = -2.946 
IndustryFinancials:log(1 + VaccineInvest) -0.022 -0.086** 
 t = -0.535 t = -2.281 
IndustryIndustrials:log(1 + VaccineInvest) -0.040 -0.048* 
 t = -0.979 t = -1.879 
IndustryOil and Gas:log(1 + VaccineInvest) -0.091 -0.279*** 
 t = -1.515 t = -23.475 
IndustryTelecommunications:log(1 + VaccineInvest) 0.033 0.042*** 
 t = 0.815 t = 3.531 
IndustryUtilities:log(1 + VaccineInvest) 0.159*** 0.231*** 
 t = 3.334 t = 5.154 
RevHomeCountry:log(1 + VaccineInvest)  -0.096** 
  t = -2.184 
IndustryConsumer Services:log(1 + HealthInvest) 0.005 0.019** 
 t = 0.858 t = 2.133 
IndustryOil and Gas:log(1 + HealthInvest) -0.004 -0.033*** 
 t = -0.562 t = -8.867 
IndustryTelecommunications:log(1 + HealthInvest) -0.009* -0.013*** 
 t = -1.945 t = -3.515 
IndustryUtilities:log(1 + HealthInvest) -0.018*** -0.013*** 
 t = -3.266 t = -3.055 
IndustryConsumer Goods:log(1 + Fiscal_measures) -0.014** -0.020** 
 t = -2.534 t = -2.556 
IndustryConsumer Services:log(1 + Fiscal_measures) -0.021*** -0.029* 
 t = -3.001 t = -1.956 
IndustryHealth Care:log(1 + Fiscal_measures) -0.018*** -0.033** 
 t = -3.630 t = -2.562 
IndustryIndustrials:log(1 + Fiscal_measures) -0.013*** -0.019*** 
 t = -3.033 t = -2.671 
IndustryOil and Gas:log(1 + Fiscal_measures) -0.026*** -0.055*** 
 t = -3.825 t = -9.856 
IndustryTechnology:log(1 + Fiscal_measures) -0.016*** -0.029*** 
 t = -3.355 t = -3.208 
IndustryTelecommunications:log(1 + Fiscal_measures) 0.035*** 0.049*** 
 t = 5.797 t = 8.752 
IndustryIndustrials:Import_change_previous 0.078 0.279** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = 0.855 t = 2.114 
IndustryUtilities:Import_change_previous -0.237** -0.218 
 t = -2.134 t = -0.976 
IndustryConsumer Goods:ScaledMarketCap -0.193 2.836** 
 t = -0.246 t = 2.351 
IndustryConsumer Services:ScaledMarketCap -0.613 -1.146* 
 t = -0.766 t = -1.806 
IndustryHealth Care:ScaledMarketCap 1.141 9.231** 
 t = 0.774 t = 1.991 
IndustryIndustrials:ScaledMarketCap -0.599 -1.154** 
 t = -1.188 t = -2.011 
IndustryTechnology:ScaledMarketCap -0.455 4.261*** 
 t = -0.859 t = 5.652 
IndustryUtilities:ScaledMarketCap 132.047*** 131.764*** 
 t = 262.884 t = 273.744 
IndustryConsumer Goods:EconomicScaled:RevHomeCountry  -0.740*** 
  t = -2.592 
IndustryTelecommunications:EconomicScaled:RevHomeCountry  -1.165*** 
  t = -10.011 
IndustryConsumer Services:RevHomeCountry:StringencyScaled  1.168*** 
  t = 2.593 
IndustryFinancials:RevHomeCountry:StringencyScaled  0.528** 
  t = 2.335 
IndustryHealth Care:RevHomeCountry:StringencyScaled  0.998*** 
  t = 2.708 
IndustryTelecommunications:RevHomeCountry:StringencyScaled  1.887*** 
  t = 15.767 
IndustryIndustrials:RevHomeCountry:log(1 + LaggedCaseChange)  0.047* 
  t = 1.932 
IndustryOil and Gas:RevHomeCountry:log(1 + LaggedCaseChange)  0.144*** 
  t = 9.009 
IndustryTelecommunications:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 -0.087*** 
 t = -5.485 
IndustryOil and Gas:RevHomeCountry:TestingScaled  0.574*** 
  t = 3.526 
IndustryHealth Care:RevHomeCountry:VaccinationScaled  -0.818** 
  t = -2.335 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryOil and Gas:RevHomeCountry:VaccinationScaled  0.713*** 
  t = 4.389 
IndustryTelecommunications:RevHomeCountry:VaccinationScaled  -0.633*** 
  t = -3.898 
IndustryConsumer Services:RevHomeCountry: 
log(1 + VaccineInvest) 
 0.268*** 
 t = 3.686 
IndustryFinancials:RevHomeCountry:log(1 + VaccineInvest)  0.138** 
  t = 2.329 
IndustryOil and Gas:RevHomeCountry:log(1 + VaccineInvest)  0.432*** 
  t = 9.792 
IndustryTechnology:RevHomeCountry:log(1 + VaccineInvest)  0.199** 
  t = 2.090 
IndustryOil and Gas:RevHomeCountry:log(1 + HealthInvest)  0.030*** 
  t = 4.777 
IndustryTelecommunications:RevHomeCountry: 
log(1 + Fiscal_measures) 
 -0.038** 
 t = -2.390 
Constant 4.514*** 4.340*** 
 t = 71.929 t = 49.432 
Observations 105,485 50,575 
R2 0.110 0.253 
Adjusted R2 0.109 0.250 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Appendix 8.7 Results for United Kingdom 
Table A8. 7: Country regression output – UK 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
Time 0.001*** 0.001*** 
 t = 4.307 t = 3.604 
IndustryConsumer Services -0.013 -0.154** 
 t = -0.561 t = -2.293 
IndustryFinancials 0.092*** 0.013 
 t = 5.786 t = 0.245 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryIndustrials 0.035* -0.049 
 t = 1.912 t = -0.847 
IndustryTechnology 0.039* -0.027 
 t = 1.678 t = -0.454 
EconomicScaled 0.061 0.150 
 t = 0.755 t = 0.943 
StringencyScaled -0.426*** -0.257 
 t = -4.446 t = -1.299 
TestingScaled 0.188** 0.056 
 t = 2.261 t = 0.409 
VaccinationScaled 0.202*** 0.250** 
 t = 3.835 t = 2.515 
log(1 + VaccineInvest) -0.020*** -0.017* 
 t = -5.683 t = -1.904 
log(1 + HealthInvest) -0.016*** -0.005 
 t = -3.778 t = -0.876 
log(1 + Fiscal_measures) -0.012*** -0.008** 
 t = -6.078 t = -2.500 
IndustryConsumer Goods:EconomicScaled -0.200*** -0.383* 
 t = -2.791 t = -1.955 
IndustryConsumer Services:EconomicScaled -0.286*** -0.295* 
 t = -4.446 t = -1.654 
IndustryFinancials:EconomicScaled -0.279*** -0.097 
 t = -4.551 t = -0.606 
IndustryHealth Care:EconomicScaled 0.233** 0.176 
 t = 2.121 t = 0.765 
IndustryIndustrials:EconomicScaled -0.232*** -0.312** 
 t = -4.012 t = -2.004 
IndustryOil and Gas:EconomicScaled -0.235*** -0.139 
 t = -2.862 t = -0.391 
IndustryUtilities:EconomicScaled -0.217* -0.796*** 
 t = -1.936 t = -2.638 
IndustryConsumer Goods:RevHomeCountry  0.233** 
  t = 1.987 
EconomicScaled:RevHomeCountry  -0.886** 
  t = -2.548 
IndustryConsumer Goods:StringencyScaled 0.236*** -0.099 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
 t = 2.761 t = -0.402 
IndustryFinancials:StringencyScaled 0.409*** -0.028 
 t = 5.116 t = -0.130 
IndustryIndustrials:StringencyScaled 0.287*** 0.043 
 t = 3.783 t = 0.217 
IndustryOil and Gas:StringencyScaled 0.312*** 0.204 
 t = 2.849 t = 0.796 
IndustryTechnology:StringencyScaled 0.258*** 0.017 
 t = 2.721 t = 0.070 
IndustryTelecommunications:StringencyScaled 0.339*** 0.177 
 t = 4.022 t = 0.936 
IndustryUtilities:StringencyScaled 0.369** 0.923*** 
 t = 2.277 t = 3.095 
IndustryConsumer Services:log(1 + LaggedCaseChange) -0.020* -0.007 
 t = -1.837 t = -0.372 
IndustryFinancials:log(1 + LaggedCaseChange) -0.033*** -0.004 
 t = -3.389 t = -0.225 
IndustryIndustrials:log(1 + LaggedCaseChange) -0.027*** -0.001 
 t = -2.930 t = -0.053 
IndustryOil and Gas:log(1 + LaggedCaseChange) -0.060*** -0.176** 
 t = -3.727 t = -2.370 
IndustryTelecommunications:log(1 + LaggedCaseChange) -0.035** -0.078*** 
 t = -2.277 t = -4.028 
IndustryUtilities:log(1 + LaggedCaseChange) -0.022* -0.045 
 t = -1.677 t = -1.580 
RevHomeCountry:log(1 + LaggedCaseChange)  -0.059** 
  t = -2.131 
IndustryConsumer Goods:TestingScaled -0.335*** -0.105 
 t = -4.169 t = -0.452 
IndustryConsumer Services:TestingScaled -0.287*** -0.133 
 t = -3.622 t = -0.718 
IndustryFinancials:TestingScaled -0.342*** -0.169 
 t = -4.607 t = -1.040 
IndustryIndustrials:TestingScaled -0.321*** -0.098 
 t = -4.609 t = -0.709 
IndustryOil and Gas:TestingScaled -0.310*** -1.081*** 
 t = -2.720 t = -3.877 
192 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryTechnology:TestingScaled -0.143* 0.048 
 t = -1.783 t = 0.298 
IndustryTelecommunications:TestingScaled -0.343*** -0.042 
 t = -3.186 t = -0.203 
IndustryUtilities:TestingScaled -0.230** -0.560*** 
 t = -2.081 t = -2.694 
IndustryConsumer Goods:VaccinationScaled -0.116** -0.056 
 t = -2.550 t = -0.471 
IndustryFinancials:VaccinationScaled -0.155*** -0.203* 
 t = -3.687 t = -1.671 
IndustryHealth Care:VaccinationScaled -0.129*** -0.273*** 
 t = -2.719 t = -2.581 
IndustryIndustrials:VaccinationScaled -0.089** -0.087 
 t = -2.184 t = -0.868 
IndustryOil and Gas:VaccinationScaled 0.007 -0.348*** 
 t = 0.112 t = -2.651 
IndustryTelecommunications:VaccinationScaled -0.153** -0.249** 
 t = -2.123 t = -2.461 
IndustryUtilities:VaccinationScaled -0.218*** -0.531*** 
 t = -2.843 t = -2.732 
RevHomeCountry:VaccinationScaled  -0.391** 
  t = -2.116 
IndustryConsumer Goods:log(1 + VaccineInvest) 0.017*** 0.005 
 t = 4.853 t = 0.396 
IndustryConsumer Services:log(1 + VaccineInvest) 0.012*** 0.008 
 t = 3.702 t = 0.771 
IndustryFinancials:log(1 + VaccineInvest) 0.016*** 0.014 
 t = 4.927 t = 1.399 
IndustryIndustrials:log(1 + VaccineInvest) 0.013*** 0.010 
 t = 4.383 t = 1.120 
IndustryOil and Gas:log(1 + VaccineInvest) 0.003 0.047** 
 t = 0.722 t = 2.559 
IndustryTelecommunications:log(1 + VaccineInvest) 0.014* -0.001 
 t = 1.925 t = -0.062 
IndustryUtilities:log(1 + VaccineInvest) 0.021*** 0.039*** 
 t = 3.565 t = 2.963 
RevHomeCountry:log(1 + VaccineInvest)  -0.009 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
  t = -0.572 
IndustryConsumer Services:log(1 + HealthInvest) -0.005 -0.016** 
 t = -1.503 t = -2.492 
IndustryIndustrials:log(1 + HealthInvest) 0.001 -0.012** 
 t = 0.261 t = -2.322 
IndustryOil and Gas:log(1 + HealthInvest) -0.012*** -0.053*** 
 t = -2.902 t = -2.891 
RevHomeCountry:log(1 + HealthInvest)  -0.031** 
  t = -2.325 
IndustryConsumer Goods:log(1 + Fiscal_measures) 0.003** -0.002 
 t = 1.990 t = -0.400 
IndustryFinancials:log(1 + Fiscal_measures) 0.006*** 0.00001 
 t = 4.220 t = 0.002 
IndustryIndustrials:log(1 + Fiscal_measures) 0.005*** 0.001 
 t = 3.488 t = 0.199 
IndustryTechnology:log(1 + Fiscal_measures) 0.004** -0.003 
 t = 2.514 t = -0.747 
IndustryUtilities:log(1 + Fiscal_measures) 0.005 0.017*** 
 t = 1.530 t = 3.370 
IndustryConsumer Goods:Import_change_previous -0.128* -0.151 
 t = -1.906 t = -0.926 
IndustryConsumer Services:Import_change_previous -0.216*** -0.294** 
 t = -3.278 t = -1.988 
IndustryFinancials:Import_change_previous -0.220*** -0.307** 
 t = -3.198 t = -2.153 
IndustryHealth Care:Import_change_previous -0.284** -0.347* 
 t = -2.559 t = -1.804 
IndustryIndustrials:Import_change_previous -0.166*** -0.129 
 t = -2.669 t = -1.008 
IndustryTechnology:Import_change_previous -0.176** -0.125 
 t = -2.142 t = -0.668 
IndustryTelecommunications:Import_change_previous -0.085 -0.600*** 
 t = -0.626 t = -3.826 
IndustryUtilities:Import_change_previous -0.151* -0.267 
 t = -1.754 t = -1.549 
RevHomeCountry:Import_change_previous  -0.843*** 
  t = -3.891 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryConsumer Goods:ScaledMarketCap 0.375** 1.021 
 t = 2.552 t = 1.069 
IndustryConsumer Services:ScaledMarketCap 1.291* 3.677*** 
 t = 1.660 t = 4.441 
IndustryFinancials:ScaledMarketCap -0.385* 0.396 
 t = -1.700 t = 0.486 
IndustryHealth Care:ScaledMarketCap -0.486* -5.839*** 
 t = -1.836 t = -3.051 
IndustryIndustrials:ScaledMarketCap 2.106** 1.318 
 t = 2.448 t = 1.121 
IndustryOil and Gas:ScaledMarketCap -0.146 75.049*** 
 t = -1.218 t = 6.334 
IndustryTelecommunications:ScaledMarketCap -0.140 -1.134*** 
 t = -0.238 t = -3.504 
IndustryConsumer Goods:EconomicScaled:RevHomeCountry  0.993** 
  t = 2.554 
IndustryConsumer Services:EconomicScaled:RevHomeCountry  0.804** 
  t = 2.178 
IndustryHealth Care:EconomicScaled:RevHomeCountry  0.907** 
  t = 2.002 
IndustryIndustrials:EconomicScaled:RevHomeCountry  0.815** 
  t = 2.285 
IndustryTechnology:EconomicScaled:RevHomeCountry  0.811** 
  t = 2.080 
IndustryUtilities:EconomicScaled:RevHomeCountry  1.501*** 
  t = 3.223 
IndustryUtilities:RevHomeCountry:StringencyScaled  -0.950* 
  t = -1.703 
IndustryConsumer Services:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.067* 
 t = 1.943 
IndustryFinancials:RevHomeCountry:log(1 + LaggedCaseChange)  0.054* 
  t = 1.689 
IndustryTechnology:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.063* 
 t = 1.714 
IndustryTelecommunications:RevHomeCountry: 
log(1 + LaggedCaseChange) 
 0.135*** 
 t = 3.865 
IndustryUtilities:RevHomeCountry:log(1 + LaggedCaseChange)  0.108** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
  t = 2.449 
IndustryConsumer Services:RevHomeCountry:VaccinationScaled  0.422** 
  t = 2.006 
IndustryFinancials:RevHomeCountry:VaccinationScaled  0.374* 
  t = 1.836 
IndustryHealth Care:RevHomeCountry:VaccinationScaled  0.558*** 
  t = 2.775 
IndustryIndustrials:RevHomeCountry:VaccinationScaled  0.364* 
  t = 1.890 
IndustryOil and Gas:RevHomeCountry:VaccinationScaled  0.656*** 
  t = 2.785 
IndustryTechnology:RevHomeCountry:VaccinationScaled  0.556** 
  t = 2.204 
IndustryTelecommunications:RevHomeCountry:VaccinationScaled  0.460** 
  t = 2.112 
IndustryUtilities:RevHomeCountry:VaccinationScaled  0.680** 
  t = 2.397 
IndustryConsumer Goods:RevHomeCountry:log(1 + HealthInvest)  0.038** 
  t = 2.473 
IndustryConsumer Services:RevHomeCountry: 
log(1 + HealthInvest) 
 0.030** 
 t = 2.095 
IndustryFinancials:RevHomeCountry:log(1 + HealthInvest)  0.030** 
  t = 2.182 
IndustryIndustrials:RevHomeCountry:log(1 + HealthInvest)  0.033** 
  t = 2.431 
IndustryOil and Gas:RevHomeCountry:log(1 + HealthInvest)  0.069*** 
  t = 3.283 
IndustryTechnology:RevHomeCountry:log(1 + HealthInvest)  0.027* 
  t = 1.781 
IndustryUtilities:RevHomeCountry:log(1 + HealthInvest)  0.041** 
  t = 2.069 
IndustryUtilities:RevHomeCountry:log(1 + Fiscal_measures)  -0.024** 








 t = 3.400 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) 
IndustryFinancials:RevHomeCountry:Import_change_previous  0.802*** 
  t = 3.281 
IndustryIndustrials:RevHomeCountry:Import_change_previous  0.621*** 
  t = 2.691 
IndustryOil and Gas:RevHomeCountry:Import_change_previous  0.769* 
  t = 1.714 
IndustryTechnology:RevHomeCountry:Import_change_previous  0.644* 




 t = 4.886 
IndustryUtilities:RevHomeCountry:Import_change_previous  0.922*** 
  t = 3.383 
Constant 4.491*** 4.556*** 
 t = 224.566 t = 89.117 
Observations 232,845 138,225 
R2 0.142 0.219 
Adjusted R2 0.141 0.218 




Appendix 9 Industries in focus: first stage regression outputs 
Regression outputs only display significant values. 
 
Example 1:  
Underlying calculation for the different effects of “StringencyScaled” on different countries 
(expressed by the level of effectiveness) in the Consumer Goods industry 
Effect of a one percentage point higher Stringency index in Italy:  
𝑆𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑐𝑦𝑆𝑐𝑎𝑙𝑒𝑑 ∗ 0.01 +  𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠: 𝑆𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑐𝑦𝑆𝑐𝑎𝑙𝑒𝑑 ∗ 0.01
∗  𝑣𝑎𝑙𝑢𝑒 𝑜𝑓 “𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠” 𝑖𝑛 𝐼𝑡𝑎𝑙𝑦 
→ 2.370% ∗  0.01 +  (−0.03)% ∗  0.01 ∗  69.23 =  𝟎. 𝟎𝟎𝟐𝟗 % 
Effect of a one percentage point higher Stringency index in Norway: 
𝑆𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑐𝑦𝑆𝑐𝑎𝑙𝑒𝑑 ∗ 0.01 +  𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠: 𝑆𝑡𝑟𝑖𝑛𝑔𝑒𝑛𝑐𝑦𝑆𝑐𝑎𝑙𝑒𝑑 ∗ 0.01
∗  𝑣𝑎𝑙𝑢𝑒 𝑜𝑓 “𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠” 𝑖𝑛 𝑁𝑜𝑟𝑤𝑎𝑦 
→ 2.370% ∗  0.01 +  (−0.03)% ∗  0.01 ∗  97.6 = − 𝟎. 𝟎𝟎𝟓𝟔%  
Notes on how to read the industry regression tables: 
The baseline country for our industry regressions is always Denmark and the baseline sector is the 
first sector of each industry. As we use the natural logarithm of share prices, we can interpret the 
effect on our dependent variable as a percentage change. As mentioned before, the “Effectiveness” 
variable can take only values between 0 and 100, therefore a 1-point increase in effectiveness can 
also be interpreted as a one percentage point increase. The variable takes the following values 
depending on the country a company is listed in: 99.04 in Denmark, 89.42 in France, 93.27 in 
Germany, 69.23 in Italy, 97.6 in Norway, 79.81 in Spain, 97.12 in Sweden and 90.38 in the UK. 
Hence, the coefficients interacted with “Effectiveness” need to be multiplied with the respective 
values in order to see the effect on share prices of a company within its respective country. For the 
variables that did not require a logarithmic transformation the coefficients need to be multiplied 
with 0.01 in order to observe the percentage effect of a one percentage point higher independent 
variable. The coefficients of the variables where we applied the logarithmic transformation can be 
interpreted as the percentage change of share prices when the independent variable increases by 
1%. Our “Country” as well as “Sector” variables can be seen as dummies that turn “1” if the 
company is part of the country or sector and therefore the coefficients can be interpreted as the 
percentage change in share prices as well. Interactions terms require additional attention when 






Underlying calculation for the different effects of “LaggedCaseChange” on different sectors in the 
Consumer Services industry in Italy:  
Effect of a 1% increase in “LaggedCaseChange” on Media in Italy:  
𝑙𝑜𝑔(1 +  𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒) +  𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠: 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒)
∗  𝑣𝑎𝑙𝑢𝑒 𝑜𝑓 “𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠” 𝑖𝑛 𝐼𝑡𝑎𝑙𝑦 + 𝑀𝑒𝑑𝑖𝑎: 𝑙𝑜𝑔(1
+ 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒)  +  𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠: 𝑀𝑒𝑑𝑖𝑎: 𝑙𝑜𝑔(1
+ 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒)
→ 0.401% + (−0.006%) ∗ 69 .23 + (−0.687%) + 0.009% ∗ 69.23  
=  −𝟎. 𝟎𝟕𝟖 % 
Effect of a 1% increase in “LaggedCaseChange” on Travel and Leisure in Italy:  
𝑙𝑜𝑔(1 +  𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒) +  𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠: 𝑙𝑜𝑔(1 + 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒)
∗  𝑣𝑎𝑙𝑢𝑒 𝑜𝑓 “𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠” 𝑖𝑛 𝐼𝑡𝑎𝑙𝑦 + 𝑇𝑟𝑎𝑣𝑒𝑙 𝑎𝑛𝑑 𝐿𝑒𝑖𝑠𝑢𝑟𝑒: 𝑙𝑜𝑔(1
+ 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒)  +  𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠: 𝑇𝑟𝑎𝑣𝑒𝑙 𝑎𝑛𝑑 𝐿𝑒𝑖𝑠𝑢𝑟𝑒: 𝑙𝑜𝑔(1
+ 𝐿𝑎𝑔𝑔𝑒𝑑𝐶𝑎𝑠𝑒𝐶ℎ𝑎𝑛𝑔𝑒
→ 0.401% + (−0.006%) ∗ 69.23 + (−0.953%) + 0.012% ∗ 69.23 
=  −𝟎. 𝟏𝟑𝟕% 
Example 3:  
Underlying calculation for the different effects of “Effectiveness” on countries in the Technology 
industry 
Effect of “Effectiveness” in Italy:  
𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠 ∗  𝑣𝑎𝑙𝑢𝑒 𝑜𝑓 “𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠” 𝑖𝑛 𝐼𝑡𝑎𝑙𝑦 + 𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝐼𝑡𝑎𝑙𝑦                 
    → 0.052% ∗ 69.23 + 1.07%  =  𝟒. 𝟔𝟕 %  
Effect of “Effectiveness” in Norway:  
𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠 ∗  𝑣𝑎𝑙𝑢𝑒 𝑜𝑓 “𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠” 𝑖𝑛 𝑁𝑜𝑟𝑤𝑎𝑦
+ 𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑁𝑜𝑟𝑤𝑎𝑦                                                                                                           




Appendix 9.1 Results for Consumer Goods 
Regression results including all companies where revenue information is available 
Table A9. 1: First stage regression output including all companies where revenue information 
is available – Consumer Goods 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.001*** 0.001*** 
 t = -16.573 t = 11.303 
EconomicScaled -1.594***  
 t = -4.898  
CaseChange_2weeks 
0.003***  
t = 4.104  
StringencyScaled  -2.557*** 
  t = -4.126 
GDPprevious  -3.264*** 
  t = -3.535 
log(1 + LaggedCaseChange) 0.120*** 0.523*** 
 t = 5.181 t = 7.811 
VaccinationScaled -0.400* 0.166 
 t = -1.717 t = 0.837 
Effectiveness:EconomicScaled 0.023***  
 t = 6.447  
Example 4:  
Underlying calculation for the different effects of “ScaledMarketCap” on countries in the 
Technology industry 
Effect of a by one percentage point higher “ScaledMarketCap” in Italy:  
𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝 ∗ 0.01 + 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝: 𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝐼𝑡𝑎𝑙𝑦 ∗ 0.01               
    →  273.448 ∗ 0.01 + (−121.561) ∗ 0.01  =   𝟏. 𝟓𝟐 %  
Effect of a by one percentage point higher “ScaledMarketCap” in Spain:  
𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝 ∗ 0.01 + 𝑆𝑐𝑎𝑙𝑒𝑑𝑀𝑎𝑟𝑘𝑒𝑡𝐶𝑎𝑝: 𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑆𝑝𝑎𝑖𝑛 ∗ 0.01               
    →  273.448 ∗ 0.01 +  (−390.225) ∗ 0.01  =  −𝟏. 𝟏𝟕 %  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:CaseChange_2weeks -0.00003***  




t = -1.818  
Effectiveness:StringencyScaled  0.037*** 
  t = 5.367 
Effectiveness:GDPprevious  0.027** 
  t = 2.313 
Effectiveness:log(1 + LaggedCaseChange) -0.001** -0.006*** 
 t = -2.298 t = -7.838 
SectorBeverages:log(1 + LaggedCaseChange) 0.092** -0.270* 
 t = 2.565 t = -1.918 
SectorFood Producers:log(1 + LaggedCaseChange) 0.077** -0.239** 
 t = 2.571 t = -2.538 
SectorPersonal Goods:log(1 + LaggedCaseChange) 0.066** -0.069 
 t = 2.195 t = -0.673 
Effectiveness:VaccinationScaled 0.008*** -0.008*** 




t = 1.788  
Effectiveness:SectorBeverages: 
log(1 + LaggedCaseChange) 
-0.001*** 0.003** 
t = -2.756 t = 2.016 
Effectiveness:SectorFood Producers: 
log(1 + LaggedCaseChange) 
-0.001*** 0.003*** 
t = -2.838 t = 2.703 
Effectiveness:SectorPersonal Goods: 
log(1 + LaggedCaseChange) 
-0.001** 0.001 
t = -2.242 t = 0.766 
Observations 41,783 47,043 
R2 0.642 0.735 
Adjusted R2 0.640 0.734 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 27.885 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 118.02 
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Table A9. 2: Final regression output including all companies where revenue information is 
available – Consumer Goods 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.033* 0.026 -0.113 0.053 
 t = 1.941 t = 1.447 t = -0.649 t = 1.181 
SectorFood Producers 0.636* 0.584 -8.332 3.445 
 t = 1.681 t = 1.292 t = -0.413 t = 0.883 
SectorHousehold Goods and Home 
Construction 
1.215*** 0.615 -28.446 -1.657 
t = 3.036 t = 1.477 t = -1.030 t = -0.561 
SectorPersonal Goods 0.482** 0.180 -17.993 -5.045 
 t = 1.991 t = 0.444 t = -1.042 t = -1.376 
StringencyScaled 1.077 -0.660 -26.353 -0.131 
 t = 0.940 t = -0.574 t = -0.963 t = -0.020 
EconomicScaled -0.953 0.738 -8.376 -2.130 
 t = -0.839 t = 0.499 t = -1.437 t = -0.619 
CountryItaly 0.861** 0.668 1.589*** 1.365* 
 t = 2.032 t = 1.447 t = 2.580 t = 1.795 
ScaledMarketCap 12.358** 15.089*** 3.609 -0.905 
 t = 2.097 t = 2.741 t = 0.464 t = -0.089 
Effectiveness:SectorHousehold Goods and 
Home Construction 
-0.013*** -0.007 0.311 0.013 
t = -2.994 t = -1.513 t = 1.034 t = 0.385 
Effectiveness:SectorPersonal Goods -0.005* -0.002 0.196 0.055 
 t = -1.858 t = -0.480 t = 1.036 t = 1.148 
SectorFood Producers:StringencyScaled -0.638 2.673* 13.057 -12.124 
 t = -0.507 t = 1.875 t = 0.365 t = -1.293 
SectorPersonal Goods:StringencyScaled 1.009 2.462* 32.138 10.882 
 t = 0.764 t = 1.901 t = 1.079 t = 1.205 
SectorFood Producers:VaccinationScaled 0.464 -1.008 0.277 4.740** 
 t = 0.541 t = -1.187 t = 0.077 t = 2.083 
CountryFrance:ScaledMarketCap -11.964** -14.700*** -3.103 1.328 
 t = -2.047 t = -2.694 t = -0.402 t = 0.131 
CountryGermany:ScaledMarketCap -12.562** -15.747*** -4.006 0.948 
 t = -2.126 t = -2.847 t = -0.513 t = 0.093 
CountryItaly:ScaledMarketCap -11.313** -13.793*** -3.125 2.014 
 t = -2.045 t = -2.632 t = -0.405 t = 0.201 
CountrySweden:ScaledMarketCap 3.518 -0.568 14.720 19.617* 
 t = 0.487 t = -0.078 t = 1.491 t = 1.791 
CountryUnited Kingdom:ScaledMarketCap -10.756* -14.036** -1.803 2.680 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = -1.748 t = -2.296 t = -0.223 t = 0.261 
CountryItaly:RevHomeCountry -0.457** -0.522** -0.183 0.039 
 t = -2.185 t = -2.232 t = -0.445 t = 0.087 
CountryNorway:RevHomeCountry -0.311 -0.406* 0.211 0.161 
 t = -1.282 t = -1.756 t = 0.583 t = 0.322 
CountrySweden:RevHomeCountry -0.261 -0.428* 0.192 0.258 
 t = -1.195 t = -1.804 t = 0.550 t = 0.579 
Effectiveness:SectorFood Producers: 
StringencyScaled 
0.012 -0.037** -0.119 0.201 
t = 0.690 t = -1.988 t = -0.305 t = 1.629 
Effectiveness:SectorPersonal Goods: 
StringencyScaled 
-0.011 -0.032* -0.347 -0.118 
t = -0.594 t = -1.887 t = -1.060 t = -0.942 
Effectiveness:SectorBeverages: 
EconomicScaled 
-0.014 0.014 -0.135* -0.034 
t = -0.737 t = 0.730 t = -1.704 t = -0.803 
Effectiveness:SectorHousehold Goods and 
Home Construction: 
log(1 + LaggedCaseChange) 
-0.003* -0.001 0.036 0.001 
t = -1.756 t = -0.303 t = 1.013 t = 0.283 
Effectiveness:SectorFood Producers: 
VaccinationScaled 
-0.011 0.008 -0.012 -0.067** 
t = -1.052 t = 0.818 t = -0.300 t = -2.350 
Observations 47,043 47,043 41,783 41,783 
R2 0.269 0.215 0.078 0.081 
Adjusted R2 0.263 0.209 0.070 0.073 





Appendix 9.2 Results for Consumer Services 
Regression results including all companies in the sample 
Table A9. 3: First stage regression output including all companies in the sample – Consumer 
Services 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0002*** 0.001*** 
 t = -6.454 t = 7.153 
EconomicScaled -2.213***  
 t = -3.012  
CaseChange_2weeks 0.003**  
 t = 2.099  
StringencyScaled  -4.045*** 
  t = -2.823 
GDPprevious  -3.363*** 
  t = -2.969 
log(1 + LaggedCaseChange) 0.151*** 0.489*** 
 t = 7.161 t = 7.842 
VaccinationScaled -0.317 0.396*** 
 t = -0.971 t = 3.217 
TestingScaled 0.897 2.062* 
 t = 0.680 t = 1.702 
Effectiveness:EconomicScaled 0.030***  
 t = 3.695  
Effectiveness:CaseChange_2weeks -0.00003**  
 t = -1.990  
Effectiveness:StringencyScaled  0.056*** 
  t = 3.428 
Effectiveness:GDPprevious  0.032** 
  t = 2.333 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.006*** 
 t = -4.384 t = -7.957 
SectorTravel and Leisure:log(1 + LaggedCaseChange) 0.017 -0.167* 
 t = 0.566 t = -1.725 
Effectiveness:VaccinationScaled 0.006 -0.008*** 
 t = 1.543 t = -5.475 
-0.0003 0.002* 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorTravel and Leisure:log(1 + 
LaggedCaseChange) t = -0.737 t = 1.837 
Observations 71,862 80,654 
R2 0.742 0.791 
Adjusted R2 0.741 0.790 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 23.34 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 88.26 
Table A9. 4: Final regression output including all companies in the sample – Consumer 
Services 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
StringencyScaled -4.846*** -3.145 52.890 11.170 
 t = -2.865 t = -0.937 t = 1.062 t = 0.745 
EconomicScaled -0.137 7.295 9.313 -5.923 
 t = -0.072 t = 1.090 t = 0.692 t = -0.432 
log(1 + LaggedCaseChange) 0.401** -0.017 -3.284 -0.226 
 t = 2.114 t = -0.094 t = -1.018 t = -0.504 
CountryFrance 0.166*** 0.150** 0.223* 0.068 
 t = 3.067 t = 2.463 t = 1.870 t = 0.669 
CountryGermany 0.199** 0.157 0.235 -0.141 
 t = 2.523 t = 1.188 t = 1.382 t = -0.648 
CountryItaly 0.748 0.674 1.333* 0.560 
 t = 1.622 t = 1.405 t = 1.671 t = 0.847 
CountryNorway -1.362 -1.352 -1.851* -2.054 
 t = -1.424 t = -1.413 t = -1.645 t = -1.536 
CountrySpain 0.559** 0.516** 0.898** 0.482 
 t = 2.313 t = 2.032 t = 2.171 t = 1.530 
Effectiveness:SectorMedia 0.012* 0.015 -0.343 -0.049 
 t = 1.749 t = 1.261 t = -1.549 t = -0.766 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:StringencyScaled 0.070*** 0.056 -0.594 -0.141 
 t = 3.226 t = 1.212 t = -1.063 t = -0.664 
SectorGeneral Retailers:StringencyScaled 4.516** 3.168 -16.027 2.863 
 t = 2.324 t = 0.904 t = -0.272 t = 0.136 
SectorMedia:StringencyScaled 7.152*** 6.067* -81.867 -11.231 
 t = 3.740 t = 1.687 t = -1.612 t = -0.744 
SectorTravel and Leisure:StringencyScaled 7.328*** 5.531 -66.799 -22.571 
 t = 3.578 t = 1.521 t = -1.082 t = -1.039 
Effectiveness:log(1 + LaggedCaseChange) -0.006** -0.001 0.036 0.002 
 t = -2.487 t = -0.473 t = 1.002 t = 0.406 
SectorMedia:log(1 + LaggedCaseChange) -0.687*** -0.365* 5.232 0.075 
 t = -3.453 t = -1.805 t = 1.581 t = 0.169 
SectorTravel and Leisure: 
log(1 + LaggedCaseChange) 
-0.953*** -0.326 3.679 0.424 
t = -3.537 t = -1.101 t = 0.945 t = 0.548 
Effectiveness:VaccinationScaled -0.013* -0.015 0.061 0.012 
 t = -1.822 t = -0.880 t = 1.001 t = 0.246 
SectorMedia:VaccinationScaled 
-2.448*** -2.463 7.391 0.744 
t = -3.151 t = -1.619 t = 1.266 t = 0.199 
Effectiveness:SectorGeneral Retailers: 
StringencyScaled 
-0.064*** -0.047 0.189 -0.045 
t = -2.620 t = -0.990 t = 0.285 t = -0.154 
Effectiveness:SectorMedia:StringencyScaled -0.095*** -0.086* 0.905 0.156 
 t = -3.913 t = -1.776 t = 1.587 t = 0.726 
Effectiveness:SectorTravel and Leisure: 
StringencyScaled 
-0.099*** -0.084* 0.751 0.277 
t = -3.853 t = -1.671 t = 1.086 t = 0.984 
Effectiveness:SectorGeneral Retailers: 
log(1 + LaggedCaseChange) 
0.005* 0.003 -0.011 0.001 
t = 1.943 t = 1.323 t = -0.259 t = 0.195 
Effectiveness:SectorMedia: 
log(1 + LaggedCaseChange) 
0.009*** 0.005** -0.057 -0.001 
t = 3.726 t = 2.222 t = -1.555 t = -0.232 
Effectiveness:SectorTravel and Leisure: 
log(1 + LaggedCaseChange) 
0.012*** 0.005 -0.041 -0.005 
t = 3.697 t = 1.452 t = -0.939 t = -0.538 
Effectiveness:SectorMedia:VaccinationScaled 0.030*** 0.030* -0.083 -0.011 
 t = 3.354 t = 1.716 t = -1.234 t = -0.238 
Observations 80,654 80,654 71,862 71,862 
R2 0.235 0.215 0.075 0.099 
Adjusted R2 0.231 0.212 0.071 0.095 
Note: *p<0.1, **p<0.05, ***p<0.01 
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Regression results including all companies where revenue information is available 
Table A9. 5: First stage regression output including all companies where revenue information 
is available – Consumer Services 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.001*** 0.001*** 
 t = -17.587 t = 11.035 
EconomicScaled -1.658***  
 t = -3.308  
CaseChange_2weeks 0.003**  
 t = 2.473  
StringencyScaled  -3.113*** 
  t = -3.396 
GDPprevious  -4.562*** 
  t = -4.925 
log(1 + LaggedCaseChange) 0.157*** 0.522*** 
 t = 4.687 t = 7.825 
log(1 + Fiscal_measures) 0.046*** -0.107*** 
 t = 4.451 t = -12.636 
Effectiveness:EconomicScaled 0.024***  
 t = 4.294  
Effectiveness:CaseChange_2weeks -0.00003**  
 t = -2.363  
Effectiveness:StringencyScaled  0.045*** 
  t = 4.287 
Effectiveness:GDPprevious  0.046*** 
  t = 3.966 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.006*** 
 t = -2.843 t = -8.054 
SectorTravel and Leisure:log(1 + 
LaggedCaseChange) 
0.046 -0.268** 
t = 1.121 t = -2.111 
Effectiveness:log(1 + Fiscal_measures) -0.001*** 0.001*** 
 t = -4.145 t = 13.188 
SectorTravel and Leisure:log(1 + Fiscal_measures) -0.043 0.082** 
 t = -1.527 t = 2.022 
Effectiveness:SectorTravel and Leisure: 
log(1 + LaggedCaseChange) 
-0.001 0.003** 




 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorTravel and Leisure: 
log(1 + Fiscal_measures) t = 1.471 t = -2.069 
Observations 52,149 58,553 
R2 0.730 0.796 
Adjusted R2 0.729 0.795 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 26.962 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 176.18 
Table A9. 6: Final regression output including all companies where revenue information is 
available – Consumer Services 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.036 0.046** 0.478 0.053 
 t = 1.390 t = 2.395 t = 1.128 t = 0.803 
StringencyScaled -4.302* -4.922 64.900 3.153 
 t = -1.912 t = -1.472 t = 0.961 t = 0.176 
EconomicScaled -0.018 1.763 12.046 -4.689 
 t = -0.012 t = 0.528 t = 0.904 t = -0.331 
log(1 + LaggedCaseChange) 0.252* 0.160 -4.543 0.034 
 t = 1.785 t = 1.104 t = -0.971 t = 0.070 
VaccinationScaled 1.566** 2.476** -4.507 0.866 
 t = 2.283 t = 2.114 t = -0.757 t = 0.226 
CountryFrance -0.123 -0.192 -0.138 -0.365* 
 t = -0.831 t = -1.219 t = -0.779 t = -1.717 
CountryItaly 0.755 0.797* 0.975 0.436 
 t = 1.375 t = 1.956 t = 1.380 t = 0.401 
CountryNorway -2.525* -3.005** -3.111* -3.368** 
 t = -1.841 t = -2.141 t = -1.886 t = -2.008 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
CountrySpain 0.456 0.446* 0.779* 0.305 
 t = 1.462 t = 1.812 t = 1.927 t = 0.543 
Effectiveness:StringencyScaled 0.062** 0.072 -0.711 -0.038 
 t = 2.000 t = 1.536 t = -0.958 t = -0.154 
SectorGeneral Retailers:StringencyScaled 4.146* 5.636 -0.764 -3.745 
 t = 1.650 t = 1.422 t = -0.008 t = -0.186 
SectorMedia:StringencyScaled 5.258** 5.485 -80.508 -8.246 
 t = 2.181 t = 1.595 t = -1.195 t = -0.428 
SectorTravel and Leisure:StringencyScaled 6.434** 4.535 -58.951 5.161 
 t = 2.516 t = 1.276 t = -0.773 t = 0.247 
Effectiveness:log(1 + LaggedCaseChange) -0.004** -0.003 0.049 -0.001 
 t = -2.129 t = -1.595 t = 0.961 t = -0.128 
SectorGeneral Retailers: 
log(1 + LaggedCaseChange) 
-0.394* -0.277 0.091 0.057 
t = -1.883 t = -1.444 t = 0.015 t = 0.104 
SectorMedia:log(1 + LaggedCaseChange) -0.429*** -0.284* 5.494 0.087 
 t = -2.700 t = -1.753 t = 1.188 t = 0.166 
SectorTravel and Leisure: 
log(1 + LaggedCaseChange) 
-0.532*** -0.582** 3.794 -0.518 
t = -2.634 t = -2.174 t = 0.743 t = -0.723 
SectorMedia:log(1 + VaccineInvest) 3.110* 2.234 8.999* 8.409 
 t = 1.794 t = 0.618 t = 1.906 t = 0.592 
Effectiveness:VaccinationScaled -0.019** -0.027** 0.050 -0.008 
 t = -2.344 t = -2.098 t = 0.751 t = -0.155 
SectorMedia:VaccinationScaled -1.932** -1.956* 6.079 0.483 
 t = -2.416 t = -1.897 t = 0.970 t = 0.118 
SectorGeneral Retailers: 
log(1 + Fiscal_measures) 
0.097** 0.057 0.013 0.129 
t = 2.069 t = 0.830 t = 0.013 t = 1.087 
CountryFrance:RevHomeCountry 0.462** 0.444** 0.543** 0.582*** 
 t = 2.497 t = 2.307 t = 2.406 t = 2.664 
Effectiveness:SectorGeneral Retailers: 
StringencyScaled 
-0.061* -0.080 -0.003 0.033 
t = -1.772 t = -1.470 t = -0.003 t = 0.116 
Effectiveness:SectorMedia:StringencyScaled -0.073** -0.076 0.885 0.108 
 t = -2.201 t = -1.599 t = 1.192 t = 0.404 
Effectiveness:SectorTravel and 
Leisure:StringencyScaled 
-0.087** -0.056 0.660 -0.063 
t = -2.497 t = -1.155 t = 0.786 t = -0.223 
Effectiveness:SectorGeneral Retailers: 
log(1 + LaggedCaseChange) 
0.006** 0.004* -0.0001 0.0004 
t = 2.294 t = 1.934 t = -0.002 t = 0.058 
Effectiveness:SectorMedia: 0.006*** 0.004** -0.060 -0.001 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
log(1 + LaggedCaseChange) t = 2.939 t = 2.061 t = -1.181 t = -0.144 
Effectiveness:SectorTravel and Leisure: 
log(1 + LaggedCaseChange) 
0.006*** 0.007** -0.042 0.006 
t = 2.669 t = 2.286 t = -0.753 t = 0.674 
Effectiveness:SectorMedia: 
log(1 + VaccineInvest) 
-0.035* -0.025 -0.100* -0.093 
t = -1.803 t = -0.628 t = -1.912 t = -0.595 
Effectiveness:SectorMedia:VaccinationScaled 0.024** 0.024* -0.066 -0.007 
 t = 2.482 t = 1.928 t = -0.947 t = -0.137 
Effectiveness:SectorGeneral Retailers: 
log(1 + Fiscal_measures) 
-0.001** -0.001 -0.0002 -0.002 
t = -2.228 t = -0.938 t = -0.020 t = -0.948 
Observations 58,553 58,553 52,149 52,149 
R2 0.288 0.252 0.093 0.241 
Adjusted R2 0.283 0.247 0.087 0.236 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Appendix 9.3 Results for Health Care 
Regression results including all companies in the sample 
Table A9. 7: First stage regression output including all companies in the sample – Health 
Care 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0004*** 0.001*** 
 t = -11.803 t = 13.464 
EconomicScaled 0.104  
 t = 0.241  
CaseChange_2weeks 0.004***  
 t = 5.356  
GDPprevious  -1.791*** 
  t = -2.878 
Import_change_previous -2.030*** 2.384*** 
 t = -7.946 t = 4.837 
log(1 + LaggedCaseChange) 0.090*** 0.144* 
 t = 4.087 t = 1.671 
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 Dependent variable: 
 StringencyScaled EconomicScaled 







 t = -3.601 t = 2.859 
log(1 + HealthInvest) -0.052** -0.168*** 
 t = -2.238 t = -5.641 
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -5.162  
Effectiveness:GDPprevious  0.013* 
  t = 1.754 
Effectiveness:Import_change_previous 0.019*** -0.026*** 
 t = 6.731 t = -4.528 
Effectiveness:log(1 + LaggedCaseChange) -0.0005* -0.002* 
 t = -1.929 t = -1.671 
Effectiveness:VaccinationScaled 0.011*** -0.017*** 
 t = 4.764 t = -4.038 
Effectiveness:log(1 + HealthInvest) 0.001*** 0.001*** 
 t = 2.849 t = 4.556 
Observations 57,567 65,235 
R2 0.656 0.746 
Adjusted R2 0.654 0.745 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 201.97 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 87.65 
 
Table A9. 8: Final regression output including all companies in the sample – Health Care 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
StringencyScaled 0.428 -1.963 -1.447 2.410 
 t = 0.726 t = -1.340 t = -0.040 t = 1.040 
EconomicScaled -1.736** 3.795 -3.065** -3.607 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = -2.041 t = 1.549 t = -2.147 t = -1.332 
Import_change_previous 0.961 -5.213* -0.675 2.035 
 t = 0.808 t = -1.703 t = -0.031 t = 0.837 
log(1 + HealthInvest) 0.016 0.279* -0.114 -0.203 
 t = 0.335 t = 1.748 t = -0.180 t = -1.028 
log(1 + Fiscal_measures) -0.056** -0.016 -0.036 -0.038 
 t = -2.040 t = -0.496 t = -0.190 t = -1.032 
CountryFrance -0.096 -0.138 -0.156 -0.238** 
 t = -0.983 t = -1.453 t = -1.454 t = -2.218 
CountryGermany -0.106* -0.220** -0.110 -0.237** 
 t = -1.669 t = -2.520 t = -1.313 t = -2.448 
CountryItaly -0.503* -0.528* -0.861*** -1.073*** 
 t = -1.868 t = -1.727 t = -2.914 t = -3.117 
CountryNorway -0.385* -0.392* -0.444* -0.559** 
 t = -1.936 t = -1.843 t = -1.909 t = -2.324 
CountrySpain -0.241 -0.246 -0.414* -0.503** 
 t = -1.266 t = -1.198 t = -1.930 t = -2.234 
CountrySweden -0.073 -0.164* -0.042 -0.121 
 t = -1.163 t = -1.930 t = -0.513 t = -1.330 
Effectiveness:EconomicScaled 0.021** -0.048* 0.037** 0.039 
 t = 2.172 t = -1.646 t = 2.051 t = 1.237 
SectorPharmaceuticals and Biotechnology: 
EconomicScaled 
2.139* -6.205 2.312 2.274 
t = 1.700 t = -1.583 t = 0.857 t = 0.664 
Effectiveness:Import_change_previous -0.011 0.059* 0.004 -0.027 
 t = -0.791 t = 1.695 t = 0.016 t = -0.942 
SectorPharmaceuticals and Biotechnology: 
Import_change_previous 
-3.984** 5.852 0.362 -3.885 
t = -2.299 t = 1.262 t = 0.010 t = -1.040 
SectorPharmaceuticals and Biotechnology: 
log(1 + LaggedCaseChange) 
-0.337** -0.010 -0.491 -0.177 
t = -2.116 t = -0.083 t = -0.186 t = -0.958 
Effectiveness:VaccinationScaled 0.011* -0.017 0.017 0.018 
 t = 1.825 t = -1.351 t = 0.301 t = 1.342 
SectorPharmaceuticals and Biotechnology: 
VaccinationScaled 
2.017** -1.148 1.859 2.631 
t = 2.149 t = -0.709 t = 0.232 t = 1.519 
Effectiveness:log(1 + HealthInvest) -0.0001 -0.003* 0.001 0.002 
 t = -0.128 t = -1.781 t = 0.192 t = 1.029 
SectorPharmaceuticals and 
Biotechnology:log(1 + HealthInvest) 
0.014 -0.454* 0.100 0.190 
t = 0.205 t = -1.767 t = 0.093 t = 0.682 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:log(1 + Fiscal_measures) 0.001** 0.0003 0.0004 0.0004 
 t = 2.069 t = 0.826 t = 0.178 t = 1.017 
SectorPharmaceuticals and 
Biotechnology:log(1 + Fiscal_measures) 
0.074* 0.016 0.039 0.086 
t = 1.789 t = 0.334 t = 0.104 t = 1.339 
CountryItaly:ScaledMarketCap 6.879*** 6.746*** 7.756*** 7.573*** 
 t = 4.374 t = 4.114 t = 3.166 t = 4.327 
CountryNorway:ScaledMarketCap 123.770 80.615 154.414* 151.459* 
 t = 1.612 t = 1.009 t = 1.744 t = 1.706 
CountrySweden:ScaledMarketCap 5.747* 4.476 6.571 6.403 
 t = 1.658 t = 1.241 t = 1.586 t = 1.614 
CountryUnited Kingdom:ScaledMarketCap -0.500* -0.469* -0.568* -0.582** 
 t = -1.919 t = -1.676 t = -1.895 t = -2.003 
Effectiveness:SectorPharmaceuticals and 
Biotechnology:Import_change_previous 
0.045** -0.068 0.001 0.047 
t = 2.313 t = -1.282 t = 0.002 t = 1.082 
Effectiveness:SectorPharmaceuticals and 
Biotechnology:log(1 + LaggedCaseChange) 
0.004** 0.0002 0.005 0.002 
t = 2.103 t = 0.121 t = 0.171 t = 0.835 
Effectiveness:SectorPharmaceuticals and 
Biotechnology:VaccinationScaled 
-0.022** 0.014 -0.022 -0.030 
t = -2.131 t = 0.776 t = -0.237 t = -1.516 
Effectiveness:SectorPharmaceuticals and 
Biotechnology:log(1 + HealthInvest) 
-0.0003 0.005* -0.001 -0.002 
t = -0.341 t = 1.766 t = -0.102 t = -0.715 
Effectiveness:SectorPharmaceuticals and 
Biotechnology:log(1 + Fiscal_measures) 
-0.001* -0.0003 -0.0004 -0.001 
t = -1.850 t = -0.685 t = -0.097 t = -1.325 
Observations 65,235 65,235 57,567 57,567 
R2 0.071 0.038 0.064 0.059 
Adjusted R2 0.066 0.033 0.059 0.054 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Regression results including all companies where revenue information is available 
Table A9. 9: First stage regression output including all companies where revenue information 
is available – Health Care 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0003*** 0.001*** 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
 t = -6.387 t = 7.134 
CaseChange_2weeks 0.003***  
 t = 3.847  
GDPprevious  -1.845** 
  t = -2.069 
Import_change_previous -2.401*** 3.326*** 
 t = -6.438 t = 7.760 
log(1 + LaggedCaseChange) 0.089*** 0.206* 
 t = 3.191 t = 1.865 
VaccinationScaled -0.581** 0.712* 
 t = -2.343 t = 1.687 
log(1 + HealthInvest) -0.021 -0.150*** 
 t = -1.149 t = -3.748 
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -3.683  
Effectiveness:Import_change_previous 0.023*** -0.037*** 
 t = 5.660 t = -7.116 
Effectiveness:log(1 + LaggedCaseChange) -0.001 -0.002* 
 t = -1.581 t = -1.804 
Effectiveness:VaccinationScaled 0.009*** -0.012*** 
 t = 3.241 t = -2.628 
Effectiveness:log(1 + HealthInvest) 0.0003 0.001*** 
 t = 1.596 t = 3.035 
Observations 25,237 28,447 
R2 0.697 0.772 
Adjusted R2 0.695 0.771 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 113.04 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 67.981 
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Table A9. 10: Final regression output including all companies where revenue information is 
available – Health Care 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness -0.047** -0.040** 0.067 -0.073** 
 t = -2.340 t = -1.968 t = 0.224 t = -2.547 
StringencyScaled 0.935 -0.370 27.995 3.152 
 t = 1.486 t = -0.386 t = 0.470 t = 1.212 
EconomicScaled -1.111 1.641 -2.957 -4.235 
 t = -1.124 t = 1.109 t = -1.077 t = -1.408 
Import_change_previous -0.883 -3.651** 13.089 1.374 
 t = -0.707 t = -2.006 t = 0.398 t = 0.509 
log(1 + LaggedCaseChange) -0.086 -0.234*** -1.303 -0.057 
 t = -0.951 t = -2.746 t = -0.449 t = -0.416 
log(1 + HealthInvest) 0.043 0.184* -0.528 -0.162 
 t = 0.774 t = 1.855 t = -0.482 t = -0.750 
CountryNorway 0.263*** 0.277** -0.107 0.052 
 t = 2.940 t = 2.099 t = -0.141 t = 0.278 
ScaledMarketCap 1.456** 1.637*** 0.691 1.315 
 t = 2.426 t = 2.665 t = 0.329 t = 1.458 
Effectiveness:Import_change_previous 0.009 0.040* -0.153 -0.021 
 t = 0.644 t = 1.880 t = -0.414 t = -0.670 
Effectiveness:log(1 + LaggedCaseChange) 0.001 0.003*** 0.015 0.001 
 t = 0.948 t = 2.665 t = 0.464 t = 0.701 
Effectiveness:log(1 + HealthInvest) -0.0004 -0.002* 0.006 0.002 
 t = -0.644 t = -1.844 t = 0.490 t = 0.764 
CountryGermany:ScaledMarketCap -2.270*** -2.571*** -0.714 -1.855 
 t = -3.026 t = -3.325 t = -0.213 t = -1.515 
CountrySweden:ScaledMarketCap 22.463* 23.027* 27.728** 25.204* 
 t = 1.937 t = 1.958 t = 1.985 t = 1.960 
CountryUnited Kingdom: 
ScaledMarketCap 
-7.201*** -7.322*** -7.232** -7.831*** 
t = -3.699 t = -3.619 t = -2.548 t = -3.599 
Observations 28,447 28,447 25,237 25,237 
R2 0.116 0.107 0.027 0.087 
Adjusted R2 0.105 0.096 0.014 0.076 





Appendix 9.4 Results for Technology 
Regression results including all companies in the sample 
Table A9. 11: First stage regression output including all companies in the sample – 
Technology 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.00001 0.0004*** 
 t = -0.284 t = 5.178 
EconomicScaled -1.402***  
 t = -6.409  
CaseChange_2weeks 0.003***  





  t = -7.902 
Import_change_previous -2.591*** 4.848*** 
 t = -11.638 t = 12.960 
log(1 + LaggedCaseChange) 0.087*** 0.369*** 
 t = 8.682 t = 8.981 
VaccinationScaled -0.474*** 0.200* 
 t = -3.645 t = 1.950 
TestingScaled 1.595*** -0.741 
 t = 5.247 t = -1.304 
log(1 + Fiscal_measures) -0.003 -0.026** 
 t = -0.318 t = -2.427 
Effectiveness:EconomicScaled 0.021***  
 t = 8.695  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -9.418  
Effectiveness:StringencyScaled  0.019** 
  t = 2.445 
Effectiveness:GDPprevious  0.027*** 
  t = 6.294 
Effectiveness:Import_change_previous 0.026*** -0.054*** 
 t = 10.632 t = -13.195 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.004*** 
 t = -4.867 t = -8.721 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:VaccinationScaled 0.007*** -0.006*** 
 t = 4.822 t = -4.891 
Effectiveness:TestingScaled -0.019*** 0.009 
 t = -5.798 t = 1.527 
Effectiveness:log(1 + Fiscal_measures) -0.00001 0.0004*** 
 t = -0.063 t = 2.845 
Observations 72,116 81,115 
R2 0.731 0.754 
Adjusted R2 0.730 0.754 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 530.89 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 790.95 
Table A9. 12: Final regression output including all companies in the sample – Technology 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.052* 0.052* -0.007 0.041 
 t = 1.942 t = 1.883 t = -0.047 t = 1.112 
StringencyScaled 0.603 0.264 -6.587 2.262 
 t = 1.253 t = 0.514 t = -0.402 t = 1.286 
EconomicScaled -0.366 2.139* -1.402 0.357 
 t = -0.927 t = 1.686 t = -0.966 t = 0.184 
Import_change_previous -0.183 -2.231* -3.752 1.162 
 t = -0.319 t = -1.799 t = -0.487 t = 0.686 
log(1 + LaggedCaseChange) -0.080 -0.197** 0.312 -0.164 
 t = -1.307 t = -2.186 t = 0.357 t = -1.436 
VaccinationScaled -0.946*** -0.690 0.214 -0.925 
 t = -2.761 t = -1.559 t = 0.069 t = -1.444 
TestingScaled -0.461 -1.819* -0.146 -2.953 
 t = -0.731 t = -1.744 t = -0.074 t = -1.304 
log(1 + Fiscal_measures) 0.017 0.038** 0.058 0.012 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = 1.516 t = 2.574 t = 0.616 t = 0.638 
CountryGermany -0.161* -0.154 -0.120 -0.179 
 t = -1.947 t = -1.475 t = -0.986 t = -1.415 
CountryItaly 1.070* 1.115* 0.694 0.845 
 t = 1.862 t = 1.868 t = 0.522 t = 1.172 
CountrySpain 0.801** 0.792** 0.654 0.717* 
 t = 2.517 t = 2.425 t = 0.990 t = 1.827 
Effectiveness:Import_change_previous 0.001 0.024* 0.040 -0.014 
 t = 0.085 t = 1.692 t = 0.463 t = -0.716 
Effectiveness:log(1 + LaggedCaseChange) 0.001 0.002** -0.004 0.002 
 t = 1.166 t = 2.117 t = -0.361 t = 1.404 
Effectiveness:VaccinationScaled 0.010** 0.006 -0.004 0.009 
 t = 2.565 t = 1.515 t = -0.107 t = 1.264 
Effectiveness:TestingScaled 0.006 0.022* 0.002 0.033 
 t = 0.916 t = 1.871 t = 0.092 t = 1.330 
Effectiveness:log(1 + Fiscal_measures) -0.0002* -0.0004** -0.001 -0.0001 
 t = -1.689 t = -2.560 t = -0.673 t = -0.519 
CountryItaly:ScaledMarketCap 28.160*** 27.541** 23.755 27.984** 
 t = 2.594 t = 2.497 t = 1.147 t = 2.178 
CountryNorway:ScaledMarketCap 21.711** 21.490** 16.283 23.883** 
 t = 2.217 t = 2.180 t = 0.706 t = 2.170 
Observations 81,115 81,115 72,116 72,116 
R2 0.097 0.090 0.017 0.064 
Adjusted R2 0.094 0.086 0.013 0.060 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Regression results including all companies where revenue information is available 
Table A9. 13: First stage regression output including all companies where revenue 
information is available – Technology 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0002*** 0.0004*** 
 t = -6.986 t = 6.288 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
EconomicScaled -0.839***  
 t = -3.328  
CaseChange_2weeks 0.004***  
 t = 10.663  
StringencyScaled  -1.408*** 
  t = -2.695 
GDPprevious  -3.179*** 
  t = -6.460 
Import_change_previous -2.444*** 4.481*** 
 t = -8.627 t = 18.699 
log(1 + LaggedCaseChange) 0.063*** 0.415*** 
 t = 3.533 t = 7.409 
VaccinationScaled -0.444** 0.270 
 t = -2.560 t = 1.181 
log(1 + Fiscal_measures) 0.002 -0.029* 
 t = 0.165 t = -1.842 
Effectiveness:EconomicScaled 0.015***  
 t = 5.252  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -10.272  
Effectiveness:StringencyScaled  0.026*** 
  t = 4.456 
Effectiveness:GDPprevious  0.029*** 
  t = 5.175 
Effectiveness:Import_change_previous 0.024*** -0.049*** 
 t = 7.657 t = -17.763 
Effectiveness:log(1 + LaggedCaseChange) -0.0002 -0.005*** 
 t = -1.155 t = -7.279 
Effectiveness:VaccinationScaled 0.007*** -0.006** 
 t = 3.602 t = -2.543 
Effectiveness:log(1 + Fiscal_measures) -0.0001 0.0004** 
 t = -0.405 t = 2.186 
Observations 49,205 55,178 
R2 0.722 0.753 
Adjusted R2 0.721 0.752 
Note: *p<0.1, **p<0.05, ***p<0.01 
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F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 340.57 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 527.28 
Table A9. 14: Final regression output including all companies where revenue information is 
available – Technology 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness -0.042** -0.054*** -0.057 -0.048 
 t = -2.565 t = -2.588 t = -1.121 t = -1.563 
StringencyScaled 0.850** 0.563 -0.704 1.420 
 t = 2.115 t = 1.308 t = -0.122 t = 0.809 
EconomicScaled -0.474 0.176 -0.837 0.086 
 t = -1.092 t = 0.172 t = -1.329 t = 0.053 
VaccinationScaled -0.767* -0.758 -0.714 -0.937 
 t = -1.908 t = -1.536 t = -0.704 t = -1.450 
log(1 + Fiscal_measures) 0.015 0.021* 0.025 0.017 
 t = 1.352 t = 1.695 t = 0.666 t = 0.833 
CountryItaly -1.105*** -1.330*** -1.213* -1.291** 
 t = -2.988 t = -2.830 t = -1.843 t = -2.062 
CountryNorway 0.261*** 0.376*** 0.231 0.291 
 t = 2.717 t = 2.733 t = 1.163 t = 1.535 
CountrySpain -2.907*** -3.036*** -3.159*** -3.215*** 
 t = -2.926 t = -3.021 t = -2.817 t = -2.844 
CountrySweden 0.214* 0.316** 0.272 0.326 
 t = 1.765 t = 2.132 t = 1.282 t = 1.623 
ScaledMarketCap 273.448*** 301.511*** 296.849*** 314.146*** 
 t = 6.619 t = 6.041 t = 4.017 t = 4.519 
Effectiveness:StringencyScaled -0.011** -0.008 0.004 -0.018 
 t = -2.182 t = -1.357 t = 0.064 t = -0.848 
SectorTechnology Hardware and 
Equipment:StringencyScaled 
-2.349** -1.083 2.757 -6.524 
t = -2.414 t = -0.753 t = 0.313 t = -1.423 
Effectiveness:VaccinationScaled 0.008* 0.008 0.007 0.010 
 t = 1.800 t = 1.596 t = 0.654 t = 1.354 
SectorTechnology Hardware and 
Equipment:VaccinationScaled 
1.806** 1.095 1.263 2.120 
t = 2.339 t = 1.264 t = 0.609 t = 1.394 
Effectiveness:log(1 + Fiscal_measures) -0.0002 -0.0003* -0.0003 -0.0002 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = -1.409 t = -1.708 t = -0.712 t = -0.893 
CountryFrance:ScaledMarketCap -273.414*** -301.467*** -296.879*** -314.126*** 
 t = -6.621 t = -6.040 t = -4.019 t = -4.520 
CountryGermany:ScaledMarketCap -273.378*** -301.446*** -296.765*** -314.076*** 
 t = -6.618 t = -6.039 t = -4.015 t = -4.518 
CountryItaly:ScaledMarketCap -121.561*** -147.396*** -131.664* -139.975** 
 t = -2.742 t = -3.007 t = -1.797 t = -2.138 
CountryNorway:ScaledMarketCap -292.440*** -320.504*** -312.146*** -329.443*** 
 t = -7.078 t = -6.422 t = -4.224 t = -4.739 
CountrySpain:ScaledMarketCap -390.225*** -418.288*** -426.931*** -444.227*** 
 t = -8.422 t = -7.570 t = -5.533 t = -5.982 
CountrySweden:ScaledMarketCap -261.712*** -289.777*** -283.741*** -301.046*** 
 t = -6.342 t = -5.828 t = -3.843 t = -4.336 
CountryUnited Kingdom: 
ScaledMarketCap 
-271.090*** -299.069*** -294.435*** -311.455*** 
t = -6.548 t = -5.986 t = -3.974 t = -4.476 
CountryNorway:RevHomeCountry 0.467*** 0.465*** 0.594*** 0.586*** 
 t = 4.624 t = 4.646 t = 5.326 t = 5.283 
CountrySpain:RevHomeCountry 6.510*** 6.507*** 7.084*** 7.076*** 
 t = 3.103 t = 3.102 t = 3.063 t = 3.062 
Effectiveness:SectorTechnology 
Hardware and Equipment: 
StringencyScaled 
0.028** 0.014 -0.023 0.075 
t = 2.389 t = 0.766 t = -0.223 t = 1.414 
Effectiveness:SectorTechnology 
Hardware and Equipment: 
log(1 + LaggedCaseChange) 
-0.004 -0.006* -0.001 -0.008 
t = -1.388 t = -1.689 t = -0.263 t = -1.596 
Effectiveness:SectorTechnology 
Hardware and Equipment: 
VaccinationScaled 
-0.019** -0.011 -0.013 -0.023 
t = -2.147 t = -1.128 t = -0.561 t = -1.290 
Observations 55,178 55,178 49,205 49,205 
R2 0.181 0.178 0.190 0.192 
Adjusted R2 0.176 0.173 0.185 0.187 





Appendix 10 Industry regression outputs 
Regression outputs only display significant values. 
Appendix 10.1 Results for Basic Materials 
Regression results including all companies in the sample 
Table A10. 1: First stage regression output including all companies in the sample – Basic 
Materials 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0002*** 0.0003*** 
 t = -4.499 t = 3.395 
EconomicScaled -2.205***  
 t = -4.090  
CaseChange_2weeks 0.001*  
 t = 1.717  
GDPprevious  -4.243*** 
  t = -4.515 
log(1 + LaggedCaseChange) 0.170*** 0.399*** 
 t = 8.934 t = 4.993 
logVaccineInvest -0.161*** 0.417*** 
 t = -2.622 t = 3.483 
VaccinationScaled -0.950** 0.637*** 
 t = -2.164 t = 3.371 
TestingScaled 1.911* -0.070 
 t = 1.776 t = -0.047 
log(1 + HealthInvest) -0.030 -0.272*** 
 t = -1.516 t = -4.687 
Effectiveness:EconomicScaled 0.030***  
 t = 5.052  
SectorIndustrial Metals and Mining: 
EconomicScaled 
3.228***  
t = 3.645  
SectorMining:EconomicScaled 3.892***  
 t = 4.214  
SectorForestry and Paper:CaseChange_2weeks 
0.004***  
t = 2.829  
SectorIndustrial Metals and Mining: 0.005***  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
CaseChange_2weeks t = 3.362  
SectorIndustrial Metals and Mining: 
StringencyScaled 
 5.063** 
 t = 1.982 
Effectiveness:GDPprevious  0.042*** 
  t = 4.100 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.004*** 
 t = -6.184 t = -4.774 
SectorIndustrial Metals and Mining: 
log(1 + LaggedCaseChange) 
-0.210*** -0.302*** 
t = -3.403 t = -3.382 
SectorMining:log(1 + LaggedCaseChange) -0.329** -0.218 
 t = -1.998 t = -1.617 
Effectiveness:logVaccineInvest 0.002** -0.004*** 
 t = 2.464 t = -3.243 
Effectiveness:VaccinationScaled 0.013*** -0.010*** 
 t = 2.658 t = -5.038 
SectorIndustrial Metals and Mining: 
VaccinationScaled 
-0.461 1.511*** 
t = -0.627 t = 2.771 
SectorMining:VaccinationScaled -0.209 1.477** 
 t = -0.338 t = 2.526 
Effectiveness:TestingScaled -0.022* 0.002 
 t = -1.925 t = 0.149 
SectorMining:TestingScaled -3.579** 1.041 
 t = -2.404 t = 0.490 
Effectiveness:log(1 + HealthInvest) 0.0004* 0.003*** 
 t = 1.959 t = 4.042 
SectorIndustrial Metals and Mining: 
log(1 + HealthInvest) 
-0.258** 0.045 
t = -2.336 t = 0.311 
SectorForestry and Paper: 
log(1 + Fiscal_measures) 
0.094** -0.082* 
t = 2.511 t = -1.919 
SectorIndustrial Metals and Mining: 
log(1 + Fiscal_measures) 
-0.213 0.325** 
t = -1.583 t = 2.249 





t = -3.615  
Effectiveness:SectorMining:EconomicScaled -0.042***  
 t = -4.127  
Effectiveness:SectorForestry and Paper: 
CaseChange_2weeks 
-0.00005***  
t = -2.900  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorIndustrial Metals and 
Mining:CaseChange_2weeks 
-0.0001***  




t = -1.654  
Effectiveness:SectorIndustrial Metals and 
Mining:StringencyScaled 
 -0.054* 
 t = -1.938 
Effectiveness:SectorForestry and Paper: 
log(1 + LaggedCaseChange) 
0.001* 0.001 
t = 1.706 t = 0.559 
Effectiveness:SectorIndustrial Metals and 
Mining:log(1 + LaggedCaseChange) 
0.002*** 0.003*** 
t = 3.343 t = 3.238 
Effectiveness:SectorMining: 
log(1 + LaggedCaseChange) 
0.003* 0.002 
t = 1.882 t = 1.621 
Effectiveness:SectorIndustrial Metals and 
Mining:VaccinationScaled 
0.005 -0.017*** 
t = 0.600 t = -2.779 
Effectiveness:SectorMining:VaccinationScaled 0.002 -0.017** 
 t = 0.336 t = -2.566 
Effectiveness:SectorMining:TestingScaled 0.038** -0.011 
 t = 2.377 t = -0.461 
Effectiveness:SectorIndustrial Metals and 
Mining:log(1 + HealthInvest) 
0.003** -0.0005 
t = 2.329 t = -0.309 
Effectiveness:SectorForestry and Paper: 
log(1 + Fiscal_measures) 
-0.001** 0.001** 
t = -2.542 t = 1.988 
Effectiveness:SectorIndustrial Metals and 
Mining:log(1 + Fiscal_measures) 
0.002 -0.004** 
t = 1.545 t = -2.195 
Observations 37,102 41,789 
R2 0.818 0.855 
Adjusted R2 0.817 0.854 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 18.724 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 353.79 
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Table A10. 2: Final regression output including all companies in the sample – Basic Materials 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
StringencyScaled -0.468 -0.049 -8.800 1.781 
 t = -0.393 t = -0.052 t = -0.465 t = 0.290 
EconomicScaled -1.111 1.932 -4.157 8.282 
 t = -0.869 t = 0.975 t = -0.672 t = 0.240 
log(1 + VaccineInvest) -0.336* -0.229 -0.474 -1.293 
 t = -1.676 t = -0.733 t = -0.795 t = -0.797 
log(1 + HealthInvest) -0.145* -0.0001 -0.125 0.113 
 t = -1.864 t = -0.001 t = -0.579 t = 0.081 
SectorForestry and Paper: 
log(1 + LaggedCaseChange) 
-0.586*** -0.395** -0.877 -0.392 
t = -3.227 t = -2.166 t = -0.329 t = -0.185 
SectorMining:log(1 + VaccineInvest) -3.153*** -2.569 4.360 0.437 
 t = -3.023 t = -1.638 t = 0.891 t = 0.009 
SectorForestry and 
Paper:VaccinationScaled 
1.664* -2.355 1.274 8.690 
t = 1.700 t = -0.768 t = 0.389 t = 0.219 
SectorMining:VaccinationScaled -3.911** -2.228 1.077 4.892 
 t = -2.470 t = -0.727 t = 0.172 t = 0.115 
Effectiveness:log(1 + HealthInvest) 0.002* 0.00001 0.002 -0.001 
 t = 1.901 t = 0.005 t = 0.623 t = -0.048 
SectorMining:log(1 + HealthInvest) -0.015 0.549* 0.915 0.712 
 t = -0.042 t = 1.653 t = 0.906 t = 0.062 
SectorIndustrial Metals and Mining: 
log(1 + Fiscal_measures) 
-0.255* 0.077 -0.346 0.421 
t = -1.843 t = 0.213 t = -0.714 t = 0.169 
ScaledMarketCap:CountryItaly 31.915* 25.833 40.609** 47.433* 
 t = 1.718 t = 1.256 t = 1.975 t = 1.867 
Effectiveness:SectorForestry and 
Paper: 
log(1 + LaggedCaseChange) 
0.007*** 0.005** 0.009 0.003 
t = 3.245 t = 2.438 t = 0.324 t = 0.099 
Effectiveness:SectorMining: 
log(1 + VaccineInvest) 
0.035*** 0.028 -0.048 -0.004 
t = 3.027 t = 1.644 t = -0.890 t = -0.008 
Effectiveness:SectorForestry and 
Paper:VaccinationScaled 
-0.023** 0.026 -0.019 -0.106 
t = -2.024 t = 0.729 t = -0.523 t = -0.226 
Effectiveness:SectorMining: 
VaccinationScaled 
0.043** 0.025 -0.015 -0.058 
t = 2.426 t = 0.731 t = -0.209 t = -0.121 
Effectiveness:SectorIndustrial Metals 
and Mining:log(1 + Fiscal_measures) 
0.003* -0.001 0.004 -0.005 
t = 1.826 t = -0.214 t = 0.716 t = -0.167 
Observations 41,789 41,789 37,102 37,102 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
R2 0.083 0.034 0.044 0.021 
Adjusted R2 0.074 0.025 0.035 0.012 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Regression results including all companies where revenue information is available 
Table A10. 3: First stage regression output including all companies where revenue 
information is available – Basic Materials 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0001 0.001*** 
 t = -0.703 t = 3.180 
EconomicScaled -1.651**  
 t = -2.084  
CaseChange_2weeks 0.002  
 t = 1.335  
GDPprevious  -2.461*** 
  t = -2.938 
Import_change_previous -2.539*** 5.571*** 
 t = -2.788 t = 4.128 
log(1 + LaggedCaseChange) 0.123*** 0.272** 
 t = 3.894 t = 2.469 
logVaccineInvest -0.049 0.511*** 
 t = -0.796 t = 2.802 
TestingScaled 2.805** -0.945 
 t = 2.109 t = -0.527 
log(1 + HealthInvest) -0.032 -0.200*** 
 t = -1.202 t = -2.597 
Effectiveness:EconomicScaled 0.024***  
 t = 2.727  
SectorIndustrial Metals and Mining: 
EconomicScaled 
2.202**  
t = 2.072  
SectorMining:EconomicScaled 2.698***  
 t = 2.805  
SectorForestry and Paper: 0.005***  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
CaseChange_2weeks t = 2.967  
SectorIndustrial Metals and Mining: 
CaseChange_2weeks 
0.004**  
t = 2.332  
SectorMining:CaseChange_2weeks 0.005**  
 t = 1.992  
Effectiveness:GDPprevious  0.022** 
  t = 2.287 
SectorIndustrial Metals and 
Mining:GDPprevious 
 4.474** 
  t = 1.965 
Effectiveness:Import_change_previous 0.026*** -0.064*** 




t = -0.868 t = -2.668 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.003** 
 t = -2.677 t = -2.425 
SectorForestry and Paper: 
log(1 + LaggedCaseChange) 
-0.121** -0.018 
t = -2.535 t = -0.096 
SectorIndustrial Metals and Mining:log(1 + 
LaggedCaseChange) 
-0.114* -0.323*** 
t = -1.726 t = -2.835 
SectorMining:log(1 + LaggedCaseChange) -0.184** -0.240** 
 t = -2.065 t = -1.976 
Effectiveness:logVaccineInvest 0.0004 -0.005*** 
 t = 0.659 t = -2.664 
SectorIndustrial Metals and Mining: 
logVaccineInvest 
0.244* -0.444 
t = 1.790 t = -0.914 
Effectiveness:VaccinationScaled 0.010* -0.005* 
 t = 1.770 t = -1.844 
SectorIndustrial Metals and Mining: 
VaccinationScaled 
-0.509 1.186*** 
t = -0.793 t = 3.021 
Effectiveness:TestingScaled -0.032** 0.012 
 t = -2.233 t = 0.618 
SectorMining:TestingScaled -3.098** 0.578 
 t = -2.027 t = 0.197 
Effectiveness:log(1 + HealthInvest) 0.0005 0.002** 
 t = 1.554 t = 2.229 
SectorIndustrial Metals and Mining: 
log(1 + HealthInvest) 
-0.265** -0.165 
t = -2.312 t = -1.020 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
SectorMining:log(1 + HealthInvest) -0.202** -0.107 
 t = -1.994 t = -0.521 
SectorForestry and Paper: 
log(1 + Fiscal_measures) 
0.087** -0.115** 
t = 1.998 t = -2.564 
SectorIndustrial Metals and Mining: 
log(1 + Fiscal_measures) 
-0.075 0.234* 
t = -0.609 t = 1.785 
Effectiveness:SectorIndustrial Metals and 
Mining:EconomicScaled 
-0.025**  
t = -2.081  
Effectiveness:SectorMining:EconomicScaled -0.029***  
 t = -2.770  
Effectiveness:SectorForestry and Paper: 
CaseChange_2weeks 
-0.0001***  
t = -3.128  
Effectiveness:SectorIndustrial Metals and 
Mining:CaseChange_2weeks 
-0.00005**  




t = -2.012  
Effectiveness:SectorIndustrial Metals and 
Mining:StringencyScaled 
 -0.042* 
 t = -1.656 
Effectiveness:SectorIndustrial Metals and 
Mining:GDPprevious 
 -0.055** 
 t = -2.034 
Effectiveness:SectorForestry and Paper: 
Import_change_previous 
0.009 0.045*** 
t = 0.794 t = 2.850 
Effectiveness:SectorForestry and Paper: 
log(1 + LaggedCaseChange) 
0.001*** 0.00001 
t = 2.702 t = 0.005 
Effectiveness:SectorIndustrial Metals and 
Mining:log(1 + LaggedCaseChange) 
0.001* 0.004*** 
t = 1.780 t = 2.751 
Effectiveness:SectorMining: 
log(1 + LaggedCaseChange) 
0.002** 0.002* 
t = 2.021 t = 1.798 
Effectiveness:SectorIndustrial Metals and 
Mining:logVaccineInvest 
-0.002* 0.005 
t = -1.700 t = 0.926 
Effectiveness:SectorIndustrial Metals and 
Mining:VaccinationScaled 
0.006 -0.015*** 
t = 0.786 t = -3.306 
Effectiveness:SectorMining:TestingScaled 0.034** -0.007 
 t = 2.036 t = -0.213 
Effectiveness:SectorIndustrial Metals and 
Mining:log(1 + HealthInvest) 
0.003** 0.002 
t = 2.298 t = 1.045 
Effectiveness:SectorMining: 0.002** 0.001 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
log(1 + HealthInvest) t = 1.971 t = 0.510 
Effectiveness:SectorForestry and Paper: 
log(1 + Fiscal_measures) 
-0.001** 0.001*** 
t = -2.078 t = 2.729 
Effectiveness:SectorIndustrial Metals and 
Mining:log(1 + Fiscal_measures) 
0.001 -0.003* 
t = 0.630 t = -1.739 
Observations 13,884 15,686 
R2 0.745 0.784 
Adjusted R2 0.742 0.782 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 14.49 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 67.293 
Table A10. 4: Final regression output including all companies where revenue information is 
available – Basic Materials 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.022*** 0.029*** 0.054 -0.013 
 t = 2.729 t = 3.197 t = 0.406 t = -0.055 
SectorIndustrial Metals and Mining 1.198 3.029** 23.534 -2.405 
 t = 1.574 t = 2.298 t = 0.226 t = -0.062 
SectorMining 1.079 3.740** 24.870 -36.235 
 t = 1.542 t = 2.379 t = 0.425 t = -0.244 
StringencyScaled 1.465*** 0.158 1.051 -4.864 
 t = 3.625 t = 0.133 t = 0.068 t = -0.118 
EconomicScaled 0.709 4.204* 7.465 1.811 
 t = 1.234 t = 1.867 t = 0.303 t = 0.220 
Import_change_previous -0.783 -6.336*** -6.535 -5.962 
 t = -0.684 t = -2.621 t = -0.206 t = -0.234 
log(1 + LaggedCaseChange) -0.098** -0.271*** -0.417 0.059 
 t = -2.002 t = -2.756 t = -0.381 t = 0.033 
log(1 + VaccineInvest) -0.447* -0.493* -0.965 0.840 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = -1.698 t = -1.944 t = -0.754 t = 0.189 
VaccinationScaled -0.923*** -1.342** 0.396 -0.090 
 t = -3.544 t = -2.291 t = 0.055 t = -0.016 
log(1 + HealthInvest) -0.002 0.167* 0.038 0.249 
 t = -0.053 t = 1.764 t = 0.090 t = 0.337 
CountryFrance -0.392*** -0.146 -0.211 0.331 
 t = -2.692 t = -0.612 t = -0.093 t = 0.174 
CountryGermany -0.318* -0.121 -0.392 -0.122 
 t = -1.830 t = -0.477 t = -1.407 t = -0.094 
CountryItaly 0.583*** 0.828*** 1.300 1.551 
 t = 3.147 t = 2.797 t = 0.418 t = 1.110 
CountryNorway -0.392*** -0.189 -0.395 -0.097 
 t = -3.686 t = -0.949 t = -0.590 t = -0.060 
RevHomeCountry -0.974*** -1.027*** -1.238*** -0.341 
 t = -3.780 t = -3.118 t = -2.789 t = -0.077 
Effectiveness: 
SectorIndustrial Metals and Mining 
-0.013 -0.034** -0.272 0.029 
t = -1.540 t = -2.229 t = -0.224 t = 0.063 
Effectiveness:SectorMining -0.012 -0.040** -0.287 0.416 
 t = -1.424 t = -2.151 t = -0.428 t = 0.246 
Effectiveness:StringencyScaled 
-0.017*** -0.002 -0.002 0.054 
t = -3.813 t = -0.170 t = -0.008 t = 0.122 
SectorMining:StringencyScaled 1.260 -11.350* -64.096 115.601 
 t = 0.577 t = -1.664 t = -0.398 t = 0.278 
Effectiveness:Import_change_previous 0.009 0.075*** 0.071 0.070 
 t = 0.663 t = 2.723 t = 0.213 t = 0.248 
Effectiveness:log(1 + LaggedCaseChange) 0.001* 0.003*** 0.004 -0.0005 
 t = 1.893 t = 2.629 t = 0.397 t = -0.026 
SectorForestry and Paper: 
log(1 + LaggedCaseChange) 
-0.196** -0.232 1.071 -0.480 
t = -2.368 t = -1.475 t = 0.179 t = -0.839 
SectorIndustrial Metals and Mining: 
log(1 + LaggedCaseChange) 
0.068 0.276* 2.224 0.177 
t = 0.783 t = 1.756 t = 0.215 t = 0.258 
Effectiveness:log(1 + VaccineInvest) 0.005* 0.005* 0.010 -0.009 
 t = 1.666 t = 1.900 t = 0.752 t = -0.186 
Effectiveness:VaccinationScaled 0.011*** 0.014** -0.0002 -0.004 
 t = 4.310 t = 2.226 t = -0.002 t = -0.047 
SectorForestry and 
Paper:VaccinationScaled 
1.288** 0.315 4.819 -3.488 
t = 2.260 t = 0.137 t = 0.302 t = -0.178 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
SectorMining:log(1 + HealthInvest) 0.138 0.989* 2.400 -6.683 
 t = 0.536 t = 1.817 t = 0.409 t = -0.261 
ScaledMarketCap:CountryFrance 5.587*** 3.451 0.450 0.296 
 t = 2.744 t = 1.002 t = 0.012 t = 0.018 
ScaledMarketCap:CountryItaly 33.739* 8.775 88.503 31.579 
 t = 1.650 t = 0.287 t = 0.721 t = 0.090 
ScaledMarketCap:CountrySweden -4.649** -3.912 -7.726 1.370 
 t = -2.224 t = -0.755 t = -0.218 t = 0.063 
CountryFrance:RevHomeCountry 1.124*** 1.108*** 1.168 0.370 
 t = 4.016 t = 2.880 t = 0.644 t = 0.082 
CountryGermany:RevHomeCountry 1.154*** 1.242*** 1.243*** 1.249 
 t = 3.231 t = 3.164 t = 2.639 t = 0.491 
CountryNorway:RevHomeCountry 1.335*** 1.387*** 1.646*** 0.747 
 t = 5.180 t = 4.213 t = 3.710 t = 0.170 
CountrySpain:RevHomeCountry 0.975*** 1.052*** 1.359** -0.050 
 t = 3.651 t = 2.696 t = 2.044 t = -0.008 
CountrySweden:RevHomeCountry 0.617** 0.716 0.736 0.132 
 t = 2.204 t = 1.402 t = 0.443 t = 0.024 
Effectiveness:SectorForestry and Paper: 
log(1 + LaggedCaseChange) 
0.002** 0.002 -0.013 0.005 
t = 2.035 t = 1.401 t = -0.185 t = 0.775 
Effectiveness:SectorIndustrial Metals and 
Mining:log(1 + LaggedCaseChange) 
-0.001 -0.003* -0.026 -0.002 
t = -1.090 t = -1.891 t = -0.216 t = -0.198 
Effectiveness:SectorForestry and Paper: 
VaccinationScaled 
-0.017*** -0.005 -0.058 0.038 
t = -2.668 t = -0.176 t = -0.310 t = 0.153 
Effectiveness:SectorMining: 
log(1 + HealthInvest) 
-0.001 -0.011* -0.027 0.075 
t = -0.470 t = -1.750 t = -0.410 t = 0.262 
Observations 15,686 15,686 13,884 13,884 
R2 0.321 0.201 0.066 0.046 
Adjusted R2 0.303 0.180 0.041 0.020 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Appendix 10.2 Results for Financials 
For the Financials industry we used the instrument CaseChange_1week (see 4.2 Independent 
variables) as our original did have an F-statistic value above 10 which is needed to ensure it is 
not a weak instrument. 
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Regression results including all companies in the sample 
Table A10. 5: First stage regression output including all companies in the sample – Financials 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0001*** 0.0005*** 
 t = -4.415 t = 8.619 
EconomicScaled -1.530***  
 t = -5.076  
CaseChange_1week 0.022***  
 t = 4.730  
GDPprevious  -1.893*** 
  t = -3.644 
Import_change_previous -1.998*** 4.215*** 
 t = -7.104 t = 9.277 
log(1 + LaggedCaseChange) 0.154*** 0.269*** 
 t = 12.212 t = 6.519 
logVaccineInvest 0.037 0.751*** 
 t = 0.897 t = 6.716 
VaccinationScaled -0.738*** 0.139 
 t = -4.114 t = 1.061 
TestingScaled 3.249*** -1.094 
 t = 6.738 t = -1.374 
log(1 + HealthInvest) -0.018 -0.169*** 
 t = -1.294 t = -6.232 
log(1 + Fiscal_measures) -0.043*** 0.051*** 
 t = -3.666 t = 4.082 
Effectiveness:EconomicScaled 0.022***  
 t = 6.451  
SectorLife Insurance:EconomicScaled -2.209***  
 t = -6.772  
SectorNonequity Investment Instruments: 
EconomicScaled 
5.559***  
t = 17.670  
SectorReal Estate Investment and Services: 
EconomicScaled 
2.478***  
t = 7.466  
SectorReal Estate Investment Trusts:EconomicScaled 2.745***  
 t = 9.063  
Effectiveness: CaseChange_1week -0.0003***  
 t = -4.719  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
SectorLife Insurance: CaseChange_1week -0.039***  
 t = -7.509  
SectorNonequity Investment Instruments: 
CaseChange_1week 
0.061***  
t = 12.997  
SectorReal Estate Investment and Services: 
CaseChange_1week 
0.018***  
t = 2.884  
SectorReal Estate Investment Trusts: 
CaseChange_1week 
0.009**  
t = 2.012  
SectorFinancial Services:StringencyScaled  -3.241*** 
  t = -3.385 
SectorLife Insurance:StringencyScaled  -6.479*** 
  t = -7.541 
SectorNonequity Investment Instruments: 
StringencyScaled 
 10.920*** 
 t = 12.874 
SectorReal Estate Investment and Services: 
StringencyScaled 
 4.384*** 
 t = 4.185 
SectorReal Estate Investment Trusts:StringencyScaled  2.181*** 
  t = 2.648 
Effectiveness:GDPprevious  0.013** 
  t = 2.009 
SectorFinancial Services:GDPprevious  -2.052*** 
  t = -3.409 
Effectiveness:Import_change_previous 0.019*** -0.046*** 
 t = 6.289 t = -9.090 
SectorLife Insurance:Import_change_previous 1.649*** -3.030*** 
 t = 5.881 t = -6.732 
SectorNonequity Investment Instruments: 
Import_change_previous 
0.334 -6.014*** 
t = 1.152 t = -12.451 
SectorReal Estate Investment and Services: 
Import_change_previous 
-0.614** -1.522** 
t = -2.016 t = -2.114 
SectorReal Estate Investment Trusts: 
Import_change_previous 
-0.639** -5.237*** 
t = -2.284 t = -11.481 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.003*** 
 t = -8.541 t = -6.278 
SectorEquity Investment Instruments: 
log(1 + LaggedCaseChange) 
-0.086*** 0.273*** 
t = -2.581 t = 3.573 
SectorFinancial Services:log(1 + LaggedCaseChange) -0.058*** 0.228*** 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
 t = -3.825 t = 4.880 
SectorLife Insurance:log(1 + LaggedCaseChange) 0.021 0.137*** 
 t = 0.733 t = 2.897 
SectorNonequity Investment Instruments: 
log(1 + LaggedCaseChange) 
-0.651*** -0.098** 
t = -48.413 t = -2.155 
SectorReal Estate Investment and Services: 
log(1 + LaggedCaseChange) 
-0.173*** -0.272*** 
t = -7.912 t = -5.908 
SectorReal Estate Investment Trusts: 
log(1 + LaggedCaseChange) 
-0.179*** -0.213*** 
t = -14.129 t = -5.194 
Effectiveness:logVaccineInvest -0.0005 -0.008*** 
 t = -1.083 t = -6.556 
SectorEquity Investment Instruments:logVaccineInvest -0.791*** 0.371 
 t = -3.053 t = 0.677 
SectorFinancial Services:logVaccineInvest -0.286*** -0.146 
 t = -2.614 t = -0.919 
SectorLife Insurance:logVaccineInvest 2.900*** 1.923 
 t = 5.136 t = 0.996 
SectorNonequity Investment Instruments: 
logVaccineInvest 
-1.546*** 0.374*** 
t = -37.178 t = 3.038 
SectorReal Estate Investment and Services:l 
ogVaccineInvest 
-0.154** -0.813*** 
t = -1.993 t = -4.238 
SectorReal Estate Investment Trusts:logVaccineInvest 2.990*** -5.748*** 
 t = 71.212 t = -53.265 
Effectiveness:VaccinationScaled 0.011*** -0.006*** 
 t = 5.523 t = -4.260 
SectorFinancial Services:VaccinationScaled 0.653*** -0.137 
 t = 3.224 t = -0.937 
SectorLife Insurance:VaccinationScaled 1.205*** 0.110 
 t = 6.535 t = 0.671 
SectorNonequity Investment Instruments: 
VaccinationScaled 
-0.263 3.308*** 
t = -1.328 t = 20.800 
SectorReal Estate Investment and Services: 
VaccinationScaled 
-0.665*** 2.121*** 
t = -2.809 t = 7.395 
SectorReal Estate Investment Trusts:VaccinationScaled -0.066 1.308*** 
 t = -0.364 t = 9.984 
Effectiveness:TestingScaled -0.038*** 0.013 
 t = -7.151 t = 1.564 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
SectorFinancial Services:TestingScaled -1.235* 2.110** 
 t = -1.894 t = 2.327 
SectorLife Insurance:TestingScaled 4.589*** 5.340*** 
 t = 8.898 t = 6.307 
SectorNonequity Investment Instruments:TestingScaled -3.082*** -1.841** 
 t = -6.412 t = -2.305 
SectorReal Estate Investment and 
Services:TestingScaled 
-3.322*** 0.238 
t = -5.550 t = 0.228 
SectorReal Estate Investment Trusts:TestingScaled -4.136*** 2.257*** 
 t = -8.597 t = 2.828 
Effectiveness:log(1 + HealthInvest) 0.0003* 0.002*** 
 t = 1.829 t = 5.040 
SectorEquity Investment Instruments:  
log(1 + HealthInvest) 
-0.041** 0.092*** 
t = -2.038 t = 2.853 
SectorFinancial Services:log(1 + HealthInvest) -0.028* 0.084*** 
 t = -1.758 t = 2.824 
SectorLife Insurance:log(1 + HealthInvest) -0.070*** 0.042 
 t = -4.318 t = 1.466 
SectorNonequity Investment Instruments: 
log(1 + HealthInvest) 
-0.381*** 0.532*** 
t = -25.218 t = 16.328 
SectorReal Estate Investment and Services: 
log(1 + HealthInvest) 
0.016 -0.165*** 
t = 0.391 t = -3.398 
SectorReal Estate Investment Trusts: 
log(1 + HealthInvest) 
0.100*** -0.173*** 
t = 6.974 t = -6.224 
Effectiveness:log(1 + Fiscal_measures) 0.001*** -0.001*** 
 t = 3.914 t = -4.037 
SectorEquity Investment Instruments: 
log(1 + Fiscal_measures) 
0.077*** -0.096*** 
t = 5.631 t = -5.246 
SectorFinancial Services:log(1 + Fiscal_measures) 0.075*** -0.099*** 
 t = 5.902 t = -6.902 
SectorLife Insurance:log(1 + Fiscal_measures) 0.087*** -0.092*** 
 t = 6.797 t = -7.255 
SectorNonequity Investment Instruments: 
log(1 + Fiscal_measures) 
-0.004 -0.045*** 
t = -0.363 t = -3.621 
SectorReal Estate Investment and Services: 
log(1 + Fiscal_measures) 
-0.184*** 0.245*** 
t = -3.750 t = 5.976 
SectorReal Estate Investment Trusts: -0.027** -0.153*** 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
log(1 + Fiscal_measures) t = -2.315 t = -9.149 
Effectiveness:SectorLife Insurance:EconomicScaled 0.026***  
 t = 6.779  
Effectiveness:SectorNonequity Investment Instruments: 
EconomicScaled 
-0.059***  
t = -16.634  
Effectiveness:SectorReal Estate Investment and 
Services: EconomicScaled 
-0.027***  
t = -7.176  
Effectiveness:SectorReal Estate Investment Trusts: 
EconomicScaled 
-0.030***  
t = -8.821  
Effectiveness:SectorLife Insurance: CaseChange_1week 
0.0004***  
t = 7.005  
Effectiveness:SectorNonequity Investment Instruments: 
CaseChange_1week 
-0.001***  
t = -12.308  
Effectiveness:SectorReal Estate Investment and 
Services: CaseChange_1week 
-0.0002***  
t = -3.025  
Effectiveness:SectorReal Estate Investment Trusts: 
CaseChange_1week 
-0.0001**  




 t = 3.755 
Effectiveness:SectorLife Insurance:StringencyScaled  0.078*** 
  t = 8.145 
Effectiveness:SectorNonequity Investment Instruments: 
StringencyScaled 
 -0.114*** 
 t = -12.387 
Effectiveness:SectorReal Estate Investment and 
Services: StringencyScaled 
 -0.046*** 
 t = -4.013 
Effectiveness:SectorReal Estate Investment Trusts: 
StringencyScaled 
 -0.024*** 
 t = -2.688 
Effectiveness:SectorEquity Investment Instruments: 
GDPprevious 
 0.040* 
 t = 1.799 
Effectiveness:SectorFinancial Services:GDPprevious  0.028*** 
  t = 3.899 
Effectiveness:SectorReal Estate Investment Trusts: 
GDPprevious 
 0.010* 




t = -5.876 t = 7.088 
Effectiveness:SectorNonequity Investment Instruments: 
Import_change_previous 
-0.003 0.069*** 
t = -0.892 t = 12.788 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorReal Estate Investment and 
Services: Import_change_previous 
0.007** 0.018** 
t = 2.113 t = 2.247 
Effectiveness:SectorReal Estate Investment Trusts: 
Import_change_previous 
0.007** 0.061*** 
t = 2.395 t = 11.871 
Effectiveness:SectorEquity Investment Instruments: 
log(1 + LaggedCaseChange) 
0.001*** -0.003*** 
t = 2.834 t = -4.039 
Effectiveness:SectorFinancial Services: 
log(1 + LaggedCaseChange) 
0.001*** -0.003*** 
t = 3.642 t = -5.510 
Effectiveness:SectorLife Insurance: 
log(1 + LaggedCaseChange) 
-0.0003 -0.002*** 
t = -0.831 t = -2.864 
Effectiveness:SectorNonequity Investment Instruments: 
log(1 + LaggedCaseChange) 
0.007*** 0.001* 
t = 42.877 t = 1.800 
Effectiveness:SectorReal Estate Investment and 
Services: log(1 + LaggedCaseChange) 
0.002*** 0.003*** 
t = 7.843 t = 5.253 
Effectiveness:SectorReal Estate Investment Trusts: 
log(1 + LaggedCaseChange) 
0.002*** 0.002*** 
t = 13.421 t = 4.663 
Effectiveness:SectorEquity Investment Instruments: 
logVaccineInvest 
0.009*** -0.004 




t = 2.590 t = 0.763 
Effectiveness:SectorLife Insurance:logVaccineInvest -0.032*** -0.022 
 t = -5.149 t = -1.014 
Effectiveness:SectorNonequity Investment Instruments: 
logVaccineInvest 
0.017*** -0.005*** 
t = 39.719 t = -3.619 
Effectiveness:SectorNonlife Insurance:logVaccineInvest -0.0001 0.003 
 t = -0.181 t = 1.337 
Effectiveness:SectorReal Estate Investment and 
Services: logVaccineInvest 
0.002** 0.009*** 
t = 2.045 t = 4.179 
Effectiveness:SectorReal Estate Investment Trusts: 
logVaccineInvest 
-0.030*** 0.058*** 




t = -3.649 t = 1.613 
Effectiveness:SectorLife Insurance:VaccinationScaled -0.014*** -0.0001 
 t = -6.901 t = -0.079 
Effectiveness:SectorNonequity Investment Instruments: 
VaccinationScaled 
0.002 -0.036*** 




 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorReal Estate Investment and 
Services: VaccinationScaled t = 2.503 t = -7.343 
Effectiveness:SectorReal Estate Investment Trusts: 
VaccinationScaled 
0.0002 -0.015*** 
t = 0.106 t = -11.140 
Effectiveness:SectorFinancial Services:TestingScaled 0.014** -0.023** 
 t = 1.996 t = -2.362 
Effectiveness:SectorLife Insurance:TestingScaled -0.051*** -0.061*** 
 t = -9.041 t = -6.447 
Effectiveness:SectorNonequity Investment Instruments: 
TestingScaled 
0.034*** 0.020** 
t = 6.420 t = 2.359 
Effectiveness:SectorReal Estate Investment and 
Services: TestingScaled 
0.037*** -0.002 
t = 5.656 t = -0.203 
Effectiveness:SectorReal Estate Investment Trusts: 
TestingScaled 
0.045*** -0.022** 
t = 8.476 t = -2.568 
Effectiveness:SectorEquity Investment Instruments: 
log(1 + HealthInvest) 
0.001* -0.001*** 
t = 1.909 t = -3.018 
Effectiveness:SectorFinancial Services: 
log(1 + HealthInvest) 
0.0003* -0.001*** 
t = 1.782 t = -2.934 
Effectiveness:SectorLife Insurance: 
log(1 + HealthInvest) 
0.001*** -0.0003 
t = 3.517 t = -0.998 
Effectiveness:SectorNonequity Investment Instruments: 
log(1 + HealthInvest) 
0.004*** -0.006*** 
t = 23.122 t = -15.780 
Effectiveness:SectorReal Estate Investment and 
Services: log(1 + HealthInvest) 
-0.00005 0.002*** 
t = -0.108 t = 3.222 
Effectiveness:SectorReal Estate Investment Trusts: 
log(1 + HealthInvest) 
-0.001*** 0.002*** 
t = -4.572 t = 4.902 
Effectiveness:SectorEquity Investment Instruments: 
log(1 + Fiscal_measures) 
-0.001*** 0.001*** 
t = -5.856 t = 5.641 
Effectiveness:SectorFinancial Services: 
log(1 + Fiscal_measures) 
-0.001*** 0.001*** 
t = -6.613 t = 7.605 
Effectiveness:SectorLife Insurance: 
log(1 + Fiscal_measures) 
-0.001*** 0.001*** 
t = -7.157 t = 8.148 
Effectiveness:SectorNonequity Investment Instruments: 
log(1 + Fiscal_measures) 
-0.0001 0.001*** 
t = -0.957 t = 4.600 
Effectiveness:SectorReal Estate Investment and 
Services: log(1 + Fiscal_measures) 
0.002*** -0.003*** 
t = 3.478 t = -5.525 
Effectiveness:SectorReal Estate Investment Trusts: 
log(1 + Fiscal_measures) 
0.0001 0.002*** 
t = 0.793 t = 9.812 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Observations 107,337 120,762 
R2 0.763 0.795 
Adjusted R2 0.761 0.794 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_1week as an instrument for StringencyScaled: 
𝐹 = 178.2 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 190.56 
Table A10. 6: Final regression output including all companies in the sample – Financials 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
StringencyScaled 1.688*** 1.187*** -3.998 -1.656 
 t = 4.071 t = 2.595 t = -0.362 t = -0.712 
EconomicScaled 0.814 -0.548 2.673 -1.312 
 t = 1.334 t = -0.330 t = 0.351 t = -0.437 
Import_change_previous 1.761*** 1.748 -2.290 0.479 
 t = 2.797 t = 1.422 t = -0.260 t = 0.328 
log(1 + LaggedCaseChange) -0.107* -0.032 0.055 0.116 
 t = -1.894 t = -0.376 t = 0.214 t = 1.132 
log(1 + VaccineInvest) 0.163 -0.079 0.058 0.223*** 
 t = 1.241 t = -0.334 t = 0.106 t = 3.267 
TestingScaled -3.156*** -1.376 -5.302** -4.168 
 t = -3.985 t = -0.884 t = -2.241 t = -1.091 
log(1 + HealthInvest) -0.014 -0.082 0.097 -0.157 
 t = -0.454 t = -0.996 t = 0.853 t = -1.220 
log(1 + Fiscal_measures) 0.044*** 0.041*** 0.125 0.068 
 t = 2.735 t = 3.323 t = 0.419 t = 1.092 
Effectiveness:StringencyScaled -0.017*** -0.012** 0.055 0.016 
 t = -3.661 t = -2.485 t = 0.355 t = 0.481 
SectorEquity Investment Instruments: 
StringencyScaled 
-1.378 -1.172 -19.602 6.506** 
t = -0.686 t = -0.817 t = -0.638 t = 2.306 
SectorFinancial Services:StringencyScaled -1.652*** -1.216* -0.160 4.315* 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = -2.695 t = -1.655 t = -0.015 t = 1.817 
SectorLife Insurance:StringencyScaled 0.228 1.806 -26.511 14.019*** 
 t = 0.439 t = 1.606 t = -0.132 t = 2.627 
SectorNonequity Investment Instruments: 
StringencyScaled 
12.640** 26.557 7.946 -91.732 
t = 2.146 t = 0.400 t = 0.086 t = -0.598 
SectorReal Estate Investment and Services: 
StringencyScaled 
-0.691 -6.903*** 1.535 33.994** 
t = -0.761 t = -3.863 t = 0.055 t = 2.100 
SectorReal Estate Investment Trusts: 
StringencyScaled 
3.206*** 1.512 63.232 -42.427 
t = 7.162 t = 0.410 t = 1.174 t = -0.227 
SectorEquity Investment Instruments: 
EconomicScaled 
3.194* 18.291 0.052 -4.081 
t = 1.770 t = 0.815 t = 0.013 t = -0.683 
SectorLife Insurance:EconomicScaled -2.631*** 0.915 18.193 -6.551 
 t = -3.424 t = 0.494 t = 0.145 t = -1.564 
SectorNonlife Insurance:EconomicScaled -2.008** 0.836 -2.681 -2.391 
 t = -2.457 t = 0.383 t = -1.383 t = -0.570 
SectorReal Estate Investment and Services: 
EconomicScaled 
-0.968 7.151 -0.428 -26.133** 
t = -0.802 t = 1.622 t = -0.037 t = -2.143 
SectorReal Estate Investment Trusts: 
EconomicScaled 
-2.464*** -0.091 -33.267 24.877 
t = -3.616 t = -0.019 t = -1.240 t = 0.249 
Effectiveness:Import_change_previous -0.020*** -0.019 0.026 -0.005 
 t = -2.727 t = -1.381 t = 0.253 t = -0.288 
SectorEquity Investment Instruments: 
Import_change_previous 
-2.275** -11.561 -12.626 3.954 
t = -2.008 t = -0.974 t = -0.631 t = 1.405 
SectorFinancial Services: 
Import_change_previous 
-2.690*** -4.584*** -1.547 0.207 
t = -3.607 t = -3.314 t = -0.239 t = 0.132 
SectorLife Insurance: 
Import_change_previous 
-1.744** -3.489*** -11.565 4.283 
t = -2.245 t = -3.052 t = -0.150 t = 1.636 
SectorNonequity Investment Instruments: 
Import_change_previous 
-16.937*** -18.893 -20.155 -42.076 
t = -2.839 t = -1.505 t = -1.054 t = -1.322 
SectorNonlife Insurance: 
Import_change_previous 
-2.136** -3.203** -1.484 -0.527 
t = -2.099 t = -2.441 t = -0.124 t = -0.216 
SectorReal Estate Investment and Services: 
Import_change_previous 
-1.391 -4.578*** 1.236 12.526* 
t = -1.398 t = -2.964 t = 0.052 t = 1.646 
SectorReal Estate Investment Trusts: 
Import_change_previous 
-1.238* -1.099 33.367 -27.888 
t = -1.812 t = -0.707 t = 0.965 t = -0.269 
SectorEquity Investment Instruments: 
log(1 + LaggedCaseChange) 
0.014 -0.603 0.994 -0.305* 
t = 0.064 t = -1.110 t = 0.589 t = -1.893 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
SectorFinancial Services: 
log(1 + LaggedCaseChange) 
-0.001 -0.189* -0.030 -0.185 
t = -0.010 t = -1.872 t = -0.055 t = -1.537 
SectorLife Insurance: 
log(1 + LaggedCaseChange) 
0.002 -0.231* 0.278 -0.384* 
t = 0.032 t = -1.918 t = 0.077 t = -1.712 
SectorNonequity Investment Instruments: 
log(1 + LaggedCaseChange) 
-1.132 -1.095* -1.424 -1.224*** 
t = -1.348 t = -1.889 t = -1.264 t = -4.328 
SectorReal Estate Investment and Services: 
log(1 + LaggedCaseChange) 
-0.064 -0.133 -0.166 -1.185** 
t = -0.713 t = -1.033 t = -0.172 t = -2.521 
Effectiveness:log(1 + VaccineInvest) -0.002 0.001 -0.001 -0.002*** 
 t = -1.235 t = 0.318 t = -0.109 t = -3.475 
SectorEquity Investment Instruments: 
log(1 + VaccineInvest) 
-1.984* 2.331 -1.442 -1.386 
t = -1.942 t = 0.191 t = -0.806 t = -0.930 
SectorLife Insurance: 
log(1 + VaccineInvest) 
-22.520*** -25.152*** -108.904 -8.037 
t = -5.216 t = -5.098 t = -0.208 t = -0.664 
SectorNonequity Investment Instruments: 
log(1 + VaccineInvest) 
-2.543*** -0.445 -2.160** -2.983 
t = -10.020 t = -0.477 t = -2.131 t = -1.508 
SectorReal Estate Investment and Services: 
log(1 + VaccineInvest) 
0.159 0.726 0.171 -1.392* 
t = 0.822 t = 1.330 t = 0.172 t = -1.662 
SectorReal Estate Investment Trusts: 
log(1 + VaccineInvest) 
1.181*** 4.070 -34.107 30.361 
t = 3.049 t = 0.935 t = -1.064 t = 0.258 
SectorEquity Investment Instruments: 
VaccinationScaled 
-1.448** 1.033 0.531 -3.948** 
t = -2.281 t = 0.184 t = 0.147 t = -1.963 
SectorFinancial Services:VaccinationScaled -0.796** -0.475 -1.468 -1.982 
 t = -2.015 t = -1.155 t = -0.692 t = -1.474 
SectorLife Insurance:VaccinationScaled -1.749** -1.709** -0.404 -3.208 
 t = -2.374 t = -2.021 t = -0.027 t = -1.644 
SectorReal Estate Investment and Services: 
VaccinationScaled 
-1.096 0.312 -2.264 -10.760*** 
t = -1.619 t = 0.164 t = -0.832 t = -2.735 
SectorReal Estate Investment Trusts: 
VaccinationScaled 
-1.597** -2.122** -5.646 0.088 
t = -2.033 t = -2.229 t = -1.390 t = 0.011 
Effectiveness:TestingScaled 0.033*** 0.014 0.059* 0.042 
 t = 3.731 t = 0.788 t = 1.773 t = 0.956 
SectorFinancial Services:TestingScaled 1.938** -0.806 4.468 3.360 
 t = 1.991 t = -0.390 t = 0.414 t = 0.828 
SectorLife Insurance:TestingScaled 3.418*** -0.582 -1.849 2.774 
 t = 3.286 t = -0.256 t = -0.067 t = 0.393 
SectorNonlife Insurance:TestingScaled 3.220*** 0.474 5.931 7.905 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = 2.592 t = 0.196 t = 0.823 t = 1.239 
SectorReal Estate Investment and Services: 
TestingScaled 
2.130* -2.117 4.075 20.551** 
t = 1.928 t = -0.613 t = 0.622 t = 2.330 
SectorReal Estate Investment Trusts: 
TestingScaled 
2.018** -0.232 24.369 -14.244 
t = 2.346 t = -0.071 t = 1.269 t = -0.215 
SectorEquity Investment Instruments: 
log(1 + HealthInvest) 
0.322*** 1.037 0.385 -0.110 
t = 2.860 t = 0.891 t = 0.957 t = -0.331 
SectorNonequity Investment Instruments: 
log(1 + HealthInvest) 
0.396* 1.169** 0.182 1.149 
t = 1.873 t = 2.055 t = 0.241 t = 0.887 
SectorReal Estate Investment and Services: 
log(1 + HealthInvest) 
0.048 0.660** -0.008 -1.764** 
t = 0.488 t = 2.465 t = -0.013 t = -2.330 
SectorReal Estate Investment Trusts: 
log(1 + HealthInvest) 
0.118*** 0.355 -2.473 2.054 
t = 2.785 t = 0.798 t = -1.142 t = 0.258 
Effectiveness:log(1 + Fiscal_measures) -0.0005*** -0.001*** -0.002 -0.001 
 t = -2.603 t = -3.305 t = -0.400 t = -1.071 
SectorNonequity Investment 
Instruments:log(1 + Fiscal_measures) 
0.113* 0.185 0.140 -0.870 
t = 1.750 t = 0.257 t = 0.178 t = -0.507 
Effectiveness:SectorEquity Investment 
Instruments:StringencyScaled 
0.023 0.035 0.215 -0.080** 
t = 0.921 t = 0.802 t = 0.662 t = -2.004 
Effectiveness:SectorFinancial 
Services:StringencyScaled 
0.018** 0.015 -0.001 -0.059* 
t = 2.321 t = 1.451 t = -0.011 t = -1.700 
Effectiveness:SectorLife 
Insurance:StringencyScaled 
-0.008 -0.025* 0.406 -0.191*** 
t = -1.278 t = -1.811 t = 0.137 t = -2.759 
Effectiveness:SectorNonequity Investment 
Instruments:StringencyScaled 
-0.128** -0.261 -0.092 0.946 
t = -2.114 t = -0.382 t = -0.098 t = 0.599 
Effectiveness:SectorReal Estate Investment 
and Services:StringencyScaled 
0.005 0.072*** -0.027 -0.375** 
t = 0.476 t = 3.322 t = -0.088 t = -2.124 
Effectiveness:SectorReal Estate Investment 
Trusts:StringencyScaled 
-0.039*** -0.021 -0.667 0.428 
t = -7.739 t = -0.547 t = -1.162 t = 0.223 
Effectiveness:SectorEquity Investment 
Instruments:EconomicScaled 
-0.040* -0.218 -0.004 0.054 
t = -1.685 t = -0.801 t = -0.070 t = 0.724 
Effectiveness:SectorLife Insurance: 
EconomicScaled 
0.034*** -0.007 -0.258 0.094 
t = 3.510 t = -0.305 t = -0.146 t = 1.635 
Effectiveness:SectorNonlife Insurance: 
EconomicScaled 
0.027** -0.008 0.036 0.035 
t = 2.566 t = -0.286 t = 1.456 t = 0.617 
Effectiveness:SectorReal Estate Investment 
and Services:EconomicScaled 
0.013 -0.076 0.010 0.296** 
t = 0.946 t = -1.431 t = 0.081 t = 2.156 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:SectorReal Estate Investment 
Trusts:EconomicScaled 
0.031*** 0.008 0.352 -0.251 
t = 3.637 t = 0.158 t = 1.232 t = -0.245 
Effectiveness:SectorEquity Investment 
Instruments:Import_change_previous 
0.028** 0.132 0.137 -0.043 
t = 2.156 t = 0.980 t = 0.646 t = -1.302 
Effectiveness:SectorFinancial 
Services:Import_change_previous 
0.030*** 0.051*** 0.015 -0.004 
t = 3.438 t = 3.214 t = 0.219 t = -0.199 
Effectiveness:SectorLife 
Insurance:Import_change_previous 
0.020** 0.039*** 0.172 -0.058* 
t = 2.100 t = 2.852 t = 0.152 t = -1.926 
Effectiveness:SectorNonequity Investment 
Instruments:Import_change_previous 
0.176*** 0.202 0.208 0.439 
t = 2.862 t = 1.563 t = 1.088 t = 1.340 
Effectiveness:SectorNonlife 
Insurance:Import_change_previous 
0.023** 0.036** 0.015 0.002 
t = 1.986 t = 2.427 t = 0.119 t = 0.069 
Effectiveness:SectorReal Estate Investment 
and Services:Import_change_previous 
0.014 0.048*** -0.018 -0.136* 
t = 1.229 t = 2.893 t = -0.069 t = -1.666 
Effectiveness:SectorReal Estate Investment 
Trusts:Import_change_previous 
0.015* 0.011 -0.348 0.288 
t = 1.878 t = 0.644 t = -0.956 t = 0.270 
Effectiveness:SectorEquity Investment 
Instruments:log(1 + LaggedCaseChange) 
-0.0001 0.006 -0.011 0.004** 
t = -0.034 t = 1.190 t = -0.588 t = 2.568 
Effectiveness:SectorFinancial Services: 
log(1 + LaggedCaseChange) 
0.0002 0.002** 0.001 0.002** 
t = 0.195 t = 2.077 t = 0.096 t = 1.985 
Effectiveness:SectorLife Insurance: 
log(1 + LaggedCaseChange) 
0.0002 0.003** -0.005 0.005* 
t = 0.285 t = 2.033 t = -0.094 t = 1.949 
Effectiveness:SectorNonequity Investment 
Instruments:log(1 + LaggedCaseChange) 
0.012 0.011* 0.015 0.013*** 
t = 1.340 t = 1.875 t = 1.303 t = 4.369 
Effectiveness:SectorReal Estate Investment 
and Services:log(1 + LaggedCaseChange) 
Effectiveness:SectorEquity Investment 
Instruments:log(1 + VaccineInvest) 
0.001 0.002 0.002 0.013** 
t = 0.823 t = 1.173 t = 0.206 t = 2.571 
0.022* -0.025 0.016 0.015 
t = 1.949 t = -0.188 t = 0.806 t = 0.912 
Effectiveness:SectorLife Insurance: 
log(1 + VaccineInvest) 
0.249*** 0.278*** 1.206 0.089 
t = 5.217 t = 5.103 t = 0.208 t = 0.663 
Effectiveness:SectorNonequity Investment 
Instruments:log(1 + VaccineInvest) 
0.028*** 0.005 0.024** 0.032 
t = 10.485 t = 0.537 t = 2.230 t = 1.560 
Effectiveness:SectorReal Estate Investment 
and Services:log(1 + VaccineInvest) 
-0.002 -0.008 -0.002 0.015* 
t = -0.853 t = -1.360 t = -0.168 t = 1.645 
Effectiveness:SectorReal Estate Investment 
Trusts:log(1 + VaccineInvest) 
-0.012*** -0.042 0.351 -0.313 
t = -3.077 t = -0.929 t = 1.064 t = -0.258 
0.014* -0.016 -0.007 0.045* 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:SectorEquity Investment 
Instruments:VaccinationScaled t = 1.722 t = -0.239 t = -0.162 t = 1.789 
Effectiveness:SectorFinancial Services: 
VaccinationScaled 
0.009** 0.005 0.017 0.024 
t = 1.980 t = 1.025 t = 0.708 t = 1.397 
Effectiveness:SectorLife Insurance: 
VaccinationScaled 
0.021** 0.020** -0.005 0.040 
t = 2.457 t = 2.052 t = -0.023 t = 1.633 
Effectiveness:SectorNonlife Insurance: 
VaccinationScaled 
0.010* 0.004 0.019 0.027 
t = 1.689 t = 0.809 t = 0.786 t = 0.834 
Effectiveness:SectorReal Estate Investment 
and Services:VaccinationScaled 
0.011 -0.005 0.025 0.120*** 
t = 1.457 t = -0.220 t = 0.797 t = 2.653 
Effectiveness:SectorReal Estate Investment 
Trusts:VaccinationScaled 
0.018** 0.025** 0.063 0.001 
t = 2.149 t = 2.171 t = 1.253 t = 0.015 
Effectiveness:SectorFinancial Services: 
TestingScaled 
-0.020* 0.011 -0.048 -0.037 
t = -1.797 t = 0.458 t = -0.396 t = -0.791 
Effectiveness:SectorLife Insurance: 
TestingScaled 
-0.040*** 0.005 0.013 -0.031 
t = -3.342 t = 0.180 t = 0.048 t = -0.391 
Effectiveness:SectorNonlife Insurance: 
TestingScaled 
-0.036** -0.005 -0.066 -0.087 
t = -2.539 t = -0.176 t = -0.858 t = -1.174 
Effectiveness:SectorReal Estate Investment 
and Services:TestingScaled 
-0.023* 0.024 -0.045 -0.223** 
t = -1.835 t = 0.613 t = -0.597 t = -2.292 
Effectiveness:SectorReal Estate Investment 
Trusts:TestingScaled 
-0.021** 0.001 -0.255 0.147 
t = -2.218 t = 0.016 t = -1.196 t = 0.216 
Effectiveness:SectorEquity Investment 
Instruments:log(1 + HealthInvest) 
-0.004*** -0.012 -0.005 0.001 
t = -2.854 t = -0.875 t = -0.990 t = 0.356 
Effectiveness:SectorNonequity Investment 
Instruments:log(1 + HealthInvest) 
-0.004* -0.013** -0.001 -0.012 
t = -1.851 t = -2.171 t = -0.193 t = -0.886 
Effectiveness:SectorReal Estate Investment 
and Services:log(1 + HealthInvest) 
-0.0004 -0.007** 0.0003 0.020** 
t = -0.399 t = -2.298 t = 0.047 t = 2.346 
Effectiveness:SectorReal Estate Investment 
Trusts:log(1 + HealthInvest) 
-0.001** -0.003 0.026 -0.021 
t = -2.358 t = -0.725 t = 1.144 t = -0.254 
Observations 120,762 120,762 107,337 107,337 
R2 0.127 0.105 0.051 0.040 
Adjusted R2 0.124 0.101 0.047 0.035 




Regression results including all companies where revenue information is available 
Table A10. 7: First stage regression output including all companies where revenue 
information is available – Financials 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0002*** 0.0004*** 
 t = -5.699 t = 5.033 
CaseChange_1week 0.116***  
 t = 7.500  
StringencyScaled  6.244*** 
  t = 17.485 
GDPprevious  -18.805*** 
  t = -11.173 
log(1 + LaggedCaseChange) 0.492*** 0.322*** 
 t = 6.542 t = 7.141 
logVaccineInvest 0.266 0.378*** 
 t = 1.592 t = 3.805 
VaccinationScaled -2.632*** -0.094 
 t = -4.238 t = -0.129 
TestingScaled 1.527 -6.474*** 
 t = 1.420 t = -13.851 
log(1 + HealthInvest) -0.621*** 0.116** 
 t = -8.826 t = 2.376 
log(1 + Fiscal_measures) -0.107** 0.121*** 
 t = -2.251 t = 4.195 
SectorFinancial Services:EconomicScaled -4.243***  
 t = -3.568  
SectorLife Insurance:EconomicScaled -5.244***  
 t = -4.437  
Effectiveness: CaseChange_1week  -0.001***  
 t = -7.234  
SectorEquity Investment Instruments: 
CaseChange_1week 
-0.033*  
t = -1.727  
SectorFinancial Services: CaseChange_1week -0.116***  
 t = -7.196  
SectorLife Insurance: CaseChange_1week -0.140***  
 t = -8.815  
SectorNonlife Insurance: CaseChange_1week -0.100***  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
 t = -5.887  
SectorReal Estate Investment and Services: 
CaseChange_1week 
-0.077***  
t = -4.550  
SectorReal Estate Investment Trusts: 
CaseChange_1week  
-0.016***  
t = -9.655  
Effectiveness:StringencyScaled  -0.060*** 
  t = -16.454 
SectorEquity Investment Instruments:StringencyScaled  5.820*** 
  t = 3.837 
SectorFinancial Services:StringencyScaled  -11.569*** 
  t = -18.712 
SectorLife Insurance:StringencyScaled  -13.398*** 
  t = -31.040 
SectorNonlife Insurance:StringencyScaled  -6.598*** 
  t = -2.846 
SectorReal Estate Investment and Services: 
StringencyScaled 
 -2.497*** 
 t = -2.629 
SectorReal Estate Investment Trusts:StringencyScaled  -0.686*** 
  t = -10.079 
Effectiveness:GDPprevious  0.195*** 
  t = 10.344 
SectorEquity Investment Instruments:GDPprevious  20.121*** 
  t = 6.486 
SectorFinancial Services:GDPprevious  15.354*** 
  t = 9.077 
SectorLife Insurance:GDPprevious  17.134*** 
  t = 9.020 
SectorNonlife Insurance:GDPprevious  17.782*** 
  t = 9.457 
SectorReal Estate Investment and Services: 
GDPprevious 
 16.186*** 
 t = 9.471 
SectorReal Estate Investment Trusts:GDPprevious  2.867*** 
  t = 14.142 
Effectiveness:log(1 + LaggedCaseChange) -0.005*** -0.003*** 
 t = -5.870 t = -6.552 
SectorEquity Investment Instruments: 
log(1 + LaggedCaseChange) 
-0.800*** -0.428 
t = -3.157 t = -0.903 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
SectorFinancial Services:log(1 + LaggedCaseChange) -0.309*** 0.167*** 
 t = -4.088 t = 3.110 
SectorLife Insurance:log(1 + LaggedCaseChange) -0.314*** 0.071 
 t = -3.776 t = 1.510 
SectorNonlife Insurance:log(1 + LaggedCaseChange) -0.212*** -0.278** 
 t = -2.682 t = -2.228 
SectorReal Estate Investment and Services: 
log(1 + LaggedCaseChange) 
-0.528*** -0.218*** 
t = -6.630 t = -4.417 
SectorReal Estate Investment Trusts: 
log(1 + LaggedCaseChange) 
-0.069*** -0.051*** 
t = -7.363 t = -10.804 
Effectiveness:logVaccineInvest -0.003 -0.004*** 
 t = -1.602 t = -3.574 
SectorEquity Investment Instruments:logVaccineInvest -1.316*** -0.328 
 t = -4.396 t = -0.610 
SectorFinancial Services:logVaccineInvest -0.447** 0.157 
 t = -2.241 t = 1.069 
SectorLife Insurance:logVaccineInvest 4.579*** 0.444 
 t = 6.956 t = 0.157 
SectorNonlife Insurance:logVaccineInvest 3.221*** -5.303*** 
 t = 4.786 t = -3.138 
SectorReal Estate Investment and Services: 
logVaccineInvest 
-0.669*** -0.524** 
t = -3.044 t = -2.007 
SectorReal Estate Investment Trusts:logVaccineInvest 0.550*** -0.995*** 
 t = 17.990 t = -53.183 
Effectiveness:VaccinationScaled 0.031*** -0.004 
 t = 4.511 t = -0.492 
SectorEquity Investment Instruments:VaccinationScaled 0.843 3.964*** 
 t = 0.727 t = 3.287 
SectorFinancial Services:VaccinationScaled 2.592*** 0.604 
 t = 4.075 t = 0.833 
SectorLife Insurance:VaccinationScaled 3.056*** 0.815 
 t = 4.882 t = 1.119 
SectorNonlife Insurance:VaccinationScaled 1.195* 1.538* 
 t = 1.677 t = 1.862 
SectorReal Estate Investment and Services: 
VaccinationScaled 
1.353** 2.419*** 
t = 2.079 t = 3.044 
SectorReal Estate Investment Trusts:VaccinationScaled 0.278*** 0.187 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
 t = 3.836 t = 1.462 
Effectiveness:TestingScaled -0.019 0.071*** 
 t = -1.626 t = 13.780 
SectorFinancial Services:TestingScaled 1.424 9.459*** 
 t = 1.042 t = 15.374 
SectorLife Insurance:TestingScaled 7.070*** 11.680*** 
 t = 6.360 t = 18.804 
SectorNonlife Insurance:TestingScaled 0.354 6.629*** 
 t = 0.203 t = 4.613 
SectorReal Estate Investment and 
Services:TestingScaled 
-2.856** 5.743*** 
t = -2.351 t = 5.176 
SectorReal Estate Investment Trusts:TestingScaled -0.617*** 1.356*** 
 t = -4.679 t = 22.755 
Effectiveness:log(1 + HealthInvest) 0.007*** -0.001*** 
 t = 8.664 t = -2.735 
SectorEquity Investment Instruments: 
log(1 + HealthInvest) 
0.209** 0.177* 
t = 2.191 t = 1.757 
SectorFinancial Services:log(1 + HealthInvest) 0.589*** -0.269*** 
 t = 8.225 t = -5.205 
SectorLife Insurance:log(1 + HealthInvest) 0.539*** -0.289*** 
 t = 7.561 t = -5.643 
SectorNonlife Insurance:log(1 + HealthInvest) 0.800*** -0.358*** 
 t = 6.937 t = -3.596 
SectorReal Estate Investment and Services: 
log(1 + HealthInvest) 
0.591*** -0.389*** 
t = 6.206 t = -4.748 
SectorReal Estate Investment Trusts: 
log(1 + HealthInvest) 
0.127*** -0.094*** 
t = 16.131 t = -15.128 
Effectiveness:log(1 + Fiscal_measures) 0.001** -0.001*** 
 t = 2.401 t = -4.149 
SectorFinancial Services:log(1 + Fiscal_measures) 0.148*** -0.177*** 
 t = 3.085 t = -5.516 
SectorLife Insurance:log(1 + Fiscal_measures) 0.150*** -0.168*** 
 t = 3.096 t = -5.755 
SectorNonlife Insurance:log(1 + Fiscal_measures) 0.074 -0.063 
 t = 1.151 t = -0.871 
SectorReal Estate Investment Trusts: 
log(1 + Fiscal_measures) 
0.030*** -0.032*** 
t = 4.962 t = -5.995 
248 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorFinancial Services:EconomicScaled 0.048***  
 t = 3.623  
Effectiveness:SectorLife Insurance:EconomicScaled 0.059***  




t = 6.907  
Effectiveness:SectorLife Insurance: CaseChange_1week 
0.002***  




t = 5.538  
Effectiveness:SectorReal Estate Investment and 
CaseChange_1week 
0.001***  
t = 4.292  
Effectiveness:SectorEquity Investment Instruments: 
StringencyScaled 
 -0.060*** 




 t = 18.870 
Effectiveness:SectorLife Insurance:StringencyScaled  0.152*** 
  t = 31.474 
Effectiveness:SectorNonlife Insurance:StringencyScaled  0.073*** 
  t = 2.859 
Effectiveness:SectorReal Estate Investment and 
Services: StringencyScaled 
 0.029*** 
 t = 2.806 
Effectiveness:SectorEquity Investment Instruments: 
GDPprevious 
 -0.210*** 
 t = -6.468 
Effectiveness:SectorFinancial Services:GDPprevious  -0.160*** 
  t = -8.455 
Effectiveness:SectorLife Insurance:GDPprevious  -0.183*** 
  t = -7.985 
Effectiveness:SectorNonlife Insurance:GDPprevious  -0.189*** 
  t = -8.891 
Effectiveness:SectorReal Estate Investment and 
Services: GDPprevious 
 -0.169*** 
 t = -8.842 
Effectiveness:SectorEquity Investment Instruments: 
log(1 + LaggedCaseChange) 
0.009*** 0.004 
t = 3.282 t = 0.886 
Effectiveness:SectorFinancial Services: 
log(1 + LaggedCaseChange) 
0.003*** -0.002*** 
t = 3.891 t = -3.407 
Effectiveness:SectorLife Insurance: 0.003*** -0.001 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
log(1 + LaggedCaseChange) t = 3.339 t = -1.528 
Effectiveness:SectorNonlife Insurance: 
log(1 + LaggedCaseChange) 
0.002** 0.003** 
t = 2.341 t = 2.437 
Effectiveness:SectorReal Estate Investment and 
Services: log(1 + LaggedCaseChange) 
0.006*** 0.002*** 
t = 6.563 t = 3.656 
Effectiveness:SectorEquity Investment Instruments: 
logVaccineInvest 
0.014*** 0.003 




t = 2.198 t = -1.155 
Effectiveness:SectorLife Insurance:logVaccineInvest -0.051*** -0.005 
 t = -7.041 t = -0.159 
Effectiveness:SectorNonlife Insurance:logVaccineInvest -0.036*** 0.059*** 
 t = -4.854 t = 3.141 
Effectiveness:SectorReal Estate Investment and 
Services: logVaccineInvest 
0.007*** 0.006** 
t = 3.058 t = 2.001 
Effectiveness:SectorEquity Investment Instruments: 
VaccinationScaled 
-0.009 -0.042*** 




t = -4.061 t = -0.676 
Effectiveness:SectorLife Insurance:VaccinationScaled -0.034*** -0.008 




t = -1.592 t = -1.877 
Effectiveness:SectorReal Estate Investment and 
Services: VaccinationScaled 
-0.015** -0.025*** 
t = -2.055 t = -3.020 
Effectiveness:SectorFinancial Services:TestingScaled -0.015 -0.102*** 
 t = -0.980 t = -15.202 
Effectiveness:SectorLife Insurance:TestingScaled -0.078*** -0.129*** 
 t = -6.380 t = -16.605 
Effectiveness:SectorNonlife Insurance:TestingScaled -0.005 -0.070*** 
 t = -0.252 t = -4.553 
Effectiveness:SectorReal Estate Investment and 
Services: TestingScaled 
0.032** -0.061*** 
t = 2.405 t = -5.124 
Effectiveness:SectorEquity Investment Instruments: 
log(1 + HealthInvest) 
-0.002** -0.002* 
t = -2.055 t = -1.851 
Effectiveness:SectorFinancial Services: 
log(1 + HealthInvest) 
-0.006*** 0.003*** 
t = -7.959 t = 4.882 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorLife Insurance: 
log(1 + HealthInvest) 
-0.006*** 0.003*** 
t = -7.338 t = 5.508 
Effectiveness:SectorNonlife Insurance: 
log(1 + HealthInvest) 
-0.009*** 0.004*** 
t = -6.931 t = 3.167 
Effectiveness:SectorReal Estate Investment and 
Services: log(1 + HealthInvest) 
-0.006*** 0.004*** 
t = -6.018 t = 4.594 
Effectiveness:SectorEquity Investment Instruments: 
log(1 + Fiscal_measures) 
-0.0005 0.001 
t = -0.633 t = 0.681 
Effectiveness:SectorFinancial Services:log(1 + 
Fiscal_measures) 
-0.002*** 0.002*** 
t = -3.380 t = 5.790 
Effectiveness:SectorLife Insurance: 
log(1 + Fiscal_measures) 
-0.002*** 0.002*** 
t = -3.342 t = 6.160 
Effectiveness:SectorReal Estate Investment and 
Services: log(1 + Fiscal_measures) 
0.001 -0.002*** 
t = 0.837 t = -2.592 
Observations 54,722 61,369 
R2 0.763 0.817 
Adjusted R2 0.762 0.816 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_1week as an instrument for StringencyScaled: 
𝐹 = 218.89 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 396.01 
Table A10. 8: Final regression output including all companies where revenue information is 
available – Financials 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
StringencyScaled 5.548** 6.452 15.610 -18.749 
 t = 2.100 t = 0.267 t = 0.419 t = -1.168 
EconomicScaled -2.560 -16.339 -8.335 7.537 
 t = -1.171 t = -0.224 t = -0.450 t = 0.656 
log(1 + LaggedCaseChange) -0.722** -0.526 -0.750 0.377 
 t = -2.552 t = -0.621 t = -1.071 t = 0.573 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
VaccinationScaled -2.984* -8.585 -7.733 3.804 
 t = -1.825 t = -0.280 t = -0.509 t = 0.635 
TestingScaled -3.748*** 8.369 -2.360 -24.068* 
 t = -2.835 t = 0.177 t = -0.173 t = -1.846 
log(1 + HealthInvest) 0.483** -0.142 0.121 0.323 
 t = 2.013 t = -0.062 t = 0.145 t = 0.775 
Effectiveness:StringencyScaled -0.058** -0.070 -0.173 0.196 
 t = -2.010 t = -0.259 t = -0.415 t = 1.143 
SectorEquity Investment Instruments: 
StringencyScaled 
43.448*** -78.340 48.459 44.346** 
t = 5.892 t = -0.571 t = 1.094 t = 2.225 
SectorFinancial Services:StringencyScaled -5.747** -5.803 -22.556 21.792 
 t = -2.049 t = -0.232 t = -0.453 t = 1.345 
SectorLife Insurance:StringencyScaled -3.693 -3.034 -7.340 33.931** 
 t = -1.376 t = -0.119 t = -0.100 t = 2.030 
SectorNonlife Insurance:StringencyScaled -6.642** -7.388 -15.260 10.372 
 t = -2.252 t = -0.320 t = -0.455 t = 0.541 
SectorReal Estate Investment and Services: 
StringencyScaled 
-3.033 -6.251 -22.661 25.982* 
t = -1.131 t = -0.312 t = -0.475 t = 1.794 
SectorReal Estate Investment Trusts: 
StringencyScaled 
-0.657* -1.266 15.849 2.064 
t = -1.754 t = -0.562 t = 0.530 t = 0.927 
SectorEquity Investment Instruments: 
EconomicScaled 
-34.617*** 234.635 -30.788 -43.231* 
t = -3.998 t = 1.022 t = -1.318 t = -1.871 
SectorFinancial Services:EconomicScaled 4.210* 18.963 7.302 -11.318 
 t = 1.793 t = 0.262 t = 0.762 t = -1.007 
SectorReal Estate Investment Trusts: 
EconomicScaled 
0.524* 2.831 -11.167 0.088 
t = 1.662 t = 0.386 t = -0.584 t = 0.080 
Effectiveness:log(1 + LaggedCaseChange) 0.007** 0.005 0.008 -0.004 
 t = 2.362 t = 0.527 t = 1.062 t = -0.561 
SectorEquity Investment Instruments: 
log(1 + LaggedCaseChange) 
0.302 -0.509 -0.565 -1.475** 
t = 0.648 t = -0.337 t = -0.475 t = -2.244 
SectorFinancial Services: 
log(1 + LaggedCaseChange) 
0.592** 0.291 1.131 -0.502 
t = 2.072 t = 0.376 t = 0.645 t = -0.732 
SectorLife Insurance: 
log(1 + LaggedCaseChange) 
0.612** 0.244 0.575 -0.874 
t = 2.158 t = 0.317 t = 0.286 t = -1.139 
SectorNonlife Insurance: 
log(1 + LaggedCaseChange) 
0.700** 0.474 0.879 -0.353 
t = 2.451 t = 0.548 t = 0.674 t = -0.456 
SectorReal Estate Investment Trusts: 0.119*** 0.084 -0.373 -0.069 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
log(1 + LaggedCaseChange) t = 3.742 t = 1.469 t = -0.435 t = -0.567 
SectorEquity Investment Instruments: 
log(1 + VaccineInvest) 
1.341* 3.149 4.003** 1.024 
t = 1.648 t = 0.497 t = 2.438 t = 0.541 
SectorLife Insurance:log(1 + VaccineInvest) -21.785*** -25.540*** 5.566 5.806 
 t = -3.839 t = -3.738 t = 0.031 t = 0.293 
SectorReal Estate Investment and Services: 
log(1 + VaccineInvest) 
0.249 0.347 -0.120 -1.257** 
t = 0.613 t = 0.274 t = -0.110 t = -1.967 
SectorReal Estate Investment Trusts: 
log(1 + VaccineInvest) 
0.341*** 1.257 -10.722 0.673*** 
t = 6.601 t = 1.430 t = -0.676 t = 3.666 
Effectiveness:VaccinationScaled 0.032* 0.094 0.084 -0.042 
 t = 1.744 t = 0.276 t = 0.513 t = -0.621 
SectorEquity Investment Instruments: 
VaccinationScaled 
-11.271*** 111.623 -5.971 -23.270** 
t = -2.905 t = 1.134 t = -0.311 t = -2.087 
SectorNonlife Insurance:VaccinationScaled 3.687** 8.924 7.127 -0.076 
 t = 2.201 t = 0.285 t = 0.800 t = -0.011 
Effectiveness:TestingScaled 0.039*** -0.094 0.022 0.255* 
 t = 2.679 t = -0.180 t = 0.145 t = 1.815 
SectorEquity Investment Instruments: 
TestingScaled 
11.855* -178.154 8.129 45.826** 
t = 1.836 t = -1.246 t = 0.344 t = 1.963 
SectorFinancial Services:TestingScaled 1.586 -11.458 1.526 22.680* 
 t = 1.031 t = -0.246 t = 0.254 t = 1.795 
SectorLife Insurance:TestingScaled 4.031*** -10.594 5.002 26.131** 
 t = 2.756 t = -0.227 t = 0.368 t = 1.974 
SectorNonlife Insurance:TestingScaled 3.277* -8.753 2.267 18.508 
 t = 1.816 t = -0.179 t = 0.297 t = 1.330 
SectorReal Estate Investment and Services: 
TestingScaled 
3.827** -9.163 -2.784 29.356** 
t = 2.397 t = -0.200 t = -0.154 t = 2.517 
SectorReal Estate Investment Trusts: 
TestingScaled 
0.429** -1.692 13.108 2.611 
t = 2.442 t = -0.338 t = 0.685 t = 1.620 
Effectiveness:log(1 + HealthInvest) -0.005* 0.002 -0.001 -0.004 
 t = -1.953 t = 0.070 t = -0.130 t = -0.792 
SectorFinancial Services: 
log(1 + HealthInvest) 
-0.429* 0.257 -0.006 -0.515 
t = -1.747 t = 0.114 t = -0.007 t = -1.257 
SectorLife Insurance:log(1 + HealthInvest) -0.553** 0.190 -0.165 -0.478 
 t = -2.264 t = 0.085 t = -0.227 t = -1.146 
SectorNonlife Insurance: 
log(1 + HealthInvest) 
-0.616** 0.004 -0.124 -0.390 
t = -2.520 t = 0.002 t = -0.105 t = -0.702 
253 
 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
SectorReal Estate Investment and Services: 
log(1 + HealthInvest) 
-0.580** 0.156 -0.079 -1.122** 
t = -2.263 t = 0.080 t = -0.082 t = -2.153 
SectorEquity Investment Instruments: 
log(1 + Fiscal_measures) 
0.348 -1.900 0.873** 0.355 
t = 1.060 t = -0.681 t = 1.960 t = 0.558 
SectorReal Estate Investment Trusts: 
log(1 + Fiscal_measures) 
0.053* 0.151** -0.287 -0.041 
t = 1.654 t = 2.133 t = -0.534 t = -1.232 
Effectiveness:SectorEquity Investment 
Instruments:StringencyScaled 
-0.452*** 0.897 -0.496 -0.476** 
t = -5.699 t = 0.603 t = -1.052 t = -2.259 
Effectiveness:SectorFinancial Services: 
StringencyScaled 
0.064** 0.067 0.253 -0.241 
t = 2.064 t = 0.240 t = 0.476 t = -1.407 
Effectiveness:SectorLife Insurance: 
StringencyScaled 
0.033 0.029 0.045 -0.414** 
t = 1.127 t = 0.101 t = 0.047 t = -2.309 
Effectiveness:SectorNonlife Insurance: 
StringencyScaled 
0.070** 0.081 0.159 -0.093 
t = 2.184 t = 0.311 t = 0.476 t = -0.448 
Effectiveness:SectorReal Estate Investment 
and Services:StringencyScaled 
0.027 0.066 0.230 -0.285* 
t = 0.949 t = 0.297 t = 0.457 t = -1.849 
Effectiveness:SectorEquity Investment 
Instruments:EconomicScaled 
0.359*** -2.602 0.316 0.477* 
t = 3.869 t = -1.036 t = 1.273 t = 1.901 
Effectiveness:SectorFinancial Services: 
EconomicScaled 
-0.048* -0.214 -0.082 0.135 
t = -1.814 t = -0.265 t = -0.828 t = 1.079 
Effectiveness:SectorLife Insurance: 
EconomicScaled 
-0.005 -0.185 0.010 0.215* 
t = -0.203 t = -0.227 t = 0.021 t = 1.697 
Effectiveness:SectorReal Estate Investment 
and Services:EconomicScaled 
-0.004 -0.186 -0.110 0.193* 
t = -0.158 t = -0.245 t = -0.517 t = 1.648 
Effectiveness:SectorEquity Investment 
Instruments:log(1 + LaggedCaseChange) 
-0.003 0.005 0.006 0.016** 
t = -0.560 t = 0.329 t = 0.493 t = 2.334 
Effectiveness:SectorFinancial Services: 
log(1 + LaggedCaseChange) 
-0.006* -0.003 -0.012 0.005 
t = -1.884 t = -0.293 t = -0.654 t = 0.757 
Effectiveness:SectorLife Insurance: 
log(1 + LaggedCaseChange) 
-0.006* -0.002 -0.005 0.011 
t = -1.912 t = -0.220 t = -0.183 t = 1.256 
Effectiveness:SectorNonlife Insurance: 
log(1 + LaggedCaseChange) 
-0.007** -0.005 -0.009 0.003 
t = -2.276 t = -0.471 t = -0.675 t = 0.412 
Effectiveness:SectorEquity Investment 
Instruments:log(1 + VaccineInvest) 
-0.014 -0.034 -0.044** -0.012 
t = -1.606 t = -0.491 t = -2.376 t = -0.569 
Effectiveness:SectorLife Insurance: 
log(1 + VaccineInvest) 
0.241*** 0.283*** -0.062 -0.065 
t = 3.844 t = 3.739 t = -0.031 t = -0.298 
-0.003 -0.004 0.001 0.013* 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:SectorReal Estate Investment 
and Services:log(1 + VaccineInvest) t = -0.619 t = -0.275 t = 0.100 t = 1.944 
Effectiveness:SectorEquity Investment 
Instruments:VaccinationScaled 
0.118*** -1.232 0.059 0.255** 
t = 2.780 t = -1.139 t = 0.287 t = 2.093 
Effectiveness:SectorNonlife Insurance: 
VaccinationScaled 
-0.040** -0.098 -0.076 -0.003 
t = -2.139 t = -0.283 t = -0.837 t = -0.033 
Effectiveness:SectorEquity Investment 
Instruments:TestingScaled 
-0.120* 1.935 -0.078 -0.489* 
t = -1.730 t = 1.248 t = -0.302 t = -1.958 
Effectiveness:SectorFinancial Services: 
TestingScaled 
-0.015 0.129 -0.013 -0.244* 
t = -0.893 t = 0.250 t = -0.197 t = -1.786 
Effectiveness:SectorLife Insurance: 
TestingScaled 
-0.047*** 0.115 -0.059 -0.290** 
t = -2.877 t = 0.223 t = -0.370 t = -2.017 
Effectiveness:SectorNonlife Insurance: 
TestingScaled 
-0.036* 0.098 -0.025 -0.191 
t = -1.773 t = 0.179 t = -0.317 t = -1.251 
Effectiveness:SectorReal Estate Investment 
and Services:TestingScaled 
-0.041** 0.103 0.031 -0.315** 
t = -2.343 t = 0.202 t = 0.156 t = -2.502 
Effectiveness:SectorLife Insurance: 
log(1 + HealthInvest) 
0.006** -0.002 0.002 0.005 
t = 2.211 t = -0.092 t = 0.199 t = 1.123 
Effectiveness:SectorNonlife Insurance: 
log(1 + HealthInvest) 
0.007** -0.0002 0.001 0.004 
t = 2.486 t = -0.008 t = 0.089 t = 0.684 
Effectiveness:SectorReal Estate Investment 
and Services:log(1 + HealthInvest) 
0.006** -0.002 0.001 0.013** 
t = 2.236 t = -0.083 t = 0.096 t = 2.188 
Effectiveness:SectorEquity Investment 
Instruments:log(1 + Fiscal_measures) 
-0.004 0.021 -0.009* -0.004 
t = -0.975 t = 0.696 t = -1.804 t = -0.570 
Observations 61,369 61,369 54,722 54,722 
R2 0.264 0.132 0.146 0.085 
Adjusted R2 0.258 0.126 0.140 0.080 





Appendix 10.3 Results for Industrials 
Regression results including all companies in the sample 
Table A10. 9: First stage regression output including all companies in the sample – Industrials 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0003*** 0.001*** 
 t = -13.087 t = 12.793 
EconomicScaled -2.540***  
 t = -6.420  
CaseChange_2weeks 0.003**  
 t = 2.094  
StringencyScaled  -3.965*** 
  t = -3.252 
GDPprevious  -4.992*** 
  t = -2.900 
log(1 + LaggedCaseChange) 0.155*** 0.566*** 
 t = 10.267 t = 7.648 
logVaccineInvest -0.147 1.225* 
 t = -0.421 t = 1.714 
TestingScaled 1.656* 1.132 
 t = 1.672 t = 0.703 
log(1 + HealthInvest) -0.051*** -0.139*** 
 t = -4.394 t = -13.125 
log(1 + Fiscal_measures) 0.050*** -0.082*** 
 t = 5.979 t = -6.263 
Effectiveness:EconomicScaled 0.034***  
 t = 7.534  
SectorConstruction and Materials:EconomicScaled 1.178**  
 t = 2.146  
Effectiveness:CaseChange_2weeks -0.00003**  
 t = -2.003  
SectorIndustrial Transportation: CaseChange_2weeks 
-0.002*  
t = -1.656  
Effectiveness:StringencyScaled  0.055*** 
  t = 3.988 
SectorConstruction and Materials:StringencyScaled  2.862* 
  t = 1.941 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
SectorGeneral Industrials:StringencyScaled  3.067* 
  t = 1.684 
SectorIndustrial Transportation:StringencyScaled  3.717** 
  t = 2.332 
Effectiveness:GDPprevious  0.049** 
  t = 2.533 
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.006*** 
 t = -6.302 t = -7.777 
SectorConstruction and Materials: 
log(1 + LaggedCaseChange) 
0.009 -0.309*** 
t = 0.388 t = -3.527 
SectorGeneral Industrials:log(1 + LaggedCaseChange) 0.008 -0.277*** 
 t = 0.283 t = -2.765 
SectorIndustrial Engineering: 
log(1 + LaggedCaseChange) 
-0.010 -0.195** 
t = -0.555 t = -2.378 
SectorIndustrial Transportation: 
log(1 + LaggedCaseChange) 
0.086*** -0.330*** 
t = 3.819 t = -3.979 
Effectiveness:logVaccineInvest 0.001 -0.013* 
 t = 0.388 t = -1.648 
SectorConstruction and Materials:VaccinationScaled -0.649* 0.787*** 
 t = -1.859 t = 3.093 
SectorElectronic and Electrical Equipment: 
VaccinationScaled 
-0.386 0.377* 
t = -1.053 t = 1.679 
SectorGeneral Industrials:VaccinationScaled -0.685 0.768** 
 t = -1.598 t = 2.487 
SectorIndustrial Engineering:VaccinationScaled -0.416 0.640*** 
 t = -1.223 t = 2.867 
SectorIndustrial Transportation:VaccinationScaled -0.911** 0.582** 
 t = -2.192 t = 2.230 
Effectiveness:TestingScaled -0.020* -0.012 
 t = -1.845 t = -0.701 
SectorIndustrial Transportation:TestingScaled 2.224* -2.186 
 t = 1.940 t = -1.160 
Effectiveness:log(1 + HealthInvest) 0.001*** 0.001*** 
 t = 4.123 t = 9.050 
SectorConstruction and Materials:log(1 + HealthInvest) 0.041** -0.102*** 
 t = 2.149 t = -3.337 
SectorElectronic and Electrical Equipment: -0.001 -0.046** 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
log(1 + HealthInvest) t = -0.047 t = -2.137 
SectorGeneral Industrials:log(1 + HealthInvest) 0.018 -0.099** 
 t = 0.724 t = -2.229 
SectorIndustrial Engineering:log(1 + HealthInvest) 0.011 -0.081*** 
 t = 0.689 t = -2.902 
SectorIndustrial Transportation:log(1 + HealthInvest) 0.047* -0.109*** 
 t = 1.815 t = -3.084 
SectorSupport Services:log(1 + HealthInvest) 0.011 -0.055** 
 t = 0.622 t = -2.158 
Effectiveness:log(1 + Fiscal_measures) -0.001*** 0.001*** 
 t = -5.957 t = 7.535 
SectorConstruction and Materials: 
log(1 + Fiscal_measures) 
-0.024* 0.058*** 
t = -1.766 t = 2.928 
SectorElectronic and Electrical Equipment: 
log(1 + Fiscal_measures) 
-0.036*** 0.056*** 
t = -2.724 t = 2.939 
SectorGeneral Industrials:log(1 + Fiscal_measures) -0.039* 0.071** 
 t = -1.870 t = 2.564 
SectorIndustrial Engineering:log(1 + Fiscal_measures) -0.033** 0.060*** 
 t = -2.425 t = 3.330 
SectorIndustrial Transportation: 
log(1 + Fiscal_measures) 
-0.084*** 0.128*** 
t = -5.539 t = 6.264 
Effectiveness:SectorConstruction and Materials: 
EconomicScaled 
-0.013**  




t = 1.666  
Effectiveness:SectorConstruction and Materials: 
StringencyScaled 
 -0.034** 








 t = -2.539 
Effectiveness:SectorConstruction and Materials: 
log(1 + LaggedCaseChange) 
-0.0001 0.003*** 
t = -0.450 t = 3.561 
Effectiveness:SectorElectronic and Electrical 
Equipment: log(1 + LaggedCaseChange) 
-0.0001 0.002* 
t = -0.400 t = 1.646 
Effectiveness:SectorGeneral Industrials: 
log(1 + LaggedCaseChange) 
-0.0001 0.003*** 
t = -0.290 t = 2.797 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorIndustrial Engineering: 
log(1 + LaggedCaseChange) 
0.0001 0.002** 
t = 0.651 t = 2.279 
Effectiveness:SectorIndustrial Transportation: 
log(1 + LaggedCaseChange) 
-0.001*** 0.004*** 
t = -3.920 t = 4.292 
Effectiveness:SectorConstruction and Materials: 
VaccinationScaled 
0.008** -0.009*** 
t = 1.961 t = -3.217 
Effectiveness:SectorElectronic and Electrical 
Equipment: VaccinationScaled 
0.005 -0.005* 
















t = -1.956 t = 1.237 
Effectiveness:SectorSupport Services:TestingScaled -0.001 0.009 
 t = -0.080 t = 0.432 
Effectiveness:SectorConstruction and Materials: 
log(1 + HealthInvest) 
-0.0004 0.001*** 
t = -1.618 t = 2.943 
Effectiveness:SectorElectronic and Electrical 
Equipment: log(1 + HealthInvest) 
0.0001 0.0005* 
t = 0.359 t = 1.895 
Effectiveness:SectorGeneral Industrials: 
log(1 + HealthInvest) 
-0.0001 0.001** 
t = -0.388 t = 2.026 
Effectiveness:SectorIndustrial Engineering: 
log(1 + HealthInvest) 
-0.00001 0.001*** 
t = -0.056 t = 2.645 
Effectiveness:SectorIndustrial Transportation: 
log(1 + HealthInvest) 
-0.0005* 0.001*** 
t = -1.659 t = 2.860 
Effectiveness:SectorSupport Services: 
log(1 + HealthInvest) 
-0.0001 0.001** 
t = -0.500 t = 2.054 
Effectiveness:SectorConstruction and Materials: 
log(1 + Fiscal_measures) 
0.0003 -0.001*** 
t = 1.635 t = -3.045 
Effectiveness:SectorElectronic and Electrical 
Equipment: log(1 + Fiscal_measures) 
0.0004*** -0.001*** 
t = 2.719 t = -3.028 
Effectiveness:SectorGeneral Industrials: 
log(1 + Fiscal_measures) 
0.0005* -0.001*** 
t = 1.822 t = -2.636 
 0.0004** -0.001*** 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorIndustrial Engineering: 
log(1 + Fiscal_measures) t = 2.347 t = -3.485 
Effectiveness:SectorIndustrial Transportation: 
log(1 + Fiscal_measures) 
0.001*** -0.002*** 
t = 5.859 t = -7.121 
Observations 147,692 167,027 
R2 0.711 0.766 
Adjusted R2 0.710 0.765 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 36.503 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 235.45 
Table A10. 10: Final regression output including all companies in the sample – Industrials 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.015** 0.020** -0.001 0.013 
 t = 2.103 t = 2.229 t = -0.016 t = 0.357 
SectorConstruction and Materials 0.465* 0.865 -9.812 -2.747 
 t = 1.797 t = 1.513 t = -0.757 t = -0.558 
SectorGeneral Industrials 0.664** 0.490 16.451 19.190 
 t = 1.987 t = 0.694 t = 0.555 t = 0.682 
StringencyScaled 2.269* 1.781** -0.662 0.502 
 t = 1.691 t = 1.989 t = -0.031 t = 0.151 
EconomicScaled 0.854 -2.380 -0.266 4.097 
 t = 0.595 t = -0.581 t = -0.034 t = 0.891 
log(1 + LaggedCaseChange) -0.350** -0.245** -0.123 -0.306** 
 t = -2.064 t = -2.524 t = -0.084 t = -2.001 
log(1 + Fiscal_measures) 0.049* 0.087 0.085 0.026 
 t = 1.914 t = 1.627 t = 0.532 t = 0.197 
CountryItaly 0.332** 0.349** 0.257 0.473 
 t = 2.232 t = 2.297 t = 1.186 t = 1.290 
CountrySpain 0.243*** 0.235*** 0.224* 0.312* 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = 2.816 t = 2.665 t = 1.723 t = 1.747 
ScaledMarketCap 0.729** 0.721** 0.950*** 0.808** 
 t = 2.460 t = 2.553 t = 2.778 t = 1.971 
Effectiveness:SectorConstruction and 
Materials 
-0.006** -0.010 0.107 0.035 
t = -1.981 t = -1.537 t = 0.757 t = 0.599 
Effectiveness:SectorGeneral Industrials -0.008** -0.006 -0.177 -0.229 
 t = -2.152 t = -0.711 t = -0.548 t = -0.679 
Effectiveness:SectorIndustrial Transportation -0.008** -0.012** -0.121 -0.043 
 t = -2.000 t = -1.999 t = -1.038 t = -0.468 
Effectiveness:StringencyScaled -0.024 -0.022* 0.005 0.004 
 t = -1.604 t = -1.936 t = 0.023 t = 0.104 
Effectiveness:log(1 + LaggedCaseChange) 0.004* 0.003** 0.001 0.003* 
 t = 1.878 t = 2.433 t = 0.084 t = 1.777 
SectorElectronic and Electrical Equipment: 
log(1 + LaggedCaseChange) 
0.327* 0.026 -0.307 0.014 
t = 1.730 t = 0.199 t = -0.186 t = 0.069 
SectorIndustrial Transportation: 
log(1 + HealthInvest) 
-0.212** 0.004 0.038 -0.347 
t = -2.420 t = 0.014 t = 0.164 t = -1.128 
Effectiveness:log(1 + Fiscal_measures) -0.001* -0.001 -0.001 -0.0003 
 t = -1.870 t = -1.572 t = -0.555 t = -0.167 
SectorElectronic and Electrical Equipment: 
log(1 + Fiscal_measures) 
-0.053* -0.091 -0.148 -0.077 
t = -1.818 t = -1.606 t = -0.800 t = -0.689 
CountryFrance:ScaledMarketCap -0.621* -0.606* -0.817** -0.705 
 t = -1.802 t = -1.816 t = -1.980 t = -1.521 
CountryGermany:ScaledMarketCap -0.576* -0.391 -0.698* -1.632 
 t = -1.737 t = -1.191 t = -1.688 t = -1.597 
CountryNorway:ScaledMarketCap 5.970* 7.299** 5.718 0.791 
 t = 1.836 t = 2.310 t = 1.282 t = 0.076 
CountrySpain:ScaledMarketCap -1.164** -1.159** -1.577** -1.099 
 t = -2.120 t = -2.091 t = -2.407 t = -0.905 
CountrySweden:ScaledMarketCap -0.692** -0.694** -0.771 -0.775* 
 t = -2.097 t = -2.209 t = -1.447 t = -1.733 
Effectiveness:SectorSupport Services: 
EconomicScaled 
0.020 -0.041 -0.041 0.142* 
t = 0.986 t = -0.691 t = -0.426 t = 1.752 
Effectiveness:SectorIndustrial Transportation: 
log(1 + HealthInvest) 
0.002** 0.00005 -0.0003 0.004 
t = 2.490 t = 0.015 t = -0.127 t = 1.150 
Effectiveness:SectorElectronic and Electrical 
Equipment:log(1 + Fiscal_measures) 
0.001* 0.001 0.002 0.001 
t = 1.764 t = 1.603 t = 0.832 t = 0.623 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Observations 167,027 167,027 147,692 147,692 
R2 0.148 0.122 0.041 0.029 
Adjusted R2 0.146 0.120 0.038 0.026 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Regression results including all companies where revenue information is available 
Table A10. 11: First stage regression output including all companies where revenue 
information is available – Industrials 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0001*** 0.0005*** 
 t = -2.864 t = 7.889 
EconomicScaled -1.955***  
 t = -3.950  
CaseChange_2weeks 0.004***  
 t = 3.062  
GDPprevious  -5.534*** 
  t = -2.729 
Import_change_previous -1.887*** 4.559*** 
 t = -5.080 t = 3.541 
log(1 + LaggedCaseChange) 0.091*** 0.595*** 
 t = 3.294 t = 7.284 
logVaccineInvest -0.359 1.141** 
 t = -1.288 t = 2.201 
VaccinationScaled -0.154 -0.534* 
 t = -0.439 t = -1.755 
TestingScaled 1.461* -0.764 
 t = 1.761 t = -0.343 
log(1 + HealthInvest) -0.074*** -0.054** 
 t = -2.882 t = -2.270 
log(1 + Fiscal_measures) 0.042*** -0.063*** 
 t = 6.117 t = -7.525 
Effectiveness:EconomicScaled 0.027***  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
 t = 4.905  
SectorConstruction and Materials:EconomicScaled 1.153*  
 t = 1.862  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -2.928  
SectorIndustrial Transportation: CaseChange_2weeks 
-0.003**  





  t = 1.843 
Effectiveness:GDPprevious  0.055** 
  t = 2.449 
Effectiveness:Import_change_previous 0.018*** -0.049*** 
 t = 4.440 t = -3.450 
SectorConstruction and Materials: 
Import_change_previous 
-1.256*** -1.601 
t = -2.664 t = -1.192 
SectorIndustrial Engineering:Import_change_previous -1.065** -0.893 
 t = -1.977 t = -0.673 
Effectiveness:log(1 + LaggedCaseChange) -0.001* -0.007*** 
 t = -1.850 t = -7.506 
SectorConstruction and Materials: 
log(1 + LaggedCaseChange) 
-0.027 -0.322*** 
t = -0.829 t = -3.089 
SectorElectronic and Electrical Equipment: 
log(1 + LaggedCaseChange) 
0.021 -0.176* 
t = 0.677 t = -1.931 
SectorGeneral Industrials:log(1 + LaggedCaseChange) 0.001 -0.176* 
 t = 0.019 t = -1.763 
SectorIndustrial Engineering: 
log(1 + LaggedCaseChange) 
-0.031 -0.172* 
t = -0.991 t = -1.891 
SectorIndustrial Transportation: 
log(1 + LaggedCaseChange) 
0.078** -0.314*** 
t = 2.297 t = -3.251 
Effectiveness:logVaccineInvest 0.004 -0.012** 
 t = 1.259 t = -2.120 
SectorConstruction and Materials:logVaccineInvest 0.301 -1.049* 
 t = 1.048 t = -1.822 
SectorConstruction and Materials:VaccinationScaled -0.337 1.037*** 
 t = -0.851 t = 2.988 
SectorGeneral Industrials:VaccinationScaled -0.477 0.736* 
 t = -0.913 t = 1.911 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
SectorIndustrial Engineering:VaccinationScaled -0.096 0.829*** 
 t = -0.257 t = 2.638 
Effectiveness:TestingScaled -0.018* 0.009 
 t = -1.957 t = 0.355 
SectorIndustrial Transportation:TestingScaled 2.127** -0.758 
 t = 2.030 t = -0.298 
Effectiveness:log(1 + HealthInvest) 0.001*** 0.0003 
 t = 3.022 t = 1.005 
SectorConstruction and Materials:log(1 + HealthInvest) 0.026 -0.163*** 
 t = 0.878 t = -3.246 
SectorIndustrial Engineering:log(1 + HealthInvest) 0.014 -0.098** 
 t = 0.513 t = -2.360 
SectorIndustrial Transportation:log(1 + HealthInvest) 0.046 -0.085** 
 t = 1.444 t = -2.304 
SectorSupport Services:log(1 + HealthInvest) 0.013 -0.064* 
 t = 0.465 t = -1.782 
Effectiveness:log(1 + Fiscal_measures) -0.001*** 0.001*** 
 t = -6.267 t = 9.687 
SectorConstruction and Materials: 
log(1 + Fiscal_measures) 
-0.032* 0.046** 
t = -1.876 t = 2.004 
SectorElectronic and Electrical Equipment: 
log(1 + Fiscal_measures) 
-0.032*** 0.054*** 
t = -2.678 t = 3.070 
SectorGeneral Industrials:log(1 + Fiscal_measures) -0.035 0.060** 
 t = -1.608 t = 2.134 
SectorIndustrial Engineering:log(1 + Fiscal_measures) -0.025* 0.034* 
 t = -1.861 t = 1.938 
SectorIndustrial Transportation: 
log(1 + Fiscal_measures) 
-0.073*** 0.111*** 
t = -4.797 t = 5.571 
Effectiveness:SectorConstruction and Materials: 
EconomicScaled 
-0.013*  








 t = -1.720 
Effectiveness:SectorConstruction and Materials: 
Import_change_previous 
0.014*** 0.017 
t = 2.579 t = 1.151 
0.012** 0.007 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorIndustrial Engineering: 
Import_change_previous t = 2.029 t = 0.486 
Effectiveness:SectorConstruction and Materials: 
log(1 + LaggedCaseChange) 
0.0003 0.003*** 
t = 0.746 t = 3.038 
Effectiveness:SectorElectronic and Electrical 
Equipment:log(1 + LaggedCaseChange) 
-0.0002 0.002** 
t = -0.612 t = 1.984 
Effectiveness:SectorGeneral Industrials: 
log(1 + LaggedCaseChange) 
0.00000 0.002* 
t = 0.006 t = 1.792 
Effectiveness:SectorIndustrial Engineering: 
log(1 + LaggedCaseChange) 
0.0004 0.002* 
t = 1.072 t = 1.731 
Effectiveness:SectorIndustrial Transportation: 
log(1 + LaggedCaseChange) 
-0.001** 0.004*** 
t = -2.332 t = 3.507 
Effectiveness:SectorConstruction and Materials: 
logVaccineInvest 
-0.003 0.012* 
t = -1.054 t = 1.810 
Effectiveness:SectorConstruction and Materials: 
VaccinationScaled 
0.004 -0.012*** 
t = 0.897 t = -3.010 
Effectiveness:SectorElectronic and Electrical 
Equipment: VaccinationScaled 
0.003 -0.006* 
















t = -2.041 t = 0.334 
Effectiveness:SectorConstruction and Materials: 
log(1 + HealthInvest) 
-0.0002 0.002*** 
t = -0.649 t = 3.066 
Effectiveness:SectorIndustrial Engineering: 
log(1 + HealthInvest) 
-0.00004 0.001** 
t = -0.142 t = 2.187 
Effectiveness:SectorIndustrial Transportation: 
log(1 + HealthInvest) 
-0.001 0.001** 
t = -1.407 t = 2.249 
Effectiveness:SectorSupport Services: 
log(1 + HealthInvest) 
-0.0001 0.001* 
t = -0.419 t = 1.758 
Effectiveness:SectorConstruction and Materials: 
log(1 + Fiscal_measures) 
0.0004* -0.001** 
t = 1.736 t = -2.032 
Effectiveness:SectorElectronic and Electrical 
Equipment: log(1 + Fiscal_measures) 
0.0004*** -0.001*** 
t = 2.629 t = -3.101 
265 
 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorGeneral Industrials: 
log(1 + Fiscal_measures) 
0.0004 -0.001** 
t = 1.548 t = -2.137 
Effectiveness:SectorIndustrial Engineering: 
log(1 + Fiscal_measures) 
0.0003* -0.0004* 
t = 1.715 t = -1.954 
Effectiveness:SectorIndustrial Transportation: 
log(1 + Fiscal_measures) 
0.001*** -0.001*** 
t = 5.076 t = -6.073 
Observations 100,621 113,500 
R2 0.749 0.779 
Adjusted R2 0.747 0.778 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 50.757 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 204.35 
Table A10. 12: Final regression output including all companies where revenue information is 
available – Industrials 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.024* 0.031* -0.109 -0.008 
 t = 1.709 t = 1.750 t = -0.635 t = -0.176 
StringencyScaled 1.860 1.533 -28.407 0.258 
 t = 1.152 t = 0.952 t = -0.704 t = 0.033 
EconomicScaled 1.025 -3.114 -2.631 6.005 
 t = 0.555 t = -0.557 t = -0.461 t = 0.887 
Import_change_previous -2.453** 0.301 -17.808 -4.138 
 t = -1.986 t = 0.074 t = -0.823 t = -0.610 
log(1 + LaggedCaseChange) -0.350 -0.173* 1.306 -0.323 
 t = -1.638 t = -1.753 t = 0.614 t = -1.133 
log(1 + Fiscal_measures) 0.055* 0.104 0.087 -0.053 
 t = 1.915 t = 1.152 t = 0.974 t = -0.298 
CountryItaly 0.576* 0.638* 0.496 0.542 
 t = 1.824 t = 1.756 t = 0.612 t = 0.977 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
CountryNorway -0.433* -0.440* -0.397 -0.634 
 t = -1.949 t = -1.811 t = -1.122 t = -1.530 
Effectiveness:Import_change_previous 0.027* -0.004 0.201 0.049 
 t = 1.897 t = -0.079 t = 0.832 t = 0.658 
SectorConstruction and Materials: 
Import_change_previous 
3.070** -1.551 14.723 12.589 
t = 2.369 t = -0.356 t = 0.560 t = 1.190 
SectorIndustrial Transportation: 
Import_change_previous 
2.916* -0.687 16.171 3.451 
t = 1.917 t = -0.161 t = 0.744 t = 0.546 
Effectiveness:log(1 + LaggedCaseChange) 0.004 0.002* -0.015 0.003 
 t = 1.493 t = 1.729 t = -0.625 t = 0.911 
Effectiveness:log(1 + Fiscal_measures) -0.001* -0.001 -0.001 0.001 
 t = -1.868 t = -1.121 t = -0.907 t = 0.344 
SectorElectronic and Electrical 
Equipment:log(1 + Fiscal_measures) 
-0.063* -0.134 -0.109 0.025 
t = -1.940 t = -1.418 t = -1.181 t = 0.175 
CountryNorway:ScaledMarketCap 12.877* 19.632 11.080 -3.477 
 t = 1.719 t = 1.572 t = 1.204 t = -0.079 
Effectiveness:SectorConstruction and 
Materials:Import_change_previous 
-0.035** 0.018 -0.166 -0.152 
t = -2.310 t = 0.357 t = -0.563 t = -1.224 
Effectiveness:SectorIndustrial 
Transportation:Import_change_previous 
-0.035** 0.006 -0.183 -0.044 
t = -1.987 t = 0.122 t = -0.755 t = -0.605 
Effectiveness:SectorElectronic and 
Electrical Equipment: 
log(1 + Fiscal_measures) 
0.001* 0.002 0.001 -0.0004 
t = 1.874 t = 1.422 t = 1.239 t = -0.218 
Observations 113,500 113,500 100,621 100,621 
R2 0.168 0.115 0.049 0.026 
Adjusted R2 0.164 0.111 0.045 0.021 









Appendix 10.4 Results for Oil & Gas 
Regression results including all companies in the sample 
Table A10. 13: First stage regression output including all companies in the sample – Oil & 
Gas 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0003*** 0.001*** 
 t = -4.733 t = 5.719 
CaseChange_2weeks 0.002***  
 t = 2.625  
GDPprevious  -1.940* 
  t = -1.865 
log(1 + LaggedCaseChange) 0.162*** 0.263** 
 t = 4.699 t = 2.384 
VaccinationScaled -0.893** 0.646** 
 t = -2.539 t = 2.478 
log(1 + HealthInvest) 0.006 -0.281*** 
 t = 0.208 t = -4.059 
Effectiveness:EconomicScaled 0.019**  
 t = 2.148  
SectorOil Equipment, Services and Distribution: 
EconomicScaled 
-1.742*  
t = -1.812  
Effectiveness:CaseChange_2weeks -0.00002**  
 t = -2.458  
Effectiveness:log(1 + LaggedCaseChange) -0.001*** -0.003** 
 t = -3.151 t = -2.328 
Effectiveness:VaccinationScaled 0.012*** -0.011*** 
 t = 3.184 t = -4.164 
SectorOil and Gas Producers:TestingScaled 3.644** 0.045 
 t = 2.373 t = 0.022 
Effectiveness:log(1 + HealthInvest) -0.00000 0.003*** 
 t = -0.010 t = 3.604 
Effectiveness:SectorOil Equipment, Services and 
Distribution EconomicScaled 
0.020*  
t = 1.901  
Effectiveness:SectorOil and Gas 
Producers:GDPprevious 
 0.027* 
  t = 1.646 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorOil and Gas 
Producers:TestingScaled -0.041
** -0.0002 
 t = -2.397 t = -0.011 
Observations 28,623 32,282 
R2 0.787 0.840 
Adjusted R2 0.786 0.839 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 39.399 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 58.485 
Table A10. 14: Final regression output including all companies in the sample – Oil & Gas 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness -0.039*** -0.042*** -0.022 -0.011 
 t = -3.739 t = -3.995 t = -0.170 t = -0.263 
StringencyScaled 1.360 0.698 3.719 5.627 
 t = 1.066 t = 0.467 t = 0.175 t = 0.950 
EconomicScaled -0.180 2.497 1.759 2.024 
 t = -0.102 t = 0.776 t = 0.486 t = 0.653 
log(1 + VaccineInvest) -1.219** -0.860 -0.091 -1.405* 
 t = -2.486 t = -1.363 t = -0.039 t = -1.773 
VaccinationScaled -1.990*** -1.647 -0.393 -1.025 
 t = -2.656 t = -1.262 t = -0.185 t = -0.761 
log(1 + HealthInvest) 0.233* 0.369* 0.132 0.113 
 t = 1.957 t = 1.762 t = 0.381 t = 0.621 
CountryItaly -1.129*** -1.089*** -1.085** -1.174** 
 t = -6.010 t = -4.249 t = -2.356 t = -2.292 
CountryNorway 0.223*** 0.300* 0.419 0.197 
 t = 2.704 t = 1.705 t = 0.840 t = 1.081 
CountrySpain -0.595*** -0.604*** -0.539* -0.619** 
 t = -3.086 t = -2.897 t = -1.900 t = -1.993 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:SectorOil Equipment, Services 
and Distribution 
-0.016** -0.013* -0.067 -0.041 
t = -2.113 t = -1.671 t = -0.485 t = -0.601 
Effectiveness:log(1 + VaccineInvest) 0.013** 0.009 0.0005 0.015* 
 t = 2.424 t = 1.342 t = 0.018 t = 1.739 
SectorOil and Gas Producers: 
log(1 + VaccineInvest) 
1.234** 0.818 0.351 1.388 
t = 1.994 t = 1.063 t = 0.181 t = 1.532 
SectorOil Equipment, Services and 
Distribution:log(1 + VaccineInvest) 
2.004*** 1.541** 0.768 2.065* 
t = 2.834 t = 1.985 t = 0.312 t = 1.707 
Effectiveness:VaccinationScaled 0.028*** 0.023* 0.007 0.017 
 t = 3.302 t = 1.675 t = 0.271 t = 1.091 
SectorOil and Gas Producers: 
VaccinationScaled 
1.637* 0.760 1.433 1.421 
t = 1.765 t = 0.524 t = 0.394 t = 0.493 
SectorOil Equipment, Services and 
Distribution:VaccinationScaled 
1.772* 0.985 0.838 1.163 
t = 1.734 t = 0.801 t = 0.211 t = 0.436 
Effectiveness:log(1 + HealthInvest) -0.003* -0.004* -0.002 -0.001 
 t = -1.832 t = -1.726 t = -0.410 t = -0.635 
SectorOil and Gas Producers: 
log(1 + Fiscal_measures) 
0.143** 0.091 0.385 0.244 
t = 1.968 t = 1.409 t = 0.962 t = 1.202 
CountryItaly:ScaledMarketCap -1.169 -1.346* -1.558 -1.341 
 t = -1.488 t = -1.684 t = -1.004 t = -1.244 
CountrySweden:ScaledMarketCap 5.449*** 5.893** 6.735** 6.572** 
 t = 2.821 t = 2.542 t = 2.331 t = 2.402 
CountryUnited Kingdom:ScaledMarketCap -0.781 -1.054* -1.567 -1.119 
 t = -1.250 t = -1.656 t = -1.002 t = -1.206 
Effectiveness:SectorOil and Gas 
Producers:log(1 + VaccineInvest) 
-0.013* -0.009 -0.003 -0.015 
t = -1.958 t = -1.063 t = -0.159 t = -1.520 
Effectiveness:SectorOil Equipment, Services 
and Distribution:log(1 + VaccineInvest) 
-0.022*** -0.017** -0.008 -0.022* 
t = -2.791 t = -1.979 t = -0.296 t = -1.694 
Effectiveness:SectorOil and Gas 
Producers:VaccinationScaled 
-0.024** -0.013 -0.019 -0.021 
t = -2.208 t = -0.789 t = -0.462 t = -0.616 
Effectiveness:SectorOil Equipment, Services 
and Distribution:VaccinationScaled 
-0.026** -0.017 -0.011 -0.019 
t = -2.166 t = -1.190 t = -0.251 t = -0.585 
Effectiveness:SectorOil and Gas 
Producers:log(1 + Fiscal_measures) 
-0.002* -0.001 -0.004 -0.003 
t = -1.909 t = -1.557 t = -0.958 t = -1.197 
     
     
     
270 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Observations 32,282 32,282 28,623 28,623 
R2 0.365 0.360 0.270 0.357 
Adjusted R2 0.358 0.353 0.262 0.350 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Regression results including all companies where revenue information is available 
able A10. 15: First stage regression output including all companies where revenue 
information is available – Oil & Gas 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0005*** 0.001*** 
 t = -5.358 t = 6.093 
CaseChange_2weeks 0.004***  
 t = 5.213  
GDPprevious  -2.311* 
  t = -1.804 
Import_change_previous -2.877*** 4.239*** 
 t = -3.572 t = 5.560 
log(1 + LaggedCaseChange) 0.033 0.397*** 
 t = 0.865 t = 4.562 
log(1 + HealthInvest) -0.042** -0.158** 
 t = -2.017 t = -2.220 
log(1 + Fiscal_measures) 0.023*** -0.050*** 
 t = 2.877 t = -7.361 
Effectiveness:EconomicScaled 0.011*  
 t = 1.859  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -5.099  
SectorOil and Gas Producers: CaseChange_2weeks 
-0.005***  
t = -3.237  
Effectiveness:StringencyScaled  0.024** 
  t = 2.370 
SectorOil Equipment, Services and Distribution: 
StringencyScaled 
 -2.228* 
 t = -1.833 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
SectorOil Equipment, Services and Distribution: 
GDPprevious 
 -2.816** 
 t = -2.130 
Effectiveness:Import_change_previous 0.030*** -0.050*** 
 t = 3.280 t = -5.160 
SectorOil and Gas Producers:Import_change_previous 2.595*** -1.700* 
 t = 2.711 t = -1.861 
Effectiveness:log(1 + LaggedCaseChange) 0.0003 -0.005*** 
 t = 0.676 t = -4.694 
SectorOil and Gas Producers: 
log(1 + LaggedCaseChange) 
0.200*** -0.227* 
t = 4.531 t = -1.694 
Effectiveness:VaccinationScaled 0.006* -0.006 
 t = 1.768 t = -1.391 
SectorOil Equipment, Services and Distribution: 
VaccinationScaled 
0.542* -0.716* 
t = 1.704 t = -1.707 
Effectiveness:log(1 + HealthInvest) 0.001** 0.001* 
 t = 2.285 t = 1.816 
SectorOil and Gas Producers:log(1 + HealthInvest) 0.092*** 0.029 
 t = 2.778 t = 0.308 
Effectiveness:log(1 + Fiscal_measures) -0.0003** 0.001*** 
 t = -2.382 t = 7.624 
SectorOil and Gas Producers:log(1 + Fiscal_measures) -0.082** 0.128** 
 t = -1.983 t = 2.448 
SectorOil Equipment, Services and Distribution: 
log(1 + Fiscal_measures) 
0.020** -0.010 
t = 2.378 t = -0.932 
Effectiveness:SectorOil and Gas 
Producers:CaseChange_2weeks 
0.0001***  
t = 3.253  
Effectiveness:SectorOil Equipment, Services and 
Distribution:StringencyScaled 
 0.029** 
 t = 1.975 
Effectiveness:SectorOil Equipment, Services and 
Distribution:GDPprevious 
 0.038** 
 t = 2.236 
Effectiveness:SectorOil and Gas Producers: 
Import_change_previous 
-0.030*** 0.023** 
t = -2.757 t = 1.994 
Effectiveness:SectorOil and Gas Producers:log(1 + 
LaggedCaseChange) 
-0.002*** 0.003** 
t = -4.968 t = 2.017 
Effectiveness:SectorOil Equipment, Services and 
Distribution:log(1 + LaggedCaseChange) 
-0.001 -0.002* 
t = -0.806 t = -1.674 
-0.007* 0.009* 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Effectiveness:SectorOil Equipment, Services and 
Distribution:VaccinationScaled t = -1.769 t = 1.782 
Effectiveness:SectorOil and Gas Producers: 
log(1 + HealthInvest) 
-0.001*** -0.0003 
t = -2.901 t = -0.318 
Effectiveness:SectorOil and Gas Producers: 
log(1 + Fiscal_measures) 
0.001** -0.002*** 
t = 2.042 t = -2.674 
Effectiveness:SectorOil Equipment, Services and 
Distribution:log(1 + Fiscal_measures) 
-0.0003** 0.0001 
t = -2.321 t = 1.031 
Observations 9,493 10,747 
R2 0.714 0.779 
Adjusted R2 0.712 0.777 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 69.033 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 48.112 
Table A10. 16: Final regression output including all companies where revenue information is 
available – Oil & Gas 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness 0.098** 0.113** 0.146** 0.115* 
 t = 2.144 t = 2.272 t = 2.132 t = 1.844 
SectorOil and Gas Producers 2.921*** 4.211** 5.499 9.067 
 t = 2.930 t = 2.499 t = 0.946 t = 1.215 
SectorOil Equipment, Services and 
Distribution 
2.142** 2.184 5.238 1.225 
t = 2.571 t = 1.521 t = 0.998 t = 0.571 
StringencyScaled 1.158 -0.792 6.639 -0.024 
 t = 1.130 t = -0.508 t = 0.639 t = -0.004 
EconomicScaled 
-0.509 1.574 -1.820 -0.692 
t = -0.451 t = 0.575 t = -0.846 t = -0.131 
VaccinationScaled -1.587* -0.769 -2.566 -1.850 
 t = -1.726 t = -0.501 t = -1.569 t = -1.230 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
CountryFrance 6.303*** 7.017*** 6.776*** 6.952*** 
 t = 4.093 t = 5.072 t = 3.908 t = 4.330 
CountryItaly 1.800 2.141 2.385** 2.390* 
 t = 1.625 t = 1.415 t = 2.016 t = 1.721 
CountryNorway 2.156*** 2.506*** 1.914*** 2.180*** 
 t = 21.021 t = 9.447 t = 8.009 t = 6.302 
CountrySpain 0.953 1.159 1.297* 1.209 
 t = 1.521 t = 1.302 t = 1.957 t = 1.549 
CountrySweden -0.864* -0.750 -0.820 -1.052** 
 t = -1.711 t = -0.872 t = -1.631 t = -2.135 
RevHomeCountry 0.794** 0.951** 0.999*** 0.830* 
 t = 2.384 t = 2.123 t = 2.887 t = 1.931 
Effectiveness:SectorOil and Gas Producers -0.043*** -0.059*** -0.081 -0.123 
 t = -3.255 t = -2.686 t = -1.239 t = -1.363 
Effectiveness:SectorOil Equipment, Services 
and Distribution 
-0.030*** -0.030 -0.066 -0.027 
t = -2.705 t = -1.571 t = -1.106 t = -1.064 
SectorOil and Gas Producers: 
StringencyScaled 
0.354 4.571** -6.155 -9.134 
t = 0.299 t = 2.300 t = -0.514 t = -0.740 
SectorOil Equipment, Services and 
Distribution:StringencyScaled 
-2.770* -0.571 -6.729 -2.946 
t = -1.651 t = -0.106 t = -0.615 t = -0.501 
SectorOil and Gas Producers: 
EconomicScaled 
0.491 -6.398** 1.781 -1.448 
t = 0.405 t = -2.003 t = 0.727 t = -0.397 
SectorOil and Gas Producers: 
Import_change_previous 
0.870 6.700** -1.254 -0.790 
t = 0.425 t = 2.091 t = -0.189 t = -0.123 
Effectiveness:VaccinationScaled 0.020* 0.009 0.032* 0.024 
 t = 1.878 t = 0.545 t = 1.703 t = 1.394 
SectorOil and Gas Producers: 
log(1 + HealthInvest) 
-0.198** -0.431** -0.104 -0.234 
t = -2.568 t = -2.500 t = -0.603 t = -0.922 
Effectiveness:log(1 + Fiscal_measures) 0.0002 0.001 -0.0003 -0.001* 
 t = 0.535 t = 1.260 t = -0.503 t = -1.797 
CountryFrance:ScaledMarketCap -13.960 -17.577** -15.638 -14.657 
 t = -1.569 t = -2.295 t = -1.605 t = -1.545 
CountryNorway:ScaledMarketCap -9.811 -13.039* -11.000 -9.844 
 t = -1.063 t = -1.648 t = -1.095 t = -1.013 
CountryFrance:RevHomeCountry -7.059*** -7.836*** -7.580*** -7.690*** 
 t = -4.192 t = -4.959 t = -4.009 t = -4.292 
CountryItaly:RevHomeCountry -0.530 -0.701 -0.726* -0.537 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = -1.426 t = -1.473 t = -1.830 t = -1.114 
CountryNorway:RevHomeCountry -2.438*** -2.595*** -2.479*** -2.310*** 
 t = -7.320 t = -5.790 t = -7.165 t = -5.371 
Effectiveness:SectorOil and Gas Producers: 
StringencyScaled 
-0.0001 -0.062** 0.093 0.129 
t = -0.008 t = -2.165 t = 0.663 t = 0.821 
Effectiveness:SectorOil Equipment, Services 
and Distribution:StringencyScaled 
0.044* 0.012 0.086 0.065 
t = 1.939 t = 0.158 t = 0.663 t = 0.873 
Effectiveness:SectorOil and Gas Producers: 
EconomicScaled 
-0.010 0.080* -0.030 0.007 
t = -0.681 t = 1.943 t = -0.933 t = 0.159 
Effectiveness:SectorOil and Gas Producers: 
Import_change_previous 
-0.028 -0.098** 0.004 0.0002 
t = -1.098 t = -2.572 t = 0.056 t = 0.002 
Effectiveness:SectorOil Equipment, Services 
and Distribution:Import_change_previous 
-0.040* -0.042 -0.017 -0.047 
t = -1.714 t = -1.254 t = -0.265 t = -0.935 
Effectiveness:SectorOil and Gas Producers: 
log(1 + HealthInvest) 
0.002** 0.005** 0.001 0.003 
t = 2.130 t = 2.531 t = 0.454 t = 0.824 
Observations 10,747 10,747 9,493 9,493 
R2 0.733 0.712 0.738 0.723 
Adjusted R2 0.724 0.702 0.728 0.713 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Appendix 10.5 Results for Telecommunications 
Regression results including all companies in the sample 
Table A10. 17: First stage regression output including all companies in the sample – 
Telecommunications 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0003*** 0.001*** 
 t = -4.401 t = 3.560 
EconomicScaled -1.190**  
 t = -2.040  
CaseChange_2weeks 0.004***  
 t = 3.599  
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
StringencyScaled  -2.777*** 
  t = -3.145 
GDPprevious  -2.552* 
  t = -1.893 
Import_change_previous -2.606*** 3.800*** 
 t = -3.120 t = 5.491 
log(1 + LaggedCaseChange) 0.106** 0.393*** 
 t = 2.429 t = 3.885 
log(1 + HealthInvest) -0.005 -0.161* 
 t = -0.194 t = -1.943 
log(1 + Fiscal_measures) 0.031*** -0.053*** 
 t = 4.176 t = -9.796 
Effectiveness:EconomicScaled 0.019***  
 t = 2.950  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -3.480  
Effectiveness:StringencyScaled  0.043*** 
  t = 4.192 
Effectiveness:Import_change_previous 0.026*** -0.042*** 
 t = 2.759 t = -4.818 
Effectiveness:log(1 + LaggedCaseChange) -0.001 -0.004*** 
 t = -1.442 t = -3.869 
SectorMobile Telecommunications:VaccinationScaled -1.203* 1.242 
 t = -1.704 t = 1.444 
Effectiveness:log(1 + Fiscal_measures) -0.0004*** 0.001*** 




t = 1.847 t = -1.520 
Observations 7,466 8,425 
R2 0.751 0.773 
Adjusted R2 0.749 0.772 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 49.537 
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F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 20.277 
Table A10. 18: Final regression output including all companies in the sample – 
Telecommunications 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness -0.815*** -0.716*** -0.921*** -0.880*** 
 t = -11.214 t = -6.441 t = -6.853 t = -6.792 
SectorMobile Telecommunications 4.925*** 3.840*** 29.532 7.673 
 t = 5.521 t = 3.323 t = 1.016 t = 1.640 
StringencyScaled -1.934*** -2.834*** 23.516 2.701 
 t = -2.821 t = -2.605 t = 0.695 t = 0.406 
EconomicScaled 2.515*** 1.655 4.882 -0.898 
 t = 3.369 t = 0.788 t = 0.906 t = -0.347 
Import_change_previous -0.494 2.403 7.611 3.079* 
 t = -0.560 t = 0.857 t = 0.575 t = 1.737 
log(1 + LaggedCaseChange) 0.209* 0.361* -1.338 0.132 
 t = 1.919 t = 1.857 t = -0.651 t = 0.306 
log(1 + Fiscal_measures) -0.029** -0.060** -0.0001 -0.021 
 t = -2.099 t = -2.124 t = -0.001 t = -0.530 
CountryGermany 2.580*** 2.084*** 3.487*** 2.759*** 
 t = 9.523 t = 3.648 t = 3.565 t = 5.790 
CountryItaly -16.874*** -14.818*** -22.128*** -18.446*** 
 t = -11.408 t = -6.582 t = -3.762 t = -5.727 
CountryNorway 6.196*** 5.230*** 8.549*** 6.725*** 
 t = 10.701 t = 5.113 t = 3.231 t = 5.312 
CountrySpain -8.544*** -7.491*** -11.131*** -9.298*** 
 t = -12.141 t = -6.666 t = -3.848 t = -5.872 
CountrySweden 5.859*** 4.989*** 8.092*** 6.406*** 
 t = 10.729 t = 5.589 t = 3.142 t = 5.456 
Effectiveness:SectorMobile 
Telecommunications 
-0.053*** -0.040*** -0.340 -0.087 
t = -5.325 t = -3.090 t = -0.990 t = -1.580 
Effectiveness:StringencyScaled 0.026*** 0.040** -0.273 -0.036 
 t = 2.896 t = 2.564 t = -0.683 t = -0.471 
SectorMobile Telecommunications: 
StringencyScaled 
3.159*** 4.562*** -45.693 -5.782 
t = 3.670 t = 2.990 t = -0.773 t = -0.563 
Effectiveness:EconomicScaled -0.031*** -0.028 -0.046 0.010 
 t = -3.526 t = -1.236 t = -0.942 t = 0.376 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
SectorMobile Telecommunications: 
EconomicScaled 
-2.668*** -1.991 0.156 3.275 
t = -3.407 t = -0.703 t = 0.029 t = 0.833 
Effectiveness:Import_change_previous 0.006 -0.025 -0.096 -0.039* 
 t = 0.582 t = -0.788 t = -0.615 t = -1.822 
Effectiveness: 
log(1 + LaggedCaseChange) 
-0.003* -0.004* 0.015 -0.001 
t = -1.956 t = -1.799 t = 0.649 t = -0.314 
SectorMobile Telecommunications: 
VaccinationScaled 
-1.703*** -2.107*** 6.470 0.179 
t = -3.137 t = -2.787 t = 0.627 t = 0.067 
Effectiveness:log(1 + HealthInvest) -0.001* -0.001 -0.001 0.001 
 t = -1.895 t = -0.443 t = -0.553 t = 0.481 
Effectiveness:log(1 + Fiscal_measures) 0.0004** 0.001** -0.0003 0.0002 
 t = 2.388 t = 2.149 t = -0.170 t = 0.278 
CountryGermany:ScaledMarketCap 2.100*** 2.106*** 2.218*** 2.242*** 
 t = 24.166 t = 22.775 t = 15.413 t = 21.865 
CountryItaly:ScaledMarketCap -11.406*** -10.738*** -14.100** -13.867*** 
 t = -13.101 t = -3.805 t = -2.267 t = -4.718 
CountrySpain:ScaledMarketCap 0.654*** 0.690*** 0.301 0.440 
 t = 9.380 t = 3.894 t = 0.420 t = 1.158 
CountryUnited Kingdom: 
ScaledMarketCap 
1.728*** 1.709*** 2.023*** 1.950*** 
t = 8.797 t = 6.384 t = 5.142 t = 8.687 
Effectiveness:SectorMobile 
Telecommunications:StringencyScaled 
-0.038*** -0.058*** 0.549 0.076 
t = -3.423 t = -2.644 t = 0.756 t = 0.576 
Effectiveness:SectorMobile 
Telecommunications:EconomicScaled 
0.034*** 0.028 -0.011 -0.039 
t = 3.168 t = 0.707 t = -0.141 t = -0.768 
Effectiveness:SectorMobile 
Telecommunications:VaccinationScaled 
0.019*** 0.024*** -0.078 -0.004 
t = 2.916 t = 2.649 t = -0.633 t = -0.119 
Observations 8,425 8,425 7,466 7,466 
R2 0.563 0.528 0.185 0.503 
Adjusted R2 0.545 0.508 0.149 0.481 




Regression results including all companies where revenue information is available 
Table A10. 19: First stage regression output including all companies where revenue 
information is available – Telecommunications 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.001*** 0.001*** 
 t = -6.154 t = 3.807 
EconomicScaled -1.453*  
 t = -1.662  
CaseChange_2weeks 0.003*  
 t = 1.749  
StringencyScaled  -3.101*** 
  t = -2.645 
GDPprevious  -3.179** 
  t = -2.191 
log(1 + LaggedCaseChange) 0.165*** 0.420*** 
 t = 2.631 t = 3.546 
Effectiveness:EconomicScaled 0.022**  
 t = 2.277  
Effectiveness:CaseChange_2weeks -0.00003*  
 t = -1.670  
Effectiveness:StringencyScaled  0.047*** 
  t = 3.494 
Effectiveness:GDPprevious  0.030* 
  t = 1.713 
Effectiveness:log(1 + LaggedCaseChange) -0.001* -0.005*** 
 t = -1.810 t = -3.502 
Observations 6,218 7,017 
R2 0.713 0.770 
Adjusted R2 0.712 0.769 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 17.258 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 70.206 
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Table A10. 20: Final regression output including all companies where revenue information is 
available – Telecommunications 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness -0.813*** -0.737*** -0.873** -0.981*** 
 t = -4.433 t = -3.844 t = -2.321 t = -4.013 
SectorMobile Telecommunications 19.631* 9.196 72.673 28.723** 
 t = 1.787 t = 0.519 t = 0.670 t = 1.981 
StringencyScaled -1.843*** -3.280** 1.301 -1.535 
 t = -3.460 t = -2.475 t = 0.052 t = -0.319 
EconomicScaled 1.537* 1.681 1.333 1.603 
 t = 1.885 t = 0.827 t = 0.356 t = 0.484 
log(1 + LaggedCaseChange) 0.236 0.346* 0.108 0.197 
 t = 1.493 t = 1.726 t = 0.061 t = 0.490 
CountryGermany 4.449*** 4.038*** 4.849*** 5.208*** 
 t = 13.629 t = 7.888 t = 4.359 t = 5.806 
CountryItaly -16.620*** -15.103*** -18.196*** -19.907*** 
 t = -4.233 t = -3.683 t = -2.909 t = -3.754 
CountryNorway 6.996*** 5.732*** 8.219** 8.906*** 
 t = 7.272 t = 4.944 t = 2.503 t = 3.948 
CountrySweden 6.565*** 5.359*** 7.740** 8.379*** 
 t = 6.250 t = 4.389 t = 2.387 t = 3.893 
ScaledMarketCap -1.916** -1.916** -2.138** -2.138** 
 t = -2.071 t = -2.071 t = -2.270 t = -2.270 
Effectiveness:SectorMobile 
Telecommunications 
-0.213* -0.099 -0.791 -0.316** 
t = -1.808 t = -0.517 t = -0.673 t = -1.994 
Effectiveness:StringencyScaled 0.023*** 0.044** -0.019 0.020 
 t = 3.522 t = 2.452 t = -0.070 t = 0.366 
SectorMobile Telecommunications: 
StringencyScaled 
2.773*** 4.738*** -91.076 -1.383 
t = 4.284 t = 2.810 t = -0.501 t = -0.236 
Effectiveness:EconomicScaled -0.019** -0.025 -0.016 -0.017 
 t = -2.131 t = -1.113 t = -0.397 t = -0.470 
SectorMobile Telecommunications: 
VaccinationScaled 
-0.863 -1.878* 6.917 0.346 
t = -1.515 t = -1.883 t = 0.404 t = 0.274 
CountryItaly:ScaledMarketCap -45.514* -22.460 -50.501 -66.243** 
 t = -1.714 t = -0.525 t = -0.966 t = -2.024 
CountryNorway:ScaledMarketCap 2.686*** 2.686*** 2.882*** 2.882*** 
 t = 6.439 t = 6.439 t = 6.783 t = 6.783 
CountrySweden:ScaledMarketCap 2.253* 2.253* 2.427** 2.427** 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = 1.875 t = 1.875 t = 1.983 t = 1.983 
CountryGermany:RevHomeCountry -1.799*** -1.799*** -1.905*** -1.905*** 
 t = -3.669 t = -3.669 t = -3.743 t = -3.743 
CountrySpain:RevHomeCountry -23.722 -9.194 -31.802 -36.428* 
 t = -1.299 t = -0.327 t = -0.875 t = -1.649 
Effectiveness:SectorMobile 
Telecommunications:StringencyScaled 
-0.031*** -0.061** 0.993 0.031 
t = -3.933 t = -2.397 t = 0.505 t = 0.401 
Effectiveness:SectorMobile 
Telecommunications:VaccinationScaled 
0.008 0.022* -0.079 -0.008 
t = 1.174 t = 1.708 t = -0.422 t = -0.501 
Observations 7,017 7,017 6,218 6,218 
R2 0.702 0.664 0.059 0.649 
Adjusted R2 0.687 0.647 0.011 0.631 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
Appendix 10.6 Results for Utilities 
Regression results including all companies in the sample 
Table A10. 21: First stage regression output including all companies in the sample – Utilities 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0003*** 0.001*** 
 t = -4.501 t = 5.691 
EconomicScaled -1.030***  
 t = -3.744  
CaseChange_2weeks 0.004***  
 t = 7.298  
StringencyScaled  -1.461*** 
  t = -2.711 
GDPprevious  -1.599* 
  t = -1.841 
Import_change_previous -2.373*** 4.622*** 
 t = -5.084 t = 10.387 
log(1 + LaggedCaseChange) 0.071*** 0.371*** 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
 t = 2.959 t = 5.791 
log(1 + HealthInvest) -0.016 -0.158*** 
 t = -1.025 t = -4.032 
Effectiveness:EconomicScaled 0.017***  
 t = 5.601  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -7.093  
SectorGas, Water and Multiutilities: 
CaseChange_2weeks 
-0.002*  
t = -1.916  
Effectiveness:StringencyScaled  0.025*** 
  t = 3.902 
Effectiveness:Import_change_previous 0.023*** -0.055*** 
 t = 4.349 t = -9.706 
Effectiveness:log(1 + LaggedCaseChange) -0.0002 -0.004*** 
 t = -0.788 t = -5.676 
Effectiveness:VaccinationScaled 0.004** -0.005** 
 t = 2.222 t = -1.991 
Effectiveness:log(1 + HealthInvest) 0.0003 0.001*** 
 t = 1.308 t = 3.242 
SectorGas, Water and Multiutilities: 
log(1 + HealthInvest) 
0.004 0.076* 
t = 0.163 t = 1.664 
Effectiveness:SectorGas, Water and Multiutilities: 
CaseChange_2weeks 
0.00002*  
t = 1.918  
Effectiveness:SectorGas, Water and Multiutilities: 
log(1 + HealthInvest) 
-0.00003 -0.001* 
t = -0.107 t = -1.737 
Observations 13,731 15,452 
R2 0.685 0.746 
Adjusted R2 0.683 0.745 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 148.28 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 66.58 
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Table A10. 22: Final regression output including all companies in the sample – Utilities 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
StringencyScaled -0.551 -0.359 -7.395* -2.120 
 t = -1.408 t = -0.671 t = -1.883 t = -1.458 
EconomicScaled 0.512 0.259 0.879 2.235 
 t = 0.947 t = 0.216 t = 1.171 t = 1.397 
log(1 + LaggedCaseChange) -0.083** -0.082 0.268 -0.076 
 t = -1.964 t = -0.727 t = 1.278 t = -0.525 
CountryFrance 0.229** 0.227** 0.262** 0.274** 
 t = 2.234 t = 2.097 t = 2.248 t = 2.228 
CountryItaly 0.501* 0.509 0.714** 0.746** 
 t = 1.911 t = 1.613 t = 2.281 t = 2.199 
CountrySweden -0.399** -0.395** -0.450** -0.499** 
 t = -2.308 t = -1.983 t = -2.082 t = -2.413 
Effectiveness:StringencyScaled 0.008 0.005 0.085* 0.030* 
 t = 1.371 t = 0.662 t = 1.868 t = 1.817 
SectorGas, Water and Multiutilities: 
StringencyScaled 
1.909*** 1.494** 7.659* 3.853** 
t = 2.724 t = 2.346 t = 1.688 t = 2.074 
Effectiveness:EconomicScaled -0.010 -0.007 -0.014 -0.030* 
 t = -1.457 t = -0.565 t = -1.526 t = -1.666 
SectorGas, Water and Multiutilities: 
EconomicScaled 
-2.263*** -1.824*** -2.150*** -2.896*** 
t = -3.000 t = -2.583 t = -2.623 t = -2.922 
Effectiveness: 
log(1 + LaggedCaseChange) 
0.001* 0.001 -0.003 0.001 
t = 1.857 t = 0.696 t = -1.203 t = 0.549 
SectorGas, Water and Multiutilities: 
log(1 + HealthInvest) 
-0.091* -0.073 -0.145* -0.155* 
t = -1.874 t = -1.232 t = -1.877 t = -1.864 
CountryFrance:ScaledMarketCap -0.920** -0.934** -0.983** -0.984** 
 t = -2.117 t = -2.121 t = -2.064 t = -2.078 
CountrySweden:ScaledMarketCap 186.976*** 186.969*** 203.853*** 203.855*** 
 t = 563.707 t = 558.233 t = 555.113 t = 559.360 
Effectiveness:SectorGas, Water and 
Multiutilities:StringencyScaled 
-0.025*** -0.019** -0.090* -0.050** 
t = -2.609 t = -2.333 t = -1.651 t = -2.105 
Effectiveness:SectorGas, Water and 
Multiutilities:EconomicScaled 
0.029*** 0.023** 0.028*** 0.037*** 
t = 2.776 t = 2.509 t = 2.667 t = 2.819 
Effectiveness:SectorGas, Water and 
Multiutilities:log(1 + HealthInvest) 
0.001** 0.001 0.002* 0.002* 
t = 2.008 t = 1.364 t = 1.902 t = 1.887 
Effectiveness:SectorGas, Water and 
Multiutilities:log(1 + Fiscal_measures) 
-0.0002* -0.0002 0.0001 -0.0001 
t = -1.742 t = -1.039 t = 0.257 t = -0.249 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Observations 15,452 15,452 13,731 13,731 
R2 0.328 0.326 0.291 0.330 
Adjusted R2 0.313 0.311 0.275 0.314 
Note: *p<0.1, **p<0.05, ***p<0.01 
Regression results including all companies where revenue information is available 
Table A10. 23: First stage regression output including all companies where revenue 
information is available – Utilities 
 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
Time -0.0004*** 0.001*** 
 t = -4.046 t = 4.836 
EconomicScaled -1.094***  
 t = -3.607  
CaseChange_2weeks 0.004***  
 t = 6.422  
StringencyScaled  -2.086*** 
  t = -5.002 
GDPprevious  -2.903*** 
  t = -2.982 
Import_change_previous -2.311*** 4.436*** 
 t = -4.440 t = 7.417 
log(1 + LaggedCaseChange) 0.059*** 0.462*** 
 t = 2.655 t = 9.072 
log(1 + HealthInvest) -0.035** -0.112*** 
 t = -2.436 t = -3.503 
log(1 + Fiskal_measures) 0.021** -0.050*** 
 t = 2.130 t = -7.801 
Effectiveness:EconomicScaled 0.017***  
 t = 5.273  
Effectiveness:CaseChange_2weeks -0.00004***  
 t = -6.253  
SectorGas, Water and Multiutilities: 
CaseChange_2weeks 
-0.002*  
t = -1.830  
Effectiveness:StringencyScaled  0.033*** 
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 Dependent variable: 
 StringencyScaled EconomicScaled 
 (1) (2) 
  t = 6.472 
Effectiveness:GDPprevious  0.026** 
  t = 1.971 
Effectiveness:Import_change_previous 0.023*** -0.053*** 
 t = 3.924 t = -6.799 
Effectiveness:log(1 + LaggedCaseChange) -0.00002 -0.005*** 
 t = -0.089 t = -9.016 
SectorGas, Water and Multiutilities: 
log(1 + LaggedCaseChange) 
0.076** -0.142 
t = 1.966 t = -1.137 
Effectiveness:VaccinationScaled 0.004* -0.003 
 t = 1.746 t = -1.136 
Effectiveness:log(1 + HealthInvest) 0.001*** 0.001** 
 t = 2.617 t = 2.443 
Effectiveness:log(1 + Fiscal_measures) -0.0003* 0.001*** 
 t = -1.878 t = 7.697 
Effectiveness:SectorGas, Water and Multiutilities: 
CaseChange_2weeks 
0.00002*  
t = 1.835  
Effectiveness:SectorGas, Water and Multiutilities: 
log(1 + LaggedCaseChange) 
-0.001** 0.002 
t = -2.051 t = 1.238 
Observations 10,342 11,646 
R2 0.697 0.757 
Adjusted R2 0.695 0.755 
Note: *p<0.1, **p<0.05, ***p<0.01 
F-statistic for CaseChange_2weeks as an instrument for StringencyScaled: 
𝐹 = 92.061 
F-statistic for GDPprevious as an instrument for EconomicScaled: 
𝐹 = 140.51 
Table A10. 24: Final regression output including all companies where revenue information is 
available – Utilities 
 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
SectorGas, Water and Multiutilities -0.991 -1.094 -4.707* -1.808 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
 t = -1.605 t = -1.475 t = -1.810 t = -1.490 
StringencyScaled -0.717 -0.940 -8.365 -1.826 
 t = -1.616 t = -1.244 t = -1.536 t = -1.408 
EconomicScaled 1.343** 2.138* 2.410** 4.643* 
 t = 2.144 t = 1.724 t = 2.567 t = 1.876 
log(1 + LaggedCaseChange) -0.126*** -0.184* 0.241 -0.217 
 t = -2.642 t = -1.726 t = 0.818 t = -1.532 
CountryGermany 2.303* 2.360** 2.421* 2.405* 
 t = 1.945 t = 1.970 t = 1.804 t = 1.773 
Effectiveness:SectorGas, Water and 
Multiutilities 
0.013* 0.014 0.054* 0.022 
t = 1.741 t = 1.555 t = 1.852 t = 1.590 
Effectiveness:StringencyScaled 0.012* 0.015 0.104 0.035** 
 t = 1.929 t = 1.386 t = 1.597 t = 1.986 
SectorGas, Water and Multiutilities: 
StringencyScaled 
2.095*** 2.014** 9.049 4.387** 
t = 3.699 t = 2.392 t = 1.596 t = 2.441 
Effectiveness:EconomicScaled -0.021*** -0.028* -0.034*** -0.059** 
 t = -2.590 t = -1.931 t = -2.751 t = -2.031 
SectorGas, Water and Multiutilities: 
EconomicScaled 
-2.781*** -2.520*** -2.482*** -3.574** 
t = -4.125 t = -2.721 t = -3.038 t = -2.273 
Effectiveness: 
log(1 + LaggedCaseChange) 
0.001** 0.002 -0.003 0.002 
t = 2.265 t = 1.611 t = -0.778 t = 1.527 
SectorGas, Water and Multiutilities: 
log(1 + HealthInvest) 
-0.105* -0.102 -0.196* -0.213* 
t = -1.958 t = -1.604 t = -1.816 t = -1.765 
CountryFrance:ScaledMarketCap -2.963* -2.950* -3.220* -3.232* 
 t = -1.840 t = -1.822 t = -1.770 t = -1.775 
CountryGermany:ScaledMarketCap -3.541** -3.616** -3.821* -3.707* 
 t = -2.002 t = -2.030 t = -1.915 t = -1.827 
CountrySweden:ScaledMarketCap 184.747*** 184.756*** 201.413*** 201.403*** 
 t = 114.225 t = 113.828 t = 110.321 t = 110.314 
CountryGermany:RevHomeCountry -2.069** -2.071** -2.251** -2.247** 
 t = -2.039 t = -2.042 t = -1.972 t = -1.968 
Effectiveness:SectorGas, Water and 
Multiutilities:StringencyScaled 
-0.030*** -0.028** -0.108 -0.057** 
t = -3.785 t = -2.423 t = -1.595 t = -2.400 
Effectiveness:SectorGas, Water and 
Multiutilities:EconomicScaled 
0.036*** 0.033*** 0.033*** 0.046** 
t = 4.049 t = 2.603 t = 2.931 t = 2.221 
Effectiveness:SectorGas, Water and 
Multiutilities:Import_change_previous 
-0.006 -0.003 -0.046 -0.025* 
t = -0.639 t = -0.291 t = -1.489 t = -1.673 
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 Dependent variable: 
 log(scaledpx) 
 (1) (2) (3) (4) 
Effectiveness:SectorGas, Water and 
Multiutilities:log(1 + HealthInvest) 
0.002** 0.002* 0.003* 0.003* 
t = 2.145 t = 1.776 t = 1.860 t = 1.820 
Effectiveness:SectorGas, Water and 
Multiutilities:log(1 + Fiscal_measures) 
-0.0002* -0.0002 -0.0001 -0.0003 
t = -1.848 t = -1.113 t = -0.632 t = -0.880 
Observations 11,646 11,646 10,342 10,342 
R2 0.494 0.488 0.462 0.482 
Adjusted R2 0.479 0.473 0.445 0.465 
Note: *p<0.1, **p<0.05, ***p<0.01 
 
